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Abstract 
Persistent physical symptoms for which there is no clear physiological 
pathology can present problems for clinical practice in that they do not fit the 
biomedical model. Biopsychosocial models of persistent physical symptoms describe 
the interrelation of beliefs and behaviours which work to maintain symptoms, with 
early evidence implicating beliefs about the unacceptability of expressing and 
experiencing emotions in this model. The current thesis explored this in relation to 
irritable bowel syndrome (IBS) and fibromyalgia (FMS). 
Chapters Three, Four and Five describe online cross-sectional research in IBS 
and FMS which found support for a mediation model where the relationship between 
beliefs about the unacceptability of emotions and outcomes was serially mediated first 
by emotional suppression and then by affective distress. The relationship was not 
mediated by support-seeking. 
In Chapter Six a new measure of beliefs about sharing illness experiences was 
validated. This chapter demonstrated that the relationship between beliefs about 
sharing illness experiences and outcomes was mediated by support-seeking and by 
all-or-nothing behaviour in FMS. 
Based on the mediation models of Chapters Three, Four and Five, Chapter 
Seven measured variables of the model before and after treatment for FMS in the NHS, 
finding that beliefs about emotions changed during intervention, though these changes 
did not predict changes in outcomes. 
The final study in this thesis is presented in Chapter Eight. This study described 
a mixed methods single case series evaluating an intervention aimed at targeting 
beliefs about emotions and emotional suppression in IBS. Both quantitative and 
qualitative evidence suggests that changes in beliefs about emotions are beneficial to 
those with IBS. 
This thesis concluded that while many beliefs and behaviours may be part of a 
maintain cycle of persistent physical symptoms, beliefs about the unacceptability of 
emotions and emotional suppression should be included in complex biopsychosocial 
models of IBS and FMS. 
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1. Chapter One: Introduction 
The current thesis looks to explore psychological factors associated with 
persistent physical symptoms for which the aetiology is uncertain, within the context 
of a cognitive-behavioural framework. In particular, this thesis focuses on beliefs 
about expressing and experiencing emotions as well as emotional suppression. This 
will be examined by considering two conditions in which the symptoms are not fully 
understood by a medical model, namely irritable bowel syndrome (IBS) and 
fibromyalgia syndrome (FMS). These conditions are often termed ‘medically 
unexplained’, a notion that will be described in the first section of this thesis. The 
chapter will then discuss cognitive-behavioural models regarding these disorders. The 
current chapter will explore the existing evidence on negative affect and emotional 
suppression in the context of ironic processing theory (Wegner, 1994) to understand 
the roles of emotional suppression and beliefs about emotions in the maintenance of 
symptoms and quality of life in these disorders. Though evidence is limited, research 
on beliefs about emotions in conditions with persistent physical symptoms (where the 
medical explanation is unclear) is growing and is also discussed.  
 
1.1. Persistent Physical Symptoms 
General practitioners, when presented with a patient who describes their 
symptoms, see their primary role as uncovering any organic disease in attempts to 
explain and treat the patient’s symptoms (Sharpe, 2013). Cases which present 
symptoms that, after testing, appear to result from no known physiological pathology 
are considered to be ‘medically unexplained’. A meeting of an expert review group 
(NHS Scotland, 2014) developing a competency framework for working with people 
with ‘medically unexplained symptoms’ and long term health conditions, discussed 
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the issues in relation the terminology to describe medically unexplained symptoms. It 
has been suggested to use the term, ‘persistent physical symptoms’ which may be more 
effective in avoiding having these symptoms viewed solely as a psychiatric as opposed 
to being of medical concern.  
There are a number of conditions which present as multiple physical symptoms 
with uncertain aetiology. Examples of these include chronic fatigue syndrome (CFS), 
IBS and FMS. Psychological aspects of CFS are comparatively well-researched (Nijs 
et al., 2013; Hughes et al., 2016; Mallet, King & White, 2016; Kempke et al., 2015; 
Jameson, 2016), while possible psychological factors that may relate to the 
development or maintenance of IBS and FMS are less understood. Thus, the current 
thesis therefore focuses on the latter two conditions. 
 
1.1.1. A Cognitive Behavioural Model of Persistent Physical Symptoms 
Models have been proposed to explain the development and maintenance of 
persistent physical symptoms without a clear aetiology, including a Cognitive 
Behavioural Model of so-called ‘medically unexplained symptoms’ (Deary, Chalder 
and Sharpe, 2007), which uses Beck’s terminology of predisposing, precipitating and 
perpetuating factors (Beck, 1976 as cited in Deary, Chalder and Sharpe, 2007). It is 
proposed that these ‘three Ps’ work together in the maintenance and development of a 
disorder in a self-perpetuating cycle. 
With regards to predisposing factors, Deary and colleagues highlight genetics 
and early experience as possible precursors to persistent physical symptoms. In terms 
of genetics, they highlight evidence showing familial trends in persistent physical 
symptoms, though the authors acknowledge that this may just reflect the inheritability 
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of other psychological predisposing factors such as neuroticism and distress (Deary et 
al., 2007).  
Distress, in some cases may be the result of an early traumatic experience, thus 
it becomes evident that these social, biological and environmental factors are likely to 
work collectively in predisposing an individual to persistent physical symptoms. Both 
neuroticism, defined as a predisposition to negative affect, and distress have been 
found to be higher in people with persistent physical symptoms which are considered 
to be medically unexplained compared with other groups, and have relationships with 
outcomes of the condition. For example, Van Middendorp et al. (2008) used self-report 
questionnaires in 403 participants with FMS recruited from three hospitals in The 
Netherlands and compared these with 136 healthy control participants. Using the 
PANAS-X measure of positive and negative affect, they found that compared to 
controls, individuals with FMS report more fear, hostility, guilt and sadness and report 
less joviality and self-assurance (Cohen’s d ranging from .32 to .76). However, it is 
possible that this negative affect is a result of the pain and disability associated with 
FMS as opposed to being a disposition towards negative affect.  
However, Hazlett-Stevens, Craske, Mayer, Chang, & Naliboff (2003) found that 
participants with IBS (n=47) scored higher on Eysenck’s personality measure of 
neuroticism compared to people who do not have IBS (n=352). Similarly, a more 
recent study of participants with FMS (n=48) and rheumatic diseases (n=115) found 
that participants with FMS scored higher on measures of neuroticism (as well as 
agreeableness and openness) (Bucourt et al., 2016). Thus, given that personality traits 
(specifically neuroticism) are considered to be relatively stable over time (Berg & 
Johansson, 2014), one might argue that this disposition towards negative affect in the 
form of neuroticism may be a predisposing factor in this model. However, both 
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Hazlett-Steven et al.’s study in IBS and Bucourt et al.’s in FMS suffer from very 
unequal sample sizes which may influence the statistical power of the analysis.  
Thus, it is possible that neuroticism or a predisposition towards negative affect 
may play a role in the development of ‘medically unexplained symptoms’ as per 
Deary’s model, but in IBS and FMS in particular, the evidence could be stronger. 
Deary, Chalder and Sharpe (2007) describe factors which might act to perpetuate 
persistent physical symptoms, bringing attention to sensitisation of and attention to 
bodily sensations,  attributions and beliefs, and response to illness. It is these proposed 
perpetuating factors, which are targeted in cognitive-behavioural interventions in the 
hope that by dismantling some of the perpetuating factors the self-perpetuating cycle 
will discontinue.  Regarding perpetuating factors, previous research has tended to 
focus on illness beliefs (Lackner, Mesmer, Morley, Dowzer, & Hamilton, 2004; Moss-
Morris et al., 2002) in addition to response to illness and illness behaviours (Spence, 
Moss-Morris, & Chalder, 2005). Another aspect focussed on in this model is distress 
intolerance. Deary et al. (2007) posit that those with persistent physical symptoms 
with no clear medical explanation perceive symptoms as aversive which encourages 
maladaptive avoidant behaviours. Though evidence with a clear timeline which 
supports this idea is lacking, there is evidence of avoidance behaviours in persistent 
physical symptoms. For example, there is a wealth of research on the fear avoidance 
approach to pain (see section 1.1.3, page 25).  
This cognitive-behavioural model of persistent physical symptoms asserts that 
particular events can activate a self-perpetuating cycle, known as precipitating factors. 
The key precipitating factors highlighted by Deary et al. (2007) are life events, which 
have been found to precede CFS (Hatcher & House, 2003 as cited in Deary et al., 
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2007), FMS (Häuser, Kosseva, Üceyler, Klose, & Sommer, 2011) and IBS (Bradford 
et al., 2012).  
It is proposed that neurobiological changes in response to negative/adverse life 
events can result in later dysfunction resulting in persistent physical symptoms. With 
regards to IBS as an example, animal models have been proposed whereby perinatal 
stress such as maternal separation can result in stress-induced visceral hypersensitivity, 
increased defecation, dysfunction of intestinal mucous and increased hypothalamic-
pituitary-adrenal axis responses in adulthood. These neurobiological changes may 
therefore result in symptoms found in IBS (Bradford et al., 2012). Other models have 
argued a more psychological perspective, where psychological factors in response to 
a physiological trigger result in the disorder: For example illness beliefs and 
behaviours (in particular all-or-nothing behaviour) at the time of acute illness 
symptoms predict the onset of post-infectious IBS six months later (Spence et al., 
2005) (see section 1.1.2, page 22). Using this evidence, Spence and Moss-Morris 
therefore argued that, while there was a physiological trigger for the symptoms, 
behaviours, beliefs and emotions contribute to the maintenance of these symptoms 
over time.  
A similar model has been described by Salkovskis et al. (2016) which combines 
trans-diagnostic features of persistent physical symptoms generally with features of 
specific symptoms. Much of this model draws upon models of health anxiety, arguing 
that physical symptoms that are experienced result in an emotional response which is 
often severe. The authors argue that symptoms are triggered by a perception of change 
in one’s physical sensations (whether this physical sensation is genuinely deviant from 
normal or just perceived as such is irrelevant in this case). This physical sensation 
often results in increased vigilance to bodily sensations and is frequently negatively 
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appraised. These negative appraisals result in strong negative emotions which 
reinforce negative thinking so as to maintain a cycle. This cycle is then further 
maintained by subsequent responses to the negative appraisal of bodily sensations, 
which may be specific to particular diagnoses (such as all-or-nothing behaviour in 
IBS). Other responses highlighted in this model include avoidance of activity, mood 
changes, emotional avoidance/suppression and beliefs about emotions. Evidence on 
these factors is discussed later in this chapter. 
Using these models, research can identify possible perpetuating factors, such as 
particular beliefs, which might be targeted through well-established cognitive-
behavioural methods in order to break the self-perpetuating cycle and bring benefits 
to individuals living with persistent physical symptoms (Salkovskis et al., 2016). 
 
1.1.2. Irritable Bowel Syndrome 
IBS is a long term condition with uncertain aetiology, characterised by 
gastrointestinal symptoms such as abdominal pain, increased frequency in bowel 
movements, looser stools, mucus present in stools, feelings of incomplete evacuation 
and abdominal distension/bloating (Manning, Thompson, Heaton, & Morris, 1978). 
IBS costs around £200m in primary care settings perhaps due to the patient group 
being frequent attenders as well as the need for repeated testing to rule out other 
possible diagnoses (Reid, Wessley, Crayford, & Hotopf, 2002). 
There has been evidence for physiological factors related to the disorder, such 
as motility dysfunction, intestinal permeability and immune function (Malone, 2011) 
though the exact pathophysiology of the disorder still remains unexplained. One key 
theory in terms of a more physiological approach to IBS is the idea of visceral 
hypersensitivity, often based on evidence of lower abdominal pain thresholds in IBS 
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compared with other patient groups (Kanazawa, Hongo, & Fukudo, 2011). Despite 
this evidence on physiological explanations, there is also evidence that psychological 
factors contribute to the maintenance and development of the symptoms of IBS and 
thus more integrative models incorporating psychosocial factors are useful in 
understanding the disorder, especially when the medical model is currently 
unsuccessful in fully explaining and treating the disorder (Deary et al., 2007; Mayer, 
Chang, & Lembo, 1998; Naliboff, 2007).  
In a cognitive model of CFS Surawy, Hackmann,  Hawton & Sharpe (1995) 
propose that physical illness (coupled with psychosocial stress) can too be a 
precipitating factor by being physically and psychologically demanding of individuals. 
This fits with Spence and Moss-Morris’s cognitive behavioural model of IBS given 
that many cases of IBS occur following a bout of gastroenteritis (Spence & Moss-
Morris, 2007). Spence and Moss-Morris state that a disposition to negative affect 
found in IBS combined with high levels of perfectionism leads to a cycle of 
overexertion followed by forced rest upon encounter with gastroenteritis (coined ‘all-
or-nothing’ behaviour). This all-or-nothing behaviour works to perpetuate symptoms. 
Spence and Moss-Morris (2007) measured anxiety, depression, illness 
perceptions, perfectionism, perceived stress, somatization and behavioural response 
to illness in 620 participants with campylobacter gastroenteritis in a primary care 
setting. These variables were then evaluated as predictors of post-infectious IBS in 
this sample six months’ post-infection (n=49).  Although anxiety, stress, negative 
illness perceptions, limiting behaviour and all-or-nothing behaviour predicted the 
onset of IBS, perfectionism did not. This is contradictory to later evidence on post-
infectious CFS where perfectionism was a significant predictor (Moss-Morris, Spence, 
& Hou, 2011), suggesting a need to explore other persistent physical symptoms to 
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identify possible differences in predisposing factors. This prospective investigation 
supports the cognitive behavioural approach to understanding IBS by demonstrating 
a role of predisposing psychological factors in the development of post-infectious IBS. 
However, the study is limited by the small number of cases of IBS that developed, 
resulting in very unequal sample sizes between groups. 
One further model of IBS has proposed self-silencing as a maintaining factor in 
the disorder (Ali et al., 2000). Ali et al. recruited a sample of 50 participants with IBS 
(n=25) and inflammatory bowel disease (IBD) (n=25) from gastroenterology services 
across three hospitals. Along with measures of emotional, physical and sexual abuse, 
and self-blame, Ali et al. measured self-silencing, where self-silencing is the silencing 
of one’s thoughts or feelings in order to maintain stable interpersonal relationships 
(Jack, 1991). They found that participants with IBS scored higher than the ‘norm’ 
score for self-silencing in the female general population and that there was a 
significant difference between those with IBS and IBD on this measure. They 
proposed this may relate to worsened symptoms through increased levels of distress – 
though they found that depression was not related to any of their psychosocial 
variables. Participants with IBD did not score significantly differently from the norm. 
This finding suggests silencing one’s emotions to be an important construct that 
is specific to IBS and not another medically explained gastrointestinal disorder. 
However, after controlling for other psychosocial factors measured (self-blame, 
physical/sexual abuse and emotional abuse), the found differences were no longer 
significant. Thus, it is possible that the differences between the two conditions could 
be explained by differences in other psychosocial variables between the two groups. 
Additionally, they did not control for depression in this multivariate analysis which 
may have also explained the differences between groups. Further to this, the sample 
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(25 participants per group) is very small and perhaps not powerful enough to detect 
differences after controlling for multiple confounds. Thus, further research using a 
larger sample (which directly compares the two groups to each other and healthy 
controls and not to a ‘norm’ value) is needed to explore the role of self-silencing in 
IBS. 
In a systematic review and meta-analysis, medium to large effect sizes for 
changes in quality of life and symptom severity were found following psychological 
therapy, with no differences between treatment types (Altayar, Sharma, Prokop, Sood, 
& Murad, 2015). However, of the 15 randomised control trials included, most of the 
trials evaluated CBT, with the remainder evaluating psychoeducational, mind-body, 
psychodynamic and contingency management therapies. Thus, there is evidence (in 
particular for CBT) that psychological intervention is beneficial to individuals with 
IBS. 
According to a Cochrane review of 25 studies evaluating treatments for IBS the 
evidence on psychological treatments for IBS is in need of improved quality in order 
to truly evaluate the effects of treatment (Zijdenbos, de Wit, van der Heijden, Rubin, 
& Quartero, 2009). Zijdenbos et al. conclude that psychological interventions show 
only a slight benefit to those with IBS over usual care and waitlist controls. However, 
the clinical significance is disputed. Perhaps evidence exploring possible mechanisms 
involved in the maintenance and development of IBS would aid in improving the 
efficacy of treatment through more targeted interventions.  
 
1.1.3. Fibromyalgia 
FMS is another condition that is not currently fully explained by the medical 
model and is characterised by widespread pain, fatigue, sleep disturbance and tender 
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points across the body (Wolfe et al., 1990). Its prevalence varies somewhat depending 
on the criteria used with prevalence ranging from 1.7 to 5.4% (Jones et al., 2015).  
Research into a cognitive-behavioural model of FMS is somewhat limited 
compared to that in IBS. In reference to Deary et al.’s (2007) model of ‘medically 
unexplained symptoms’, there is evidence that adverse life events (such as physical, 
emotional or sexual abuse or trauma) are a predisposing factor in FMS (Häuser et al., 
2011). Häuser et al.’s systematic review and meta-analysis found that having 
experienced abuse predicted whether a person had FMS. However this was conducted 
across 18 cross-sectional studies of low quality. Prospective designs testing abuse as 
a predictor of FMS would support the role of abuse as a predisposing factor further.  
Possible routes through which these stressful events predispose and/or maintain 
the disorder have been suggested though the evidence is inconsistent and not specific 
to FMS samples (Häuser et al., 2011). These potential mechanisms revolve around 
hypothalamic-pituitary-adrenal axis dysfunction with evidence for elevated 
corticotrophin-releasing factor concentrations in cerebrospinal fluid and increased 
cortisol levels (Zhang & Yu, 1998; McLean et al., 2006; as cited in Häuser et al., 2011). 
These neurobiological responses to stress may therefore be one way in which stress 
results in problematic symptoms and disability. 
Using the theories, ideas and evidence of the transition from acute to chronic 
pain, van Koulil and colleagues highlight a more integrative biopsychosocial model 
of FMS (van Koulil et al., 2007). They draw attention to three systems involved in 
response to pain; behavioural, cognitive and bodily reactions to pain. A particular 
behavioural response to pain which has been well-evidenced is avoidance behaviour, 
as part of a fear-avoidance model of chronic pain (Lethem, Slade, Troup, & Bentley, 
1983). Under this model, individuals with pain experience a fear of pain recurrence 
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and as such avoid activities which, in their view, might trigger pain. This avoidance 
behaviour may then be reinforced by cognitions regarding beliefs about which 
activities will cause pain. Through conditioning, this behaviour is reinforced in that 
the avoidance of pain is attributed to successful avoidance of activity. Furthermore, 
reduction in activity leads to deconditioning of muscles and increased pain, thus 
forming a maintaining cycle.  
This fear-avoidance relationship is further exacerbated by catastrophizing 
beliefs. Individuals who have inflated interpretations and expectations of pain exhibit 
more pain-related fear (Crombez, Vlaeyen, Heuts, & Lysens, 1999), which may then 
feed into this fear-avoidance relationship. Furthermore, increased fear of pain is 
related to hyper-vigilance to pain and increased attention to bodily sensations, which 
may encourage avoidance behaviours by increasing perceptions of bodily discomfort 
and pain in the face of activity (McCracken & Gross, 1993). Evidence from chronic 
back pain patients shows that safety-seeking behaviours are greater in those with 
health anxiety and that safety-seeking behaviours are related to catastrophizing (Tang 
et al., 2007). This evidence demonstrates a clear role of avoidance in chronic pain 
conditions. 
Along with activity avoidance, there has been growing evidence supporting a 
role for emotional avoidance and suppression in FMS, finding correlations between 
suppression and outcomes in FMS (van Middendorp et al., 2008) through emotional 
expression interventions (Broderick, Junghaenel, & Schwartz, 2005; Gillis, Lumley, 
Mosley-Williams, Leisen, & Roehrs, 2006) and through experimental pain procedures 
(Sullivan, Rouse, & Bishop, 1997). Thus, based on the existing biopsychosocial 
models of FMS and models of pain more generally, it appears that emotional 
avoidance may also be part of a maintaining cycle of FMS.  
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1.1.4. Summary 
Existing literature on persistent physical symptoms (in particular IBS and FMS) 
has explored a multitude of psychological and physiological factors that appear to be 
associated with the onset and maintenance of the symptoms. While these 
physiological factors are not yet fully understood, the evidence to date suggests that 
psychological factors play a part in at least the maintenance, if not also the 
development, of symptoms.  
Though it is likely that some of the psychological variables explored in this 
evidence may play a role in other physical conditions – including those with medical 
explanations (Salkovskis et al., 2016)– the lack of understanding surrounding the 
aetiology of IBS and FMS and the need for improved treatments warrants an 
exploration into possible psychological factors which may be involved in these two 
conditions. The research to date, as discussed above, suggests a potential role of 
emotional suppression in the presentation of individuals with persistent physical 
symptoms.  
 
1.2. Emotional Suppression 
Before understanding the effects of the suppression of emotions, one must 
understand why the presence of emotions is necessary. There are a number of 
models which attempt to explain why we experience emotions.  
From an evolutionary standpoint, emotions can be seen as adaptive in that they 
can be an indicator of a threat and may then facilitate an adaptive response to that 
threat (Shariff & Tracy, 2011). For example, the experience of fear may alert the 
individual to a threat which may result in the behavioural response of avoidance – 
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which would be adaptive (at least in the short term). Similarly, the experience of 
disgust can alert one to a noxious substance which may pose a threat. The facial 
expression related to disgust then restricts the intake of air which is an adaptive 
automatic response to a potentially noxious environment (Shariff & Tracy, 2011). 
Emotions may also inform the prioritising and maintenance of multiple goals 
occurring at the same time (Oatley & Johnson-laird, 1987). 
Focussing on distress in particular, the Affect Alarm model of control argues 
that distress can bring attention to the presence of conflict. This can then motivate 
behaviour aimed at reducing the distress, including attempts to resolve the conflict 
itself (Oatley & Johnson-laird, 1987). This is then moderated by acceptance of 
emotions as the acceptance of emotion enables the individual to orient towards the 
distressing conflict and find a resolution. By directly address the cause of the distress 
as opposed to avoiding or suppressing this emotion, the cause of conflict can be 
resolved which can thereby reduce distress. Those who are not accepting of emotions 
will find addressing the cause of the distress more difficult, highlighting one way in 
which the suppression or avoidance of an emotion can be maladaptive. 
There are a number of ways in which the suppression of an emotion can be 
considered maladaptive. The suppression of emotion occurs after the emotion has 
already been experienced. Thus while other strategies (e.g. cognitive reappraisal – 
defined as a cognitive change where the perception of a potentially emotion-eliciting 
situation is seen in a new light that alters its emotional impact (Brockman, Ciarrochi, 
Parker, & Kashdan, 2017)) can reduce the experience of an emotion by being used in 
response to an emotional cue before the onset of the emotional experience, emotional 
suppression cannot reduce the experience of emotion, only the expression (John & 
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Gross, 2004). This therefore means those who suppress emotions still feel the 
emotions they do not want to experience. 
Furthermore, suppression, as opposed to cognitive reappraisal (largely 
considered a more adaptive form of emotion regulation (Brockman et al., 2017)) is 
cognitively demanding meaning that the suppression of emotion can result in 
cognitive impairment, such as impaired working memory (John & Gross, 2004).  
Thinking beyond internal consequences of emotional suppression, an individual 
who is externally emotionally suppressive is at a disadvantage socially. Firstly 
cognitive impairment is likely to affect social interaction. Secondly, the suppression 
of emotion can inhibit the development of emotionally close relationships through 
avoidant, strained and distracted behaviour, leaving the individual alienated (John & 
Gross, 2004).  
Through this array of mechanisms, emotional suppression can result in an 
increase in distress. Another theory of the consequences of internal suppression is 
ironic processing effects. 
 
1.2.1. Ironic Processing Effects 
Wegner’s theory of ironic processing suggests that suppressing thoughts can 
lead to an ironic increase in those thoughts when there is a high cognitive load (Wegner, 
1994). It was proposed that there are two cognitive processes which work in 
cooperation to provide successful mental control. The first of these two systems is a 
conscious and effortful operating process which intentionally searches for mental 
contents that pertain to the desired mental state. The second is an unconscious 
monitoring process which searches instead for mental contents which indicate that 
attempts to achieve the desired state have failed. The operating process brings to mind 
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thoughts and feelings that will lead to the desired mental state while the monitoring 
process checks that this process is effective and reactivates the operating process when 
it detects any signs of failure of mental control. This system can function successfully, 
however it comes under threat when there is a high cognitive load. By increasing one’s 
cognitive load, the operating process (which is more cognitively demanding and 
effortful than the monitoring process) can become limited such that when the 
monitoring process detects mental contents indicative of failure, the operating process 
is compromised in rectifying the failure. This can be compromised to such an extent 
where the monitoring system’s search for thoughts or feelings that are 
counterproductive to the desired state can be enough to bring such thoughts into the 
consciousness, thereby producing an ironic effect where these negative thoughts are 
experienced, despite efforts to suppress them. 
Dalgleish and colleagues applied Wegner’s theory to emotional suppression in 
people with high and low negative affect, under the assumption that high negative 
affect leads to a high cognitive load (Dalgleish, Yiend, Schweizer, & Dunn, 2009). 
Twenty-eight participants were grouped by high or low negative affect based on the 
Hospital Anxiety and Depression Scale (HADS), with participants scoring eight or 
higher on either the anxiety or depression subscale assigned to the high negative affect 
group. Participants completed an emotion regulation task in three different conditions. 
They were asked to think about distressing memories and write down their stream of 
consciousness. Participants in the no-instruction condition were asked to think about 
their distressing memory as vividly as possible and were instructed not to try to 
regulate their emotions in any way. In the suppression condition however, participants 
were asked this time to think of a different memory but to try to suppress their 
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emotions regarding this memory. In a third condition, the task was the same however 
participants were instructed to accentuate any emotions they felt.  
They found that participants with high negative affect showed an ironic increase 
in negative emotions when asked to suppress their emotions compared with the no 
instruction condition. Low negative affect participants were able to successfully 
regulate their emotions and did not show such ironic processing effects, instead, low-
negative affect participants showed a significant lowering of negative mood in the 
suppression condition compared with other conditions. Furthermore, it was found that 
HADS anxiety and depression scores are individually correlated with increases in 
negative mood in the suppression and experience conditions. 
 
Figure 1.1 Ironic processing effects in relation to emotional suppression 
 
Thus, there are two requisites for ironic processing effects in regards to emotion 
regulation. First is negative affect, which exerts a high cognitive load leading to a 
resulting failure of the operating process and second the presence of efforts to suppress 
one’s emotions (see Figure 1.1). Furthermore, the presence and recognition of 
negative affect is necessary in that the individual must experience an unpleasant 
emotion in order to desire to suppress it. 
Unpleasant 
emotion 
Negative 
affect 
High cognitive load 
Suppression 
Increased 
distress 
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Increased negative affect is well-evidenced in those with persistent physical 
symptoms, with some distress considered an expected or even healthy response to 
diagnosis (Moss-Morris, 2013). Research has shown higher levels of trait anxiety in 
students with IBS compared with healthy controls (Gick & Thompson, 1997). 
Furthermore, using the “negative affect” subscale of the Beck Depression Inventory, 
Kovács and Kovács (2007) found that patients with IBS and not those with 
inflammatory bowel disease scored significantly higher than healthy controls, a 
finding which mirrors the findings of Ali et al. (2000).  
van Middendorp and colleagues measured positive and negative affect in 
patients with FMS and found that compared with healthy controls, patients with FMS 
reported higher levels of negative affect (fear, hostility, guilt and sadness) and lower 
levels of positive affect (joviality and self-assurance) (van Middendorp et al., 2008).  
Thus, given the increased negative affect found in persistent physical symptoms, 
and that this negative affect can act as a high cognitive load resulting in ironic 
processing effects, it would appear that people with persistent physical symptoms may 
be more prone to ironic processing effects if they exert any efforts to suppress their 
emotions. Further to this, the presence of increased negative affect in persistent 
physical symptoms means there are undesirable emotions present that individuals may 
attempt to suppress. 
 
1.2.2. Emotional Suppression and Physical Symptoms 
The terms emotional suppression, emotional avoidance and emotional control 
(among others) are used differentially in research to refer to similar concepts. As the 
literature on emotion regulation grows, there is an increasing need to establish distinct 
definitions for these terminologies.  
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It should be noted that there is a distinction between ‘internal’ and ‘external’ 
emotional suppression. For the purpose of this thesis internal emotional suppression 
is defined as the avoidance of experiencing one’s emotions and external emotional 
suppression is the avoidance of expressing that emotion to others. Emotional 
suppression encompasses both of these. Different measures (including those in the 
current thesis) capture the cognitive strategy of avoiding experiencing one’s emotions 
to varying degrees.   
A separate, though related line of research has found alexithymic traits in 
individuals with persistent physical symptoms. Alexithymia is a personality trait 
characterised by difficulty regulating one’s emotions (including identifying, 
describing and expressing emotions) (Graeme, Taylor, Bagby, & James, 1999). There 
is a range of evidence, beyond the aims of this thesis, which argues that alexithymia 
is related to persistent physical symptoms, with specific studies in FMS (van 
Middendorp et al., 2008) and IBS (Phillips, Wright, & Kent, 2013) finding higher 
levels of alexithymic traits in these groups compared to healthy controls. Other similar 
approaches have explained the relationship between emotional suppression and 
clinical outcomes with regards to those with somatoform disorders (diagnosed 
primarily by the presence of physical symptoms in the absence of medical 
explanation) demonstrating impaired emotion regulation and instead attending to and 
reporting physical as opposed to psychological symptoms (Waller & Scheidt, 2006). 
While this line of research shows how emotion dysregulation more broadly might be 
related to persistent physical symptoms, the current thesis focussed on emotional 
suppression in particular and thus issues with the identification and description of 
emotions, though perhaps related, are beyond the scope of the current thesis. 
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In terms of Acceptance and Commitment Therapy (ACT) experiential avoidance 
is defined as an unwillingness to experience, and attempts to control or avoid 
negatively evaluated private thoughts, feelings and bodily sensations (Hayes, 1994 as 
cited in Kashdan, Barrios, Forsyth, & Steger, 2006). According to ACT models, 
experiential avoidance can in some cases be beneficial in the short-term however 
when applied rigidly and inflexibly it becomes problematic. Instead acceptance of 
undesirable experiences is encouraged (McCracken, 2011). Indeed, in a systematic 
review of ten randomised control trials of ACT interventions for chronic pain 
conditions, it was found that across seven studies with an inactive control group, ACT 
showed small to large improvements in a range of primary outcomes (including 
physical functioning and disease impact) (Hann & McCracken, 2014). In particular, 
two of the three studies which looked at FMS specifically and found improvements in 
both physical function (Wicksell et al., 2013 as cited in Hann & McCracken, 2014; 
Wicksell et al., 2013) and disease impact (Luciano et al., 2014; Wicksell et al., 2013 
as cited in Hann & McCracken, 2014; Wicksell et al., 2013). The third reviewed study 
investigating ACT intervention for FMS only examined changes in values (in relation 
to intimate relations and work) (Luciano et al., 2014). Though there were significant 
improvements in these measures, these were not maintained at follow-up and more 
evidence with comparisons to active control conditions is needed.  
Evidence on ACT in IBS is more limited with a recent systematic review finding 
no randomised control trial evaluating this particular intervention in IBS, despite 
having clearly defined search terms for ACT (Altayar et al., 2015). However it has 
been previously noted that the principles of ACT may well apply to those with IBS 
based on their style of emotional processing (Naliboff, Fresé, & Rapgay, 2008), even 
if this particular intervention has not been subject to a randomised control trial. 
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Evidence into emotional processing in IBS would therefore be useful to help build a 
rationale for further treatment options directed towards acceptance of emotion, such 
as ACT. 
This evidence supports the idea that encouraging acceptance (of emotions and 
of pain) and discouraging avoidance in participants with FMS can illicit benefits. 
However, with only a limited number of randomised control trials looking specifically 
at FMS, further exploration into the role of experiential avoidance in FMS is needed. 
Furthermore, research looking specifically at the avoidance and acceptance of 
emotions as opposed to experiences more generally (which would include physical 
symptoms such as pain) is warranted. 
The investigation of emotional suppression in clinical and health psychology 
has been growing. There has been research into the role of emotional suppression in 
anorexia nervosa with one study finding that participants with anorexia (n=40) and 
those with CFS (n=45) scored higher on measures of affect avoidance and self-
silencing compared to healthy controls (Hambrook et al., 2011). Similarly, in breast 
cancer patients (n=40) anger suppression predicted higher reports of symptoms 
(Schlatter & Cameron, 2010). With regards to psychological disorders, participants 
with anxiety or depression diagnoses (n=60) were found to be more suppressive than 
those without psychiatric diagnosis (n=30). While all of this evidence suggests that 
emotional suppression is of interest when researching persistent physical symptoms, 
these studies did not control for negative affect when comparing groups on measures 
of suppression. As such, it could be that those with physical symptoms may experience 
some negative affect as a result of their condition and this increase in negative affect 
may drive them to become more suppressive. The sample sizes of these studies are 
also generally very small. 
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Research into persistent physical symptoms has suggested that people who 
suffer from persistent physical symptoms might also be more likely to suppress their 
emotions. Using a sample of 403 women with FMS from The Netherlands, van 
Middendorp and colleagues measured emotional approach, emotional avoidance, 
affect intensity and symptomatology (van Middendorp et al., 2008). Emotional 
approach was defined to include emotional processing, cognitive reappraisal, 
emotional expression more generally and the expression of anger specifically. 
Emotional avoidance was measured to include emotional suppression and alexithymia. 
Compared to controls (women without FMS with no exclusion criteria for other 
disorders), participants with FMS showed significantly lower levels of emotional 
expression, higher levels of emotional suppression and more difficulty identifying and 
describing feelings.  
Findings regarding the role of emotional suppression in FMS have been  
mirrored in research looking at participants with IBS (Ali et al., 2000, see section 1.1.2, 
page 13), comparing patients with IBS to those with inflammatory bowel disorder 
(IBD) on the Silencing of the Self Scale (Jack & Dill, 1992). The research found that 
patients with IBS showed higher levels of self-silencing. However this self-silencing 
measure (also used in evidence on CFS (Hambrook et al., 2011)) incorporates not just 
emotionally suppressive tendencies but also motivations and beliefs pertaining to 
emotional suppression. It would therefore be useful to explore emotional beliefs and 
behaviour separately, fitting with a cognitive-behavioural approach to persistent 
physical symptoms. 
Consistent with findings on the role of emotional suppression in maintenance of 
symptoms, other researchers have focused on thought suppression. Based on evidence 
showing patients who catastrophize report more pain during pain experiments 
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(Heyneman, Fremouw, Gano, Kirkland, & Heiden, 1990), Sullivan and colleagues 
argue that this relationship is mediated by thought intrusions; patients who 
catastrophize during a pain experience will encounter more thought intrusions and this 
will result in more pain (Sullivan et al., 1997). They also argued that due to the higher 
level of thought intrusions, catastrophizers are more likely to engage in thought 
suppression. Seventy undergraduate participants were informed of an upcoming ice 
water immersion pain procedure and asked to write their on-going thoughts on paper 
for nine minutes. Half of the participants were instructed to suppress thoughts about 
the upcoming procedure. Following the thought recording task, participants then 
underwent the pain procedure. Through analysis of the thought records, Sullivan et al. 
found that participants in the suppression condition, compared to those in the control 
condition experienced more thought intrusions during the thought recording task and 
experienced more pain during the pain procedure.  
Their finding supports ironic processing theory (Wegner, 1994) in that those 
who attempted to suppress their thoughts experienced an ironic increase in those 
thoughts. Furthermore, Sullivan et al. demonstrate that suppressing thoughts about 
upcoming pain can result in the experience of more pain (Sullivan et al., 1997). Thus, 
is may be that those with more catastrophic beliefs are more inclined to suppress their 
fearful thoughts about pain. This may then in turn modulate the perception of pain. 
Once the frequency of thought intrusions was controlled for, there was no longer a 
significant difference in pain ratings between those who did and did not suppress their 
thoughts, suggesting thought intrusions might mediate the relationship between 
suppression and pain. This supports the notion that attempts to suppress a thought can 
result in an increase of that particular thought and that these intrusive thoughts are 
then related to the perception of pain. 
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More recent evidence conducted with participants who have CFS has 
demonstrated a role for emotional suppression in fatigue (Rimes, Ashcroft, Bryan, & 
Chalder, 2016). In a behavioural experiment, 80 participants with CFS and 80 healthy 
controls took part in a negative mood induction task involving watching a distressing 
film clip. Half of each patient group was instructed to suppress thoughts about how 
they feel and to hide how they feel. The other half of each patient group was instructed 
to regulate their emotions as they wish. Measuring sadness, anger and anxiety as 
outcomes revealed a main effect of patient group whereby participants with CFS were 
sadder than controls. For anger, there was a main effect of time where all participants 
were angrier after watching the clip. For sadness and anger, there were no interactions. 
For anxiety, there was a significant interaction in which both controls’ and patients’ 
anxiety increased after watching the video in the suppression condition demonstrating 
that the suppression of anxiety can result in an increase in that emotion. 
However, using a comparison condition of the participants’ choice in emotional 
regulation could be problematic. Previous research has reported increased beliefs 
about the unacceptability of the experience and expression of emotions in CFS (Rimes 
& Chalder, 2010) and therefore it might be that those in the CFS condition would 
choose to suppress more than healthy controls when given the choice. Asking 
participants in this condition which method of regulation they used revealed this to be 
true. This might explain the lack of significant findings in sadness and anger 
conditions. Measuring skin conductance response while watching the distressing clip 
revealed greater skin conductance in response to the clip in the CFS group, regardless 
of whether they suppressed their emotions. This increase in skin conductance found 
after watching the video clip was significantly related to fatigue, the primary symptom 
of CFS. 
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In addition, a main effect of condition was found whereby participants in the 
suppression condition had greater skin conductance responses regardless of patient 
group. This finding indicates increased physiological arousal in response to negative 
mood induction when emotional suppression is exercised. While no group by 
condition by time interaction was found, this could again be due to the high levels of 
suppression in the free regulation condition in the CFS group in that for healthy 
controls (who experience less negative affect and therefore reduced cognitive load) 
the suppression condition had little effect while for the CFS participants (who have 
greater negative affect and higher cognitive load) this suppression may have resulted 
in an ironic increase in emotion. However, since the free-regulation condition for the 
CFS participants may have still involved the suppression of emotion, no interaction 
would be detected. 
Thus, given that those with persistent physical symptoms exhibit both increased 
levels of negative affect and higher rates of emotional suppression, it seems possible 
that such individuals might be prone to ironic processing effects whereby they 
experience an unpleasant emotion, attempt to suppress this emotion and consequently 
experience an ironic increase in that unpleasant emotion. Furthermore, it could be that 
individuals with persistent physical symptoms who are emotionally suppressive may 
also avoid asking for help or avoid certain social situations, which may further 
maintain the cycle of distress and symptoms (Rimes & Chalder, 2010). These indirect 
relationships warrant further investigation. 
The study of emotional suppression is particularly important in physical 
symptoms for which there is no clear physiological explanation due to the role of 
stigma. In particular, it has been noted that those with long term conditions perceive 
social stigma surrounding their disorder, with a distinct role of secrecy in disorders 
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where pathophysiology is uncertain such as CFS and FMS (McInnis, McQuaid, 
Bombay, Matheson & Anisman, 2015).  In reference to FMS, Griffith and Ryan (2010) 
have argued that a person with FMS ‘feels obligated to act as though normal before 
others, despite high internal distress, since revealing one’s authentic suffering could 
risk judgement, rejection, or punishment’ (p. 178). Further evidence that secrecy in 
FMS and in CFS is related to reduced social support (McInnis, McQuaid, Bombay, 
Matheson & Anisman, 2015) suggests a need to test beliefs about sharing illness 
experience in relation to support-seeking and indeed the impact on a person’s life.  
While the study of the relationship between disclosure and social support is 
limited in FMS and IBS, a study of 500 clients of a mental health outpatient service 
in The Netherlands showed that perceived stigmatisation was related negatively with 
disclosure and perceived social support, while disclosure was related positively with 
social support. It is worth noting here however that the coefficients were small 
(r=.24-.40) suggesting that stigma and disclosure may only explain a small amount of 
the variance in social support. Additionally, the study is based on correlations so the 
causal direction cannot be inferred: It may be that disclosure results in increased social 
support, or it could be that having a good support network better facilitates disclosure 
(Bos, Kanner, Muris, Janssen, & Mayer, 2009). However in an online study of 451 
healthy individuals, support-seeking was not a significant mediator of the relationship 
between beliefs that emotional expression is unacceptable and three outcomes 
(depression, anxiety and fatigue) (Sydenham, Beardwood, & Rimes, 2016), which is 
unexpected and warrants further investigation in other samples with persistent 
physical symptoms.  
To surmise, the suppression of unpleasant emotions can result in a counter-
intuitive increase in psychological distress. The above evidence suggests that those 
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with IBS and FMS may be more prone to these ironic processing effects through their 
higher levels of negative affect and their possible higher levels of emotional 
suppression. Thus, the impact of this increased distress on the individual and their 
condition warrants further discussion. 
 
1.3. Distress is related to Poor Health-Related Outcomes 
Research into long term conditions has demonstrated a clear link between 
distress and health related outcomes. The extensive research into biopsychosocial 
models of pain has demonstrated how fear of pain is related to feeling more pain 
through increased attention, hypervigilance to bodily sensations, deconditioning and 
increased bodily tension (van Koulil et al., 2007), with experimental (Lee, Watson, & 
Frey-Law, 2013) and prospective research designs (Montgomery, Schnur, Erblich, 
Diefenbach, & Bovbjerg, 2010) providing support for this. Thus, there is clearly a role 
for distress in the maintenance of pain in FMS. This is further evidenced by Van 
Middendorp and colleagues who found in 403 participants with FMS that negative 
affect was related to more pain and fatigue (van Middendorp et al., 2008).  
The neurobiopsychosocial model of pain (Moseley & Butler, 2015) proposed 
the mechanism through which increased distress, and perceived ‘dangers’ lead to an 
output of pain, and thus experience of pain. Experimental evidence that negative affect 
can increase the perception of pain (Wiech & Tracey, 2009) further demonstrates a 
relationship between increased distress and pain supporting the notion of increased 
distress being associated with greater symptoms of FMS. 
Research into IBS has demonstrated a possible causal link between distress and 
symptoms. Blomhoff and colleagues investigated intestinal reactivity to emotive 
words in people with and without IBS (excluding those with constipation-predominant 
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IBS) (Blomhoff, Spetalen, Jacobsen, Vatn, & Malt, 2000). Participants’ rectal tone was 
recorded throughout exposure to auditory tones and words relating to anger, sadness 
and anxiety. They found changes in rectal tone in response to emotive words compared 
to the auditory tone in all participants. However, these changes varied in terms of 
increases and decreases among the participants suggesting a more complex 
relationship between emotive stimuli and gastrointestinal response. Furthermore, the 
authors acknowledged that rectal tone changes have been found in dichotic listening 
tasks and thus the changes across participants in rectal tone may simply be a result of 
attention to auditory stimuli with semantic meaning which requires a deeper level of 
cognitive processing compared to an auditory tone. 
Turning to evidence in clinical samples, Dancey, Taghavi, & Fox (1998) asked 
31 participants with IBS to complete measures of daily symptoms, stress and daily 
hassles every day for 28 days. The authors examined the time series of these variables 
to test whether symptoms are a consequence of stress or if the inverse is true. Dancey 
and colleagues found that the best model that suited their data had symptoms as a 
function of hassles and symptoms on the previous two days and hassles on the same 
day. Furthermore, the authors found that the reverse relationship was also true; finding 
that for over a third of participants, worsening symptoms resulted in an increase in 
their perceived stress.  
Consequently, the observed relationships between distress and symptomatology 
in IBS, FMS and perhaps other disorders, are likely bidirectional whereby the 
worsening of symptoms can lead to more distress and distress can result in worsening 
symptoms, fitting with Deary et al.’s (2007) idea of a self-perpetuating cycle.  
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1.4. Emotional Expression Interventions 
Some of the best experimental evidence for the role of emotional suppression in 
persistent physical symptoms comes from randomised trials whereby an intervention 
that encourages emotional expression (often through emotive writing) is investigated 
in terms of its effects on quality of life and/or symptoms. 
These studies involve inviting participants to express their emotions in writing 
(usually about a specific upsetting or traumatic event) with the expectation that this will 
elicit improvements in well-being. There are a number of proposed mechanisms of this 
effect, though it is not yet clear what these mechanisms are: It is likely that there are 
multiple mechanisms working in parallel or interacting and that the mechanisms may 
vary across individuals (Halpert, Rybin, & Doros, 2010). It has been argued that written 
emotional disclosure allows for previously avoided emotions to be experienced, which 
may facilitate emotional processing and cognitive reflection and reframing. There may 
be habituation or desensitisation which may then result in the emotions becoming less 
intense or overwhelming and may result in cognitive and/or interpersonal changes, all 
of which may result in improved well-being and quality of life (Gillis et al., 2006; 
Halpert et al., 2010). 
In a sample of 72 participants with FMS, Gillis et al. (2010) conducted a 
randomised control trial using a written emotional disclosure intervention. After 
completing baseline measures, participants were instructed to write for four 
consecutive days for around 20 minutes. Those in the disclosure condition were asked 
to write about a particular stressful experience and told to focus on the facts about the 
experience as well as their deepest feelings. The control participants were asked to 
write about their plans across different time periods with a focus on actual plans and 
behaviours as opposed to their own feelings about these plans.   
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At the one month follow-up, there was no significant group by time interaction 
on global impact measured using the Fibromyalgia Impact Questionnaire (FIQ). 
However, they did find a significant interaction for sleep quality whereby disclosure 
participants improved and control participants worsened. There was also a significant 
group by time interaction for social support and negative affect. However, this was 
explained by a reduction in negative affect and increase in social support for the 
control group.  
Three months after the intervention was completed, there was a significant 
group by time interaction whereby participants in the disclosure condition improved 
in FIQ scores compared to controls who showed no significant changes in FIQ scores. 
Significant interactions were also found for sleep quality and health care utilization in 
which the disclosure participants showed improvements (better sleep quality and less 
health care utilization) compared to slight non-significant worsening for the control 
group. While participants in the disclosure condition showed higher levels of negative 
affect and lower levels of social support compared to controls at the one-month 
follow-up, these differences had disappeared by the three-month mark. While this 
does support the notion that emotional expression may result in improvements for 
people with FMS, the quality of this evidence should be questioned due to its small 
sample size, brief intervention and the delay in the effect of the intervention. 
Gillis and colleagues argue that the delay in improvements could be due to 
mediating processes which take more time to transform, such as changes in cognitions 
which may then lead to behaviour changes. Thus, it is proposed that changes in 
behaviour may need to continue for benefits to be seen. Once this behaviour continues, 
they propose it may also influence cognitions. In particular, it could be that continued 
expression of emotion may modulate beliefs about emotions which might then 
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influence outcomes. Thus this cycle would become self-maintaining, in line with 
Deary, Sharpe and Chalder’s (2007) cognitive behavioural model. However, the 
mediating effects of cognitions were not investigated by Gillis et al. (2007) and 
warrant further investigation. 
Similar to Gillis and colleagues, Broderick et al. (2005) conducted a randomised 
control trial using a written emotional disclosure intervention for participants with 
FMS. Participants were randomly allocated to one of three conditions, emotional 
disclosure writing, neutral writing and usual care. In both the writing conditions 
participants were asked to write for 20 minutes on three occasions, each roughly one 
week apart. Participants in the emotional disclosure condition were asked to write 
about a past or current traumatic event and were instructed to include their deepest 
thoughts and feelings about the event. Although Broderick and colleagues found 
improvements in pain and fatigue, and less worsening of psychological wellbeing at 
four-month follow-up (compared to neutral writing controls and treatment as usual 
controls); these differences were not maintained at 10-month follow-up (Broderick et 
al., 2005). They argue this could be due to the brevity of the intervention. However, it 
could be argued that it may also be due to the intervention addressing simply the act 
of suppression as opposed to the beliefs which precede it. In order to encourage longer 
lasting changes in behaviour, perhaps beliefs relating to the expression of emotion that 
determine suppressive behaviours should also be addressed. 
There has been little research into written emotional disclosure for individuals 
with IBS, with only one non-randomised pilot study without a control condition 
having been published. Halpert, Rybin and Doros (2010) recruited participants with 
IBS online and asked them to write emotively. They found a significant reduction in 
IBS severity at one-month and three-month follow-up, in addition to significant 
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improvements in cognitive function and coping strategies at one-month and three-
month follow-up. Quality of life measures showed significant improvements at three-
month follow-up but not at one-month, suggesting that improvements in the overall 
impact of the disorder on a person’s life may take longer, perhaps due to slower 
mediating processes (such as those discussed by Gillis et al., 2010).  
Further to this is a randomised-control trial of written emotional disclosure in 
11-18 year olds with medically unexplained abdominal pain attending a 
gastrointestinal speciality clinic found significant treatment effects (Wallander, 
Madan-Swain, Klapow, & Saeed, 2012). With 27 participants in the standard care 
condition and 36 in the treatment condition, they found significant reductions at six 
months, but not at three months, in pain frequency for the written emotional disclosure 
group compared to controls. Furthermore, they found significantly less service use in 
participants in the written emotional disclosure condition at six-months compared to 
baseline and this was not found in the treatment as usual group. While there was no 
significant difference in measures of quality of life at three and six months, there was 
a non-significant trend at six months in the expected direction; a slight improvement 
in quality of life for the written emotional disclosure group (Wallander et al., 2012). 
However, the use of treatment as usual as opposed to a neutral writing control group 
does not sufficiently rule out the possibility of placebo effects. 
Despite methodological issues, Wallander and colleagues’ findings, taken in 
addition to findings in FMS (such as Gillis et al., 2010; and Broderick et al., 2005) 
and the pilot study in IBS (Halpert et al., 2010) support the role of emotional 
suppression in persistent physical symptoms and indicate that targeting this may have 
some therapeutic benefit. It therefore seems plausible that by encouraging the 
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expression of emotions, it might be possible to improve outcomes in persistent 
physical symptoms.   
 
1.5. Beliefs about Emotions 
Given the current trend towards cognitive-behavioural treatments (with CBT 
specifically recommended in the treatment of FMS, IBS and CFS (Häuser et al., 2008; 
NICE, 2007, 2008)), attention should be turned towards the beliefs that might relate 
to such suppressive tendencies. These beliefs about emotions have been researched in 
terms of worry and anxiety, with limited research in the realm of health psychology 
and more limited still, in persistent physical symptoms.  
Evidence exploring a cognitive-behavioural model of worry has established a 
possible role of meta-cognition (Wells, 2009). This research proposes that there are 
two types of cognition to be considered when looking at emotional disorders; these 
are appraisals of external events and non-cognitive internal events (such as somatic 
sensations) and appraisals of cognition itself.  
Wells argues that beliefs about cognitions can motivate an individual by 
encouraging attempts to control cognitions (Wells, 2009). He describes two types of 
beliefs, which can do this. The first is beliefs about the process of cognition, for 
example the belief that one should be able to control their thoughts and feelings. The 
second is beliefs about the content of cognitions, for example believing that a 
particular thought is ‘bad’. In a similar vein, within the context of worry and meta-
worry, Wells argues that meta-worry can drive attempts to control and can increase 
worry through a number of mechanisms. These include priming the cognitive system 
for detection of worry (which relates to Wegner's (1994) description of an over-
representation of the monitoring system) and incomplete processing of the original 
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worry due to limited cognitive resources. Thus, these appraisals and beliefs regarding 
mental events seem to be crucial in emotion regulation.  
A similar line of research has been conducted with regards to emotional schema 
(Leahy, 2002), stating that the experience of an emotion is something to which 
individuals will respond differently through activation of beliefs about the 
implications of this emotional state. Leahy (2002) asserts that individuals will 
conceptualise their emotions differently; they have different emotional schemas which 
are understood through 14 dimensions. Furthermore, Leahy goes on to state the 
importance of uncontrollability as a dimension for emotional schema, highlighting the 
problems that occur with beliefs that emotions are uncontrollable or that one might 
feel a sense of losing control in the face of certain emotions.  
In a study of 53 psychiatric patients from a cognitive behavioural clinic, Leahy 
demonstrated that depression and anxiety were related to the belief that emotions were 
uncontrollable but that emotional expression (measured by the items “I believe that it 
is important to let myself cry in order to get my feelings out” and “I feel that I can 
express my feelings openly”) was not related to anxiety and depression. While 
emotional schemas provide valuable early evidence on the importance of thinking 
about emotions, the focus of the current thesis is on beliefs that more directly relate to 
the expression of emotions. Furthermore, Leahy’s measure of emotional expression is 
poorly defined in that crying is only one form of expression and does not apply as well 
to anxiety compared to sadness. In addition, feeling as though one can express their 
emotions is not strictly measuring their level of emotional expression. For example, 
one might feel like they should not express their emotions (perhaps due to a belief that 
this is unacceptable) or it may be that they have difficulty in identifying the correct 
emotion or expressing this accurately.  
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Despite the research dedicated to meta-cognition and emotional schemas, there 
is a comparative lack of research looking into cognitions which might relate to 
emotional suppression. Rimes and Chalder (2010) constructed a scale which measures 
beliefs about the unacceptability of expressing and experiencing one’s emotions, the 
Beliefs about Emotions Scale (BES). Using this measure, they found higher levels of 
beliefs concerning the unacceptability of emotions in people with CFS compared to 
healthy controls. They also found in those with CFS that these scores were moderately 
significantly correlated with perfectionistic self-beliefs, dysfunctional attitudes, self-
sacrifice schemas, anxiety and depression, and fatigue (effect sizes ranging from .25 
to .59). Twenty-two of the participants with CFS underwent CBT and completed the 
BES before and after the 12-week intervention. There were significant changes in 
beliefs about emotions following CBT, whereby there was a reduction in scores, 
indicating that these beliefs can be manipulated through cognitive behavioural 
techniques. 
Further research using the BES has shown beliefs about emotions to be related 
to emotional suppression, emotional avoidance (i.e. the avoidance of experiences 
which might elicit undesired emotions), alexithymia and the ability to distinguish 
emotions from physical symptoms (Rimes, 2015). Rimes puts forward the idea that 
beliefs about emotions could be related to fatigue in CFS through a number of 
mechanisms, including emotional suppression, emotional avoidance, difficulty 
recognising and describing emotions and difficulty identifying physical sensations 
related to emotions. In an online study with healthy individuals, Sydenham et al. 
(2016) found that beliefs about the unacceptability of emotions were related to more 
emotional avoidance, reduced support-seeking and lower levels of self-compassion. 
They also found that the relationships between beliefs about emotions and anxiety, 
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depression and fatigue were mediated by emotional avoidance and by self-compassion, 
but not by social support. While the research on these beliefs about emotions thus far 
is limited to those with CFS, it becomes clear with the aforementioned research that 
beliefs about emotions are likely to relate to suppression in clinical samples. Under 
the cognitive-behavioural paradigm, identifying these beliefs is crucial for shaping 
CBT in such a way to incur long-lasting benefits for individuals with persistent 
physical symptoms where behaviours and cognitions can both be addressed. 
 
1.6.  Summary 
Given the above evidence that suggests that negative affect combined with 
emotional suppression can result in an ironic increase in the distress which is being 
suppressed, and given the evidence suggesting that the requisites for ironic 
processing effects are more common in those with IBS and FMS; it seems likely 
that these individuals may be particularly prone to these ironic processing effects. 
Further to this, research demonstrating a relationship between distress and health-
related outcomes in these disorders coupled with the growing literature on the 
benefits of written emotional disclosure interventions, suggests that these higher 
levels of emotional suppression might work to perpetuate symptoms and that 
encouraging the expression of emotion may have therapeutic benefits. Evidence on 
beliefs about emotions suggests that holding such beliefs about the unacceptability 
of emotions might result in poorer health-related outcomes for people with 
persistent physical symptoms (see Figure 1.2). 
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Figure 1.2 Hypothesised relation between variables 
 
1.7. Aims 
The current thesis aims to investigate the role of beliefs about emotions and 
emotional suppression in FMS and IBS. In this way, the thesis will investigate 
cognitive behavioural factors in relation to persistent physical symptoms; in particular, 
the thesis describes research into the role of emotional suppression, proposing a model 
whereby believing emotions to be unacceptable is hypothesised to be related to more 
emotional suppression, which can result in increased distress. This distress is then 
hypothesised to result in worse outcomes. Through cross-sectional, longitudinal and 
experimental methods, the current thesis explores these variables with the aim of using 
this model to inform cognitive-behavioural intervention. 
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2. Chapter Two: Methods 
The current thesis used correlational and experimental methods to explore the 
role of emotional suppression and beliefs about the unacceptability of experiencing 
and expressing emotions in IBS and fibromyalgia. Across the six studies in this thesis, 
a number of complementary methodologies and analyses were used to address the 
aims of this thesis (see sections 2.5 and 2.6 of this chapter, pages 73 and 76). 
Throughout these studies a number of questionnaires were used consistently to screen 
for particular diagnoses (i.e. IBS and fibromyalgia) and to measure psychological 
constructs, namely, beliefs about the unacceptability of emotions, emotional 
suppression, affective distress, quality of life in IBS and global impact in FMS. These 
questionnaires are discussed in detail below. Details on how these measures were 
modified to suit particular studies and details of measures which were used only in 
particular instances in this thesis can be found in the methods sections of the 
experimental chapters. 
 
2.1.  Screening Tools 
2.1.1. Manning Criteria for Irritable Bowel 
In addition to participants reporting a diagnosis of IBS from a clinician, the 
Manning Criteria for Irritable Bowel were used as inclusion criteria for participants 
with IBS. The Manning Criteria for Irritable Bowel is a set of six items used to 
determine the presence of IBS (Manning et al., 1978). This is used primarily for 
diagnosis as opposed to being used as a measure of severity. Participants are presented 
with six statements about the symptoms of IBS and are asked to indicate whether they 
regularly experience this symptom. A positive diagnosis categorised by meeting three 
criteria (see Figure 2.1) 
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Figure 2.1 Manning Criteria for Irritable Bowel 
 
In the current thesis, participants who met three or more of the Manning Criteria 
and stated a diagnosis of IBS were considered to have IBS. Participants who state a 
diagnosis of IBS but did not meet at least three of the criteria were excluded. In 
Chapter Three, participants were included if they had self-diagnosed IBS or if a 
physician had provided a diagnosis. However, in order to improve the validity of the 
diagnoses, in Chapter Four participants were only included if the participant reported 
that a physician had diagnosed them with IBS. 
Using the six criteria in 33 participants with organic bowel disease and 32 with 
IBS, Manning et al. (1978) found that people with IBS tend to meet three or more of 
the six criteria (n=27) whereas for those with an organic bowel disorder (i.e. peptic 
ulcer disease), fewer patients reported three or more of the six criteria (n=8). However, 
the statistical significance of this was not examined. Building on from this study 
whose sample is small, Talley et al. (1990) investigated the ability of the Manning 
Criteria to discriminate between those with IBS (n=82), non-ulcer dyspepsia (n=33), 
organic bowel disease (n=101) and healthy controls (n=145) in a larger sample. 
Manning Criteria for Irritable Bowel 
• Visible abdominal distension 
• Pain relief with defecation 
• More frequent stools at pain onset 
• Looser stools at pain onset 
• Mucus per rectum 
• Feeling of incomplete evacuation 
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Talley et al. found that those with IBS scored significantly higher on the 
Manning Criteria than healthy controls, patients with non-ulcer dyspepsia and those 
with organic diseases. Specifically, when looking at the percentage of participants 
meeting three or more of the criteria, 53% of those with IBS met three or more criteria 
compared to 27%, 26% and 7% of the non-ulcer dyspepsia, organic disease and 
healthy control groups (respectively).  This demonstrates a large difference between 
groups in the proportion meeting three criteria, however it is perhaps more informative 
to explore the sensitivity (correctly identifying those with the disorder) and specificity 
(correctly identifying those without the disorder) of the measure.  
Talley et al. tested the sensitivity and specificity of the Manning Criteria for each 
of their control groups. The comparison with healthy participants demonstrated 65% 
sensitivity and 86% specificity, which is good. The tool’s ability to identify those with 
and without IBS was slightly weaker for the other groups however, with 58% 
sensitivity and 75% specificity when compared with organic bowel disease, and 97% 
sensitivity and 3% specificity with non-ulcer dyspepsia.  
The Manning Criteria for Irritable Bowel, while demonstrating some 
discriminability between those with organic and functional bowel disorders, does not 
include criteria relating to constipation symptoms. Constipation type IBS (IBS-C) is 
less common than alternating or diarrhoea type IBS (Brandt et al., 2009) and is not 
represented in the Manning Criteria. In the original creation of the criteria, Manning 
tested multiple items which included the criterion “less frequent stools at the onset of 
abdominal pain”. However this item did not discriminate between those with organic 
and functional bowel disorders, having only one out of 31 patients with IBS report 
this, and two out of 30 patients with peptic ulcer disease (Manning et al., 1978). 
Though Manning et al. found this in a small sample, when comparing patients with 
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IBS-C and diarrhoea predominant IBS (IBS-D) in a larger sample, Talley et al. (1990) 
found that there were no significant differences in Manning Criteria scores. In the 
same experiment, Talley et al. tested the validity of additional symptoms added to 
these criteria that addressed constipation and found that they did not provide any 
additional value to the diagnostic tool. These symptoms included having less than 
three bowel movements a week, often having hard stools, straining more often and 
laxative use. Thus, while this symptom is an important part of the experience for 
patients with IBS, and indeed may constitute a subgroup of the disorder, it is arguably 
not necessary as a criterion for the diagnosis of IBS. 
The Rome Criteria are another diagnostic tool that are more frequently used and 
have been recommended for the diagnosis of IBS by clinicians, though this is not the 
current NICE recommendation for practice in the NHS (NICE, 2008). The current 
thesis used the Manning Criteria to validate self-reported diagnosis which varies 
slightly from the Rome Criteria. However, the American College of Gastroenterology 
Task Force state that there is a slight improvement in specificity in the Rome criteria 
compared to the Manning criteria (85% compared to 72%) and comparable sensitivity 
(78% for the Manning criteria and 71% for Rome). They argue that the Rome criteria 
require further evaluation and importantly, cases should be identified based on the 
presence of abdominal pain associated with alternating bowel habit over a period of 
at least three months (Brandt et al., 2009). Thus, perhaps the only key difference is 
that the Manning criteria do not specify the duration for which participant must have 
experienced these regular symptoms.  
The six Manning criteria have good discriminative validity in IBS (Manning et 
al., 1978; Talley et al., 1990) and also capture a broader scope of symptoms across six 
criteria compared with fewer criteria listed in the Rome criteria, making these more 
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limited diagnostic tools unnecessarily more restrictive  considering their comparative 
sensitivity and specificity (Boyce, Koloski, & Talley, 2000). 
 
2.1.2.  The London Fibromyalgia Epidemiological Study Screening 
Questionnaire 
In order to screen for fibromyalgia, The London Fibromyalgia Epidemiological 
Study Screening Questionnaire (LFESSQ) was used in studies with participants who 
had FMS. This screening tool was chosen over the American College of 
Rheumatology (ACR) classification for FMS due to its better sensitivity (100%) 
compared to the ACR (88.4%) and the specificity of the LFESSQ is higher (100%) 
compared to the ACR (81.1%) (White et al., 1999; Wolfe et al., 1990). The 
Fibromyalgia Rapid Screening Tool (FiRST), is similarly inferior in terms of 
sensitivity (90.5%) and specificity (85.7%) as a diagnostic tool for FMS (Perrot, 
Bouhassira, & Fermanian, 2010). Based on this evidence, the LFESSQ was considered 
advantageous as a screening tool in the current thesis. 
The LFESSQ (White et al., 1999) asks participants to select the symptoms they 
have experienced in the past 3 months. These include symptoms of pain in muscles, 
bones or joints; shoulders, arms or hands; legs or feet; and neck, chest or back. 
Participants must respond yes to all of these symptoms in order to meet the criteria for 
a diagnosis of FMS. Additionally, for the symptoms regarding shoulders/arms/hands 
and legs/feet, participants must state on which side of their body they experience the 
pain; left, right or both sides. To meet the criteria for a diagnosis of FMS, participants 
must either state that the pain occurs on both sides across these two items. For example, 
participants who state that both arm and leg pain only occurs on the right or only on 
the left side, would not meet the criteria. Conversely if a participant states that their 
58 
 
arm pain is on the right and their leg pain is on the left or vice versa, they would meet 
the criteria. Thus, it is a requirement that the pain across the body parts must be present 
on both sides. In addition to the pain criteria, there are two items relating to fatigue. 
Specifically, these items ask about the presence of fatigue and whether it significantly 
limits activity. Diagnosis can be determined by either yes responses to all items across 
the pain and fatigue criteria, or to the pain criteria alone (Marcus & Deodhar, 2011). 
Testing of this screening tool in participants with FMS who were diagnosed 
using the 1990 American College of Rheumatology criteria (n=31), rheumatoid 
arthritis (n=30) and healthy controls (n=30) demonstrated that when using pain criteria 
alone, 100% of people with FMS were correctly identified (White et al., 1999). This 
was 93.5% when using the fatigue criteria as well. In participants without chronic pain, 
100% were correctly not diagnosed with FMS, regardless of whether the fatigue 
criteria were included. Test-retest reliability in a community sample of 672 adults was 
high for both pain criteria alone (95%) and for pain and fatigue criteria together (81%). 
However, this sample size for testing specificity and sensitivity is small and thus 
further exploration of the tool’s validity is needed. 
For the purpose of the current thesis, participants were diagnosed using only the 
pain criteria as the specificity and reliability of this is superior to using alongside the 
fatigue criteria. In the current thesis, participants who met the LFESSQ Criteria and 
stated a diagnosis of FMS by a physician were considered to have FMS (those who 
stated they had self-diagnosed FMS were excluded). Those who reported a diagnosis 
of FMS but did not fulfil the necessary criteria were excluded.  
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2.2.  Measures 
2.2.1.  Beliefs about Emotions Scale 
To measure beliefs about the unacceptability of experiencing and expressing 
emotions, the Beliefs about Emotions Scale (BES) was used (Rimes & Chalder, 2010). 
This scale was selected over other similar measures due to its particular focus on 
beliefs as opposed to focussing more broadly on emotionally suppressive/expressive 
behaviours. The full questionnaire can be found in Appendix A. 
 Participants rate, on a seven-point (0-6) Likert scale (from ‘totally disagree’ to 
‘totally agree’), their agreement with twelve statements which each represent a belief 
about emotional experience and expression. These statements were based on clinical 
reports and cognitive models of CFS (Surawy et al., 1995) and eating disorders 
(Corstorphine, 2006). High scores are indicative of high levels of beliefs that the 
expression and experience of emotion is unacceptable.  
In 121 patients with CFS, the construct validity of this scale was evaluated 
(Rimes & Chalder, 2010). Beliefs about emotions scores for participants with CFS 
were correlated with scores on the subscales of the Perfectionistic Self-Beliefs Scale 
(aside from the Perfectionist Striving subscale), all subscales of the Dysfunctional 
Attitudes Scale-24, and both subscales of the Hospital Anxiety and Depression Scale. 
The questionnaire has been demonstrated to be internally consistent (Cronbach’s 
alpha= .91) indicating excellent reliability of the scale (Rimes & Chalder, 2010). The 
scale was correlated with distress in 94 patients with multiple sclerosis (r=.33) 
(Dennison, Moss-Morris, Silber, Galea, & Chalder, 2010) and showed large 
improvements (partial η2=.19)  following mindfulness-based cognitive therapy in 
sample of 35 participants with CFS (Rimes & Wingrove, 2013). 
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In addition to the BES, there exists a Beliefs about Emotions Questionnaire 
(Manser, Cooper, & Trefusis, 2012). The BES was chosen over this alternative 
measure as the Beliefs about Emotions Questionnaire focuses on beliefs purely 
relating to the experience of emotions and not the expression of emotions. Another 
scale measuring a similar construct is Leahy’s Emotional Schema Scale (Leahy, 2002). 
This 50-item scale measures schema surrounding values, views, comprehensibility, 
guilt, validation, numbness and control regarding emotions. Of these factors, only the 
three items relating to emotional control would be of interest for the current thesis, 
and these are specific to the experience of emotion (e.g. “I worry that if I have certain 
feelings I might go crazy”) as opposed to emotional expression. Thus, due to the focus 
of the current thesis on emotional suppression, the BES is better suited. 
The BES does not make use of reverse scoring and therefore all items are 
worded in the direction that expressing and experiencing emotions is unacceptable. It 
is possible that the negatively worded items could prime participants to view the 
expression of emotion as unacceptable.  From Chapter Four onwards, the 
questionnaires were presented in randomised order so as to avoid order effects such 
as these. 
 
2.2.2. Courtauld Emotional Control Scale 
Emotional suppression was measured in this thesis using the Courtauld 
Emotional Control Scale (CECS). This scale was chosen partly because it places 
behavioural responses to emotions within the context of a particular emotion (i.e. 
anger, depressed mood and anxiety). Doing so provides participants a clear scenario 
which may enable them to better estimate how they are likely to react. Furthermore, 
for the purpose of the current thesis, only the suppression of emotions which are 
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undesirable or unpleasant are considered and thus providing clear examples of 
emotions in these statements rules out the possibility that participants may consider to 
what degree they are also likely to suppress or control pleasant emotions. This measure 
predominantly focusses on external suppression (i.e. sharing emotions with others) 
though one item of each scale regards ‘smothering’ one’s emotions, which can be 
viewed as internal suppression (i.e. avoiding the experience of emotions). The full 
questionnaire can be found in Appendix B. 
The CECS was constructed based on interviews with 71 patients with breast 
cancer (Watson & Greer, 1983). Patients were asked to describe how they react to 
feelings of anger, anxiety and depression in order to develop a scale that measures the 
controlling of a particular emotion. This scale measures how much a person expresses 
or suppresses anger, unhappiness and anxiety with seven items for each subscale.  
Participants are presented with statements regarding certain behaviours 
pertaining to emotional expression/suppression and state on a four-point scale how 
often they behave in such a way (from almost never to almost always). Each item 
begins with “When I feel [angry/upset/worried] …” and ends with a reaction, for 
example “I refuse to say anything about it.” It has been used widely in breast cancer 
patients and found to be related to adjustment to cancer and its progression (e.g. 
Schlatter & Cameron, 2010). 
Using item correlations, Watson and Greer found the scale to be internally 
consistent (Cronbach’s alphas=.86-.88), with significant correlations between the 
three subscales (anger and anxiety r=.45, anger and depressed mood r=.62, anxiety 
and depressed mood r=.62) as well as correlations between each subscale and overall 
scores (anxiety r=.79, anger r=.81, depressed mood r=.89) indicating reliability of an 
overall score of emotional control.  
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Test-retest reliability over a three to four-week period indicated strong reliability 
with correlation coefficients for anger, anxiety and upset being .86, .84 and .89 
respectively. Overall emotional control scores over the three to four week period were 
also significantly correlated (r=.96), again suggesting reliability of scores across the 
three subscales as an overall measure of emotional control (Watson & Greer, 1983). 
The Lie subscales of the Eysenck Personality Questionnaire were significantly 
positively correlated with total CECS scores (r=.34). This Lie subscale has been 
previously used as a measure of the tendency of individuals to falsely present 
themselves in a positive light and thus its correlation with the CECS suggests good 
construct validity of the scale (Watson & Greer, 1983). 
The CECS demonstrated significant correlations with only some of the related 
questionnaires when convergent validity was tested by the original authors (Watson & 
Greer, 1983). The lack of consistent significant findings in testing the convergent 
validity of this measure can in part be explained by the selection of questionnaires 
used in this testing. The Marlowe-Crowne (which was not related to CECS scores), 
for example, was used under the assumption that those who control their emotions do 
so for the purpose of social desirability, which may only be part of the explanation. 
For example, one might exert less control over their emotions, not because they do 
not consider social desirability, but because they are seeking support for their problem.   
While it may be considered beneficial that the CECS addresses three emotions 
in particular, these emotions may not truly encompass the range of emotions that are 
being suppressed. For example, while an individual may not suppress feelings of 
depressed mood, anxiety and anger, they may try to control feelings of stress or being 
overwhelmed.  
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While previous research on emotional suppression in persistent physical 
symptoms has used other measures of emotional suppression (e.g. the Self-Silencing 
scale), the current thesis aimed to look at beliefs about emotions and emotional 
suppression as distinct constructs (thereby distinguishing between beliefs and 
behaviours). This meant that scales such as Jack’s (1991) Self-Silencing scale were 
inappropriate due to including items on motivations behind the expression or 
suppression of emotion (for example “I try to bury my feelings when I think they will 
cause trouble in my close relationship(s)”). 
 
2.2.3. The Hospital Anxiety and Depression Scale 
The Hospital Anxiety and Depression Scale (HADS) (Zigmond & Snaith, 1983) 
was used in the current studies as a measure of affective distress. This measure was 
selected as the HADS has been used reliably to detect anxiety and depression in 
participants with physical symptoms due to its lack of reference to somatic features of 
depression and anxiety compared with other measures such as the Patient Health 
Questionnaire-9 and Beck’s Depression Inventory (Bjelland, Dahl, Haug, & 
Neckelmann, 2002; Smarr & Keefer, 2011). The full questionnaire can be found in 
Appendix C. 
This scale asks participants to rate their symptoms on varying four-point scales 
across 14 items. For example, for the item “I still enjoy the things I used to enjoy” the 
responses are on a scale from “definitely as much” to “hardly at all.” Seven of the 14 
items pertain to depression and the remaining seven to anxiety.  
For the purpose of the current thesis, scores were summed across the two 
subscales (anxiety and depression) to provide a marker of affective distress that is not 
contaminated by physical symptoms. Scores were therefore summed over all 14 items 
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to provide a score where the maximum possible score is 42. High scores on this scale 
indicate higher levels of affective distress.  
While many studies use the anxiety and depression subscales as separate 
measures, the use of overall HADS scores as a measure of distress has been validated. 
Pallant and Tennant (2007) demonstrated strong validity of overall HADS scores in a 
sample of 296 patients attending an out-patient musculoskeletal rehabilitation 
program. Using Rasch analysis, they found support for the overall fit of the model 
where psychological distress is measured with all 14 items of the HADS. This has 
been further validated more recently in primary care demonstrating internal 
consistency was good for the overall HADS scores (Cronbach’s alpha=.89 for the 
English version of the scale) (Roberge et al., 2013).  
In a review of the literature, the two subscales of the HADS were examined in 
relation to their concurrent validity (Bjelland et al., 2002). In the four studies identified 
that assess correlations between the HADS depression scale and Beck’s Depression 
Inventory (BDI), correlations ranged between .62 and .73 with a total sample size of 
1552 participants (consisting of medical inpatients, patients with HIV, Swedish adults, 
and patients with motor neuron disease). Overall HADS scores were also strongly 
correlated with BDI scores (r=.73) (Lisspers, Nygren & Soderman, 1997, as cited in 
Bjelland et al., 2002). The HADS anxiety subscale has been assessed in regards to its 
relation to the State-Trait Anxiety Inventory (STAI) in five studies with correlation 
coefficients ranging from .64 to .81 in four empirical studies (totalling 1562 
participants) and a review of 200 studies (Herrman, 1997, as cited in Bjelland, 2002). 
Total HADS scores were also correlated with STAI trait (r=.71) and state (r=.68) 
scores in one study included in the review (Lisspers, Nygren & Soderman, 1997, as 
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cited in Bjelland et al., 2002). Overall this therefore suggests the HADS validly 
measures anxiety and depression. 
There have been a number of criticisms relating to the factor structure and the 
ability of the HADS to predict cases of depression and anxiety in both clinical and 
general populations (Coyne & von Sonderen, 2015; Hansson, Chotai, Nordstöm, & 
Bodlund, 2009; Julian, 2011; Tanaka & Huba, 1984;  Watson et al., 1995). It has 
therefore been suggested that the HADS may not be valid as a measure of depression 
and anxiety but instead is a strong measure of psychological distress more broadly as 
the factor structure seems to be better explained by one factor of general distress 
(Coyne & von Sonderen, 2015; Johnston, Pollard, & Hennessey, 2000; Norton, Cosco, 
Doyle, Done, & Sacker, 2013; Tanaka & Huba, 1984). For the purpose of the current 
thesis which aimed to measure affective distress (as opposed to finding cases of 
depression and anxiety) in individuals with physical symptoms, this scale was 
therefore still the most appropriate as it is not contaminated by somatic symptoms and 
loads well onto a factor of general distress. 
 
2.2.4.  General Help-Seeking Questionnaire 
Both symptom-related and personal/emotional support-seeking were measured 
in the current thesis using the General Help-Seeking Questionnaire (GSHQ).  
This measure was chosen as there were few measures of support/help-seeking 
identified by the researchers. In particular, measures that existed were not considered 
appropriate as they did not adequately address support-seeking in relation to physical 
symptoms but instead focussed on emotional difficulties (e.g. The support seeking 
subscale of the Coping Strategies Inventory (Amirkhan, 1990)). While scales do exist 
which are directed towards physical symptoms (e.g. the practical and emotional 
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support seeking scales of the Behavioural Response to Illness Questionnaire (Spence 
et al., 2005)), this particular measure is focussed on the negative consequences of 
overreliance on social support as opposed to measuring support-seeking more 
neutrally. Additionally, an author of the measure advised that these measures would 
not be appropriate for the aims of the current thesis (R. Moss-Morris, personal 
communication, 1st June 2015). As such, the GHSQ was selected for the current thesis. 
The General Help-Seeking Questionnaire (GHSQ) was developed in response 
to growing research demonstrating a preference of young people to seek informal help 
(i.e. the help of friends and family) before seeking formal help (Wilson, Deane, 
Ciarrochi, & Rickwood, 2005). Participants using the GHSQ are presented with items 
in the format “If you were having [problem-type], how likely is it that you would seek 
help from the following people?” The participant is then asked to rate from one to 
seven (extremely unlikely to extremely likely) how likely they are to seek help from 
the people listed (e.g. a parent, friend, religious leader). Participants are also given the 
option to rate how likely they are to seek help from another person not listed (and are 
asked to state who that person is) and how likely they are to seek help from no one. 
Wilson et al. created this template to allow researchers to modify the list of people and 
the problem statement to suit the target population. The ability to target particular 
symptoms for specific populations was an advantage to choosing this measure of 
support-seeking. 
For the purpose of the current thesis, the GHSQ was modified to suit symptoms 
of FMS and IBS. The item relating to emotional and personal problems was retained, 
however for the second statement; the ‘problem type’ was replaced with “particularly 
troublesome bowel symptoms/symptoms of pain or fatigue”. The pre-modifying 
statement of “particularly troublesome” was included due to the nature of these 
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symptoms varying in intensity. Thus, it may be that if a person is experiencing only 
mild symptoms, there is no need to seek-help.  
In addition to the mentioned changes, the word ‘help’ was replaced with the 
word ‘support’ so as to encourage the participants to include forms of emotional help 
and support as opposed to physical/pragmatic support which is often what the term 
‘help’ can denote. Scores were summed across items for each question to provide two 
overall support-seeking scores out of 35 for each participant. 
Fitting with the focus on informal (social) support as opposed to formal support, 
sources of formal support (i.e. mental health professional, phone helpline and 
doctor/GP) were excluded from the questionnaire thus leaving the options, intimate 
partner, friend, parent, other relative, religious leader. 
The GHSQ has been shown to be a reliable measure of help-seeking intentions 
and its reliability and validity was assessed in a sample of 218 high school students. 
The original version (containing two problem statements addressing personal and 
emotional problems, and suicide ideation) was first assessed as a whole, 
demonstrating good internal consistency (Cronbach’s alpha=.85) and had good test-
retest reliability over a three-week period (r=.92).  Due to the distinct nature of the 
problem types, the scale was again assessed for reliability looking at the two problems 
separately and found for suicide ideation the scale was internally consistent 
(Cronbach’s alpha=.83) and test-retest reliability over a three week-period proved 
reliable (r=.88). Similarly the personal-emotional problems items were considered 
reliable (Cronbach’s alpha=.70, test-retest reliability over three weeks=.86) (Wilson 
et al., 2005). 
To determine the validity of the GHSQ, Wilson and colleagues measured actual 
help-seeking behaviours of participants using self-report three weeks after completion 
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of the GHSQ to observe correlations between the two. Analyses revealed significant 
correlations between help-seeking intentions and actual help-seeking behaviour, 
though these correlations were only moderately sized with correlation coefficients 
below .5. While this was found for both problems (personal/emotional and suicide) 
correlations were not observed for all potential sources of help; with significant 
correlations occurring for intimate partner, friend, parent, non-parent family member, 
mental health professional and youth worker for emotional-personal problems, and 
significant correlations only for intimate partner, non-parent family member and youth 
worker for suicidal ideation. However, given the validity of the personal/emotional 
item and the fact that the current thesis is not measuring seeking help for suicide 
ideation, the measure is likely valid for current purposes.  
Due to the modification of this questionnaire in each study, internal consistency 
is tested in each sample which used this measure. This can be found in the methods 
sections of these chapters. 
 
2.3.  Outcome Measures 
2.3.1.  Irritable Bowel Syndrome-Quality of Life 
Quality of life in participants with IBS was measured using the Irritable Bowel 
Syndrome – Quality of Life measure (IBS-QoL), a 34-item questionnaire addressing 
quality of life in relation to symptoms of IBS. This questionnaire covers eight different 
factors, each addressing different aspects of their lives which might be affected by the 
disorder: dysphoria, interference with activity, body image, health worry, food 
avoidance, social reaction, sex and relationships (Patrick, Drossman, Frederick, 
DiCesare, & Puder, 1998). The full questionnaire can be found in Appendix D. 
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Participants are presented with 34 statements relating to the impact of IBS on 
their quality of life and are asked to rate their agreement on a five-point scale from 
‘not at all’ to ‘extremely’ or ‘a great deal’ depending on the statement. Scores are 
summed and converted to a score out of 100 for overall quality of life, whereby higher 
scores depict better quality of life. 
The overall measure of quality of life was tested in 156 participants with IBS 
and was found to be internally consistent (Cronbach’s alpha= .95). Test-retest 
correlations over a one week period with a random sample of 89 participants suggested 
good reliability for the IBS-QoL and its subscales whereby the correlation coefficient 
was .86 for overall scores in participants who reported that there were no changes in 
their bowel symptoms (Patrick et al., 1998). Convergent validity was tested in patients 
with IBS by correlating scores on the IBS-QoL with scores on the Medical Outcome 
Study Short Form (SF-36) and the Psychological General Well-Being Scale. Patrick 
et al. (1998) predicted whether overall IBS-QoL scores would relate strongly or 
weakly to each subscale of the SF-36 and Psychological General Well-Being Scale. 
They found that six out of eight predictions for the SF-36 subscales were met while 
two out of seven of the predictions for the Psychological General Well-Being Scale 
were met. However, the authors define strong correlations as coefficients greater 
than .4 which is not by usual standards considered a large effect size. Thus while they 
describe these correlations as strong, the largest correlation coefficient was .44, which 
would generally be considered medium (Fields, 2011).  
Although the Psychological General Well-Being subscales were not as strongly 
related to IBS-QoL scores as expected, IBS-QoL scores were related as authors 
predicted to the subscales of the SF-36, thereby suggesting some level of convergent 
validity. Construct validity for the IBS-QoL score was also tested through methods of 
70 
 
discriminant validity, testing the scale’s ability to discriminate between mild, 
moderate and severe cases of IBS, finding that the IBS-QoL scores increased with the 
severity of cases (as indicated by the Functional Bowel Disorder Severity Index). 
This measure of quality of life was selected as it measures quality of life directly 
related to symptoms of IBS.  Other measures of health-related quality life have been 
used effectively in research into IBS, but lack specificity about the exact symptoms 
and challenges experienced day-to-day by those with the syndrome.  While using the 
IBS-QoL in the current thesis resulted in a more specific measure of IBS-related 
quality of life, it also meant that control participants could not produce data about their 
quality of life. The current thesis piloted the IBS-QoL with control participants asking 
them to reflect on a time when they have experienced bowel symptoms. However, this 
resulted in a floor effect and in many participants leaving the questions blank. 
 
2.3.2.  Fibromyalgia Impact Questionnaire revised 
In order to measure outcomes for participants with FMS, the revised 
Fibromyalgia Impact Questionnaire (FIQr) was used (Bennett et al., 2009). This 
measure was chosen as the outcome measure for participants with FMS in the current 
thesis as it is the most well-used outcome measure that is specific to FMS as opposed 
to measuring pain more generally. This specificity means the outcome encompasses 
all symptoms of FMS (including psychological) as opposed to just measuring pain 
and/or disability (Salgueiro et al., 2013). The full questionnaire can be found in 
Appendix E. 
This questionnaire measures the impact of the disorder across three domains: 
function, overall impact and symptoms. Participants are asked to rate their ability in 
nine tasks over the past seven days on a scale of zero (no difficulty) to ten (very 
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difficult) as part of the ‘function’ domain, providing a score out of 90. Overall impact 
is measured across two items on an 11-point scale from never to always. These two 
items address goal accomplishment and feeling overwhelmed within the same seven-
day time frame. Participants are then asked to rate the severity of ten listed symptoms 
on varying 11-point scales. For example, the item “please rate your level of balance 
problems” is rated on a scale from “no imbalance” to “severe imbalance”.  
Scores for each domain are summed and then for domain one, divided by three 
and for domain three divided by two. The final score is calculated by summing the 
three calculated domain scores to give a score out of 100, where high scores indicate 
greater impact of the disorder. 
The FIQr was derived from the longer FIQ (Burckhardt, Clark & Bennet, 1991). 
This previous version has since been criticised for items relating only to more affluent 
western cultures (for example items asking about the ease of using a washer/dryer and 
driving a car). Further criticisms were also made with regards to the scoring system 
as many items were on different scales (Bennet et al., 2009). As a result, the FIQr was 
developed addressing these issues and adding/replacing items in relation to the 
growing evidence on other symptoms of fibromyalgia (for example balance issues). 
The revised questionnaire was evaluated in a sample of 202 fibromyalgia patients 
demonstrating good internal consistency (Cronbach’s alpha = .95) with item 
correlations ranging from .56 to .93 (Bennet et al., 2009).  
Convergent validity was also assessed by Bennet et al. correlating FIQr scores 
with scores on the original FIQ and the Short-Form Health Survey (SF-36). Overall 
FIQr scores strongly correlated with the physical functioning and pain subscales of 
the SF-36 (r=-.71 and -.69 respectively). Furthermore, the pain item of the FIQr 
correlated most strongly with the pain subscale of the SF-36 (r=.66) while the anxiety 
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and depression items correlated most strongly with the mental health subscale of the 
SF-36 (r=-.72 and -.63 respectively). While there was a significant difference in FIQ 
and FIQr scores, there was a strong correlation between the two (r=.88).  
2.4. Participant groups and recruitment 
Participants with IBS and FMS were selected as the focus of these studies as 
they are highly prevalent conditions which significantly impact the individual’s 
quality of life (Patrick et al., 1998; Salgueiro et al., 2013). Both conditions have 
evidence that psychological factors play a role in the maintenance of symptoms and 
that further research on psychological factors is needed (Creed, 2007; Deary et al., 
2007; Lami, Martínez, & Sánchez, 2013; Salkovskis et al., 2016).  
Participants with IBS were recruited in Chapters Three and Four and Chapter 
Four was replicated in participants with FMS. Chapter Six involved psychometrically 
evaluating a questionnaire in participants with FMS. FMS was chosen over IBS 
because this particular questionnaire was thought to be more relevant to this patient 
group and participants with FMS were involved in the development of the measure. 
These chapters recruited participants online by posting in forums and social media 
pages dedicated to the particular conditions. Healthy controls in these studies were 
also recruited online from participant recruitment webpages (e.g. Reddit’s 
r/samplesize and FindParticipants.com) and through the PhD student’s and PhD 
supervisor’s social networks (email, Facebook and Twitter). Appendix F contains 
example recruitment posts for IBS, healthy controls and FMS. 
Chapter Seven recruited participants with FMS in an NHS setting due to the 
opportunities available with contacts in NHS services. Chapter Eight recruited 
participants who were local to the university and therefore investigated participants 
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with IBS as this condition is more prevalent than FMS (Jones et al., 2015; Mearin et 
al., 2001), which improved the ability to find participants locally. 
 
2.5.  Study Designs 
This thesis investigated the role of beliefs about emotions and emotional 
suppression in fibromyalgia and IBS across a range of designs. The studies described 
in Chapters Three, Four and Five used online questionnaire data to investigate 
mediation models and to also compare clinical groups with control groups using 
correlational designs and group comparisons. These studies aimed to establish 
whether a model of beliefs about emotions and emotional suppression would be 
supported in these samples, and whether beliefs about emotions and emotional 
suppression are specific to IBS and FMS. 
Based on the findings in Chapter Five, a previously designed, but unvalidated 
questionnaire was validated in Chapter Six, investigating beliefs about illness 
experiences, in particular relating to sharing experiences with others. Reliability and 
validity were examined in data collected from online samples using procedures 
recommended for scale validation (Comrey, 1988; Hinkin, Tracey, & Enz, 1997; 
Robinson, Shaver, & Wrightsman, 1991). Factor analyses allowed for the 
investigation of subscales within the measure by exploring the underlying factor 
structure of the questionnaire. Reliability was then explored with regards to internal 
consistency of the measure and its factors. Construct validity was evaluated by 
assessing the relationships between the questionnaire and measures of similar 
constructs as well as by known-group comparisons (i.e. comparing a group of 
participants one would expect to score highly with a group of participants one would 
expect to score lower). Convergence with similar constructs was assessed in order to 
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determine the scale’s criterion validity. The new measure was then examined in a 
mediation model that was hypothesised based on the findings of Studies One, Two 
and Three. 
Despite testing causal chains using mediation models, the first four studies’ 
correlational methods mean causality cannot be inferred. To build upon the 
correlational methods used in this thesis, a quasi-experimental design with a clear 
timeline was adopted for Chapter Seven.  
The studies in Chapters Three, Four, Five and Six used online samples. Online 
data collection is beneficial in that it avoids issues with manual data entry (e.g. human 
error and time), is less costly and makes it easier for hard-to-reach groups (e.g. those 
with physical disabilities that make it difficult to leave the house) to take part (Cantrell 
& Lupinacci, 2007; Lefever, Dal, & Matthíasdóttir, 2007). However these samples 
have been argued to be different from student samples with regards to financial motive, 
personality and self-esteem (Goodman, Cryder, & Cheema, 2012). It has also been 
argued that there is bias among these samples with higher rates of missing data 
(Cantrell & Lupinacci, 2007). However many of the studies that find characteristic 
differences between online participants compared with pencil-and-paper participants 
do not use sufficiently comparable data collection and recruitment methods to 
accurately contrast the two types of sample (Weigold, Weigold, & Russell, 2013). In 
a study addressing these methodological issues, online and pencil-and-paper 
completers were found to be comparable in terms of personality and social desirability 
though they were faster to complete the questionnaires (Weigold et al., 2013). Given 
that the evidence is mixed on this matter, further investigation into patient groups in 
Chapter Seven allows for the findings of this thesis to be applied to wider samples. 
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A quasi-experimental design with a clear timeline was thereby adopted for 
Chapter Seven recruiting patients from NHS pain services.  This longitudinal study 
involved measuring variables before and after usual psychological treatment in the 
NHS in a sample of participants with FMS. This study investigated potential 
mechanisms of change in psychological interventions and tested whether these 
variables are manipulable using these techniques. In addition to this, the study 
investigated relationships between changes in beliefs about emotions and suppression 
with changes in outcome measures. However, as this study was quasi-experimental, it 
was necessary to also investigate changes in these mechanisms and outcomes in 
response to directly manipulating beliefs about emotions and emotional suppress. 
Therefore, the final study in this thesis (Chapter Eight) used a single case 
experimental design to determine whether aiming to modulate participants’ beliefs 
about emotions and emotional suppression in a targeted way would in turn influence 
outcomes. For the purpose of this study, a short group-based intervention using 
cognitive behavioural techniques was designed and delivered.  
The use of a single case series however is not sufficient to determine the efficacy 
of this intervention as there is no control condition. Furthermore, the small sample 
size means findings are difficult to generalise to wider participant groups. However, 
this design allows for a low-cost, time-efficient method to test the feasibility of this 
intervention and the theoretical model behind it. While future research using 
randomised control trials would be necessary, a single case series provides a solid 
primary investigation of this intervention. 
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2.6. Statistical Analyses 
Studies one, two and three made use of mediation analyses in order to test 
multiple models. Mediation models aim to test the extent to which a particular variable 
accounts for the relation between a predictor and outcome variable (Baron & Kenny, 
1986). For example, a particular outcome might be predicted by a specific belief. This 
relationship between the two might be explained by a particular behaviour, which 
would then be considered a mediator of this relationship.  
Though other methods exist (e.g. Baron & Kenny,1986; Sobel, 1982) a non-
parametric bootstrapping method was used in order to provide estimated effect sizes 
and confidence intervals for the direct and indirect effects (Preacher & Hayes, 2004). 
Therefore, this analysis was carried out using the Process plug-in for SPSS (Hayes, 
2004), using models four and six (depending on the number of mediators being tested 
in a particular indirect effect).  
Process mediation was chosen over structural equation modelling firstly because 
the models being tested were fairly simple, with only one or two mediators per path 
and only up to 4 paths being tested within a model. Due to the relative simplicity of 
the models, Process mediation analysis was appropriate over structural equation 
modelling. Furthermore, it has been argued that structural equation modelling is 
preferable in larger samples (over 200) (Kleine, 2011). More recent evidence explored 
the number of participants required for different models in structural equation 
modelling and found that when the expected amount of explained variance is small, a 
sample size of 440 is required (Wolf, Harrington, Clark, & Miller, 2013). Given the 
constraints of the current thesis in regards to sample size, an analysis which can 
achieve sufficient statistical power with smaller samples was preferred.  
77 
 
Chapter Six made use of tests of internal consistency, factor analysis and 
correlational methods to validate a questionnaire in addition to further mediation 
analyses and group comparisons using this newly developed measure. Chapter Seven 
compared participants’ scores before, immediately after and three months after 
treatment to investigate whether beliefs about emotions, emotional suppression, 
affective distress and/or the impact of fibromyalgia on the patient changed following 
existing psychological treatments within the NHS. Therefore a repeated measures 
linear mixed model was used to investigate changes in scores before treatment, after 
treatment and at follow-up. Further to this, to examine beliefs about emotions, 
emotional suppression and affective distress as mechanisms of change, change scores 
for beliefs about emotions, emotional suppression and affective distress were 
investigated in regression models as predictors of change in global impact scores. 
The final study, Chapter Eight, used a single case experimental design where 
only a small sample is required to assess changes in response to an intervention. 
Idiographic measures were taken regularly before, during and after the intervention. 
Data were analysed using statistical as opposed to visual analysis, making use of Tau-
U non-overlap analyses to assess changes in the level and slope of the trends in each 
phase of the experiment (Willson, Veale, & Freeston, 2016). 
The combination of these methods allows for a comprehensive examination of 
the role of beliefs about emotions and emotional suppression in IBS and FMS. 
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3. Chapter Three: Beliefs about emotions and emotional suppression 
in irritable bowel syndrome 
 
3.1.  Introduction 
As stated in Chapter One, the current thesis focuses on emotional suppression 
in persistent physical symptoms. As such, one of the conditions on which the current 
thesis focussed is IBS. The current chapter explores beliefs about emotions, emotional 
suppression and quality of life in IBS. 
 Previous research has shown IBS to be related to psychological factors such as 
distress, trauma and previous stressful life events (Creed, 2007; Hazlett-Stevens et al., 
2003). In addition to this relationship between affective distress and IBS, in 
comparison to those with IBD, individuals with IBS tend to report higher levels of 
self-silencing of their emotions (Ali et al., 2000). 
In a cross-sectional study, Ali et al. compared patients with IBS (n=25) and 
patients with inflammatory bowel disease (n=25) on a measure of self-silencing where 
self-silencing is the silencing of one’s thoughts or feelings (Jack, 1991). They found 
that participants with IBS showed significantly more self-silencing than participants 
with IBD. This difference was no longer significant after controlling for self-blame 
and a history of abuse. It could be that this difference in self-silencing can be explained 
by other psychosocial factors however the sample size may have been too small to 
achieve statistical power once controlling for confounds. 
Ali et al. compared participants with IBS to those with IBD, while other studies 
on persistent physical symptoms have compared clinical groups to healthy controls 
(Rimes & Chalder, 2010; van Middendorp et al., 2008). There is value in comparing 
two clinical groups, especially when one condition has a clear physiological pathology 
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while the other has a less certain aetiology. However, comparing these two groups 
alone makes it difficult to uncover whether those with IBS are more emotionally 
suppressive than average, whether those with IBD are less suppressive than average, 
or indeed both. Ali et al. did attempt to address this by using a reference score of 
healthy individuals’ self-silencing, though a more statistically sound approach would 
be to recruit a sample of individuals without IBS and directly compare their scores to 
those with IBS. Thus comparing participants with IBS to a healthy population would 
be useful in understanding whether people with this condition tend to be more 
emotionally suppressive.  
Ali et al. had a small sample with just 25 participants in each group meaning 
this finding may not be representative of other participants with IBS. The current study 
therefore tests a larger sample of participants with IBS. Furthermore, the Self-
Silencing scale used by Ali et al. includes items which reflect more cognitive aspects 
of emotional suppression that may in fact be reflective of beliefs about emotions as 
opposed to the behaviour of emotional suppression. For example ‘Considering my 
needs to be as important as those of the people I love is selfish’ which is a belief as 
opposed to a self-reported behaviour (Jack & Dill, 1992). Therefore it may be that 
patients with IBS may differ from those with IBD on beliefs about emotions and not 
actual emotional suppression. Similarly they may differ only on actual emotional 
suppression and not beliefs. Thus it is vital to explore the cognitive and the 
behavioural concepts surrounding emotional suppression individually in order to truly 
uncover where these differences lie. 
 The current study therefore compared a sample of individuals with IBS to a 
group of healthy controls in line with research on other conditions with persistent 
physical symptoms (e.g. Rimes & Chalder, 2010; van Middendorp et al., 2008) and 
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distinguishes between beliefs about emotions and actual emotional suppression by 
using two separate scales. 
Given the predisposition to negative affect found in individuals with IBS (Creed, 
2007; Gick & Thompson, 1997) and these individuals’ tendency to self-silence (Ali et 
al., 2000), it would make sense that people with IBS would be more susceptible to 
ironic processing effects. As explained in Chapter One, such ironic processing effects 
suggest that under high levels of negative affect (inducing high cognitive load), 
attempts to suppress emotions would result in an increase of that unpleasant emotion 
(Wenzlaff & Wegner, 2000). Thus affective distress, when suppressed may be 
exacerbated. 
Research into affective distress and negative affect has demonstrated its role in 
IBS symptomatology. As discussed in Chapter One, there is evidence that negative 
affect can influence symptoms in IBS. Biopsychosocial models of IBS discuss the 
brain-gut axis (in particular its serotonergic pathways) in relation to the link between 
negative affect and bowel symptoms. Research in this field has found that negative 
affect affects pain thresholds and the neural processing of visceral stimuli (Muscatello, 
Bruno, Scimeca, Pandolfo, & Zoccali, 2014). In a longitudinal study with 31 
participants with IBS, Dancey Taghavi and Fox (1998) asked participants to report 
their daily symptoms, stress and hassles for 28 days. They found that the best fitting 
model had symptoms of IBS as a function of symptoms of IBS and hassles of the 
previous two days as well as hassles of the same day. Thus, there is evidence that 
distress and negative affect can lead to symptoms in IBS. 
In this way, consistent with the cognitive behavioural view of IBS (Spence & 
Moss-Morris, 2007), an individual’s thoughts, feelings, behaviours and bodily 
symptoms are likely to be influential in a maintaining cycle. In particular, the evidence 
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in IBS supports the notion that beliefs about emotions and emotional suppression play 
a role in this cycle where these factors relate to increased distress and consequently 
worsened symptoms. Similar evidence has come from other research into other 
chronic conditions with aetiological uncertainty such as CFS (Rimes & Chalder, 2010). 
Cross-sectional research in CFS has shown that people with CFS (n=121) more 
strongly believe the expression and experience of emotions to be unacceptable 
compared to healthy controls (n=73), and scores on this measure were positively 
correlated with fatigue in people with CFS  (Rimes & Chalder, 2010). Further research 
has demonstrated that this relationship is mediated by emotional suppression (as well 
as self-compassion) in healthy individuals (Sydenham et al., 2016). This mediation 
model was therefore tested in the current study in participants with IBS, based on the 
above evidence of emotional suppression.  
The relationship between emotional suppression/expression and symptom 
severity has also been tested experimentally. For example, in another condition with  
aetiological uncertainty, FMS, it was demonstrated that written emotional disclosure 
interventions showed benefits in terms of physical symptoms and global impact of the 
disorder (Broderick et al., 2005; Gillis et al., 2006). Research by Broderick et al. 
(2005) involved participants (recruited from hospitals and the community) with FMS 
either writing expressively about trauma (n=31), writing about day-to-day activities 
(n=32), or receiving treatment as usual (n=29). They found improvements for the 
emotional disclosure group in psychological well-being, pain and fatigue at four 
months post-intervention, and not immediately after nor at ten months after 
intervention. There were no treatment effects on global impact. However the 
intervention itself was brief (20 minutes of writing on three occasions) and thus it is 
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possible that this limited treatment duration is insufficient to induce changes in global 
impact or long-lasting changes in any treatment outcome.  
This evidence suggests that benefits from emotional disclosure interventions are 
not immediate - there is a delayed onset to these beneficial effects, through mediating 
factors. This delayed benefit has been found in another trial of written emotional 
disclosure in FMS (Gillis et al., 2006). Gillis et al. argue that the delay in health 
benefits may be due to mediating mechanisms such as continued emotional processing 
and decisions to communicate or approach relationships differently. In addition, Gillis 
et al. (2006) propose “changes in cognitions pertaining to self and others” (pp 11) as 
a factor which may mediate the delayed change in global impact following written 
emotional disclosure. It is therefore possible that the relationship between emotional 
suppression and outcomes (i.e. global impact in the case Gillis et al.) is mediated by 
beliefs about the unacceptability of expressing emotions in that confronting emotions 
on paper may shift beliefs towards being more accepting of both expressing emotions 
externally and experiencing emotions internally. 
One online pilot study with 103 participants with IBS has shown promising 
results for written emotional disclosure interventions (Halpert et al., 2010). Their 
findings indicated a significant improvement in IBS symptom severity scores one 
month after intervention (i.e. writing online at home for 30 minutes on four 
consecutive days). At three months’ post-intervention, this mean change in symptom 
severity had increased and significant improvements in quality of life were also 
apparent. While there was no control group, meaning placebo effects cannot be ruled 
out, these findings demonstrate the delayed onset of benefits in written emotional 
disclosure interventions, which is consistent with the proposal of possible cognitive 
mediatory factors in IBS as those Gillis et al. proposed in FMS. 
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Based on the current theories, and findings in written emotional disclosure 
interventions, the current study also tested whether the relationship between emotional 
suppression and quality of life is mediated by beliefs about the unacceptability of 
emotions.  
 
3.1.1.  Hypotheses 
1. There will be a significant difference in beliefs about the unacceptability 
of emotions scores and emotional suppression scores between those with IBS and 
healthy controls. 
2. The relationship between beliefs about the unacceptability of emotions 
and quality of life in IBS will be mediated by emotional suppression. 
3. The relationship between emotional suppression and quality of life will 
be mediated by beliefs about the unacceptability of emotions. 
 
3.2.  Methods 
3.2.1. Procedure 
Participants (n=166) were recruited online through the IBS Network as well as 
social networking pages dedicated to IBS (i.e. Facebook and Reddit) and healthy 
controls were recruited through participant recruitment pages (e.g. Reddit’s 
r/samplesize). They completed a series of questionnaires, following an information 
page about the study. This online questionnaire included questions about demographic 
information (including age, sex, employment status, home country and education 
level) and a checklist for the criteria to reach diagnosis for IBS. Participants then 
completed questionnaires measuring beliefs about emotions, emotional suppression 
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and quality of life. Ethical approval was provided by the university’s departmental 
ethics committee 
 
3.2.2. Diagnostic Criteria 
Participants were labelled ‘IBS group’ if they: (i) met three or more of the 
Manning Criteria for Irritable Bowel (Manning et al., 1978), (ii) stated that they have 
received a medical diagnosis of IBS or had self-diagnosed IBS; and (iii) stated that 
the symptoms could not be accounted for by another medical diagnosis. In order to 
meet criteria for the ‘control group’ participants were required to: (i) meet less than 
three of the Manning Criteria; (ii) neither state that they had received a medical 
diagnosis of IBS nor had self-diagnosed IBS; and (iii) state that any symptoms could 
not be accounted for by another medical diagnosis. Those who did not fulfil the 
inclusion criteria for either group were excluded from analysis. 
 
3.2.3. Participants 
Participants were recruited online through IBS forums and websites. 
Participants in the healthy control group were also recruited online, however through 
non-IBS channels (for example participant recruitment websites and through social 
media). Both groups were informed that the study was about emotion expression in 
IBS with the purpose of investigating how this might affect people living with IBS. A 
priori sample size analyses indicated that 42 participants in each group was an 
appropriate sample size to achieve sufficient statistical power, while a larger sample 
was required to detect correlations within the IBS sample. Therefore, the current 
sample consisted of a larger number of IBS participants in comparison to controls. 
This sample size analysis was based on the effect size of the difference between 
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participants with CFS and healthy controls found by Rimes and Chalder (2010), where 
Cohen’s D=.55, the hypothesis is one-tailed, the alpha is set to .05 and the desired 
power is .8. 
Of the 166 participants, 87 met the criteria to be in the IBS group and 37 met 
the criteria to be in the control group, while 42 participants were excluded from the 
analyses, as they did not meet criteria for the IBS group or the control group. Only the 
IBS group and control group are considered from this point on. 
 
3.2.4. Measures 
Participants completed questionnaires measuring beliefs about emotions, 
emotional suppression and quality of life in IBS (see Chapter Two: Methods, page 53, 
for further details on these measures). These were completed in that particular order, 
following demographic questions and diagnostic criteria. 
 
3.2.4.1. Beliefs about emotions 
Beliefs about the unacceptability of experiencing and expressing emotions were 
measured using the Beliefs about Emotions scale (BES) across 12 statements. Scores 
can range from zero to 72, where high scores indicate more/stronger beliefs that 
expressing and/or experiencing emotions is unacceptable (Rimes & Chalder, 2010). 
In the current study, there was good internal consistency (Cronbach’s alpha=.896). 
 
3.2.4.2. Emotional Suppression 
Emotional suppression was measured using the Courtauld Emotional Control 
Scale (CECS) (Watson & Greer, 1983). This questionnaire measures the suppression 
of anger, anxiety and sadness across 21 items (seven items per emotion). Scores can 
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range from 21 to 84 where high scores indicate higher levels of emotional suppression. 
In the current study, there was excellent internal consistency (Cronbach’s alpha=.922). 
 
3.2.4.3. Quality of Life 
Quality of Life in IBS was measured across 34 items using the IBS-QoL. These 
items encompass eight sub-domains. Scores across these eight domains are totalled 
and converted into a score out of 100, where high scores indicate a better quality of 
life (Patrick et al., 1998). In the current study, there was excellent internal consistency 
(Cronbach’s alpha=.958). 
 
3.2.5. Design and Statistical Analysis 
The hypotheses were tested using a cross-sectional, quasi-experimental and 
correlational design. To test hypothesis one, tests of differences were required and 
were conducted using two independent measures t tests where the independent 
variable was group (IBS or healthy control) and the dependent variables were beliefs 
about emotions and emotional suppression. 
In regards to hypothesis two, the Process plug-in for SPSS was used, using 
model four to test for one mediator variable in a particular relationship (Hayes, 2012). 
In this model, the predictor variable was beliefs about the unacceptability of emotions 
and the outcome variable was quality of life. The mediator variable for this hypothesis 
was emotional suppression.  
Similar to hypothesis two, the same plug-in and model were used to test for a 
single mediator variable. In this test, the predictor variable was emotional suppression 
and the outcome was quality of life. The mediator for this hypothesis was beliefs about 
emotions. For the indirect effects of hypotheses two and three to be significant, the 
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95% confidence intervals of the unstandardised indirect effect size must not contain 
zero.  
Missing values were addressed using the expectation maximisation algorithm in 
SPSS. Participants with more than 20% of values missing for a variable were excluded 
in analyses for that variable based on evidence that missing data imputation methods 
are reliable where between 10% and 30% of values are missing (Shrive, Stuart, Quan, 
& Ghali, 2006). 
 
3.3.  Results 
3.3.1. Sample Characteristics 
Group differences in demographic information were measured using chi-square 
tests of association, except age (which was analysed using an independent t test) (see 
Table 3.1). Analyses revealed frequency distributions significantly different from what 
was expected by chance for home country (χ2=34.664, p=.004), however 85.3% of 
the expected values were less than five which means this finding is not robust. All 
other demographic information did not differ significantly between the two groups. 
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Table 3.1 Sample Characteristics for each group 
 
 
Characteristics IBS Controls 
Age (years) (mean (S.D)) 25.1  (7.4) 23  (4.9) 
Sex 
   Female 
 
62 
 
(71.3) 
 
27  
 
 (75.0) 
Employment status 
   Full-time employment 
   Part-time employment 
   Full-time student 
   Part-time student 
   Self-employed 
   Unemployed 
 
29  
15  
37  
7 
3 
10 
 
(33.3) 
(17.2)  
(42.5) 
(8.0) 
 (3.4) 
 (11.5) 
 
7  
7  
21  
3 
2  
2  
 
(19.4) 
(19.4) 
(58.3) 
(8.3) 
(5.6) 
(5.6) 
Ethnicity 
Caucasian 
White and Black Caribbean 
White and Asian 
Other mixed/multiple ethnic background 
Pakistani 
Other Asian background 
Other ethnic group 
 
78   
0  
0  
2  
1 
0  
5 
 
(90.7) 
(0.0) 
(0.0) 
(2.3) 
(1.2) 
(0.0) 
(5.8) 
 
32   
1  
1  
0  
0 
1  
1 
 
(91.5) 
  (2.9) 
(2.9) 
(0.0) 
(0.0) 
(2.9) 
(2.9) 
Home country 
United Kingdom 
North America 
Other Europe 
Australasia 
Asia 
South America 
 
26 
51 
6 
2 
0 
1 
 
(30.2) 
(59.3) 
(7.0) 
(2.3) 
(0.0) 
(1.2) 
 
22 
6 
4 
1 
2 
1 
 
(61.1) 
(16.7) 
(11.1) 
(2.8) 
(5.6) 
(2.8) 
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3.3.2. Group Differences 
3.3.2.1. Hypothesis One 
Levene’s test of homogeneity of variance indicates this assumption has been 
met for both beliefs about emotions (F=.125, p=.724) and emotional suppression 
(F=.326, p=.569) scores. There was a significant difference in beliefs about emotions 
scores between those with IBS and healthy controls (t(122)=2.92, p=.002) whereby 
those with IBS score higher than healthy controls, suggesting greater beliefs about 
the unacceptability of emotions in the IBS group (see Table 3.2). There was however 
no significant difference between those with IBS and healthy controls in emotional 
suppression (t(122)=.421, p=.674). 
Table 3.2 Means and standard deviations for beliefs about emotions and emotional 
suppression for both groups. 
 IBS 
(n=87) 
Healthy Controls 
(n=37) 
 Mean (S.D) Mean (S.D) 
Beliefs about Emotions 40.73 (12.87) 33.40 (12.41) 
Emotional Suppression 55.09 (12.23) 54.10 (11.11) 
 
 
3.3.3.  Mediation Analyses 
3.3.3.1. Hypothesis Two 
The relationship between beliefs about emotions and quality of life was not 
significantly mediated by emotional suppression (see Figure 3.1). The significance of 
the indirect effect (standardised indirect effect=-.120) was tested using bootstrapping 
procedures. The bootstrapped unstandardized indirect effect was -.202 and the 95% 
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confidence interval ranged from -.470 to .049 meaning the indirect effect with 
emotional suppression as a mediator was not statistically significant.  
 
 
Figure 3.1 Unstandardized regression coefficients for the overall mediation model, 
where the relationship between beliefs about emotions and quality of life while controlling 
for emotional suppression is presented in parentheses  
Note. **p<.001 *p<.050. 
 
3.3.3.2. Hypothesis Three 
The relationship between emotional suppression and quality of life was 
significantly mediated by beliefs about emotions (see Figure 3.2). The significance of 
the indirect effect (standardised indirect effect=-.194) was tested using bootstrapping 
procedures. The bootstrapped unstandardized indirect effect was -.343 and the 95% 
confidence interval ranged from -.638 to -.055 meaning the indirect effect with beliefs 
about emotions as a mediator was statistically significant.  
Beliefs about 
emotions 
Emotional 
Suppression 
Quality of 
life -.697** (-.494)* 
.632** -.662** 
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Figure 3.2 Unstandardized regression coefficients for the mediation model where the 
relationship between emotional suppression and quality of life while controlling for beliefs 
about emotions is presented in parentheses.  
Note. **p<.001 
 
3.4. Discussion 
The current study found that participants with IBS held significantly greater 
beliefs about the unacceptability of emotions than healthy controls, but the groups did 
not differ with regards to emotional suppression. Emotional suppression did not 
mediate the relationship between beliefs about emotions and quality of life. However, 
the relationship between emotional suppression and quality of life was mediated by 
beliefs about emotions. 
This study explored differences between those with and without IBS on 
measures of beliefs about emotions and emotional suppression, finding a significant 
difference in beliefs about emotions scores but no difference in emotional suppression. 
Higher scores on the BES for the IBS group support evidence by Rimes and Chalder 
(2010) in CFS suggesting these beliefs to be something particularly relevant to those 
with chronic conditions with uncertainty about the aetiology of the disorder. In order 
to determine the specificity of this finding to conditions where persistent physical 
symptoms are not currently explained by the medical model, as opposed to conditions 
Emotional 
Suppression 
Beliefs about 
emotions 
Quality of 
life -.662** (-.320) 
.632 -.697
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where the symptoms are explained, further research comparing healthy controls to 
participants with persistent physical symptoms that are and are not medically 
explained is needed.  
Furthermore, Ali et al. found that after controlling for self-blame and whether 
the individual had experienced abuse, the difference in self-silencing between those 
with IBS and those with IBD was no longer significant. Therefore, there may be other 
psychosocial variables that explain the difference between groups. In particular, it 
could be that those who experience more negative affect (which is common in IBS 
(Muscatello et al., 2014)) are likely to score highly on measures of emotional 
suppression and beliefs about the unacceptability of emotions simply because they 
experience more unpleasant emotions and therefore have a stronger drive to suppress 
these. It is therefore possible that by not accounting for affective distress in the current 
group comparisons, the difference found in beliefs about emotions may be 
overestimated. Future research should therefore consider controlling for affective 
distress when testing for group differences.  
The fact that there were no differences in emotional suppression is not in line 
with previous research showing significantly higher self-silencing in IBS participants 
(Ali et al., 2000). However, Ali et al. tested participants with IBD as a control group 
as opposed to healthy controls. Thus, those with IBD may differ from those with IBS 
on measures of emotional suppression, but healthy controls may not. Future research 
should explore differences between participants with IBS in comparison to both 
healthy and clinical (IBD) controls.  
The non-significant difference in emotional suppression between the two groups 
could be due to the order in which the questionnaires were completed. In the current 
study, all questionnaires were completed in the same order with the BES preceding 
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the CECS. Since the BES has no reverse scored items, it is possible that the wording 
of this questionnaire primed all participants to score higher on the CECS which may 
have masked any existing differences between the groups.  
Alternatively, those with IBS who are willing to complete questionnaires online 
asking about emotional experiences may be those who are already slightly more 
expressive than other subgroups of IBS. That is, the particular sub-group of IBS 
participants who might have scored higher on the CECS might be less willing to take 
part in the kind of research that asks these questions or may be more inclined to give 
more neutral responses. The BES by comparison is less about emotional experience 
and instead focuses on beliefs, which might be easier to disclose than more 
experiential information about emotions. 
Across the research into emotional suppression in persistent physical symptoms, 
no single consistent measure has been used and thus the lack of a significant difference 
in emotional suppression found in this research may in part be due to differences in 
the measurement of emotional suppression. Ali et al. (2000) used the Self-Silencing 
scale which incorporates cognitive aspects of emotional suppression. It might be that 
those with IBS hold more maladaptive beliefs about emotions and may not necessarily 
suppress their emotions more which might explain the differences found in Ali et al.’s 
study in comparison to the current study’s findings. Further exploration of these 
beliefs as a distinct construct is therefore needed in IBS. 
Due to the need for a larger sample size to conduct mediation analyses, the IBS 
group was larger than the control group in the current study. This has been found to 
be problematic with regards to statistical power when using t tests, with larger 
differences in sample sizes resulting in reduced power. It is therefore possible that the 
lack of significant difference in emotional suppression could be explained by a 
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reduction in power. However, a difference in beliefs about emotions was still evident 
in this unequal sample size and post-hoc power analyses using the expected effect size 
for emotional suppression (based on Ali et al.’s effect size) with the current unequal 
sample size indicates that there was sufficient power to detect the expected effect1. 
The two groups were compared on demographic features, finding only a 
significant difference in the distribution of frequencies for nationality across the two 
groups. Though the residuals could not be interpreted due to the small expected 
frequencies, it is possible that there was an overrepresentation of participants from the 
United States in the IBS group compared with the healthy control group. Given that 
there are cultural differences in emotion regulation, coping and expression 
(Matsumoto, 2006), it is possible that this group difference in nationality might have 
confounded the group comparisons in emotional suppression and beliefs about 
emotions. Further research should enter demographic variables that differ between 
groups as confounds in tests of group differences. 
Emotional suppression did not mediate the relationship between beliefs about 
emotions and quality of life in IBS. This is unexpected given the evidence on 
emotional disclosure interventions and ironic processing effects. However, the current 
study did not measure affective distress which (according to ironic processing effects) 
is a key mechanism through which emotional suppression might result in poorer 
outcomes. Given that an increase in distress is proposed as result of the suppression 
of undesirable emotions, a statistical model testing this should include affective 
distress as a second mediator.  
                                                 
1 For this post-hoc power analysis, the estimated effect size was .72, the alpha level .05 and 
the n’s of the current study (87 and 37). This resulted in a power of .98, which is high suggesting the 
difference in sample size between the two groups should not have impacted the ability to detect the 
group differences.  
 
95 
 
The current study also tested a model whereby beliefs about emotions 
significantly mediated the relationship between emotional suppression and quality of 
life. This significant finding is in line with the evidence on emotional disclosure 
interventions, which commonly finds benefits are not immediate. Gillis et al. (2006) 
posit that this improvement in outcomes as a result of emotional disclosure is mediated 
by changes in cognitions. Thus, it would be expected that emotional suppression may 
result in altered beliefs about emotions which then might influence quality of life, 
which is supported by the second mediation analysis tested in the current study.  
However, in the current study, emotional expression was not manipulated, instead 
cross-sectional data was analysed using mediation analyses. Experimental evidence 
with a clear timeline would be beneficial in exploring both mediation models further. 
The relationships found warrant further research to fully understand the role of 
beliefs about emotions and emotional suppression in the development and 
maintenance of IBS and related quality of life. Given that the current study is 
correlational, this model should be further explored experimentally by manipulating 
emotional suppression and beliefs about emotions to determine a direction of causality. 
The current research is a step towards improving our understanding of the relationship 
between beliefs about emotions, emotional suppression and quality of life in IBS, 
which alongside further experimental evidence, could be used to develop effective 
psychological interventions for individuals living with IBS. This evidence also sheds 
light to potential mechanisms of change in existing interventions; the exploration of 
which could improve outcomes for those receiving psychological treatment in IBS. 
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4. Chapter Four: Placing affective distress and support-seeking 
within a model of beliefs about emotions in IBS 
4.1. Introduction 
As highlighted in Chapters One and Three, higher levels of emotional 
suppression have been found in individuals with IBS compared to those with 
inflammatory bowel disease (IBD) in a cross-sectional study (Ali et al., 2000). An 
uncontrolled trial of expressive writing as an intervention demonstrated improvements 
in symptoms and quality of life in IBS (Halpert et al., 2010) suggesting a relation 
between emotional expression and improved outcomes. Further still, there is evidence 
from Chapter Three of this thesis that emotional suppression is related to poorer 
quality of life in IBS. 
Other evidence on emotional suppression more broadly has demonstrated that 
attempts to suppress emotions, particularly unpleasant emotions, can result in an 
increase in that particular emotion, as detailed in Chapter One (section 1.2.1, page 30). 
This ‘ironic processing effect’ is thought to occur especially with high negative affect 
(Dalgleish et al., 2009). Those with IBS commonly experience more negative affect 
than those without IBS (Gick & Thompson, 1997) and tend to suppress their emotions 
(Ali et al., 2000). Thus, those with IBS may be more prone to ironic processing effects. 
As discussed in Chapter One, this increase in distress through emotional suppression 
may then impact quality of life through psychosocial as well as biological mechanisms 
(Hall et al., 2011).  
Compared to healthy controls, scores on a measure of beliefs about the 
unacceptability of experiencing and expressing emotions have been found to be higher 
in participants with chronic fatigue syndrome (CFS) (Rimes & Chalder, 2010) and in 
participants with IBS (see Chapter Three of this thesis, page 78). These two studies 
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also found that these beliefs were related to more fatigue and reduced quality of life 
for CFS and IBS respectively. Together the above evidence highlights the need to 
investigate emotional suppression and beliefs about emotions in individuals with IBS, 
in order to understand further any potential maintaining factors of these persistent 
symptoms. 
Chapter Three investigated differences in emotional suppression and beliefs 
about emotions between participants with IBS and healthy controls in line with 
previous evidence finding differences in emotional suppression in IBS compared to 
participants with IBD (Ali et al., 2000). However, Chapter Three found no significant 
differences between participants with IBS and healthy controls in emotional 
suppression, only in beliefs about emotions. In line with Ali et al.’s finding that those 
with IBS are more emotionally suppressive than those with IBD, the current study 
employed a second control group who have IBD in addition to a healthy control group 
in order to test whether Ali et al.’s findings can be replicated with a similar comparison 
group. Having a clinical control group and a healthy control group will also test the 
specificity of the differences found in beliefs about emotions in Chapter Three, in that 
it could be that those with bowel-related persistent physical symptoms, and not 
specifically those with medically unexplained bowel-related persistent physical 
symptoms, hold more beliefs about the unacceptability of emotions compared with 
healthy controls. While Ali et al. did find that those with IBS scored significantly 
higher than a ‘norm’ value of women in the general population, the sampling methods 
for this norm value are not clearly reported and therefore the results may not be 
reliable. 
 Interestingly, in Ali et al.’s study, after controlling for self-blame and abuse, the 
difference between participants with IBS and IBD on the measure of self-silencing 
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was no longer significant. It could be that this is due to the small sample size of the 
study, where too few participants with too many variables being tested resulted in 
insufficient statistical power. Alternatively, it could be that self-silencing is explained 
by other psychosocial variables such as self-blame and previous abuse, or is explained 
by a variable common to all of these factors (for example increased levels of distress). 
Furthermore, Ali et al. used the Self-Silencing scale, which contains items 
referring to both cognitive and behavioural aspects of emotional suppression. It could 
thus be that those with IBS and those with IBD only differ in regards to beliefs about 
the unacceptability of emotions or only in terms of emotional suppression. Therefore, 
given that those with IBS showed differences from healthy controls in terms of beliefs 
about emotions and not emotional suppression in Chapter Three, the current study 
compared participants on separate measures of emotional suppression and beliefs 
about emotions. 
It was argued in Chapter Three that there may have been order effects which 
might have led to priming participants on the emotional suppression measure which 
may have masked group differences. Therefore, the current study has randomised the 
order of questionnaires. Furthermore, it might be argued that any differences found 
between groups on measures of beliefs about emotions and emotional suppression 
might be explained by the increased levels of affective distress found in these groups 
in that those who are more distressed may have greater need to suppress their emotions. 
Therefore, the current study will also investigate whether the expected differences are 
maintained after controlling for affective distress. 
Due to the unexpected non-significant mediation findings of Chapter Three, 
where the relationship between beliefs about emotions and quality of life was not 
mediated by emotional suppression, the current study looked to investigate the 
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hypothesised model further. Whereas Sydenham, Beardwood, & Rimes (2016) and 
Chapter Three of this thesis looked at emotional suppression as a single mediator (with 
mixed results), ironic processing effects suggest an important role of increased 
affective distress as a consequence of emotional suppression, which may then result 
in changes in quality of life. Therefore, to test the full model in line with ironic 
processing effects, the current study investigated a model whereby the relationship 
between beliefs about emotions and quality of life was serially mediated by emotional 
suppression, and then affective distress. 
Rimes and Chalder (2010) proposed that the relationship between beliefs about 
emotions and health-related outcomes could be related to social support. They argue 
that believing the expression of emotions to be unacceptable might then result in a 
reduction in support-seeking where individuals who do not want to share their 
emotions will therefore inhibit others from knowing they need help. This reduction in 
social support-seeking may therefore be another mediating factor in maintenance of 
persistent physical symptoms.  
It has been argued that in disorders with aetiological and prognostic uncertainty 
(such as IBS, CFS and FMS) there is an element of secrecy and that this secrecy is 
related to reduced social support in CFS and FMS (McInnis et al., 2015). Interviews 
with 14 participants with IBD demonstrated a perception of stigma around the 
embarrassing and unpredictable nature of the symptoms (Frohlich, 2014). Together 
this research suggests that stigma experienced by those with ‘embarrassing’ symptoms 
and ‘unexplained’ symptoms might too be present in IBS. Indeed it has been found 
that perceived stigma and two subscales of internalised stigma (social withdrawal and 
alienation) were related to poorer quality of life in 243 participants with IBS (Taft, 
Riehl, Dowjotas, & Keefer, 2014). Given that IBS is related to stigma and secrecy, it 
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may be that individuals do not express their emotions. Further to this, the evidence 
that support seeking and secrecy are related suggests that support seeking might be 
related to beliefs about expressing emotions and to quality of life in IBS.  
However, Sydenham et al. (2016) tested the role of social support in a mediation 
model and found that the relationship between beliefs about emotions and fatigue in 
healthy individuals was not significantly mediated by social support. Similarly 
Lackner et al. ( 2010) found that perceived social support did not predict quality of 
life or psychological distress in IBS. These findings are somewhat surprising.  
It may be argued that measuring support-seeking intentions of the participant as 
opposed to their perceived social support (as was done in Lackner et al.’s (2010) 
study) would be a better measure to test this model as perceived social support might 
be influenced by other confounding variables (for example, the individual’s 
perception of offered support might be influenced by cognitive biases meaning actual 
offered support and the participant’s perception of support are different). This might 
then consequently weaken the tested relationships. Support-seeking intentions 
however are behaviours of the participant (as opposed to their perceptions of a third 
party’s behaviour) and may therefore be more accurately measured meaning they may 
be more closely related to believing that expressing emotions is unacceptable.  
Similarly, Sydenham et al. (2016) used the Support Seeking subscale of the 
Berlin Social Support Scale, which measures very broadly asking others for help as 
opposed to specifically measuring asking for help in relation to difficult emotional 
problems or help in relation to physical symptoms. It may be that beliefs about 
emotions are more specifically related to asking for support when dealing with a 
difficult emotional situation or when dealing with difficult physical symptoms, and 
therefore support-seeking in relation to these factors should be measured specifically.  
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Therefore, the current study tested whether support-seeking significantly 
mediates the relationship between beliefs about emotions and quality of life in IBS. 
In this thesis, Chapter Three found that the relationship between emotional 
suppression and quality of life in IBS was mediated by beliefs about emotions.  
Though the evidence is cross-sectional and causality cannot be inferred, it was argued 
that this model supports Gillis et al. (2006) who argued that the benefits of written 
emotional disclosure are delayed in onset (occurring after three months as opposed to 
immediately after intervention) due to the role of mediating cognitions. In order to test 
the robustness of this finding, this mediation model was tested in a larger sample in 
the current study where questionnaire order was randomised. 
 
4.1.1. Hypotheses 
1. Participants with IBS will score significantly higher than healthy 
controls and participants with IBD on measures of beliefs about emotions and 
emotional suppression before and after controlling for affective distress. 
2. The relationship between beliefs about emotions and quality of life in 
IBS will be significantly serially mediated by emotional suppression and then 
affective distress. 
3. The relationship between beliefs about emotions and quality of life in 
IBS will be significantly individually mediated by both support-seeking measures. 
4. The relationship between emotional suppression and quality of life in 
IBS will be mediated by beliefs about emotions. 
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4.2. Methods 
4.2.1. Participants 
Participants were recruited online through websites and forums dedicated to the 
particular disorders of interest using the same sample size calculations as in Chapter 
Three. Healthy participants were recruited through online participant recruitment 
websites and forums as well as through social media and university advertisements. 
Of the 226 participants who took part, 91 met the criteria for IBS, 43 stated a diagnosis 
of IBD, and 54 were considered healthy controls as they stated no diagnosis of any of 
the above disorders and did not meet the Manning criteria. Only participants in the 
three groups stated above will be considered from this point on. Due to missing data 
(i.e. participants with more than 20% missing data in a single variable (Shrive et al., 
2006)), only 84 participants with IBS were included along with 41 healthy controls 
and 42 with IBD. Participants with IBD were asked to describe their diagnosis. Sixteen 
participants reported having Crohn’s disease, 22 ulcerative colitis, one microscopic 
colitis, one intermittent IBD and one indeterminate colitis.  
Participants were considered to have IBS if they both met three or more of the 
Manning Criteria for Irritable Bowel (Manning et al., 1978), and stated a physician 
had diagnosed them with IBS. Participants who met three or more of the Manning 
criteria but did not claim to have physician-given diagnosis of IBS (i.e. they had self-
diagnosed IBS) (n=18) were not included in the analysis. Participants who stated they 
have a different diagnosis that might explain the symptoms were also excluded (n=3). 
Seventeen participants who stated that they did not have IBS but met the Manning 
criteria were excluded.  
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4.2.2. Measures.  
After completing demographic questions and the Manning Criteria for Irritable 
Bowel, participants completed questionnaires measuring beliefs about emotions, 
emotional suppression, affective distress, support-seeking intentions in relation to IBS 
symptoms, support-seeking intentions in relation to personal and emotional problems 
and IBS-related quality of life. These measures were presented in a randomized order. 
Beliefs about emotions were measured using the BES which is scored from zero to 72 
(Rimes & Chalder, 2010), emotional suppression using the CECS which is scored 
from 21 to 84 (Watson & Greer, 1983) and quality of life with the IBS-QoL which is 
scored from zero to 100 (Patrick et al., 1998), all in the same manner as in Chapter 
Three. The BES, CECS and IBS-QoL all had excellent internal consistency in this 
study (Cronbach’s alphas=.939, .943 and .945 respectively). Further details on all of 
these measures can be found in Chapter Two of this thesis (see Chapter Two, sections 
2.2.1, 2.2.2 and 2.3.1 on pages 59, 60 and 68). Two questionnaires were included in 
the current study that were not in Chapter Three, which are described below.  
 
4.2.2.1. General Help Seeking Questionnaire.  
The GHSQ is divided into two questions. Both questions ask participants to rate 
for each person/role listed how likely (on a seven-point scale) they are to go to that 
person for help (Wilson et al., 2005). Question one of the original questionnaire asks 
about help-seeking in relation to personal and emotional problems, while the second 
question asks about suicide ideation. The authors recommend the adaptation of the 
GHSQ to suit the symptoms of the disorders being researched. Therefore, for the 
current study, though question one was the same, for question two participants were 
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asked “If you were having particularly troublesome bowel symptoms, how likely is it 
that you would seek support from the following people?” For the purpose of the 
current study, the research was interested in social support-seeking only and therefore 
removed health care professionals from the list of people/roles one might seek support 
from. The remaining people/roles included intimate partner, friend, parent, other 
relative/family member and minister/religious leader. Total scores range from five to 
35 with higher scores implying a greater intention to seek support. 
In addition to the mentioned changes, the word ‘help’ was replaced with the 
word ‘support’ so as to encourage the participants to include forms of emotional help 
and support as opposed to physical support which is often what the term ‘help’ denotes. 
The modified personal/emotional support-seeking measure showed poor 
internal consistency in the current sample (Cronbach’s alpha=.580) while the 
symptom-related support seeking measure was questionable (Cronbach’s alpha=.620). 
 
4.2.2.2. The Hospital Anxiety and Depression Scale (HADS) 
The HADS was included in this study as a measure of affective distress. Fitting 
with the model suggested by previous research, affective distress appears to be an 
important component in the relationship between emotional suppression and 
outcomes. The HADS asks participants to rate symptoms of anxiety and depression 
on 14 items (seven for depression and seven for anxiety) on a 4-point scale. Total 
scores across both domains are used as a composite score for affective distress. The 
minimum possible score is zero and the maximum 42 where high scores indicate 
greater affective distress (Zigmond & Snaith, 1983). In the current study, the HADS 
had good internal consistency (Cronbach’s alpha=.894). 
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4.2.3. Design and Statistical Analysis 
To test group differences for hypothesis one, a MANCOVA was first conducted 
to test for differences between the three groups (independent factor) in beliefs about 
emotions and emotional suppression (the two dependent variables) while accounting 
for sample characteristics that significantly differed between groups. In line with the 
hypothesis, a simple planned contrast (comparing the IBS group to both the healthy 
controls and the IBD group) was used to break down any significant main effects. A 
second MANCOVA was then conducted with the same independent and dependant 
variables, using affective distress as a covariate in addition to the demographic 
covariates. Main effects were broken down in the same manner as previously reported. 
Hypothesis Two was tested in a serial mediation model (Model One). Serial 
multiple mediation tests a model that “assumes a causal chain linking the mediators, 
with a specific direction of causal flow” (Hayes, 2012, pp14). Thus, for this hypothesis 
the particular causal chain was beliefs about emotions → emotional suppression 
→affective distress → quality of life. As the current study tested a causal flow of 
mediators using cross-sectional data, an alternate model was also tested to evaluate 
the direction of the indirect effect. In this alternate model, the causal chain was beliefs 
about emotions → affective distress → emotional suppression → quality of life, where 
the two mediators from Hypothesis Two have been inverted to further examine the 
direction of Hypothesis Two. In this alternate model, and for Hypothesis Two, the 
variance explained by both support-seeking variables was statistically accounted for 
as these support-seeking variables were tested as parallel mediators (see Figure 4.1). 
The two further paths were tested in the same model (Model One), with parallel 
individual mediators to test the third hypothesis. These are single mediators that are 
hypothesised to mediate in parallel to the above proposed serial mediation. The 
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predictor and the outcome were beliefs about emotions and quality of life 
(respectively) and the two individual mediators tested in parallel are 
personal/emotional support-seeking intentions and IBS-related support-seeking 
intentions. Hypotheses Two and Three were tested simultaneously in the same model 
so as to account for any overlapping variance explained between mediators (see Figure 
4.1). 
Hypothesis Four involved testing one mediator in a separate model (Model Two). 
For this hypothesis, the predictor variable was emotional suppression and the outcome 
variable was quality of life. The mediator is this model was beliefs about emotions.  
Using bootstrapping procedures, the indirect effects were tested. For each 
indirect effect to be significant, the upper and lower 95% confidence intervals of the 
indirect effect must not contain zero. Where there was more than 20% missing data in 
a single variable, cases were excluded. For those with less than 20% missing data in a 
single variable, values were imputed using estimation maximisation techniques (Little 
& Rubin, 1987). 
 
Figure 4.1 Model One, testing Hypotheses Two and Three. 
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4.3. Results 
4.3.1. Sample Characteristics 
Chi-Square tests were conducted on demographic information to compare 
frequencies across the three groups (see Table 4.1 for sample characteristics). 
Significant results were broken down by examining standardised residuals, whereby 
residuals above 2 or below -2 are considered significant. There were significant 
differences in frequency distributions for employment status, with more full-time 
students than expected in the healthy control group and fewer than expected in the 
IBS group (χ²=12.530, df=2, p=.002). This may be explained by recruitment methods 
(i.e. people who take part in online research that is not specifically targeted towards 
them may often be students) as well as disability in the IBS group. There were also 
significantly different distributions of unemployment across the three groups 
(χ²=6.260, df=2,p=.044), however none of the residuals were above 2 or below -2.  
There were significantly fewer males than expected in the IBS group (χ²= 11.9.5, 
df=2, p=.003). There were also significantly different distributions for ethnic group 
(χ²=38.095, df=18, p=.004) and nationality (χ²=81.935, df=32, p<.001) however due 
to 80.0% and 88.9% (respectively) of expected values being less than 5, the Chi-
Square test is not considered robust in this instance (Fields, 2011). There was a 
significant difference in ages between the three groups (F(2, 161)=23.789, p<.001), 
though equal variances were not assumed (F(2,161)= 26.752, p<.001). Participants 
with IBS were significantly older than the participants in the two control groups (both 
ps<.001). This age difference may also be reflective of differences in student status 
between the IBS group and the healthy controls. This does not however explain the 
differences between participants with IBS and IBD. Means and standard deviations 
were calculated for all variables within the mediation model (see Table 4.2). 
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Table 4.1 Sample characteristics broken down by group 
Characteristics [n(%)] IBS (n=84) Healthy (n=41) IBD(n=42) 
Age [M(SD)] 43.79 (17.96) 28.35 (12.48) 27.60 (7.97) 
Sex       
Female 74 (88.1) 28 (68.3) 26 (63.4) 
Employment status       
Full-time employed 26 (28.7) 13 (31.7) 18 (43.9) 
Part-time employed 18 (21.4) 4 (9.8) 4 (9.8) 
Full-time study 12 (14.3) 17 (41.5) 14 (34.1) 
Part-time study 2 (2.4) 1 (2.4) 1 (2.4) 
Self-employed 3 (3.6) 1 (2.4) 2 (4.9) 
Unemployed 26 (31.0) 6 (14.6) 6 (14.6) 
Ethnicity       
White British 71 (84.5) 20 (50.0) 21 (51.2) 
Other White 8 (9.5) 11 (27.5) 13 (31.7) 
African Caribbean 2 (2.4) 0 (0.0) 1 (2.4) 
Indian 1 (1.2) 2 (5.0) 0 (0.0) 
Other Asian 0 (0.0) 2 (5.0) 0 (0.0) 
White and Asian 1 (1.2) 0 (0.0) 0 (0.0) 
Other mixed ethnic group 0 (0.0) 1 (2.5) 2 (4.9) 
Other ethnic group 1 (1.2) 4 (10.0) 4 (9.8) 
Home country       
United Kingdom 73 (86.9) 19 (47.5) 13 (31.7) 
North America 5 (5.6) 12 (30.0) 24 (58.5) 
Other Europe 5 (5.6) 5 (12.5) 2 (4.9) 
Australasia 0 (0.0) 2 (5.4) 2 (4.9) 
Asia 0 (0.0) 1 (2.5) 0 (0.0) 
Africa 1 (1.2) 1 (2.5) 0 (0.0) 
Education level       
Secondary school 13 (15.5) 1 (2.5) 2 (4.9) 
Sixth form 21 (25.0) 8 (20.0) 9 (22.0) 
Undergraduate 34 (39.3) 19 (47.5) 21 (51.2) 
Post-graduate 17 (19.1) 12 (30.0) 9 (22.0) 
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Table 4.2 Means and standard deviations for all measured variables 
 IBS Healthy controls IBD 
M   SD M SD M SD 
Beliefs about emotions 42.55 15.81 36.15  12.89 40.61 14.29 
Emotional suppression 56.80 11.56 51.73 12.53 58.85 11.11 
Affective distress 19.24 8.25 11.24 5.89 17.09 7.20 
Personal/emotional support-
seeking 
23.46 5.98 25.11 6.46 22.44 5.79 
Symptom support-seeking 22.46 5.97 - - - - 
Quality of life 45.80 22.41 - - - - 
 
 
4.3.2. Group Differences (Hypothesis One) 
Two MANCOVAs were conducted. In both tests the independent factor was 
participant group and the dependent variables were BES and CECS scores. In the first 
MANCOVA ethnicity (Caucasian and non-Caucasian), nationality (British and non-
British), age, sex, full-time student status and unemployment status were entered as 
covariates. Levene’s test of homogeneity of variances showed the assumption was met 
for both beliefs about emotions (F(2,159)=1.189, p=.307) and emotional suppression 
(F(2,159)=0.013, p=.987). 
Of the covariates entered into the model full-time student status was the only 
significant confound in beliefs about emotions scores (F(2,253)=4.315, p=.039). 
Nationality (F(2,253)=3.768, p=.054), unemployment (F(2,253)=3.843, p=.052), sex 
(F(2,253)=1.220, p=.271), ethnicity (F(2,253)=0.582, p=.447) and age 
(F(2,253)=1.296, p=.257) were not significant confounds. For emotional suppression 
however, nationality (F(2,253)=15.026, p<.001), and sex (F(2,253)=20.725, p<.001) 
were significant confounds while unemployment (F(2,253)=3.843, p=.052), ethnicity 
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(F(2,253)=.582, p=.447), full-time student status (F(2,253)=3.789, p=.053) and age 
(F(2,253)=.996, p=.320) were not. 
 There was a marginally significant main effect of group on beliefs about 
emotions scores (F(2, 153)=2.481, p=.087, η=.031). There was also a significant main 
effect of group on emotional suppression scores (F(2, 154)=4.875, p=.009, η=.060). 
Simple planned contrasts (where the IBS group were the comparison group) 
revealed that the IBS group scored significantly higher on measures of beliefs about 
emotions (p=.038) but not on emotional suppression (p=.100) compared to healthy 
controls and were not significantly different from the IBD group in beliefs about 
emotions (p=.683) or emotional suppression (p=.155) (see Table 4.3 for estimates). 
 
Table 4.3 Estimated marginal means and standard errors for beliefs about emotions 
and emotional suppression after controlling for demographic variables. 
 IBS Healthy controls IBD 
 EMM SE EMM SE EMM SE 
Beliefs about emotions 42.28 1.83 35.42 2.46 40.88 2.51 
Emotional suppression 56.16 1.33 52.21 1.78 59.68 1.82 
 
In a MANCOVA with the above demographic variables (ethnicity, nationality, 
age, sex, full-time student status and unemployment status) and affective distress as 
covariates, equal variances were assumed for beliefs about emotions (F(2, 159)=1.900, 
p=.153) and emotional suppression (F(2,159)=0.090, p=.914). 
Unemployment (F(2,152)=7.760, p=.006) and affective distress 
(F(2,152)=31.551, p<.001) were the only significant covariates in beliefs about 
emotions scores. Nationality (F(2,152)=3.036, p=.083), sex (F(2,152)=1.752, p=.188), 
ethnicity (F(2,152)=0.885, p=.348), full-time student status (F(2,152)=2.164, p=.143)  
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and age (F(2,152)=0.112, p=.738)  were not significant confounds in beliefs about 
emotions scores. For emotional suppression, nationality (F(2,152)=14.481, p<.001), 
unemployment (F(2,152)=4.655, p=.033), sex (F(2,152)=24.402, p<001), age 
(F(2,152)=0.059, p=.048) and affective distress (F(2,152)=21.428, p<.001) were 
significant confounds. Ethnicity (F(2,152)=0.022, p=.883) and full-time student status 
(F(2,152)=1.982, p=.161) were not significant covariates in emotional suppression. 
 There was no significant main effect of participant group for beliefs about 
emotions (F(2,153)=0.107, p=.898). However there was a main effect for emotional 
suppression (F(2,164)=3.097, p=.048) after controlling for affective distress and 
demographic variables. Planned contrasts revealed no significant difference between 
those with IBS and healthy controls in emotional suppression (p=.788). However 
those with IBD scored significantly higher than those with IBS (p=.026). Estimated 
marginal means and standard errors are presented in Table 4.4 
 
Table 4.4 Estimated marginal means and standard errors for beliefs about emotions 
and emotional suppression after controlling for affective distress. 
 IBS Healthy controls IBD 
 EMM SE EMM SE EMM SE 
Beliefs about emotions 40.49 1.69 40.14 2.42 39.99 2.20 
Emotional suppression 55.79 1.31 54.87 1.87 57.90 1.70 
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4.3.3. Mediation Model One (Hypotheses Two and Three) 
Zero order correlations for all variables in the model are presented in Table 4.5. 
The relationship between beliefs about emotions and quality of life was significantly 
serially mediated by emotional suppression and affective distress (see Figure 4.2). The 
significance of the indirect effect (standardised indirect effect=-.0921) was tested 
using bootstrapping procedures.  The bootstrapped unstandardized indirect effect was 
-.1302 and the 95% confidence interval ranged from -.2782 to -.0430 meaning the 
indirect effect containing both emotional suppression and affective distress was 
statistically significant: There was a significant negative indirect effect where stronger 
beliefs about the unacceptability of emotions relate to poorer quality of life via 
emotional suppression and distress.  
 
Table 4.5 Zero order correlations for all variables in the model 
 1. 2. 3. 4. 5. 
1. Beliefs about Emotions      
2. Emotional Suppression .381**     
3. Affective Distress 384** .436**    
4. Personal/emotional support seeking -.342* -.406** -.358*   
5. Symptom-related support seeking  -.301* -.288* -.204 .709**  
6. Quality of life -.346* -.278* -.721** .242* .101 
Note. * * p<.001, * p<.050 
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Figure 4.2 Unstandardized regression coefficients for the overall mediation model for 
IBS, where the relationship between BES and IBS-QoL while controlling for mediator 
variables is presented in parentheses.  
Note. *p<.010, **p<.001 
 
An alternate model where the two mediators’ order was inverted was also tested 
in order to support the direction of the effect of Hypothesis Two. In this alternate 
model the predictor was beliefs about emotions and the outcome was quality of life. 
The first mediator was affective distress and the second mediator was emotional 
suppression. This indirect effect was tested using bootstrapping procedures 
(standardised indirect effect=.0121).  Affective distress and emotional suppression, in 
that particular order, did not serially mediate the relationship between beliefs about 
emotions and quality of life (unstandardized indirect effect=.0153, 95% CI 
[-.0132, .0690].  
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The relationship between beliefs about emotions and quality of life was not 
significantly mediated by personal/emotional support-seeking intentions when tested 
with bootstrapping procedures (standardised indirect effect=-.0061). The bootstrapped 
unstandardized indirect effect was -.0092 (95% CI [-.1804, .0530]) and was not 
significant. 
The relationship between beliefs about emotions and quality of life was not 
mediated by IBS-related support-seeking intentions (standardised indirect 
effect=.0012). The indirect effect was tested with bootstrapping procedures and found 
to be not significant (unstandardized indirect effect=.0111, 95% CI [-.0130, .1232]). 
 
4.3.4. Mediation Model Two (Hypothesis Four) 
The relationship between emotional suppression and quality of life was 
significantly mediated by beliefs about emotions with a standardised effect size of 
-.1070. The bootstrapped unstandardized indirect effect was -.2073 (95%CI [-.4590, 
-.0532]), indicating a significant negative indirect effect (see Figure 4.3 for 
coefficients).  
 
 
Figure 4.3 Standardised regression coefficients where the relationship between 
emotional suppression and quality of life after controlling for beliefs about emotions is 
presented in parentheses  
Emotional 
suppression 
Beliefs about 
emotions 
Quality of life 
-.539* (-.332) 
.521** -.490** 
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Note: *p<.050, **p≤.001  
 
4.4. Discussion 
The current study compared those with IBS to both clinical and healthy control 
groups. Those with IBS scored higher on measures of beliefs about emotions 
compared to healthy controls (though the main effect was only approaching 
significance), but were not different from the IBD group. Though there was a 
significant main effect for emotional suppression, the planned contrasts (comparing 
those with IBS to those with IBD and to healthy controls) revealed no significant 
differences. These findings support the findings reported in Chapter Three in that a 
significant difference was found for beliefs about emotions and not emotional 
suppression. Consequently it appears that while those with IBS hold different beliefs 
about the unacceptability of emotions compared to healthy participants, their actual 
levels of emotional suppression are not statistically different.  
The current study’s finding that there is no significant difference between those 
with IBS and IBD is however discordant with Ali et al. (2000) who found that 
participants with IBS scored higher on a measure of self-silencing when compared 
with participants with IBD. This may be explained by Ali et al.’s use of the Silencing 
of the Self Scale which includes items on both cognitions and behaviours with regards 
to self-silencing. While some of the cognitions measured by Ali et al. are similar to 
beliefs about the unacceptability of emotions (e.g. “I try to bury my feelings when I 
think they will cause trouble in my close relationship(s)”), there are other cognitions 
and motivations surrounding self-silencing that are different (e.g. “When I am in a 
close relationship I lose my sense of who I am”). It may be that those with IBD differ 
from those with IBS on other related cognitions that were not measured in the current 
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study and that when measuring beliefs about the unacceptability of emotions and 
emotional suppression specifically, those with IBD score similarly to those with IBS. 
There were group differences in employment, sex, ethnicity, nationality and age. 
Such differences may have influenced the results of the group comparisons and these 
demographic variables were therefore entered as covariates in the group comparisons. 
As such the results of the ANCOVAs comparing those with IBS, IBD and healthy 
controls on beliefs about emotions and emotional suppression accounted for any 
variance in emotional suppression and beliefs about emotions that might be explained 
by these demographic variables. Though these demographic differences do not explain 
the current differences as they have been controlled for, future research may wish to 
further explore the role of employment, sex, ethnicity, nationality and age in emotional 
suppression and in beliefs about emotions.  
After controlling for affective distress, the group difference in beliefs about the 
unacceptability of emotions between those with IBS and healthy controls was no 
longer significant. For participants with IBS, the higher levels of beliefs about 
emotions compared to healthy controls might be explained by greater affective distress, 
which is consistent with the idea that the more unpleasant emotions one experiences, 
the more unpleasant emotions they have that they may want to suppress. Since the 
difference in beliefs about emotions between those with IBS and healthy controls 
appears to be explained by affective distress, it is possible there may be a reciprocal 
relation between distress and beliefs about emotions. Though not tested in the current 
study, this reciprocal relation may form part of a self-maintaining cycle where higher 
levels of affective distress in the IBS sample might result in a greater belief that 
emotional expression is unacceptable and these beliefs in turn relate to more distress 
(via emotional suppression as indicated in the current mediational findings). Further 
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research would need to explore group differences in affective distress as well as 
investigate these variables with a clear timeline in order to explore this potential cycle. 
Surprisingly, after controlling for affective distress, those with IBD were 
significantly more emotionally suppressive than those with IBS. Again, this is 
contradictory to Ali et al. (2000) who found that participants with IBS showed more 
self-silencing. This suggests that emotional suppression possibly plays some role in 
IBD. Given that this difference only became significant after controlling for affective 
distress, it could mean that individuals with IBS and IBD are equally emotionally 
suppressive but in IBS emotional suppression is explained by higher levels of affective 
distress, while in IBD it is not. While the relationship between emotional suppression 
and distress in IBD is unexplored in the current study, it appears to be different from 
the pattern found in IBS with regards to distress explaining the variance in emotional 
suppression.  
However, the finding that those with IBS held similarly strong beliefs about 
emotions to those with IBD supports this idea that beliefs about emotions may be 
relevant to both disorders. Further evidence exploring the relationships between 
beliefs about emotions, emotional suppression affective distress and quality of life in 
IBD would help explore the possibility that beliefs about the unacceptability of 
emotions and emotional suppression may play a maintaining role in other long term 
conditions regardless of whether they have explained aetiology. The current study 
found support for a model in which emotional suppression and affective distress 
serially mediate the relationship between beliefs about emotions and outcomes, in that 
particular order. This supports the idea that believing emotions to be unacceptable and 
suppressing them relates to an increase in that emotion which can then have 
implications for quality of life. This model is in line with the idea of ironic processing 
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effects and with evidence on emotional expression interventions (Broderick et al., 
2005; Gillis et al., 2006; Halpert et al., 2010; Wenzlaff & Wegner, 2000). The direction 
of this ‘causal’ chain is supported by the non-significant alternate model in which 
inverting the two serial mediators resulted in a non-significant indirect effect. 
However the current study used correlational methods to test a causal model, meaning 
causality cannot be inferred until experimental methods with a clear timeline have 
been employed. This cross-sectional evidence does however provide a theoretical 
basis for exploring emotional suppression and beliefs about emotions in a practical 
clinical context under experimental conditions. 
In line with Chapter Three, the current study also found that beliefs about 
emotions mediate the relationship between emotional suppression and quality of life 
in IBS. This is in line with the argument previously highlighted in Chapter One 
regarding a cyclical relationship between beliefs, behaviours and outcomes (see 
section 1.1.2 on page 22). This may also be reflective of processes outlined by Gillis 
et al. (2006) who argued that expressive behaviour can influence outcomes through 
changes in cognitions. Though this would need to be explored experimentally. 
The current study, as in Chapter Three, used the Manning Criteria for Irritable 
Bowel to screen for participants who had IBS. This criteria is slightly different from 
more recent diagnostic tools (such as Rome III) and therefore there may be a small 
number of participants who, for example, met the Manning criteria but may not have 
met Rome III criteria. However evidence comparing diagnostic tools for IBS have 
suggested comparable specificity and sensitivity across the measures (Saito et al., 
2000). Further to this, participants reported having been diagnosed with IBS by their 
clinician in Chapter Four and will therefore have met the criteria set out by the NICE 
guidelines to diagnose IBS (NICE, 2016) which strengthens the reliability of the 
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current sample selection methods. However, relying on participants to accurately 
report their symptoms and diagnosis may be unreliable.  
The relationship between beliefs about emotions and quality of life in IBS was 
not significantly mediated by either support-seeking variable. This suggests that the 
seeking of support may not be a key mechanism through which beliefs about the 
unacceptability of emotions and quality of life relate. Alternatively, it could be due to 
problems with the measure itself. As this measure was adapted for the purpose of the 
current study, the amended version had not been validated and was shown to have 
poor and questionable internal consistency in the current study. Thus, if reliability and 
possibly validity were lacking in the measure of support seeking, it is possible the 
construct was unable to account for a significant portion of the relationship between 
beliefs about emotions and quality of life. 
The current study has furthered previous research by examining the role of 
emotional suppression separately from the role of beliefs about emotions. In doing so, 
the current model fits within a cognitive behavioural framework which may have 
implications for interventions in IBS. Furthermore, the current study has extended 
upon Chapter Three, not just through improved methodologies (regarding the sample 
and randomisation of the questionnaires) but also through the addition of measuring 
affective distress. Firstly, this measure allowed for the exploration of group differences 
in beliefs about emotions and emotional suppression while accounting for affective 
distress. Secondly, with affective distress in the mediation model, support for ironic 
processing effects in has been established. 
The current study has therefore found theoretical support, using correlational 
methods, for emotional suppression and affective distress as mediators of the 
relationship between beliefs about emotions and quality of life in IBS. However, 
120 
 
support-seeking did not mediate this relationship. Future research should extend the 
evidence on beliefs about emotions, emotional suppression and distress in IBS using 
experimental methods with a clear timeline to establish a causal model. 
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5. Chapter Five: Beliefs about Emotions and Global Impact in 
Fibromyalgia 
 
5.1. Introduction 
Chapter Four found support for a mediation model whereby the relationship 
between beliefs about the unacceptability of emotions and quality of life was serially 
mediated by emotional suppression and affective distress in participants with IBS. 
This particular model can be explained by ironic processing effects whereby the 
suppression of unpleasant emotions results in an ironic increase of that emotion 
(Wenzlaff & Wegner, 2000). In particular, this model suggested (using correlational 
methods) that believing the expression of emotions to be unacceptable is related to an 
increase in emotional suppression. This emotional suppression was then related to an 
increase in affective distress and subsequently poorer quality of life in IBS.  
However, in Chapter Four, the relationship between beliefs about the 
unacceptability of emotions and quality of life was not mediated by support-seeking 
intentions as was proposed by Rimes and Chalder (2010). This non-significant 
mediation is supported by evidence from Sydenham, Beardwood and Rimes (2016), 
who found that social support did not mediate the relationship between beliefs about 
emotions and fatigue in healthy individuals. This relationship was again tested in FMS 
in the current study in order to explore whether support-seeking is a significant 
mediator in this sample. 
Evidence from participants with FMS has shown that emotional suppression is 
correlated with fatigue (though not with pain) (van Middendorp et al., 2008). Further 
to this, as discussed in Chapter One, interventions encouraging written emotional 
expression have shown to elicit improvements in global impact, health care utilisation, 
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disability, pain, fatigue and psychological well-being (Broderick et al., 2005; Gillis et 
al., 2006) (see section 1.4, page 44).  
Research into the relationships between cognitions, behaviours emotions and 
outcomes is essential to develop further treatments for FMS. A meta-analysis of 
treatments for FMS concluded that CBT is superior to other psychological treatment 
methods (Glombiewski et al., 2010) and a Cochrane review of chronic pain treatments  
(including treatments for FMS) suggests the need for further investigation into 
possible cognitive and behavioural mechanisms of treatment, stating  there is a need 
for better theory driven hypotheses of the mechanisms of change in treatments for pain 
(Eccleston, Williams, Morley, & Eccleston, 2009). Given the evidence on the role of 
beliefs about emotions and emotional suppression in the third and fourth chapters of 
this thesis, current investigations into the role of beliefs about the unacceptability of 
emotions and emotional suppression are needed in order to provide a more theoretical 
basis for evidence on treatments in FMS.  
Furthermore, evidence for treatments for chronic pain syndromes with comorbid 
depression have shown that stepped care (involving anti-depressant treatment 
followed by a self-management pain program) elicits clinically significant 
improvements in both depression and pain for only 26% of patients (Kroenke et al., 
2007). A secondary analysis revealed that the beliefs and cognitions of participants (in 
particular higher levels of fear avoidance) predicted reduced response to this two-step 
treatment (Ang et al., 2010). This suggests a need to focus on specific maladaptive 
cognitions in clinical samples, and in particular those with chronic pain, which is why 
beliefs about emotions are included in the current study in addition to emotional 
suppression. 
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Chapters Three and Four revealed that participants with IBS demonstrated 
significantly higher scores on measures of beliefs about the unacceptability of 
emotions compared with healthy controls, though there was no group difference in a 
measure of actual emotional suppression. In Chapter Four those with IBS did not differ 
from participants with IBD on either measure. Furthermore, after controlling for 
affective distress there was no longer a difference between those with IBS and healthy 
controls in beliefs about the unacceptability of emotions, suggesting this group 
difference might be explained by distress. Interestingly after controlling for distress, 
participants with IBD scored higher than participants with IBS in regards to emotional 
suppression. This contradicted previous research which did not account for affective 
distress (Ali et al., 2000), indicating the value of testing for group differences with 
both healthy and clinical controls while controlling for affective distress in these 
samples. The research highlights the likely role of beliefs about emotions in both IBS 
and IBD as they did not significantly differ. Furthermore, the role of distress appears 
to be key in explaining the variance in beliefs about emotions scores and emotional 
suppression. Given the differences and similarities between IBS and IBD highlighted 
in the previous chapter’s findings, it is essential to examine these variables in other 
long term conditions with persistent physical symptoms – both those with and without 
a clear aetiology. 
Previous research has found that participants with FMS are more emotionally 
suppressive than healthy controls (van Middendorp et al., 2008). However, this 
research compared participants with FMS only to healthy controls meaning this 
finding may not be specific to individuals FMS and could apply to chronic pain or 
persistent physical symptoms more broadly. The current study therefore uses a healthy 
control group and a control group with arthritis (specifically psoriatic arthritis), a 
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condition that also results in persistent pain and fatigue, but is considered to have a 
medical explanation for its symptoms. Furthermore, van Middendorp et al. did not 
control for affective distress. It might be that individuals with FMS suppress their 
emotions more because they experience a greater level of unpleasant emotions. The 
current study explored these group differences before and after controlling for 
affective distress. 
Chapters Three and Four also found that the relationship between emotional 
suppression and quality of life was mediated by beliefs about emotions, suggesting a 
more cyclic relation between these variables. This was argued to be in line with Gillis 
et al.’s (2006) supposition that the reason written emotional disclosure interventions 
show a delay in the onset of improvement is because there are cognitive mediatory 
mechanisms at play. Thus, it may be that changes in beliefs about the unacceptability 
of emotions are one of the mechanisms to which Gillis et al. refer. This model was 
also tested in the current study as emotional disclosure interventions have been shown 
to improve outcomes in participants with FMS (Broderick et al., 2005; Gillis et al., 
2006). 
Thus, the current study explores a mediation model in line with ironic 
processing effects and includes two support-seeking measure as potential mediators 
in parallel to this mediation effect. The relationship between emotional suppression 
and global impact is also explored with beliefs about emotions as the mediator. Group 
differences are tested to examine whether there is greater emotional suppression 
and/or beliefs about the unacceptability of emotions in participants with FMS and 
whether this difference is maintained after controlling for affective distress. 
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5.1.1. Hypotheses 
1. Participants with FMS will score significantly higher than healthy 
controls and participants with arthritis on measures of beliefs about emotions and 
emotional suppression before and after controlling for affective distress. 
2. The relationship between beliefs about emotions and global impact in 
FMS will be significantly serially mediated by emotional suppression and then 
affective distress. 
3. The relationship between beliefs about emotions and global impact in 
FMS will be significantly individually mediated by personal/emotional support-
seeking and symptom-related support-seeking. 
4. The relationship between emotional suppression and global impact in 
FMS will be mediated by beliefs about emotions. 
 
5.2. Methods 
5.2.1. Participants  
Participants with FMS and psoriatic arthritis were recruited online through 
websites and forums dedicated to the particular disorders of interest. Healthy 
participants were recruited through online participant recruitment websites and forums 
as well as through social media and university advertisements. A priori sample size 
calculations based on Sydenham, Beardwood and Rimes’ (2016) coefficients for the 
paths of the mediation effect of emotional suppression were used. Using these 
coefficients, a sample size of 124 was desired (Fritz & Mackinnon, 2007). 
Due to the nature of online questionnaire testing, this number was exceeded and 
recruitment was terminated once it was apparent the target had been reached. 
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To detect group differences, a minimum of 41 participants were needed in each 
group (based on G Power sample size calculations using the effect size of Rimes and 
Chalder’s (2010) comparison between those with CFS and controls on BES scores). 
Therefore 41 healthy controls and 41 IBD participants were required. This large 
difference in group sizes is thus explained by differences in required sample size for 
sufficient power.  
As a clinical control group, psoriatic arthritis was chosen as it is a condition 
involving persistent symptoms of pain that is medically explained and has a lower 
average age of onset compared to other forms of arthritis, which made the sample 
more comparable in age to participants with FMS (Scott, et al., 2013; Ramos-Remus 
et al., 2007; Wilson et al., 2009).  
Participants completed the London Fibromyalgia Epidemiology Study 
Screening Questionnaire (White et al., 1999). Further to these criteria, participants 
must state that a physician has diagnosed them with FMS. If participants did not meet 
the criteria (by either stating no to any item, not answering an item or experiencing 
symptoms only on one side) but state a diagnosis of FMS they were not included in 
the analysis. Those with other comorbid conditions were not excluded from the 
analysis so as to represent the complex nature of FMS, which includes frequent 
comorbidities such as CFS (Ciccone & Natelson, 2003) and rheumatoid arthritis 
(Wolfe & Michaud, 2004). 
Of the 357 participants who took part, after excluding 152 responses that did not 
complete a sufficient amount of questionnaires within the study, 182 met the criteria 
for FMS according to the LFESSQ and said they had been given a diagnosis of FMS 
by a clinician, 42 stated a diagnosis of psoriatic arthritis and 60 stated no diagnosis of 
any of the above disorders and did not meet the criteria for FMS. Eighteen participants 
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stated a diagnosis of FMS but did not meet the criteria and seven participants stated 
they did not have FMS or psoriatic arthritis but met the criteria for FMS and were 
excluded. Thirty-one participants said they had another diagnosis which would better 
explain the symptoms listed as opposed to a diagnosis of FMS, and one participant 
had both FMS and psoriatic arthritis. These participants were excluded, therefore only 
participants in the three groups stated above (FMS, psoriatic arthritis and healthy 
controls) will be considered from this point on.  
 
5.2.2. Measures 
Participants completed the same measures as in Chapter Four (the BES, CECS, 
HADS and GHSQ) however they did not complete the IBS-QoL or the Manning 
Criteria for Irritable Bowel. Instead they completed the LFESSQ and the FIQr. Only 
questionnaires that differ from those in Chapter Four are outlined below. 
The BES, CECS, HADS and FIQr all had excellent internal consistency in this 
study (Cronbach’s alphas=.921, .948, .901, .933 respectively). 
 
 
5.2.2.1. The General Help Seeking Questionnaire 
The GHSQ was modified in the same respect as in Chapter Four regarding the 
list of possible responses and replacing the term ‘help’ with ‘support’. In line with 
Chapter Four, the second item of this questionnaire was amended to address 
“particularly troublesome symptoms of FMS”. The amended personal/emotional 
support-seeking and symptom-related support seeking measures showed good 
internally consistency (Cronbach’s alphas = .797 and .773 respectively). 
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5.2.2.2. The Revised Fibromyalgia Impact Questionnaire 
The FIQr (Bennett et al., 2009) measured global impact of the disorder and 
contains items measuring the impact of the disorder on a participant’s life across three 
domains: function, overall impact and symptoms. Participants rated their functional 
ability in eight tasks on a scale from zero to ten, then rated the overall impact across 
two items on the same eleven-point scale. Scores are summed and converted into 
scores out of 100, where high scores indicate greater impact of the disorder on the 
participant’s life. 
 
5.2.3. Design and Statistical Analysis 
To test Hypothesis One, a one-way MANCOVA was conducted to test for 
between-group differences in BES and CECS scores after controlling for demographic 
variables which significantly differed between groups. Significant main effects were 
broken down using repeated planned contrasts comparing the FMS group to healthy 
controls and to those with arthritis. To test whether these differences remained 
significant after controlling for affective distress, the same one-way MANCOVA with 
affective distress as an additional covariate was conducted, again using planned 
contrasts to break down significant main effects. 
Hypotheses Two and Three were tested in a single mediation model with 
multiple paths assessing potential indirect effects that might explain the relationship 
between beliefs about emotions and global impact in FMS. The indirect effects were 
tested using Preacher and Hayes’s (2004) Process plug-in for SPSS with bootstrapping. 
For an indirect effect to be significant the 95% confidence intervals for that indirect 
effect must not contain zero.  
129 
 
The first path tested (Hypothesis Two) consists of two mediators working 
serially: emotional suppression and affective distress. For this path, the particular 
chain being tested was beliefs about emotions → emotional suppression →affective 
distress → global impact. As all paths were tested in one model (see Figure 5.1), this 
path was tested while also accounting for variance explained by the two support-
seeking mediators of Hypothesis Three. The direction of this path was further tested 
by inverting the two mediators in an additional alternate model to produce the 
following chain: beliefs about emotions → affective distress → emotional suppression 
→ global impact. In this new model (again controlling for support-seeking) the 
predictor and outcome were the same. However, the serial order of the mediators was 
affective distress and then emotional suppression.  
Hypothesis Three was tested in two paths which consisted of the same predictor 
(beliefs about emotions) and outcome (global impact). The two mediators were tested 
in parallel in the same model as Hypothesis Two. For one of the paths, the mediator 
was personal/emotional support-seeking and for a separate parallel path the mediator 
was symptom-related support-seeking (see Figure 5.1). As before, since all paths were 
tested in one model, the variance explained by other mediators is accounted for when 
testing each individual path. 
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Figure 5.1 Mediation model tested for Hypotheses Two and Three. 
 
Hypothesis Four was tested in a separate mediation model to test a single 
mediator (beliefs about emotions) of the relationship between emotional suppression 
and global impact. 
Where more than 20% of data were missing for items of a single scale, cases 
were excluded. Where less than 20% of data were missing values were imputed using 
estimated maximisation techniques (Little & Rubin, 1987; Shrive et al., 2006). 
 
5.3. Results 
5.3.1. Sample characteristics 
Means and standard deviations were calculated for all measured variables (see 
Table 5.1) Chi-Square tests were conducted on demographic information to compare 
frequencies across the three groups and significant results were broken down by 
examining standardised residuals, where standardised residuals above 2 and below -2 
were considered significant (see Table 5.2 for sample characteristics). There were 
significant differences in frequency distributions for employment status, with more 
full-time students in the healthy control group and the FMS group than expected 
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(χ²=66.205, df=2, p<.001), more full-time work in the arthritis group and the FMS 
group than expected (χ²=39.351, df=2, p<.001) and more unemployment in the FMS 
group than expected, while there was also less unemployment than expected in the 
two control groups (χ²=34.103, df=2, p<.001). Though there were fewer males than 
expected in the FMS group and more males than expected in both control groups 
(χ²=31.470, df=2, p<.001). There were also significantly different distributions for 
ethnic group (χ²==67.582, df=24, p<.001) and country of birth (χ²=102.264, df=44, 
p<.001) however 82.1% and 88.4% of expected values for ethic group and country of 
birth (respectively) were less than 5, meaning the Chi-Square test is not considered 
robust in this instance (Fields, 2011). In the FMS group, there were more people than 
expected whose highest qualification was secondary education and less than expected 
for both control groups (χ²=34.484, df=6, p<.001). The FMS participants were 
significantly older than both the control group and arthritis group (p<.001 for both 
comparisons), while the healthy controls were the youngest group (F(2,293)=52.859, 
p<.001).  
 
Table 5.1 Means and standard deviations for all measured variables. 
 FMS (n=182) Healthy controls 
(n=60) 
Arthritis 
 (n=42) 
M SD M SD M SD 
Beliefs about emotions 41.56 15.40 41.07  13.99 46.21 14.79 
Emotional suppression 59.76 13.56 52.12 13.92 62.64 12.31 
Affective distress 22.75   7.75 11.65   6.11 18.53   6.90 
Personal emotional support-
seeking 
22.47   7.75  22.07    6.11 17.76   7.15 
Symptom support-seeking 21.51   8.18 - - - - 
Global impact 68.36 16.38 - - - - 
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Table 5.2 Sample characteristics for each group. 
Characteristics [n(%)] FMS (n=182) Healthy (n=60) Arthritis (n=42) 
Age [M(SD)] 46.75 (11.95) 29.10 (12.33) 37.39 (12.52) 
Sex       
Female 174 (95.6) 44 (72.1) 31 (70.5) 
Employment status       
Full-time employed 31 (17.0) 17 (15.4) 27 (64.3) 
Part-time employed 36 (19.8) 11 (18.3) 7 (16.7) 
Full-time study 6   (3.3) 24 (40.0) 1   (2.4) 
Part-time study 6   (3.3) 4   (6.7) 2   (4.8) 
Self-employed 14   (7.7) 3   (5.0) 4   (9.5) 
Unemployed 90 (31.4) 10 (16.7) 5 (11.9) 
Ethnicity       
Caucasian 176 (96.7) 48 (79.9) 40 (95.3) 
Pakistani 0   (0.0) 1   (1.7) 0   (0.0) 
Bangladeshi 0   (0.0) 1   (1.7) 0   (0.0) 
Chinese 0   (0.0) 2   (3.3) 0   (0.0) 
Other Asian 0   (0.0) 2   (3.3) 0   (0.0) 
Black/African/Caribbean 2   (1.1) 0   (0.0) 0   (0.0) 
White and Black 1   (0.5) 0   (0.0) 0   (0.0) 
White and Asian 1   (0.5) 3   (5.0) 1   (2.4) 
Other mixed ethnic group 2   (1.1) 1   (1.7) 0   (0.0) 
Other ethnic group 0   (0.0) 2   (3.3) 1   (2.4) 
Home country       
United Kingdom 146 (80.2) 19 (31.1) 29 (69.0) 
North America 17   (9.3) 25 (41.7) 10 (23.8) 
Other Europe 13   (7.1) 9 (15.0) 1   (2.4) 
Australasia 1   (0.5) 3   (5.0) 2   (4.8) 
Asia 2   (1.1) 2   (3.3) 0   (0.0) 
Africa 3   (1.6) 1   (1.7) 0   (0.0) 
Education       
Secondary school 44 (24.7) 1   (1.7) 0   (0.0) 
Sixth form 58 (32.6) 15 (20.2) 19 (45.2) 
Undergraduate 48 (53.9) 26 (43.3) 14 (33.3) 
Post-graduate 28 (15.7) 18 (30.0) 9 (21.4) 
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5.3.2. Group Differences (Hypothesis One) 
Two MANCOVAs were conducted with beliefs about emotions and emotional 
suppression as the dependent variables and group (FMS, arthritis and healthy controls) 
as the independent factor. For the first MANCOVA, ethnicity (coded as Caucasian and 
non-Caucasian), nationality (coded as UK and not UK), full-time employment, full-
time student, unemployment, sex, highest education level and age were entered as 
covariates. 
Before controlling for affective distress, the assumption of homogeneity of 
variances was met for both beliefs about emotions (F(2,275)=0.386, p=.678) and 
emotional suppression (F(2,275)=0.283, p=.745).  
Ethnicity (F(2,267)=0.007, p=.931), being a full-time student (F(2,267)=1.385, 
p=.240), being unemployed (F(2,267)=0.077, p=.782), sex (F(2,267)=0.418, p=.519), 
education (F(2,267)=0.068 ,p=.795) and age (F(2,267)=0.001 ,p=.980) were not 
significant confounds in beliefs about the unacceptability of emotions. However 
nationality (F(2,267)=4.571, p=.033) and full-time employment (F(2,267)=4.960, 
p=.027) were significant covariates.  
For emotional suppression scores, ethnicity (F(2,267)=0.049, p=.824), 
nationality (F(2,267)=1.861, p=.174), unemployment (F(2,267)=1.109, p=.293) and 
sex (F(2,267)=0.058, p=.809) were not significant covariates. However full-time 
employment (F(2,267)=8.886, p=.003), being a full-time student (F(2,267)=5.354, 
p=.021), education level (F(2,267)=6.749, p=.010) and age (F(2,267)=9.659, p=.002) 
were. 
There was no significant main effect of group on beliefs about emotions scores 
(F(2,267)=2.170, p=.116, η=.016), though there was a significant main effect for 
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emotional suppression (F(2,278)=5.309, p=.005, η=.038) whereby those with FMS 
had higher emotional suppression scores than healthy controls (p=.017) but did not 
significantly differ from those with psoriatic arthritis (p=.178) (see Table 5.3 for 
estimates). 
Table 5.3 Estimated marginal means and standard errors for emotional suppression 
and beliefs about emotions after controlling for demographic variables. 
 FMS Healthy Controls Arthritis 
 EMM SE EMM SE EMM SE 
Beliefs about emotions 43.23 1.22 38.33 2.32 44.85 2.46 
Emotional suppression 59.43 1.09 53.36 2.06 62.85 2.20 
 
A second MANCOVA was conducted as above however affective distress was 
added as an additional covariate. After controlling for affective distress and 
demographic variables, the assumption of homogeneity of variance was met for both 
beliefs about emotions (F(2,275)=1.334, p=.265) and for emotional suppression 
(F(2,275)=0.236, p=.790).  
Ethnicity (F(2,266)=0.002, p=.964), nationality (F(2,266)=3.549, p=.061), 
being a full-time student (F(2,266)=0.893, p=.346), unemployment (F(2,266)=0.205, 
p=.651), sex (F(2,266)=0.005, p=.346), education level (F(2,266)=1.949, p=.164) and 
age (F(2,266)=0.001, p=.977) were not significant confounds in beliefs about 
emotions scores. However being employed full-time (F(2,266)=4.661, p=.032) and 
affective distress (F(2,266)=28.304, p<.001) were significant covariates. With regards 
to emotional suppression, ethnicity (F(2,266)=0.038, p=.846), nationality 
(F(2,266)=1.265, p=.262), unemployment (F(2,266)=0.247, p=.619), sex 
(F(2,266)=0.051, p=.822) and education level (F(2,266)=3.013, p=.084) were not 
significant covariates. However being employed full-time (F(2,266)=8.582, p=.004), 
135 
 
being a full-time student (F(2,266)=4.642, p=.032), age (F(2,266)=10.518, p=.001) 
and affective distress (F(2,266)=17.136, p<.001) were significant confounds in 
emotional suppression. 
After accounting for affective distress and demographic variables, there was no 
significant main effect of group on beliefs about emotions scores (F(2,266)=0.693, 
p=.501, η=.005).  
There was a marginally significant main effect for emotional suppression scores 
after controlling for affective distress (F(2,266)=2.468, p=.087, η=.018). There was a 
trend approaching significance where those with FMS scored lower than those with 
psoriatic arthritis (p=.068) but did not score significantly differently from healthy 
controls (p=.555) (See Table 5.4 for estimated marginal means). 
Table 5.4 Estimated marginal means and standard errors for emotional suppression 
and beliefs about emotions after controlling for demographic variables and affective distress. 
 FMS Healthy Controls Arthritis 
 EMM SE EMM SE EMM SE 
Beliefs about 
emotions 
41.65 1.20 43.07 2.38 44.84 2.35 
Emotional suppression 58.31 1.09 58.31 2.16 62.85 2.13 
 
5.3.3. Model One (Hypotheses Two and Three) 
Zero order correlations for all variables in this model are presented in Table 
5.5. Mediation analyses were conducted with beliefs about emotions, emotional 
suppression, affective distress, personal/emotional support-seeking, symptom-
related support-seeking and global impact in the model. 
An indirect effect was tested where the relationship between beliefs about 
emotions and global impact was mediated by emotional suppression and affective 
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distress in a serial manner. Emotional suppression and affective distress serially 
mediated the relationship between beliefs about emotions and global impact 
(standardised indirect effect=.0809). The significance of this positive indirect effect 
was tested using bootstrapping procedures (indirect effect=.0862, 95% CI 
[.1549, .1652]) and was found to be significant. 
An alternate model testing the direction of path one was analysed with both 
support-seeking variables also entered in the model. In this model the two serial 
mediators were inverted. Affective distress and emotional suppression did not serially 
mediate the relationship between beliefs about emotions and global impact in that 
order (standardised indirect effect=-.0045). Bootstrapping procedures were used to 
test the significance of this indirect effect (indirect effect=-.0047, 95% CI 
[-.0199, .0002]). 
Personal/emotional support-seeking was tested as a mediator of the relationship 
between beliefs about emotions and global impact, in parallel with paths one and three. 
Personal/emotional support-seeking did not mediate this relationship (standardised 
indirect effect = -.0009). Using bootstrapping procedures, this indirect effect was 
found to be non-significant (indirect effect=-.0010, 95% CI [-.0751, .0479]. 
Symptom-related support-seeking was tested as a mediator of the relationship 
between beliefs about emotions and global impact, in parallel with paths one and three. 
Symptom-related support-seeking did not mediate this relationship (standardised 
indirect effect = -.0044). Using bootstrapping procedures, this indirect effect was 
found to be non-significant (indirect effect=-.0047, 95% CI [-.0402, .0277]. See 
Figure 5.2 for coefficients. 
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Table 5.5 Zero order correlations for all variables in the model 
 1. 2. 3. 4. 5. 
1. Beliefs about Emotions      
2. Emotional Suppression .463**     
3. Affective Distress .229* .318**    
4. Personal/emotional support seeking -.459** -.512** -.253*   
5. Symptom-related support seeking -.495** -.514** -.172* .848**  
6. Global Impact -.009 .028 .579** -.045 .022 
Note. **p<.001 *p<.050 
 
 
Figure 5.2 Standardised regression coefficients for the relationships between the three 
paths. Each path tested controlling for the unique variance in alternate paths 
Note. ***p<.001 ** p<.010 * p<.050 
 
 
5.3.4. Model Two (Hypothesis Four) 
In a separate model, the relationship between CECS and FIQr was not 
significantly mediated by BES (standardised indirect effect=-.0130). The 
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unstandardized indirect effect was -.0161 with 95% confidence intervals ranging from 
-.1011 to .0910. 
 
5.4. Discussion 
In the current study, participants with FMS were more emotionally suppressive 
than healthy controls but did not differ from participants with psoriatic arthritis. 
However, there was no significant difference between groups in beliefs about 
emotions. This could be explained by uncharacteristically high beliefs about emotions 
scores in the healthy control group in Chapter Five compared with the scores in 
Chapter Four2. This high scoring control group is arguably due to sampling biases 
from online recruitment, though this perhaps does not explain why this group scores 
higher on the BES compared to other healthy control groups also recruited online in 
Chapters Three and Four. 
There were also differences in the frequencies of ethnicity, employment status, 
education level, sex and country of birth across the three groups as well as a difference 
in age. It is possible that these variables might have influenced the group comparisons 
and these variables were therefore entered as covariates in all group comparisons in 
the current study. Only education level, employment status and nationality were 
significant confounds. The variance in the group differences in beliefs about emotions 
and emotional suppression that was explained by these confounds was therefore 
covaried out and all differences found were over and above any potential confounding 
influence of these variables. However, future research investigating the role of 
education, employment and nationality in emotional suppression and beliefs about 
emotions may be useful. 
                                                 
2 A one-sample t-test on the healthy controls in the current study using the mean score for 
healthy controls in Chapter Four as a reference value indicated the controls in the current study scored 
significantly higher on the BES than the healthy controls in Chapter Four (t(59)=2.726, p=.008). 
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After controlling for affective distress there was still no significant main effect 
for beliefs about emotions and the main effect for emotional suppression became non-
significant (though it was trending towards significant). The planned contrasts for 
emotional suppression indicated a marginally significant difference between those 
with FMS and those with arthritis, where participants with arthritis were more 
emotionally suppressive. While this finding is not statistically significant, the trend is 
similar to the previous chapter. Therefore, it is possible that the role of emotional 
suppression is not specific to persistent physical symptoms with an uncertain aetiology, 
but actually there is something more broadly about persistent physical symptoms and 
long-term conditions which is related to more emotional suppression.  
With regards to the psoriatic arthritis group scoring marginally higher on the 
measure of emotional suppression compared to those with FMS, there is evidence that 
those with psoriasis (which is related to comorbid psoriatic arthritis, with estimates of 
84% of psoriatic arthritis patients reporting cutaneous symptoms (Gottlieb et al., 
2008)) control negative emotions more than healthy controls and demonstrate higher 
levels of alexithymia than a clinical control group (participants with vitiligo) 
(Kossakowska, Cieścińska, Jaszewska, & Placek, 2010; Picardi et al., 2005). Thus, it 
is also possible that psoriatic arthritis comes with its own complex emotion regulation 
difficulties that are not specifically related to other long-term conditions, which might 
explain the trend found in the current study. 
As the observed differences in emotional suppression scores ceased to be 
significant after controlling for affective distress, it appears the difference between 
healthy controls and participants with FMS in emotional suppression might be 
explained by affective distress. This mirrors the results in Chapter Four where the 
difference in beliefs about the unacceptability of emotions was no longer significant 
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after accounting for affective distress. This again supports the postulation that there 
may be a bidirectional relationship between distress and beliefs about emotions (with 
distress potentially explaining stronger beliefs that its unacceptable to express 
emotions in the IBS group, and stronger beliefs about the unacceptability of emotions 
resulting in more distress) that warrants further investigation. 
The current findings also suggest that the role of emotional suppression is not 
specific to FMS or IBS, given the higher scores in other clinical samples who 
experience persistent physical symptoms (namely IBD and arthritis) after controlling 
for affective distress.  This suggests that emotional suppression may play a similar 
role in persistent physical symptoms with and without a clear aetiology (though it is 
likely that the extent to which distress explains the variance in emotional suppression 
varies between disorders with and without aetiological uncertainty). This is evidenced 
by some existing research supporting group differences in emotional suppression 
between those with and without other conditions and evidence that emotional 
suppression is related to outcomes in different conditions such as anxiety and mood 
disorders (Campbell-Sills, Barlow, Brown, & Hofmann, 2006), anorexia nervosa and 
CFS (Hambrook et al., 2011), depression (Liverant, Brown, Barlow, & Roemer, 2008), 
breast cancer (Schlatter & Cameron, 2010), social anxiety (Spokas, Luterek, & 
Heimberg, 2009) and psoriasis (Kossakowska et al., 2010).  
The current findings support the proposed model in line with ironic processing 
effects as the relationship between beliefs about emotions and global impact was 
significantly mediated by emotional suppression and then affective distress. As such, 
it appears that having these beliefs that expressing emotions is unacceptable is related 
to more emotional suppression. The findings are consistent with the proposal that this 
emotional suppression is then related to an increase in affective distress which in turn 
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is related to a greater impact of the disorder on the person’s life. It appears that these 
ironic processing effects in relation to beliefs about emotions and emotional 
suppression may be present in both IBS and FMS. 
An alternate model where the two serial mediators were inverted was not 
significant. This suggests that the particular path being tested is supported in that 
particular direction. However, the current study has used correlational methods to test 
a causal chain of variables. While this finding theoretically supports the notion of a 
causal relationship in this particular direction, experimental methods with a timeline 
are needed to truly establish causality in this proposed model. 
Though there was a significant indirect effect found in both studies, the 
relationship between beliefs about emotions and global impact in the current study 
was not significant before or after controlling for the mediators. This suggests that 
there is no direct relationship between beliefs about emotions and global impact in 
FMS. This is somewhat unexpected given that there was a significant positive indirect 
effect via emotional suppression and affective distress. While there may be some 
detriment to holding these beliefs about the unacceptability of emotions, there may 
also be a protective factor, thereby cancelling out any significant direct relationship. 
This is known as inconsistent mediation whereby multiple mediators may elicit 
separate indirect effects that are in opposing directions, resulting in a non-significant 
overall effect (Mackinnon, Fairchild, & Fritz, 2010). This therefore might indicate that 
there is both a positive indirect effect (as found in the current study, where beliefs 
about the unacceptability of emotions were related to greater impact of the disorder) 
and a significant negative indirect effect.  
Though no mediator measured in the current study indicated a significant 
negative indirect effect, other possible mediators may exist. For example, it may be 
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that those who believe it is unacceptable to express their emotions may feel a need to 
appear unaffected by their condition to others. This may result in less avoidance of 
activity and limiting behaviours. This may then relate to better outcomes (i.e. less 
impact on the person’s life). It may be that for some individuals, beliefs about 
emotions relate to more emotional suppression, thereby resulting in poorer outcomes; 
while for others, these beliefs relate to better outcomes because they are less avoidant 
of activity. Further research into potential mediators of this relationship may help 
explain the inconsistent mediation found in the current study. 
The existence of subgroups may also explain this inconsistent mediation. There 
may be individual differences not only in the levels of beliefs about emotions, 
emotional suppression, affective distress and global impact; but also in the strength 
and direction of the relationships between these variables. Indeed, there is early 
evidence that there are clusters within FMS that differ based on their relationships 
between emotional expression and distress (López-Cicheri, van Middendorp, & 
Geenen, 2013). Future research with larger samples could explore subgroups with 
regards to the current mediation model. 
The evidence for a significant indirect effect is nonetheless supportive of 
previous evidence showing emotional expression interventions to be beneficial in 
patients with FMS (Broderick et al., 2005; Gillis et al., 2006) in that believing 
emotions to be unacceptable and emotional suppression were related to greater impact 
of the disorder in this indirect path. The current study has extended this evidence on 
emotional expression in relation to outcomes in FMS to include beliefs, which enables 
a more cognitive behavioural approach to be taken when addressing emotionally 
suppressive behaviours during intervention - though further evidence is required 
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before addressing beliefs about emotions in a therapeutic context to test other possible 
factors that might explain the inconsistent mediation found in the current study. 
This study also tested models using support-seeking as mediators of the 
relationship between beliefs about emotions and outcomes. Conversely to the 
hypotheses, neither support-seeking variable significantly mediated the relationship 
between beliefs about emotions and global impact. This was also found to be non-
significant in participants with IBS in Chapter Four.  
In the current study, support-seeking was found to be related to beliefs about 
emotions but not to global impact. It could be that measuring support-seeking 
intentions as opposed to actual received social support could explain this finding. 
There may be confounding variables influencing the amount of social support received 
which might ultimately be more closely related to impact of the disorder on a person’s 
life. For example, there may be possible interactions between whom they ask for help 
and how they ask for help that have not been adequately measured in the current study. 
It is also possible that beliefs associated with support-seeking are different from 
beliefs specifically about emotional expression, for example the individual may hold 
beliefs about the acceptability of sharing struggles in relation to the symptoms, which 
are different from beliefs about sharing emotions. Furthermore, the current measure 
of support-seeking was adapted for use in the current sample and therefore was not 
validated. While the amended scales did show good internal consistency, their 
construct validity may be questioned as the amended item had not been rigorously 
tested against other measures. Furthermore, the perception of this questionnaire to the 
target population has not been investigated which means incomprehension of the 
question cannot be sufficiently ruled out. Reliability tests would also need to be carried 
out using the amended scale to ensure the measure is consistent over time. Future 
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research using psychometrically tested measures of support-seeking might provide 
evidence for a role of support-seeking in the current model. 
In Chapters Three and Four, the relationship between emotional suppression and 
quality of life in IBS was mediated by beliefs about the unacceptability of emotions. 
It was suggested this might be reflective of processes outlined by Gillis et al. (2006) 
who argued that expressive behaviour can influence outcomes through changes in 
cognitions. However, Gillis et al. suggested this based on findings in patients with 
FMS and the tested mediation effect was not supported in the current study which also 
tested participants with FMS. It is possible therefore that other cognitive factors might 
mediate this relationship between increased emotional expression and improved 
outcomes in FMS in line with what Gillis et al. suggested. Research exploring 
mechanisms of change in trials of written emotional disclosure would best address this 
research question as there are differences between written emotional disclosure and 
other forms of emotional expression (such as talking with others incurring a risk of 
judgement and stigma that is not present when writing). Furthermore the timing of the 
changes in the mediator are crucial when attempting to explain delayed health benefits 
and thus experimental evidence is essential in answering this research question. 
Evidence of a slight bias can be found in the overrepresentation of women and 
Caucasian participants in the current study particularly in the FMS group (though Chi 
Square analyses on ethnicity may not be considered robust in this instance). This may 
be due to online recruitment sources (e.g. FMS forums and Facebook groups) 
appealing to these particular demographics. The generalisability of these findings to 
non-Caucasian and male participants with FMS may therefore be questioned. Further 
research should explore differences between subgroups of participants with FMS, 
especially in the light of evidence that black and minority ethnic participants with CFS 
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differ from white British participants with CFS in terms of damage beliefs, 
catastrophizing, all-or-nothing behaviour, avoidance/resting behaviour and 
embarrassment avoidance (Ingman, Ali, Bhui, & Chalder, 2016). However, the large 
differences in sample sizes between the ethnic groups studied by Ingman et al., and 
the failure to apply corrections for multiple testing, question the reliability of the 
findings, suggesting more research on diverse ethnic groups is needed in order to 
apply the current study’s findings more widely. 
The current study found support for emotional suppression and affective distress 
as mediators of the relationship between beliefs about emotions and global impact, 
despite the direct relationship being non-significant. Further research should explore 
this model using experimental methods to understand the value of these variables 
within the context of intervention. Support-seeking did not significantly mediate the 
relationship between beliefs about the unacceptability of emotions and global impact 
in FMS or in IBS. This finding is unexpected and support-seeking should perhaps be 
explored further with regards to different cognitions and outcomes. 
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6. Chapter Six: Validating a new measure of beliefs about sharing 
illness experiences 
6.1. Introduction 
The previous chapter found that the relationship between beliefs about 
emotions and global impact was serially mediated by emotional suppression and then 
affective distress in individuals with FMS. However, this relationship was not 
mediated by support-seeking. Furthermore, the direct relationship between beliefs 
about emotions and global impact was not significant.  
Studies to this point in the thesis have explored the role of beliefs about the 
unacceptability of experiencing and sharing emotions with others. It was then 
hypothesised that this would be related to support-seeking based on cognitive 
behavioural models of persistent physical symptoms, which suggest that if one 
believes that emotions are unacceptable, they may try to hide their emotions and not 
ask for help, which can in turn lead to lead to increased distress and physiological 
symptoms such as fatigue, pain (Ali et al., 2000; Rimes & Chalder, 2010; Surawy et 
al., 1995). However it can be argued that there is an important distinction between 
sharing emotional experiences and sharing experiences regarding one’s illness in that 
discussing illness experiences may be more relevant to support-seeking intentions 
compared with openness to disclosing emotional experiences, for example, when 
considering stigma related to a disorder (McInnis, McQuaid, Bombay, Matheson, & 
Anisman, 2015). 
There are barriers to sharing illness experiences for those with persistent 
physical symptoms, especially when there is no clear medical explanation, which may 
include fear of people’s judgements. McInnis et al. (2015) have argued that in 
conditions that lack clear medical explanations (for example FMS and CFS) there is 
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stigma which results in increased secrecy about the condition. This secrecy may then 
result in the individual trying to appear as though they are not struggling with their 
condition to others and this may then be related to a reduction in social support 
(McInnis et al., 2015). Evidence for this relation between stigma and perceived 
support has also been found in patients with mental health conditions. In a Dutch 
sample of participants with mental health diagnoses, it was found that there were 
significant, though small, relationships between stigma, disclosure and social support 
(Bos et al., 2009).  
One way in which stigma in relation to non-disclosure of illness can be 
damaging to an individual is if they then internalise prejudice (Corrigan et al., 2010). 
This has been termed internalised stigma or self-stigma, where individuals believe the 
stereotypes that exist among the community. Regarding mental health for example 
“Because I have a mental illness, I am dangerous” and “Nobody would be interested 
in getting close to me because I have a mental illness” are internalised stigma beliefs 
(Corrigan et al., 2012; Ritsher, Otilingam, & Grajales, 2003).  This internalised/self-
stigma has been studied in relation to mental health conditions and the stigma 
surrounding them. In a study of 87 participants with mental health conditions, it was 
found that the relationship between self-stigma and quality of life was mediated by 
the benefits of disclosing one’s mental health status to others (Corrigan et al., 2010).  
The effects of having a strong and supportive social network are well 
documented in health psychology research, with reduced social ties being linked to 
increased morbidity and mortality (Uchino, 2013). There is evidence in FMS and other 
pain populations that suggests social support is related to better outcomes. For 
example, low social support in the workplace is considered a risk factor for developing 
chronic low back pain (Hoogendoorn, Vanpoppel, Bongers, Koes, & Bouter, 2000). 
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And in rheumatoid arthritis, it has been found that disappointment with social support 
is associated with maladaptive coping and that social support measured at the time of 
diagnosis predicted long-term functional disability (Evers, Kraaimaat, Geenen, Jacobs, 
& Bijlsma, 2003; Holtzman, Newth, & Delongis, 2004). 
One study has looked both quantitatively and qualitatively at social support in 
FMS and CFS, combining the two patient groups. With 46 participants who had either 
or both FMS and CFS, it was found that perceived support from family and friends, 
and not support from health care providers, was significantly related to quality of life, 
with large effect sizes (r=.509 and .610 respectively). During an interview with 16 of 
these participants, it was noted that individuals with CFS and FMS tend to report low 
levels of social support (Schoofs, Bambini, Ronning, Bielak, & Woehl, 2004). 
However, these results were found in a small sample that consisted of individuals with 
CFS and FMS when there may be important distinctions between these two patient 
groups. Additionally, reporting low levels of social support in an interview is not 
sufficient evidence. Comparisons would need to be made with other groups to confirm 
whether social support is perceived to be lower in these individuals compared with 
others. 
It has been suggested that there are different kinds of social support and that 
some may be more helpful than others. For example, Sherbourne and Stewart (1991) 
distinguished between tangible support (defined as behavioural and material 
assistance and emotional support (referring to attachment or affect). In a study looking 
at 94 adults who had been diagnosed with juvenile FMS, perceived social support and 
social network size significantly predicted physical functioning and depressive 
symptoms after controlling for pain intensity and condition (i.e. FMS or healthy 
control) (Lynch-Jordan, Sil, Bromberg, Ting, & Kashikar-Zuck, 2015). The study also 
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found that compared with 33 healthy controls, perceived tangible support, perceived 
emotional support, social network size and positive social interactions were all 
significantly lower in the FMS than the healthy control group. While the authors 
acknowledged issues with unequal samples and addressed these by adjusting their 
alpha level, there were no corrections for multiple comparisons indicating an 
increased risk of Type I error.  
Though specific facets of social support were not tested as predictors in Lynch-
Jordan et al.’s study, when looking at correlations, emotional support and positive 
social interaction were related to physical functioning, while tangible support and 
affectionate support were not. All four facets of perceived social support (i.e. 
emotional, tangible and affectionate support, and positive social interaction) however 
were related to depression symptoms. The authors concluded (though based on a small 
sample specifically with juvenile FMS) that social support has a relationship with 
physical functioning that is not explained by greater pain intensity (i.e. those with 
more pain need more support). 
The above evidence on the relation between social support and outcomes in 
chronic pain and in FMS suggests there may be a link between social support and 
outcomes in FMS, but the quality of evidence to date is poor. Furthermore, the 
evidence suggests that different kinds of support may be more or less related to 
outcomes around physical functioning. The above evidence also appears to suggest a 
trend in that there is less social support perceived in individuals with FMS. Since 
support-seeking did not mediate the relationship between beliefs about the expression 
of emotions and global impact in the previous study (Chapter Five), exploration of 
other beliefs that may be more relevant to social support (such as beliefs about sharing 
the experiences of one’s illness) is warranted. By doing so it may be possible to 
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uncover a potential maintaining cycle similar to that found in Chapters Four and Five 
with regards to beliefs about emotions and emotional suppression. In this cycle, it may 
be that unhelpful beliefs about sharing illness experiences relate to reduced support-
seeking and greater symptoms and/or reduced function.  Based on research described 
above, it is suggested then that the consequent struggles with symptoms and poorer 
functioning will again not receive support from one’s social network so as to maintain 
symptoms and disability. 
Another way in which fear of stigma and social judgements surrounding 
sharing one’s illness experiences might relate to outcomes is by individuals trying to 
appear well to others (McInnis et al., 2015), which may alter their level of activity. 
Activity pacing is often a target of pain management programmes for a range of 
chronic pain conditions (Andrews, Professor-Strong, Meredith, 2012). Both 
avoidance of activity due to fear of symptoms and confrontation/persistence of activity 
with a disregard for symptoms have been associated with the maintenance of chronic 
pain, where in particular a pattern has been described where excessive persistence 
cannot be sustained which then results in an increase in symptoms and consequently 
enforced rest (Antcliff, Keeley, Campbell, Woby & McGowen, 2015). 
 Previous research into behavioural responses to illness has investigated the 
role of all-or-nothing and limiting behaviour. All-or-nothing behaviour is a cycle of 
over-activity and a consequent need to rest, while limiting behaviour refers to 
individuals resting and limiting activity in the response to illness.  As described in 
Chapter One, research has shown that all-or-nothing and limiting behaviour predicted 
the onset of IBS following Campylobacter infection, suggesting that this boom-and-
bust activity pattern and inadequately limiting activity when faced with illness works 
as part of a maintaining cycle in IBS (Spence & Moss-Morris, 2007;  Spence, Moss-
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Morris, & Chalder, 2005). With regards to FMS physical activity is considered a key 
component in the maintenance of FMS symptoms (Steiner, Bigatti, & Ang, 2015), and 
although there is little evidence of this all-or-nothing cycle in research focusing on 
people with FMS, evidence can be drawn from research focusing on chronic pain.  
A recent study, using qualitative methods, argues that boom-and-bust activity 
patterns may work to maintain symptoms of FMS (Antcliff, Keeley, Campbell, Woby, 
& Mcgowan, 2015). This was based on interview data from 16 individuals diagnosed 
with either CFS (n=2), FMS (n=5) or chronic low back pain (n=9). Similarly, in a 
study of 132 individuals with musculoskeletal pain, all-or-nothing behaviour was 
related to pain and to disability (Kindermans et al., 2011). Together, this evidence 
suggests that all-or-nothing/boom-and-bust cycles of behaviour may play a role in 
maintaining symptoms of pain, though further evidence on samples specifically 
diagnosed with FMS are warranted. 
Spence, Moss-Morris and Chalder (Spence & Moss-Morris, 2007;  Spence, 
Moss-Morris, & Chalder, 2005) found that initially limiting behaviour at the onset of 
illness was beneficial and predicted not developing later IBS,  although ongoing 
limiting behaviour is unhelpful. This in part is consistent with the fear-avoidance 
model of pain that argues that fear of pain results in limiting activity and this limited 
activity over a longer period of time then results in greater disability through 
deconditioning (Lethem et al., 1983).  
It is proposed that helpful beliefs about sharing illness experiences may enable 
individuals to engage in a level of activity that is helpful for them (e.g. graded return 
to activity after a period of acute illness or fatigue), as this enables greater 
understanding from others of the particular needs of that person at that time. 
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In summary, based on previous research described above, it is proposed that 
in response to the fear of social judgements when sharing illness experiences, and the 
resulting need to appear as though one is not struggling (McInnis et al., 2015), 
individuals with FMS may overexert themselves, which forces them into periods of 
prolonged rest, or they may avoid activities. This may, in turn, result in deconditioning 
and greater pain and/or disability. Similarly, these beliefs about social judgements of 
sharing illness experiences might result in a reduction in the intention to seek support. 
This reduction in social support may in turn relate to poorer outcomes.  
Based on the above evidence, it would be useful to identify and measure 
cognitions that relate to talking about one’s illness experiences however such a tool 
was not identified by the author in the existing literature. This tool may be useful, not 
only as an instrument in research, but also in clinical practice. The current studies 
presented in this chapter therefore validated a measure named the Beliefs about 
Sharing Illness Experiences scale (BASIE) that was developed by the academic 
supervisor of this project. The second study in this chapter tested hypothesised 
mediation models using this measure. 
 
6.2. Study One: Validating the BASIE 
6.2.1. Hypothesis 
It is hypothesised that the measure will demonstrate a clear factor structure and 
will be internally consistent. When comparing individuals with FMS to healthy 
controls, it is expected that those with FMS will score higher. It is also hypothesised 
that the new tool will correlate with similar constructs and with outcomes in FMS. 
The BASIE is expected to have large negative correlations with the two support-
seeking scales (personal/emotional and symptom-related) and moderate positive 
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correlations with all-or-nothing behaviour, limiting behaviour and self-sacrifice 
schema. 
 
6.2.2. Methods 
6.2.2.1. Participants and procedure 
All participants provided informed consent before taking part in online 
questionnaires. Participants with FMS (n=147) were recruited online through social 
networking FMS communities (for example on Reddit and Facebook) in addition to 
online FMS forums (FMAUK and UK Fibromyalgia). Ninety-five was the target 
sample size for this study. The BASIE was considered similar in content and structure 
to the BES (Rimes & Chalder, 2010). The validity of the BES was evaluated by 
correlating scores with similar constructs and the coefficients of the significant 
correlations of Rimes and Chalder’s validation study ranged from .25 to .73. Using 
the minimum effect size of this study, 95 was calculated to be the sample size required 
to achieve statistical power at .8.Of the participants who took part, 16 did not meet the 
LFESSQ criteria for FMS and were excluded from the analysis. Nine participants did 
not respond to a sufficient number of items (less than 80%) of the BASIE and were 
therefore excluded from all further analyses.  
Of the remaining 122 participants, if more than 20% of data was missing for any 
given scale, the participant was not included in the analysis for that particular scale. 
For missing data less than 20% of a particular scale, estimation maximisation 
techniques were used to impute missing data (Shrive et al., 2006).  
Healthy controls (n=47) were recruited online through participant recruitment 
webpages and social media and through word of mouth, employing snowballing 
methods. The desired sample size for this group (n=41) was calculated in the same 
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manner is the previous three studies, using the effect size of Rimes and Chalder’s 
(2010) comparison between participants with and without CFS on the BES. Five 
participants met the criteria for FMS despite stating they do not have the disorder. Two 
of the remaining participants did not complete more than 80% of the BASIE and were 
excluded. Therefore, the final sample consisted of 122 participants with FMS and 40 
controls. 
 
6.2.2.2. Questionnaire Development 
The questionnaire was developed by a Clinical Health Psychologist, working 
with people with persistent physical symptoms, including FMS. Items were developed 
based on the cognitions regarding beliefs about sharing illness experiences identified 
by clients with persistent physical symptoms (including FMS) during Cognitive 
Behavioural Therapy sessions as opposed to in formal cognitive interviews, for 
example “If I ask for help, then I have failed in some way” and “If people know about 
this condition, they will judge me”. Several beliefs were discussed in depth with 
individuals with coeliac disease, lung condition and persistent pain, as well as 
individuals without persistent symptoms, to check that the questions were acceptable 
to participants, and that they understood them. Once a draft questionnaire had been 
developed, this was shared with other clinical psychologists and subsequent 
amendments were made. No statistical analyses (including factor analysis) had been 
conducted prior to the current study. The scale was therefore developed outside of the 
current study. However, this draft measure, with 26 items, was then used in the current 
study to examine the reliability and validity of the scale. The questionnaire was named 
the Beliefs about Sharing Illness Experiences questionnaire (BASIE). The full 
questionnaire as it appeared online can be found in Appendix G. The response scale 
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was designed to be 11 points initially however when adding the questionnaire to the 
online platform, it was decided to use a slider scale which was from zero to 100 as 
this appeared to be more user-friendly and avoids issues with individual differences 
in interpreting the differences or intervals between responses (e.g. the difference 
between very much disagree and totally disagree).  
Participants were asked to rate from totally disagree to totally agree (on a slider 
scale from zero to 100) with each statement. The questionnaire covers both positively 
and negatively focused beliefs about illness disclosure and therefore the positively 
worded items (items 21 to 26) were reverse scored to create a total score on this 
measure. This meant that high scores indicated more negative beliefs about sharing 
illness experiences. 
The instructions given to the participants with FMS instructs participants to 
reflect on how they think most of the time: “Please move the slider to a position that 
best describes how you think. Please note that because people are different, there are 
no right or wrong answers to these statements. The way you think about these things 
might vary depending on who you are talking to, but try focus on how you tend to 
think in general.” 
 However, for the purpose of recruiting healthy controls as a comparison group, 
participants who do not have FMS were instructed to reflect on a time when they have 
experienced “significant pain or fatigue”, which might have been due to illness or 
injury: “For these questions, you will need to think of a time when you have 
experienced significant pain or fatigue. This might have been due to an illness or due 
to an injury. When we refer to condition in these questions, we are referring to the pain 
or fatigue experience you have chosen to think about.” For these participants, there 
was a question asking them to describe the experience they chose to reflect on. This 
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response was not analysed, but used to ensure participants saw the instruction to 
consider a specific time when they experienced pain or fatigue. 
 
6.2.2.3. Measures 
To test the construct validity of the BASIE, similar constructs to the BASIE 
were selected to be measured. In addition, the FIQr and the HADS were measured as 
outcomes (current study Cronbach’s alphas=.927 and .856 respectively). These two 
outcome measures are described in detail in Chapter Two of this thesis (sections 2.2.3 
and 2.3.2). The measures which are specific to the current study and the details of 
these which are not described earlier in the thesis are described below. 
 
6.2.2.3.1. Self-Sacrifice Schema Scale 
In order to test convergent validity, it was proposed to use a questionnaire that 
measured similar beliefs to that of the proposed questionnaire. However, a 
questionnaire specifically measuring beliefs about sharing illness experiences could 
not be found. The closest questionnaire, which measures beliefs about receiving and 
giving support to others, is The Self-Sacrifice Schema Scale (SSSS), a subscale of 
Young’s Schema Questionnaire (Young, 1998). It consists of 17 items with responses 
rated on a six-point scale (from ‘completely untrue of me’ to ‘describes me perfectly’). 
These items measure schemas pertaining to helping others even at the expense of one’s 
own needs or wants (e.g. “I give more to other people than I get back in return”). The 
subscales of Young’s Schema Questionnaire have been supported using factor analysis 
(Saariaho, Saariaho, Karila, & Joukamaa, 2009; Welburn, Coristine, Dagg, Pontefract, 
& Jordan, 2002). Total scores have a maximum score of 35 and a minimum score of 
5, where higher scores demonstrate a stronger presence of self-sacrifice schemas.  
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In 271 Finnish patients with pain, internal consistency was good (Cronbach’s 
alpha=.83) (Saariaho et al., 2009). Waller, Meyer, & Ohanian (2001) evaluated the 
Schema Questionnaire and found that all subscales (including Self Schema) had a 
Cronbach’s alpha greater than .80 for both participants with bulimia and the female 
non-bulimic comparison group. When comparing bulimics with the comparison group, 
bulimics scored higher. The Self-Sacrifice subscale was not however related to 
binging or purging behaviours in the bulimic group. In the current study, the SSSS had 
excellent internal consistency (Cronbach’s alpha=.901). 
 
6.2.2.3.2. GHSQ 
In order to test convergent validity further, additional scales were used, that 
measures behaviours associated with beliefs about sharing illness experiences. As 
explained in the introduction to this chapter, relevant behaviours include support-
seeking, as individuals who believe there are negative consequences to sharing these 
experiences are expected to be less likely to seek social support. The GHSQ was used 
to measure support-seeking. The GHSQ was modified as in Chapter Five to create two 
scores measuring personal/emotional support-seeking and symptom-related support-
seeking separately. For more details on this measure refer to Chapter Two: Methods 
(page 53) and Section 5.2.2.1 (page 127). Internal consistency for personal/emotional 
(Cronbach’s alpha=.602) and symptom-related support seeking (Cronbach’s 
alpha=.630) in the current study was questionable. 
 
6.2.2.3.3. Behavioural Response to Illness Questionnaire (BRIQ) 
The BRIQ was developed in order to measure behavioural responses to acute 
illness and how these relate to the development of persistent physical symptoms for 
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which there is no known medical explanation (Spence et al., 2005). The scale has four 
subscales, all-or-nothing behaviour, limiting behaviour, emotional support-seeking 
and practical support-seeking. While emotional and practical support-seeking appear 
relevant for the current study, an author of the measure has stated that both these 
subscales of the questionnaires are problematic and advised against using them in the 
current study (R. Moss-Morris, June 1st, 2015). In a study validating the measure, 
practical support-seeking and emotional support-seeking did not predict later cases of 
IBS in a sample of 580 participants with Campylobacter (Spence et al., 2005). This 
finding has been used to argue that these two subscales are not valid. The all-or-
nothing and limiting behaviour subscales were therefore used. These were only used 
with participants with FMS and not healthy controls as they measure behavioural 
responses to illness. 
 
6.2.2.3.4. All-or-nothing behaviour 
 All-or-nothing behaviour is a pattern of activity characterised by periods of 
over-exertion and periods of excessive resting, often viewed as a ‘boom-and-bust’ 
cycle of activity (Surawy, 1995). This subscale of the BRIQ uses six items to address 
all-or-nothing activity patterns in participants with physical symptoms. In the current 
study, internal consistency was good (Cronbach’s alpha= .847). 
In response to each statement, participants are asked to rate the frequency with 
which it applies to their life on a five-point scale from ‘not at all’ to ‘everyday’. 
Structural validity was evident in the validation of this measure with all six items 
loading onto the same factor, and the scale was found to be internally consistent 
(Cronbach’s alpha=.81). In a sample of 758 participants with campylobacter, the 
authors of the scale correlated all-or-nothing behaviour with symptoms of 
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campylobacter and with days off work. However, these correlations, though 
significant, were only small. It might be that all-or-nothing behaviour shows only a 
small (negative) relationship with days off work because participants scoring highly 
on this measure are more likely to persist with work during the ‘boom’ phase of the 
cycle. Additionally, these all-or-nothing behaviours might not relate strongly with 
symptoms of infection, but may still relate to symptoms of later IBS.  
In a prospective study of 580 individuals with Campylobacter, it was found that 
all-or-nothing behaviour predicted later onset of IBS (n=99) (Spence et al., 2005). It 
would be expected that individuals who do not disclose their illness experiences may 
instead persist with activity (Griffith & Ryan, 2015), which may then result in forced 
periods of rest. 
 
6.2.2.3.5. Limiting behaviour 
The limiting subscale of the BRIQ comprises items measuring the avoidance of 
activities due to one’s illness (e.g. “I would put parts of my life on hold”). This 
subscale contains seven items which are rated in the same way as the all-or-nothing 
subscale described above. This subscale was deemed internally consistent 
(Cronbach’s alpha=.89) and was correlated positively with days off work and with 
Campylobacter symptoms suggesting it is a valid measure. In the current study, 
internal consistency was questionable (Cronbach’s alpha= .671). In the initial study 
validating the measure, limiting behaviour did not significantly predict the onset of 
later IBS following infection with Campylobacter, though there was a trend in the 
expected direction (p=.105) (Spence et al., 2005). However, in a later study with 581 
participants with Campylobacter, limiting behaviour was a significant predictor of the 
onset of IBS, with those who exhibit more limiting behaviour after infection less likely 
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to develop IBS. Again, it may be that those who feel the need to continue with activity 
as a means of avoiding sharing illness experiences (Griffith & Ryan, 2015) may 
engage in less protective limiting behaviour. 
 
6.2.2.4. Design and statistical analysis 
The current study employed a correlational and cross-sectional design. In order 
to assess the psychometric properties of the BASIE, Cronbach’s Alpha was used for 
internal consistency and exploratory factor analysis using direct oblimin rotation to 
test dimensionality (thereby allowing for correlations between factors).  
 To evaluate construct validity, participants with FMS were compared to 
participants without FMS on the BASIE using a randomly selected 40 participants 
with FMS so as to avoid the influence of unequal sample sizes on statistical power. A 
one-way MANCOVA compared groups on the BASIE and its two factors while 
controlling for affective distress and demographic features found to be significantly 
different between the two groups. 
Convergent validity was examined using partial correlations controlling for 
affective distress (using HADS scores) with all participants with FMS to determine 
whether the BASIE correlates with other scales measuring similar constructs (GHSQ, 
SSSS, and the BRIQ all-or-nothing behaviour and limiting behaviour subscales). 
Affective distress was controlled for as there is strong evidence for greater negative 
affect in individuals with FMS and chronic conditions more generally (Deary et al., 
2007; Moss-Morris, 2013; van Middendorp et al., 2008) and this might explain the 
relation between these measured variables over and above the scales measuring 
similar constructs. Bivariate correlations were also used to test for relationships 
between the BASIE and outcomes (HADS and FIQr).  
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6.2.3. Results 
6.2.3.1. Sample characteristics 
Demographic information about the participants was analysed using chi-square 
tests of association and significant associations were broken down using standardised 
residuals (i.e. if the standardised residual is greater than 2, it was considered 
significantly different from chance). Demographic information for each group is 
presented in Table 6.1.  
There was no significant difference between groups in age (t(158)= .199, 
p=.343) or sex (χ2= 1.441, df=1, p=.230). There were more participants in the healthy 
control group who were employed full-time than expected by chance (χ2= 10.571, 
df=1 p=.001) and fewer participants in this group who were unemployed (χ2=9.032, 
df=1, p=.003). This difference in employment could be explained by those with FMS 
being unable to work full-time or perhaps being unable to work at all due to their 
disorder.  
There were significantly different distributions of ethnicity across the two 
groups than would be expected by chance (χ2=17.10, df=8, p=.029), however 83.3% 
of expected values were less than 5 so the chi-square test cannot be considered robust 
in this instance.  
There were more participants in the healthy control group with post-graduate 
education than expected by chance and more participants in the FMS group whose 
highest level of education was secondary school (up to 16 years) (χ2= 20.363, df=3, 
p<.001). This education difference might be explained by recruitment methods. 
Participants in the control group were in part recruited through word of mouth, thus 
the two researchers were perhaps more likely to reach out to people who also have 
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completed post-graduate education. The higher rate of education finishing at 
secondary level in the FMS group could be explained by symptoms preventing 
participants from completing education past what is compulsory.  
No other demographic variables showed differences in frequencies across the 
two groups. The variables which did show differences (i.e. education and 
employment) were entered as covariates in tests of group differences so as to account 
for any differences in BASIE scores which might be explained by these characteristics. 
Means and standard deviations for all measured variables are presented in Table 6.2.  
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Table 6.1 Demographic information for both groups. 
Characteristics [n(%)] FMS (n=122) Healthy (n=40) 
Age [M(SD)] 44.19 (11.32) 42.23 (11.39) 
Sex     
Female 114 (87.5) 35 (93.4) 
Employment status     
Full-time employed 28 (23.0) 20 (50.0) 
Part-time employed 22 (18.0) 12 (30.0) 
Full-time study 3 (2.5) 1 (2.5) 
Part-time study 1 (0.8) 1 (2.5) 
Self-employed 5 (4.1) 3 (7.5) 
Unemployed 29 (23.8) 7 (2.5) 
Retired 15 (12.3) 1 (2.5) 
Chosen not to work 6 (4.9) 0 (0.0) 
Home maker 19 (15.6) 3 (7.5) 
Ethnicity     
Caucasian 119 (97.5) 34 (85.0) 
Pakistani 0 (0.0) 1 (2.5) 
Bangladeshi 0 (0.0) 1 (2.5) 
Indian 1 (0.8) 2 (5.0) 
Chinese 0 (0.0) 1 (2.5) 
Other Asian ethnic group 1 (0.8) 1 (2.5) 
Other mixed ethnic group 1 (0.8) 0 (0.0) 
Nationality at birth     
United Kingdom 107 (87.7) 30 (75.0) 
North America 10 (8.2) 3 (7.5) 
Other Europe 2 (1.6) 5 (12.5) 
Australasia 1 (0.8) 1 (2.5) 
Asia 0 (0.0) 1 (2.5) 
Africa 2 (1.6) 0 (0.0) 
Education     
Secondary school 33 (27.7) 3 (7.5) 
Sixth form 37 (31.1) 7 (17.5) 
Undergraduate 35 (29.4) 14 (35.0) 
Post-graduate 15 (11.8) 16 (40.0) 
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 Table 6.2 Means and standard deviations for all measured variables.  
 FMS  Healthy Controls 
 Mean SD  Mean  SD 
BASIE total 1257.21 427.19  620.69 430.81 
BASIE factor 1 460.22 208.91  238.20 199.66 
BASIE factor 2 335.87 127.75  203.81 112.98 
BASIE factor 3 457.00 155.17  183.98 156.64 
SSSS 75.67 14.21  63.74   11.76 
GHSQ: 
Personal/Emotional 
3.27 1.21  4.24    1.08 
GHSQ: Symptoms 3.25 1.23  4.03    1.08 
HADS total 23.56 7.25  11.26    7.23 
FIQr 75.26 15.99  - - 
 
 
6.2.3.2. Dimensionality 
Principal components analysis was conducted to explore the factor structure of 
the BASIE. Direct Oblimin rotation was used to allow for correlations between the 
factors. The Kaiser-Meyer-Olkin test indicated sampling adequacy (KMO=.895) and 
Bartlett’s test of sphericity demonstrates sufficient correlations among items for factor 
analysis (χ²=3086.060, df=325, p<.001). 
There was evidence of multicollinearity in the data 
(determinant=.0000000000009544). Examination of the inter-item correlations table 
revealed 11 inter-item correlation coefficients greater than .8 (see Appendix H). 
Removing high inter-item correlations can reduce multi-collinearity between items. 
The removal of these items with high correlations (items 3, 6, 7, 11, 17) did improve 
the determinant (determinant =.0000000197). The fewest possible number of items 
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were removed in order to eliminate inter-item correlations greater than .8.  This 
determinant was still below the desired value (.00001) despite removing the most 
highly correlated items, but was much closer to this value after items were removed. 
Further analysis was therefore based on this solution, however there is still some issue 
with regards to multicollinearity. After the removal of items, there was evidence of 
sampling adequacy (KMO=.893) well above the acceptable limit of .5 (Fields, 2011) 
and sufficient correlations between items (χ²=2007.924, df=210, p<.001). 
In this final factor analysis, three factors were extracted based on factor loadings 
greater than .4 with Eigenvalues greater than 1 being considered factors (factor one 
Eigenvalue=10.048, factor two Eigenvalue=2.756, factor three Eigenvalue=1.246). 
Factors one and two explain a total of 60.97% of the variance, with factor three only 
explaining an additional 5.9%.  
 Three items (items 12, 20 and 23) loaded onto both factor three (with factor 
loadings of .53, .44 and .50 respectively) and either factor one or two. These items 
were assigned to either factor or one or two, depending on which factor they loaded 
onto (see Table 6.3). No other items loaded onto more than one factor. Item 14 only 
loaded onto factor three (factor loading=.52) and was therefore removed from the 
scale. Item 15 did not load onto any item and was also removed from the questionnaire. 
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Table 6.3 Factor loadings and communality for each item onto each factor 
Item  Factor 
one 
Factor 
two 
Commun
ality 
1 If people know that I am struggling in any way 
(physically or emotionally) with this condition, 
they will think I am a weak person 
.78  .64 
2 If people know that I am struggling in any way 
(physically or emotionally) with this condition, 
then I am a weak person 
.97  .78 
4 If people know that I am struggling in any way 
(physically or emotionally) with this condition, 
then I have failed in some way 
.95  .81 
5 If people know that I am struggling in any way 
(physically or emotionally) with this condition, 
they will think I have failed in some way 
.78  .72 
8 If I ask for help, then I am letting people down .89  .81 
9 If I have difficulties with this condition, I should 
not admit it to others 
.79  .65 
10 It is shameful to be struggling in any way 
(physically or emotionally) with this condition 
.71  .64 
12 Experiencing symptoms of this condition in front 
of others is embarrassing 
.42  .63 
13 With respect to living with my condition, I should 
put on a brave face in front of others 
.68  .62 
14 If people know about this condition, they will 
judge me 
  .61 
15 If people know about this condition, they will treat 
me like a different person 
  .52 
16 I should keep this condition a secret from most 
people I know 
.56  .65 
18 People will not want to be friends with me if they 
know I have difficulties with my condition 
 .58 .65 
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It was therefore thought that the overall scale consists of two subscales. 
Subscales were labelled based on discussion with the PhD student and academic 
supervisor regarding the content of the items. The first factor was named the Beliefs 
about Sharing Struggles subscale and the second factor the Benefits of Sharing Illness 
Experiences subscale. 
The two subscales were significantly correlated with each other and with overall 
scores on the BASIE with all three correlations significant at p<.001 (see Table 6.4). 
 
Table 6.4 Correlation coefficients between the BASIE and its two scales. 
 
 
 
19 To be acceptable to others, I should keep my 
condition mainly to myself 
.51  .75 
20 Others will expect me to manage this condition 
without support from them 
 .45 .60 
21 If I tell people about my condition, they will 
support me 
 .81 .65 
22 If people know about my condition, they will still 
treat me like “me” 
 .83 .69 
23 It would be helpful for people to know   .47 .45 
24 People will not judge me for having this condition  .87 .68 
25 If I talk to people about my condition, they will 
feel pleased that I have shared this with them 
 .85 .73 
26 Telling friends about my condition would 
strengthen our friendship 
 .89 .79 
 Overall BASIE Factor 1 
BASIE – Sharing Struggles .936 - 
BASIE – Benefits of sharing .807 .548 
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6.2.3.3. Internal consistency 
Internal consistency was analysed using Cronbach’s alpha. The overall scale 
with the highly-correlated items, and items 14 and 15 removed demonstrates excellent 
internal consistency (Cronbach’s alpha=.939). The removal of item 23 would improve 
the alpha to .942 but as this is only a minor improvement and since the level of internal 
consistency is already excellent, this item was not removed. 
Reliability analyses were then conducted for each of the extracted factors. For 
the Beliefs about Sharing Struggles scale, internal consistency was excellent 
(Cronbach’s alpha=.943). The Benefits of Sharing Illness Experiences scale also had 
very good internal consistency (Cronbach’s alpha=.886). The deletion of item 23 
would have increased the alpha to .903 for this scale. However, the internal 
consistency is already very good and the improvement made by deleting this item is 
only small. Therefore, the item was not deleted.  
 
6.2.3.4. Group differences 
A one-way MANCOVA was conducted on BASIE scores to compare healthy 
controls with a randomly selected sample of 40 participants with FMS 3  whilst 
accounting for distress (measured using HADS) and demographic variables which are 
significantly different between groups (namely being employed full time, being 
unemployed, highest level of education up to 16 years and highest level of education 
post-graduate). A random sample of 40 was chosen to account for problems with 
unequal sample sizes. 
                                                 
3 These results were comparable to group comparisons using entire sample of individuals with 
FMS, which can be found in Appendix I. 
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Due to missing data on the demographic items entered into the model, there 
were 38 healthy controls and 40 participants with FMS included in this analysis. 
Homogeneity of variance was assumed for overall BASIE scores (F(1,76)=.002, 
p=.969), factor one (F(1,76)=.699, p=..406) and factor two (F(1,77)=.090, p=.764). 
Distress was a significant confound in overall BASIE scores (F(1,71)=10.362, 
p=.002) and in the Beliefs about Sharing Struggles scale (F(1,71)=10.857, p=.002) 
and the Benefits of Sharing Illness Experiences scale (F(1,71)=5.196, p=.026). Having 
a post-graduate qualification was not a significant confound for overall BASIE scores 
(F(1,71)=.017, p=.896), Beliefs about Sharing Struggles (F(1,71)=.766, p=.384) or the 
Benefits of Sharing Illness Experiences scale (F(1,71)=1.356, p=.248). Neither was 
being educated up to secondary school level (total F(1,71)=1.402, p=.240), Beliefs 
about Sharing Struggles F(1,71)=.988, p=.324), Benefits of Sharing Illness 
Experiences F(1,71)=1.459, p=.231), being unemployed (total F(1,71)=.009, p=.924), 
Beliefs about Sharing Struggles F(1,71)=.646, p=.424), Benefits of Sharing Illness 
Experiences F(1,71)=.092, p=.762), or being employed full-time (total F(1,71)=.009, 
p=.924, Beliefs about Sharing Struggles F(1,71)=.002, p=.967, Benefits of Sharing 
Illness Experiences F(1,71)=.928, p=.339).  
After controlling for affective distress and for demographic variables, 
participants with FMS scored significantly higher on overall BASIE scores and scores 
on the two subscales compared to healthy controls (see Table 6.5 for estimates, F 
statistics and effect sizes). 
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Table 6.5 Estimated marginal means, standard errors, F statistics and effect sizes for overall 
BASIE scores and its two factors after controlling for distress and demographic variables 
 FMS n=40 Healthy Controls 
n=38 
F 
statistic 
η2 
 EMM SE EMM  SE   
BASIE 
total 
1028.22 64.02 587.43 66.12 F(1,71)=1
8.335, 
p<.001 
.205 
Sharing 
Struggle
s 
590.275 44.42 316.69 45.87 F(1,71)=1
4.675, 
p<.001 
.171 
Benefits  437.941 26.20 270.75 27.06 F(1,71)=1
5.751, 
p<.001 
.182 
 
6.2.3.5. Convergent validity 
Correlations using Pearson’s R were calculated for the FMS sample among 
overall BASIE scores, the two subscales, personal/emotional support-seeking, 
symptom-related support-seeking, two subscales of the BRIQ (all-or-nothing 
behaviour and limiting behaviour),  and self-sacrificing schemas (see Table 6.6). 
Overall BASIE scores and its two subscales were moderately positively related 
to self-sacrifice and the BRIQ subscale all-or-nothing behaviour, and were negatively 
to personal/emotional support-seeking and symptom support-seeking. 
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Table 6.6 Correlations between overall BASIE scores, its factors, and measures of related 
behaviours and cognitions after controlling for affective distress. 
 
 
6.2.3.6. Relations to outcomes 
A second correlation analysis was conducted correlating the overall BASIE 
scores and its two subscales with affective distress and global impact.  
 Overall scores on the BASIE, and scores on the two subscales were significantly 
correlated with global impact. Affective distress was significantly correlated with 
overall BASIE scores and scores on the two subscales (see Table 6.7 for coefficients). 
 
 
  
 Overall BASIE Sharing 
Struggles 
Benefits 
 r p r p r p 
Personal Emotional 
support- seeking 
-.471 <.001 -.400 <.001 -.443 <.001 
Symptom-related support-
seeking 
-.447 <.001 -.355 <.001 -.462 <.001 
BRIQ- All or Nothing  .489 <.001  .401 <.001 .485 <.001 
BRIQ – Limiting  -.007   .940  -.052   .595 .067   .493 
Self-Sacrifice Schema 
Scale 
 .362 <.001  .325 <.001 .312 <.001 
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Table 6.7 Correlations between overall BASIE scores and its two factors, and outcome 
measures. 
 
 
6.3. Study Two: Exploring mediators of the relationship between 
beliefs about sharing illness experiences and global impact. 
 
Using the same sample of individuals with FMS, mediation analyses were 
conducted in line with research from Chapter Five of this thesis. It was expected that 
the relationship between beliefs about sharing illness experiences and global impact 
would be mediated by the behaviours found to correlate with the BASIE in study one 
of this chapter (Section 6.2.3.5, on page 170), that is support-seeking 
(personal/emotional and symptom-related), all-or-nothing behaviour and limiting 
behaviour. This analysis was conducted based on the finding that support-seeking did 
not significantly mediate the relationship between beliefs about the unacceptability of 
expressing emotions and global impact. The current study therefore sought to 
investigate beliefs about sharing illness experiences, as opposed to beliefs about the 
unacceptability of expressing and experiencing emotions in relation to support-
seeking and global impact. 
 
 Overall BASIE Factor One Factor Two 
 r p r p r P 
Global impact .231   .010 .184   .042 .241   .008 
Affective distress .329 <.001 .358 <.001 .241 <.001 
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6.3.1. Hypothesis 
It was predicted that the relationship between beliefs about sharing illness 
experiences and global impact would be mediated in parallel by all-or-nothing 
behaviour, limiting behaviour, personal/emotional support-seeking and symptom-
related support-seeking. 
 
6.3.2. Methods 
6.3.2.1. Participants and procedure 
The same sample from the above validation study was used for the current study. 
Refer to section 6.2.3.1 (page 161) for sample characteristics. For this study, only 
participants with FMS are considered. The questionnaires included are the BASIE, the 
two BRIQ subscales (all-or-nothing behaviour and limiting behaviour), 
personal/emotional support-seeking, symptom-related support-seeking and the FIQr. 
For details on these measures refer to section 6.2.2.3 (page 156) of this chapter. 
 
6.3.2.2. Design and statistical analysis 
Process model 4 was used (Preacher & Hayes, 2004). In this model, beliefs 
about sharing illness experiences was the predictor and global impact the outcome. 
The four mediators were the behaviours found to correlate with beliefs about sharing 
illness experiences, namely all-or-nothing behaviour, limiting behaviour, 
personal/emotional support-seeking and symptom-related support-seeking. These 
mediators were tested in parallel. 
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6.3.3. Results 
Of the four mediators tested, all-or-nothing behaviour and personal/emotional 
support-seeking were the only significant mediators. The all-or-nothing subscale of 
the BRIQ (standardised indirect effect= .0987) and personal/emotional support-
seeking (standardised indirect effect= .1627) positively mediated the relationship 
between beliefs about sharing illness experiences and global impact indicating that 
more negative beliefs about sharing illness experiences is related to greater impact of 
the disorder through these two mediators. The bootstrapped unstandardized indirect 
effect for all-or-nothing behaviour was .0038 (95% CI [.0006, .0080]) and for personal 
emotional support-seeking was .0063 (95% CI [.0010, .0132]). 
 Limiting behaviour was not a significant mediator of the relationship between 
beliefs about sharing illness experiences and global impact (standardised indirect 
effect=.0399). The unstandardized indirect effect was .0001 (95% CI [-.0001, .0003]). 
Similarly, symptom-related support seeking was not a significant mediator 
(standardised indirect effect=-.0770). The unstandardized indirect effect was -.0002 
(95% CI [-.0006, .0002]). See Figure 6.1 for coefficients. 
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Figure 6.1. Standardised regression coefficients for the mediation model where the 
BASIE is the predictor, global impact is the outcome and the four parallel mediators are 
symptom support-seeking, personal/emotional support-seeking, limiting behaviour and all-
or-nothing behaviour. For each path, the parallel mediators are included as control variables. 
Note: *p<.050, **p<.010, ***p<.001 
 
6.4. Discussion 
The current study aimed to validate a questionnaire that measures beliefs about 
sharing illness experiences. The questionnaire was administered online to participants 
with FMS. Due to issues with multicollinearity five items were removed from the 
questionnaire resulting in a total of 21 items. Factor analysis of these 21 items revealed 
two factors: Beliefs about sharing struggles and benefits of sharing illness experiences. 
BASIE 
All or nothing 
behaviour 
Limiting behaviour 
Symptom 
Support-Seeking 
Global Impact 
-.159* 
.156 
.283** (.059) 
.008 .466*** 
.201* 
-.507*** 
Personal/emotional 
support-seeking 
-.333* 
-.011 
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The overall scale and the two subscales were internally consistent and were 
significantly correlated with scales measuring similar cognitive and behavioural 
constructs. The sizes and the directions of the correlations largely supported 
hypotheses with the correlation coefficients for support-seeking approaching large 
(defined as >.5 (Fields, 2011)) and the correlations for all-or-nothing behaviour and 
self-sacrifice schema being moderate and positive. However, there was no significant 
correlation between the BASIE and limiting behaviour despite a moderate positive 
correlation being expected. 
This, in addition to finding higher scores in the FMS group compared to 
controls, suggests good construct validity for the measure. The sample size was 
smaller than most recommendations suggest for factor analysis (Maccallum, Widaman, 
Zhang, & Hong, 1999) meaning it may have been underpowered. However, the KMO 
indicates excellent sampling adequacy. Thus, despite evidence of some 
multicollinearity in the factor analysis and the small sample, the findings of the current 
study largely suggest the scale is reliable and valid, though further psychometric 
testing is needed. 
There were group differences in sociodemographic features of the healthy 
controls and participants with FMS regarding employment status, ethnicity and 
education. These were therefore entered in the ANCOVA when comparing groups on 
the BASIE. However none of these were found to significantly confound the 
differences between the two groups in BASIE overall scores or the scores of the two 
subscales. 
Beliefs about sharing illness experiences (both as an overall measure and as 
two subscales) were correlated with affective distress and global impact as outcome 
measures in FMS. The relation between beliefs about sharing illness experiences and 
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outcomes suggest that these beliefs may be particularly important in a therapeutic 
context. This measure may therefore be considered for use in clinical practice in order 
to identify potential unhelpful beliefs about sharing illness experiences in clients 
which could be useful in cognitive behavioural interventions. However, the 
questionnaire and its subscales require further testing in its final form (with only the 
final included items) in order to validly examine the relationship between beliefs about 
sharing illness experiences and global impact in FMS. 
This measure may be valuable in future research. As biopsychosocial and 
cognitive behavioural models of persistent physical symptoms are still under 
investigation, it might be that this measure can open a new avenue of research into 
psychosocial factors that contribute to the maintenance and possibly development of 
FMS. In particular, future prospective research testing beliefs about sharing illness 
experiences as a predictor of the onset of FMS in individuals at risk of the disorder 
would be valuable.  
All-or-nothing behaviour and seeking support for personal/emotional 
problems significantly mediated the relationship between beliefs about sharing illness 
experiences and global impact, in that holding more unhelpful beliefs about sharing 
illness experiences was related to greater impact of the disorder via reductions in all-
or-nothing behaviour and personal/emotional support-seeking. It could be that 
believing that sharing illness experiences can lead to forms of social 
rejection/judgement which might result in overexertion in order to ‘put on a brave 
face,’ as suggested by McInnis et al. (2015). This overexertion might worsen 
symptoms.  
The finding that personal/emotional support-seeking and not symptom related 
support-seeking was a mediator of the relationship between beliefs about sharing 
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illness experiences and global impact is unexpected (though the internal consistency 
of these scales is questionable and future research with stronger measures of support 
seeking is warranted). While the two measures of support-seeking did differentiate 
between seeking-support for emotional problems and for symptoms, it does not 
distinguish between emotional problems that are caused by FMS and emotional 
problems that are distinct from the experience of FMS. Future research may want to 
distinguish between seeking support for general emotional difficulties and seeking 
support for emotional difficulties that arise as a result of living with FMS in order to 
determine whether both, or just seeking support for symptom-related emotional 
difficulties are related to unhelpful beliefs about sharing illness experiences in line 
with evidence that there are different kinds of support (Lynch-Jordan et al., 2015; 
Matos, Bernardes, Goubert, & Carvalho, 2015). 
A similar line of research has argued that different kinds of social support can 
promote functional autonomy or functional dependence. It is argued that this is 
particularly important with regards to individuals with chronic pain who may engage 
in activity avoidance as a result of receiving support which promotes functional 
dependence as opposed to support which promotes functional autonomy (Matos et al., 
2015). As such, support which promotes dependence was found to be related to worse 
physical function while support which promotes autonomy was found to be related to 
greater physical functioning in elderly participants with chronic pain (Matos et al., 
2015).  
With regards to the current finding that personal/emotional support-seeking 
and not symptom-related support-seeking was a significant mediator, it could be that 
symptom-related support-seeking relates to more practical forms of support and such 
practical support may include completing physical activities (e.g. household chores) 
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on behalf of an individual with FMS. This may mean that this symptom-related 
support-seeking could be confounded by the difference between promoting autonomy 
or dependence in relation to outcomes, while personal/emotional support-seeking may 
not be so greatly influenced by this confound. As such, the presence of the conflicting 
positive and negative correlations of support-seeking promoting autonomy and 
support-seeking promoting dependence with outcomes may have resulted in a non-
significant mediation effect when looking at symptom-related support-seeking. 
However, for personal/emotional support-seeking, these conflicting relationships 
were not present and therefore did not mask the mediation effect. 
These mediation findings suggest potential mechanisms through which 
cognitive behavioural interventions may help those with FMS, in particular those who 
hold beliefs about the unacceptability of sharing their illness experiences with others. 
Cognitive Behavioural Therapy, which is supported as a treatment for FMS 
(Glombiewski et al., 2010), focuses on understanding maintaining cycles of beliefs 
and behaviours in order to improve outcomes. The current study’s finding that beliefs 
about sharing illness experiences relates to global impact of FMS via all-or-nothing 
behaviour and support-seeking for personal/emotional problems therefore indicates 
that these beliefs and behaviours should be investigated as process variables in 
cognitive behavioural treatment for FMS.  
Chapter Five of this thesis (page 121) found that the relationship between 
beliefs about the unacceptability of expressing emotions and global impact was not 
significantly mediated by support-seeking (neither personal/emotional nor symptom-
related). Similarly, in Chapter Five, it was found that the direct relationship between 
beliefs about the unacceptability of emotions and global impact was not significant. 
In the current study however, beliefs about sharing illness experiences was directly 
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related to global impact. The current findings suggest that beliefs about sharing illness 
experiences as opposed to beliefs about the unacceptability of expressing emotions, 
may be more relevant with regards to the relationship between support-seeking 
(specifically for personal/emotional problems) and global impact in FMS and further 
research into support-seeking in FMS should include this measure of beliefs about 
sharing illness experiences. 
The current study has produced a scale that from current analyses can be 
considered reliable and valid. However further tests are warranted in order to fully 
determine the reliability, validity and acceptability of the BASIE. For example, future 
research in a second sample of individuals with FMS could test the correlations 
between scores at two time points, within-participants to measure test-retest reliability. 
The current study did not examine the factor structure beyond principle components 
analysis. Therefore (using a new sample) the factor structure found in the current study 
should be tested using confirmatory factor analysis to see if the factor structure is a 
good fit in a new data set with the removed items excluded. Further research testing 
the BASIE’s sensitivity to change would especially be useful given the implications 
for use in clinical practice.  
The current study validated the BASIE with participants with FMS. However, 
the questionnaire is designed in such a way that means it can be used with individuals 
with any health condition. There are a number of health conditions where individuals 
experience stigma, such as obesity, HIV, mental health problems and diabetes (Hackler, 
Cornish, & Vogel, 2016; Kato et al., 2016; Latner, 2016; Lokko & Stone, 2016). It 
may therefore be useful to validate this measure in other conditions in order to explore 
unhelpful beliefs about sharing illness experiences in individuals with a range of 
health problems. Further research comparing individuals with FMS to individuals with 
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other health conditions would also be useful in determining the specificity of the 
mediation models supported in the current study.  
While the current study and Chapters Three, Four and Five have provided 
valuable insight into the relationships between particular beliefs relating to sharing 
illness experiences and emotional experience, and outcomes in IBS and FMS, these 
relationships cannot fully support a direction of causality. For example, in the current 
study, it could be that those who are impacted more greatly by their disorder will seek 
more emotional support. They may then shape beliefs about sharing these experiences 
based on negative interactions with their support network when the individual has 
approached them for support. Further experimental evidence is needed where 
measures are taken at multiple time points to establish a direction of causality for these 
models. 
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7. Chapter Seven: Examining beliefs about emotions and emotional 
suppression in patients attending therapy for fibromyalgia 
7.1.  Introduction 
Chapter Five investigated the role of beliefs about emotions and emotional 
suppression in people with FMS in an online sample. This study found that there was 
a significant indirect effect whereby the relationship between beliefs about the 
unacceptability of emotions and global impact of FMS was mediated by emotional 
suppression and then affective distress. It was argued that this linear path may reflect 
ironic processing effects (Wenzlaff & Wegner, 2000) in that believing it to be 
unacceptable to express one’s emotions was related to more emotional suppression. 
This emotional suppression was then related to an increase in affective distress which 
in turn was related to a greater impact of the disorder on a person’s life. This was 
found using online samples as opposed to clinical samples who have been diagnosed 
and referred for treatment by a clinician. Given previous research has highlighted 
problems in collecting data online (see Chapter Two, section 2.5, page 73), it was 
noted that replication in a clinical sample would be beneficial. 
The role of emotional suppression in FMS is supported by studies evaluating 
written emotional disclosure interventions. Two studies discussed in Chapter One 
found that written emotional disclosure (compared to neutral writing) resulted in 
improvements in physical symptoms (i.e. pain and fatigue) and in global impact 
(Broderick et al., 2005; Gillis et al., 2006). This limited evidence indicates that 
changes in emotional expression may lead to improvements for individuals with FMS. 
It is possible therefore (based on this evidence alongside the mediation findings of 
Chapter Five) that beliefs about the unacceptability of emotions and emotional 
suppression could be of interest when investigating psychological therapies for FMS. 
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The findings from Chapter Five support evidence in IBS (Chapters Three and 
Four), which also found this significant indirect effect where believing emotions to be 
unacceptable was related to greater emotional suppression and in turn greater affective 
distress which was then related to poorer quality of life. In FMS, the direct relationship 
between beliefs about the unacceptability of emotions and global impact was not 
significant (the direct relationship in IBS was however significant). It was suggested 
that while the indirect effect tested in Chapter Five was significant, there may also be 
an indirect effect in the opposing direction which was not measured. For example, it 
might be that for some individuals with FMS, believing it is unacceptable to express 
emotions results in acting ‘normal’ and less avoidance of activity. This might then lead 
to better outcomes. Due to the contradicting nature of the role of beliefs about the 
unacceptability of emotions in FMS, further research into their role within a 
therapeutic context is warranted to understand whether emotional expression is 
believed to be more acceptable following psychological intervention and whether this 
change is related to improvements in outcomes.  
 Evidence-based guidelines recommend psychological approaches, as part of 
multimodal approaches including pharmacological, psychological and exercise 
treatments in  FMS (Häuser et al., 2008; Lami et al., 2013). A meta-analysis of 23 
studies demonstrated small short-term reductions in pain and small-to-medium sized 
long-term reductions in pain following psychological treatment for FMS. These 
studies use second and third wave CBT approaches, all of which aim to help the 
individual to understand the relationship between thoughts, feelings, behaviours and 
pain, and support individuals to make changes in a way that is helpful for them 
(Mccracken & Morley, 2014). The techniques used to support behaviour change may 
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however vary between these approaches, and any of the approaches may focus more 
or less on beliefs and behaviours around emotional expression.  
In a meta-analysis, CBT was associated with greater short-term pain reductions 
when compared to all other psychological interventions included (i.e. mindfulness-
based treatment, education, behavioural intervention, relaxation and biofeedback) 
(Glombiewski et al., 2010). However, across the literature on psychological treatments 
for FMS, studies are generally of poor quality (Bernardy, Klose, Busch, Choy, & 
Häuser, 2013; Lauche, Cramer, Dobos, Langhorst, & Schmidt, 2013; Turk, Okifuji, 
Sinclair, & Starz, 1996). A Cochrane review of randomised control trials found 
benefits of CBT as a treatment in FMS (Bernardy et al., 2013). Twenty-three studies 
were reviewed and found that there was a reduction in pain (SMD=-.30), negative 
mood (SMD=-.34) and disability (SMD=-.31) in the CBT arms of studies compared 
to control conditions, though this evidence was considered of low quality and these 
effects were small. Similar findings have emerged from a systematic review and meta-
analysis of six trials of mindfulness-based stress reduction in FMS, with small 
improvements in quality of life (SMD=-.35) and pain (SMD=-.23) when compared to 
usual care or an active control conditions (i.e. education, support, relaxation, 
stretching and discussion) (Lauche et al., 2013).  
While there is yet to be a systematic review of acceptance and commitment based 
interventions in FMS specifically, there is evidence that ACT is a beneficial treatment 
for chronic pain conditions (Hann & McCracken, 2014). In a review of ten randomised 
control trials with small sample sizes (n ranging from 16 to 156 across the ten studies), 
ACT was considered to be an effective treatment for chronic pain when compared to 
waitlist controls, treatment as usual and pharmacological controls, with pain and 
distress as outcome measures. When compared with CBT however, there were no 
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differences, suggesting an advantage for psychological therapy over non-
psychological therapy though there appeared to be no difference overall between 
different psychological therapies.  
There is evidence for the use of ACT compared to wait list controls specifically 
in FMS: In a randomised control trial of ACT with 40 participants with FMS, 
participants in the ACT condition showed moderate to large improvements in quality 
of life, self-efficacy, depression, anxiety and psychological flexibility (Wicksell et al., 
2013). A later randomised control trial with a larger sample (n=156) comparing ACT 
to waitlist controls and to recommended pharmacological treatment also found that 
group ACT was an effective intervention for FMS, eliciting large improvements in 
global impact (Cohen’s d=2.35) (Luciano et al., 2014). Again, this indicates that 
psychological treatment is beneficial when compared with non-psychological 
treatment for FMS, though it does not indicate if this treatment is comparable to the 
effects of treatment with other psychological approaches. In this study, acceptance did 
not mediate the treatment effect, suggesting other possible psychological variables 
might mediate the effect of psychological treatment on outcomes in FMS which 
warrants further investigation.  
The small effect sizes in these studies suggest that while these psychological 
interventions may be useful in helping those with FMS, there is a need to improve the 
treatments. Furthermore, while two randomised control trials have reported moderate 
to large effect sizes for ACT, further research, and further meta-analyses are need to 
examine the potential benefits of ACT as an intervention in FMS.   
Whilst it is widely accepted that psychological approaches are a key part of 
treatment of FMS, the particular psychological approach and the mechanisms of 
change through the psychological interventions are not clear (Lami et al., 2013). In 
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addition to the need for improved quality of evidence, Lami et al. therefore 
recommended that research on psychological treatments for FMS should focus in 
particular on which components of treatment are effective, and for whom. Perhaps by 
understanding the mechanisms of treatment, it would be possible to design 
interventions that better target mechanisms of change which may result in larger 
improvements following treatment.  
In an uncontrolled trial (n=72), a psychological intervention was developed and 
tested which aimed to specifically target emotional awareness and expression in adults 
with musculoskeletal pain (Burger et al., 2016). In this study, it was found that 
emotional awareness, emotional approach coping (defined as the understanding, 
validating and acknowledge of emotions as well as valuing the expression of 
emotions) and alexithymia all changed significantly from baseline to post-intervention 
suggesting that this intervention did influence change in these variables. However, 
Burger et al. did not control for changes in affective distress when measuring changes 
in emotional approach and emotional awareness. It may be that the intervention simply 
reduced distressed which resulted in fewer unpleasant or difficult emotions needing 
to be aware of or expressed. 
Furthermore, increases in emotional awareness were related to decreases in 
measures of pain at post-treatment and at follow-up. Increases in emotional approach 
were related to decreases in depressive symptoms and psychological distress at post-
treatment, though not at follow-up. All effect sizes were small, ranging from .24 to .35 
and this study did not have a control condition. However, this evidence seems to 
suggest emotional variables as mediators in treatment for FMS and it is possible that 
these emotional variables are addressed in existing group therapies. The role of these 
potential process variables has not been tested in current third-wave treatments for 
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FMS. Research on NHS prescribed interventions in relation to emotional expression 
is therefore needed.  
Given the prior mediation evidence on the role of emotional suppression and 
beliefs about emotions in FMS and the evidence that psychological therapies may be 
beneficial to individuals with FMS, the current study aimed to assess the extent to 
which changes in these particular beliefs and behaviours, from before to after 
psychological intervention, are associated with changes in outcome, thus potentially 
being a mechanism of change for people with FMS.  
Beliefs about emotions, emotional suppression, affective distress and global 
impact were therefore measured before, immediately after and 12 weeks after 
individuals with FMS received psychological treatment in the NHS. The particular 
psychological intervention used was the not the focus of the study, as each cognitive 
behavioural approach could focus to a greater or less extent on beliefs and/or 
behaviours related to emotional suppression. The focus of the study was on the 
association between changes in beliefs and behaviours and outcomes. It is also worth 
noting that the psychological interventions were all group-based, and as such, afford 
the opportunity for individuals to express thoughts and feelings to others. It is thus 
possible that the group processes may also result in changes in beliefs about emotions 
and emotional suppression even if this is not a specific focus of the intervention.  
Furthermore, the study aimed to replicate the mediation findings of Chapter Five 
in a clinical sample, based on evidence that emotional suppression can result in an 
‘ironic’ increase in distressing emotions (Wenzlaff & Wegner, 2000). It was found in 
Chapter Five that beliefs about emotions was related to more emotional suppression, 
which was in turn related to an increase in affective distress which was related to 
higher impact of FMS on a person’s life. This indirect effect was therefore tested in 
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the current study (using data from only the first time point) in order to uncover whether 
this finding can be replicated in a clinical sample.   
 
7.1.1. Hypotheses 
1. The relationship between beliefs about emotions and global impact will be 
mediated by emotional suppression and then affective distress (all measured at the 
first time point). 
2. There will be a significant reduction in beliefs about the unacceptability of 
emotions and emotional suppression following the intervention. This reduction will 
be maintained at 12 weeks’ follow-up. 
3. Changes in beliefs about the unacceptability of emotions and changes in 
emotional suppression will be related to changes in affective distress and changes in 
global impact.  
4. Change scores between pre-treatment and post-treatment in beliefs about 
emotions, emotional suppression and affective distress will significantly predict 
changes in global impact from pre-treatment to follow-up. 
 
7.2.  Methods 
7.2.1.  Participants 
In total, 79 participants (mean age=47.50, SD=11.01; 66 females) were recruited 
from NHS trusts in the south of England. Participants were patients referred to a 
clinical psychologist for psychological treatment for FMS. To be eligible for the study, 
participants must have had a diagnosis of FMS from either their GP or a 
rheumatologist.  
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Sample size calculations to detect changes in process variables over time were 
conducted using the effect size from Burger et al.’s (2016) uncontrolled trail 
measuring changes in emotional awareness and expression (Cohen’s d=.28 for 
changes in emotional approach coping from baseline to follow-up). Using G Power 
calculations for this comparison between two means (as Burger et al. did not report 
sufficient information for the calculation of main effect sizes) a sample size of 81 
participants is recommended to achieve .8 power.  
Sample size calculations for correlations between changes were based on the 
correlation coefficient from Burger et al.’s correlation between changes in emotional 
approach coping and changes in psychological distress (r=-.27). Using G power with 
the desired power level set to .8, 81 participants were recommended. The current study 
therefore aimed to recruit 81 participants to achieve statistical power. 
 
7.2.2. Treatment 
Participants underwent a pain management group programme as part of their 
standard care after referral to an NHS pain management team. The particular content 
of the pain management programme varied across NHS sites, and the details of the 
psychological approach was determined, using current evidence-base, by the clinical 
psychologist and their team. Participants were not randomised into treatment groups 
and treatment groups were not compared for the purpose of the current study.  
There were four collaborators on this project who recruited participants for this 
study. This meant participants received four variations of psychological therapy. All 
groups were jointly run by a clinical health psychologist and a specialist pain 
physiotherapist. All psychological interventions were in a group setting and used 
second and third wave CBT. Three of the collaborators used and integrative approach 
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while one primarily used ACT and MBCT. Two of the pain management programmes 
used in this research were offered specifically to participants with FMS, while the 
other two were for patients with chronic pain more broadly. The number of sessions 
ranged from six to nine with the lengths of sessions being two or three hours each. 
Group sizes varied with the smallest group containing four patients and larger groups 
containing ten patients.  
All four variations of the therapies discussed mindfulness, goal-setting, values, 
boom-and-bust or pacing activity, education about pain and how it is processed, 
managing unhelpful thoughts, advice on exercise and sleep. One group also covered 
communication and self-compassion. Another was geared more towards mindfulness 
compared with other groups. Two of the groups included discussions and information 
about medication. 
 
7.2.3. Procedure 
Participants were notified of the study by post in advance of their first session of 
the pain management programme. Participants were informed of their right to 
withdraw and that doing so would have no impact on their treatment with the service. 
This experiment received ethical approval from the psychology departmental ethics 
committee at Royal Holloway and from the NHS Research Ethics Committee (REC 
ref: 14/WM/1003). 
Participants were given a questionnaire pack by their therapist either before or 
during their first session of the intervention, at the final session of the intervention and 
then again 12 weeks after the intervention either at a follow-up meeting, by post or 
online. The questionnaire pack included an information sheet, consent form, 
demographic questions, the BES, CECS, HADS and FIQr (see section 2.2, page 59 
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for details on these measures). Internal consistency of the four scales was examined 
and found the BES (Cronbach’s alpha=.909) and FIQr (Cronbach’s alpha=.909) has 
excellent internal consistency, while the CECS (Cronbach’s alpha=.800) and HADS 
(Cronbach’s alpha=.881) had good internal consistency. Participants were asked 
demographic questions regarding sex, age, nationality, education level, employment 
status and ethnicity.  Questionnaires were given either by the researcher, the clinical 
psychologist leading the group or by the physiotherapist at the group. 
 
7.2.4. Design and Statistical Analysis 
This quasi-experimental design compared scores across three time points in 
individuals who were allocated non-randomly to treatment. The independent factor 
was therefore time and there were four dependent variables: beliefs about the 
unacceptability of emotions, emotional suppression, affective distress and global 
impact. 
Hypothesis one was an attempt to replicate the cross-sectional mediation model 
of Chapter Five and was tested using model six in Process to test a mediation model 
with serial mediators in one path (Preacher & Hayes, 2004). As in Chapter Five, the 
predictor was beliefs about emotions and the outcome was global impact. The two 
mediators were emotional suppression and affective distress, in that particular order. 
All measures for this model were taken from the first time point which had the largest 
number of participants.  
Before correlating changes in measures, it was first tested whether beliefs about 
emotions and emotional suppression changed significantly during the interventions. 
Hypothesis two was therefore tested using a linear mixed model to test the main effect 
of a repeated measures factor whilst accounting for a covariate. This method was 
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chosen over a one-way repeated MANOVA due to missing data across different time 
points. By using linear mixed modelling, all participants are analysed, even if they did 
not complete all time points. It uses all observed data by allowing varying intercepts 
and slopes for each individual participant and does not require imputation of missing 
data (Muth et al., 2016; Peters et al., 2012). This improved the power of the current 
study despite the inability to reach the desired sample size across all three time points.  
The repeated measures fixed factor in the linear mixed model was time with three 
levels (pre-intervention, post-intervention and follow-up). The dependent variables 
were beliefs about the unacceptability of emotions and emotional suppression. 
Individuals’ affective distress scores across each time point were entered as a covariate 
in order to explore changes in beliefs about emotions and emotional suppression that 
are not explained by a reduction in affective distress. Due to testing multiple 
dependent variables individually as opposed to in one MANOVA, Bonferroni 
corrections were applied and the alpha level for this particular test for the main effects 
was therefore set to .025 (.050/2).  
For this linear mixed model, the covariance type was set to compound symmetry 
as this covariance type is suitable for repeated measures due to the greater likelihood 
of equal variances and covariances. Furthermore, it retains power compared to other 
covariance types due to its larger degrees of freedom (Jennrich & Schluchter, 1986; 
Littell, Pendergast, & Natarajan, 2000). Significant main effects were broken down 
using Bonferroni post-hoc comparisons as planned comparisons were not available in 
linear mixed modelling in SPSS. 
To test hypothesis three, change scores were calculated for all four dependent 
variables. These scores were the difference between the first and second time point. 
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The change scores were then entered into a bivariate correlation matrix using 
Pearson’s correlation. 
A hierarchical regression model was used to test hypothesis four. Change scores 
calculated as the difference between pre- and post-treatment for beliefs about 
emotions, emotional suppression and affective distress were entered as predictors. In 
block one, beliefs about emotions was the sole predictor, emotional suppression was 
added in block two and affective distress in block three. The outcome variable was the 
change in global impact scores between pre-treatment and follow-up. 
7.3. Results 
7.3.1. Sample Characteristics 
Sample characteristics as measured by these questions are presented in Table 
7.1. Of the 79 participants who took part, only 21 completed questionnaires at all 3 
time points (see Figure 7.1 for attrition rates). One participant was excluded from the 
analysis as this participant’s global impact score worsened by 28 points (out of a 
total score of 100 on the FIQr) over the course of the study to the extent that the 
calculated difference between pre-treatment and follow-up was two standard 
deviations above the mean difference score. Means and standard deviations for all 
variables are presented in Table 7.2. 
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Figure 7.1 Flow chart of participation throughout the study 
  
Pre-treatment  
n=70 
Post-treatment 
n=40 
Follow-up 
n=21 
Did not return 
questionnaire 
n=30 
Did not return 
questionnaire 
n=18 
Outlier excluded 
n=1 
Completed 
follow-up  
n=8 
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Table 7.1 Sample characteristics 
Variable N   (%) 
  
Age: Mean years (S.D) 47.50 (11.01) 
Sex  
    Female 64 (91.4) 
Ethnicity  
    Caucasian 60 (85.7) 
   Mixed White and Black Caribbean 1 (1.4) 
    Mixed White and Black African 1 (1.4) 
    Indian 2 (2.9) 
    Black/African/Caribbean 1 (1.4) 
    Any other ethnic group 1 (1.4) 
Highest education level  
    Senior/secondary school (up to 16) 23 (32.9) 
    Sixth form/college (up to 18) 28 (40.0) 
    University undergraduate 8 (11.4) 
    University postgraduate 9 (12.9) 
Employment  
    Full time employee 12 (17.1) 
    Part time employee 12 (17.1) 
    Full time student 0 (0.0) 
    Part time student 1 (1.4) 
    Self-employed 5 (7.1) 
   Unemployed 38 (54.3) 
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Table 7.2 Means and standard deviations for beliefs about emotions, 
emotional suppression, affective distress and global impact 
 Pre-treatment Post-treatment Follow-up 
 M   SD M   SD M   SD 
Beliefs about emotions 45.36 13.72 40.44 15.18 38.40 16.53 
Emotional suppression 55.83 11.85 55.23 14.75 52.52 11.18 
Affective distress 22.36   8.13 20.58   6.28 19.10   9.00 
Global impact 69.23 14.04 62.34 17.13 62.98 18.55 
  
Participants who completed all three time points’ baseline scores were compared with 
participants who completed two time points and those who completed just one. None 
of the groups were significantly different on baseline measures. Descriptive statistics 
can be found in Table 7.3.  
Table 7.3 Descriptive statistics of baseline scores for participants who completed 
one, two and three of the three time points. 
 Completed all 
three time 
points 
Completed two 
time points 
Completed one 
time point 
 M   SD M   SD M   SD 
Beliefs about emotions 43.31 17.65 45.72 12.90 45.78 12.48 
Emotional suppression 58.40 13.44 55.83 12.26 52.60 11.19 
Affective distress 21.31   6.38 22.71   8.24 23.18   8.98 
Global impact 66.41 13.18 70.01 16.08 72.55 11.97 
 
7.3.2. Hypothesis one: Mediation 
Using the Process plug-in for SPSS, a serial mediation model was tested using 
model six using data from all participants in the first time point (the pre-treatment 
phase). Emotional suppression and affective distress did not serially mediate the 
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relationship between beliefs about emotions and global impact before the intervention 
(standardised indirect effect = .0288). The indirect effect was .0271 and was not 
significant (95% CI [-.0051, .1205]) (see Figure 7.2 for coefficients). 
 
 
 
 
 
 
 
Figure 7.2 Standardised coefficients for paths in the serial mediation model 
Note: *p<.050, **p<.010, ***p<.001 
 
7.3.3. Hypothesis two: Changes over time 
Four linear mixed models were tested using repeated measures. The within-
participants fixed factor was time and the four dependent variables were beliefs about 
emotions, emotional suppression, affective distress and global impact.  
There was a significant main effect of time on beliefs about emotions after 
controlling for affective distress (F(2, 82.390)=5.941, p=.004) where beliefs about 
emotions decreased after the intervention (p=.011) and did not change from post-
intervention to follow-up (p=1.000). The difference between pre-treatment and 
follow-up was also significant (p=.034). See Table 7.4 for descriptive statistics. There 
was however no significant effect of time on emotional suppression scores after 
controlling for affective distress (F(2, 67.146)=1.784, p=.176).  
 
Beliefs about 
emotions 
Emotional 
suppression 
Affective 
Distress 
Global impact 
.609 *** (.346)** 
.420*** 
.634*** .517*** 
198 
 
7.3.4. Hypothesis three: Changes in processes are related to changes in 
outcomes 
Before correlating changes in beliefs about emotional suppression and affective 
distress with outcomes, linear mixed modelling was used (as for hypothesis two) to 
determine whether affective distress and global impact did significantly change during 
the study. 
Affective distress scores significantly changed over time (F(2, 42.371)=4.771, 
p=.010). There was a decrease in affective distress after the intervention compared to 
pre-treatment scores (p=.018). Comparisons between pre-treatment and follow-up 
were not significant (p=.085) though were approaching significance with a trend 
towards lower scores at follow-up compared with pre-treatment. There was no 
significant change in affective distress from post-treatment to follow-up (p=1.000). 
Global impact scores significantly reduced over time (F(2, 72.337)=8.307, 
p=.001), with scores being significantly lower at post-treatment (p=.001) and follow-
up (p=.040) compared with pre-treatment. The difference between post-treatment and 
follow-up was not significant (p=1.000). 
 
Table 7.4 Estimated marginal means and standard error for the three treatment times 
for each of the four measures. 
 BES CECS HADS FIQr 
 M SE M SE M SE M SE 
Pre-treatment 45.09 1.75 56.47 1.68 22.44 0.95 69.57 1.81 
Post treatment 38.96 2.13 54.55 1.81 20.16 1.07 63.77 2.03 
Follow-up 39.09 2.40 53.79 1.95 20.40 1.16 65.28 2.18 
 
Change scores for each dependent variable were calculated in SPSS based on 
subtracting the pre-intervention scores from the post-intervention scores (see Table 
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7.5 for means and standard deviations of change scores). The difference between pre- 
intervention and post-intervention scores (n=40) were chosen over follow-up scores 
(n=30) due to the high attrition rate meaning a reduction in power when using the later 
time point.  
 
Table 7.5 Mean and standard deviation of the change scores for each measured variable. 
 Mean SD 
Beliefs about emotions -5.43 15.19 
Emotional suppression -1.98   7.99 
Affective distress -2.17   5.19 
Global impact -5.36 10.42 
 
Changes in beliefs about emotions were significantly positively related to 
changes in emotional suppression but not affective distress (though this was 
approaching significance) or global impact. Emotional suppression was not related to 
changes in global impact, but was related to changes in affective distress. Changes in 
affective distress were strongly related to changes in global impact. See Table 7.6 for 
correlation coefficients and p values. 
 
Table 7.6 Correlations between change scores for each variable comparing pre- and 
post-treatment 
 CECS HADS FIQ 
 r p r p r p 
BES .378 .019 .307 .054 .061   .714 
CECS - - .334 .041 .105   .538 
HADS - - - - .543 <.001 
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7.3.5. Hypothesis Three: Predicting later global impact 
A hierarchical regression model was tested where changes between pre-treatment 
and post-treatment in beliefs about emotions (block one), emotional suppression 
(block two) and affective distress (block three) were predictors of changes in global 
impact between pre-treatment and follow-up. This hierarchical model was used to 
investigate the individual contribution of each variable included in Chapter Five’s 
mediation model before and after accounting for the next variable in the model. Due 
to attrition rates and missing data, only 20 participants were tested in this model. 
There was no evidence of multicollinearity in the model (BES tolerance=.592, 
VIF=1.69; CECS tolerance=.69, VIF=2.709; HADS tolerance=.535, 1.871) (see Table 
7.7  for zero order correlations between predictors and the outcome). Residuals were 
roughly randomly distributed across the continuum and were normally distributed. No 
outliers of the model were identified. 
Model one, where changes in beliefs about emotions from pre-treatment to post-
treatment is the sole predictor, was not significant (F(1,18)=.769, p=.392) and 
explained 0% of the variance in changes in global impact from before treatment to 
follow-up. Adding changes in emotional suppression to the model did not significantly 
improve the model (F change (1,17)=1.262, p=.277) with the model not significantly 
predicting changes in global impact from pre-treatment to follow-up (F2,17)=1.021, 
p=.381), explaining 0.2% of the variance in changes in global impact.  
Adding changes in affective distress between pre-treatment and post-treatment 
as a predictor in the model did not significantly improve the model (F change 
(1,16)=.1.736, p=.206). The overall model with all three predictors was not significant 
(F3,16)=1.290, p=.312) explaining 4.4% of the variance in the changes in global 
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impact from pre-treatment to follow-up. Unstandardized coefficients are presented in 
Table 7.8. 
 
Table 7.7 Correlations between predictors and outcomes for participants included in the 
model 
 CECS HADS FIQ 
 r p r p r p 
BES 639 .001 395 .054 .217 .179 
CECS - - 689 .001 .107 .327 
HADS - - - - .038 .437 
 
Table 7.8 Unstandardized regression coefficients for individual predictors for each 
block of the model. 
Block Variable    B     t    p 
1 BES  .126  0.877 .392 
2 BES  .257  1.395 .181 
 CECS -.342 -1.123 .277 
3 BES  .287  1.566 .137 
 CECS -.652 -1.718 .105 
 HADS  .601  1.319 .206 
 
7.4. Discussion 
The current study aimed to investigate beliefs about emotions, emotional 
suppression, affective distress and global impact before and after psychological 
treatment for FMS. The current study did not find support for the mediation model 
evidenced in Chapter Five, finding that the relationship between beliefs about 
emotions and global impact was not mediated by emotional suppression and affective 
distress, all measured before treatment.  
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Beliefs about emotions were significantly lower after the intervention compared 
to pre-treatment and stayed significantly lower at follow-up. However emotional 
suppression scores did not change. Changes in beliefs were correlated with changes 
in emotional suppression and there was a marginally significant correlation with 
changes in affective distress. Emotional suppression changes were correlated with 
changes in affective distress, which in turn was correlated with changes in global 
impact. However, changes in beliefs about emotions, emotional suppression and 
affective distress from pre-treatment to post-treatment did not predict changes from 
pre-treatment to follow-up in global impact. 
Using only the questionnaires taken before treatment, the mediation model found 
in Chapter Five was tested in the current sample. The current study did not find support 
for this model with the relationship between beliefs about emotions and global impact 
having no significant indirect effect via emotional suppression and affective distress. 
This suggests that perhaps there is something distinct about this clinical sample which 
is different from the previous online sample where those attending secondary care do 
not show evidence of this ironic processing path. Instead they may show a different 
pattern with regards to the relationship between beliefs about emotions and global 
impact.  
It is possible that those who are receiving psychological treatment for FMS may 
be struggling more than those recruited online and as such, the relation between beliefs 
about emotions and global impact may be different. Interestingly, there was a 
significant direct positive relationship between beliefs about emotions and global 
impact in this sample (see Figure 7.2) which this was not found in Chapter Five. Again, 
it appears that this clinical group are different from the online sample regarding the 
role of beliefs about emotions. This may reflect possible subgroups within the wider 
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FMS population where for some emotional suppression is related to more negative 
affect, while for others this is not the case (López-Cicheri et al., 2013). The exact 
implications of these differing relationships for each subgroup should be investigated 
further with regards to treatment as it appears there may be other mediators of this 
direct relationship between beliefs about emotions and global impact.  
Alternatively, it may be that the current study lacked statistical power due to the 
small sample size and therefore was unable to detect the significant mediation (which 
has a small effect size) but was sufficiently powered to detect the direct relationship.  
There were significant reductions in beliefs about emotions immediately after 
treatment which were maintained at follow-up after controlling for affective distress. 
This suggests that there were changes in these beliefs beyond just experiencing less 
distress and thereby being more willing to express and experience this lower level of 
distress. This supports Burger et al.’s finding that valuing emotional expression can 
change during intervention and further demonstrates that this change may be 
independent of changes in affective distress. This finding indicates firstly that beliefs 
about emotions may be changed through psychological group interventions and 
secondly that existing interventions are modulating these beliefs (though comparison 
with a control group to rule out any significant changes over time not attributable to 
treatment is necessary).  
On the basis of this research, it is difficult to draw conclusions regarding what 
may have led to changes in beliefs about emotions due to the integrative and varied 
nature of the psychological interventions. One possible explanation for this is that 
these psychological group therapies all involve an element of sharing thoughts and 
feelings within a group, which provides an opportunity for individuals to be more 
expressive and receive positive or helpful responses to this expression, which then 
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modulate beliefs about the unacceptability of expressing emotions. Beliefs may 
therefore change as a result of practicing being more expressive in these group settings. 
However, if this were the case, emotional expression would have been expected to 
also change. Either beliefs were not changed through this mechanism, or somehow 
despite beliefs changing, this did not translate into behavioural changes outside of the 
context of treatment. 
Alternatively, the content of these interventions did in part revolve around the 
idea of acceptance. While the focus in some cases may have been more on the 
acceptance of pain, mindfulness and ACT based discussions around acceptance of 
emotions in relation to pain also may have been discussed. This may have then 
influenced patients’ beliefs about the unacceptability of expressing emotions through 
encouraging the acceptance of emotions. The second wave CBT aspects of the 
psychological intervention focuses on unhelpful behaviours around the experience of 
emotions (e.g. emotional avoidance), and individuals may have focused on beliefs 
about suppressing emotions. In one group, time was spent discussing 
‘communication’, which may also have resulted in changes in beliefs about sharing 
emotions. 
Emotional suppression did not change during or after the intervention which is 
unexpected, especially given that beliefs about the unacceptability of expressing 
emotions did change. As previously stated, it could be that patients were willing to be 
more emotionally expressive within the context of the group (and this may have 
influenced beliefs) but this did not extend beyond the group sessions and therefore 
was not reflected in the questionnaire which asks how one behaves most of the time. 
Alternatively, if greater acceptance more generally explains the changes in beliefs 
about emotions, it is possible that emotional suppression was not influenced and 
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instead only beliefs about this changed. In this case, other factors which may influence 
emotional suppression beyond beliefs about the unacceptability of expressing 
emotions should be explored in future research. Furthermore, given that changes in 
emotional suppression were significantly related to changes in affective distress, 
research on treatments which encourage emotional expression in addition to 
addressing beliefs may result in longer term improvements in distress, which was not 
found in this study. 
The changes in each variable from pre-treatment to post-treatment were tested 
for bivariate correlations to test the extent to which changes in beliefs about emotions 
and emotional suppression were related to changes in affective distress and global 
impact. Changes in beliefs about emotions and emotional suppression were related 
which suggests that as beliefs change, so might behaviour (though emotional 
suppression did not significantly change in the current study). Changes in emotional 
suppression were correlated with both changes in affective distress and changes in 
beliefs about emotions. Changes in beliefs about emotions showed a trend that was 
approaching significance where changes in beliefs were related to changes in affective 
distress. This is in line with Burger et al. (2016) who found that changes in emotional 
approach coping were related to changes in psychological distress but not pain in an 
intervention aimed at addressing emotional awareness and coping. Interestingly, 
Burger et al. found that changes in emotional awareness and alexithymia were related 
to changes in pain. Perhaps future research should measure awareness of emotions 
and alexithymia as process variables in NHS psychological treatments for FMS as 
these may be related to changes in global impact, while beliefs about emotions and 
emotional suppression were not. 
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Changes in emotional suppression related to changes in affective distress and 
changes in affective distress related to changes in global impact. These correlational 
findings support the expected relationships of the mediation model outlined in 
Chapters Four and Five. However, these correlations were bivariate and therefore each 
correlation did not account for variance explained by other variables included in the 
correlation matrix. This would need to be explored using mediation analyses to fully 
test the proposed effects of beliefs about emotions on global impact via emotional 
suppression and affective distress. The current study’s high attrition rate however 
meant that the sample size was insufficient for tests of mediation across the three time 
points.  
Before testing the correlations between changes from pre-treatment to post-
treatment between processes and outcomes, the current study tested whether the 
outcomes (affective distress and global impact) significantly changed with treatment. 
Global impact, like beliefs about the unacceptability of emotions, significantly 
improved (i.e. reduced) during the intervention and was still significantly lower at 
follow-up which suggests that the treatments provided lasting improvements to the 
individuals’ lives (though a control group would be useful in ruling out any effects not 
directly related to the psychological intervention, such as group processes). This 
supports previous research that psychological interventions are beneficial to 
individuals with FMS (Bernardy et al., 2013; Hann & McCracken, 2014; Lauche et 
al., 2013; Luciano et al., 2014). Affective distress significantly reduced during the 
intervention, though this difference was not maintained at follow-up (but it was 
approaching significance). This suggests that perhaps there was a slight worsening for 
some participants during the follow-up period to the extent that the difference between 
pre-treatment and follow-up did not reach significance: The small sample size of this 
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study and the high attrition rate might have meant that the test was underpowered 
when testing for the significance of the difference between pre-treatment and follow-
up and therefore may have been more affected by a slight worsening during the follow-
up period than if there had been a larger sample. Looking at the estimated marginal 
means, the worsening from pre-treatment compared to post-treatment is very small 
which indicates that statistical power was a key issue as opposed to there being a 
substantial worsening in affective distress. 
Regardless, the difference between pre-treatment and follow-up is not 
statistically significant, therefore it would be useful to explore the possible factors 
which may lead to worse outcomes following an intervention. For example, it might 
be that some individuals revert back to previous ways of thinking and/or behaving 
following the intervention. Alternatively, other factors external to the intervention 
such a stressful life events may result in more distress. Changing beliefs about the 
unacceptability of emotions may work to buffer the effects of distress on a person’s 
life, thus while distress did not remain significantly reduced at follow-up, global 
impact remained lower, and beliefs about emotions were still significantly lower at 
follow-up. 
A regression model was also tested in which changes in beliefs about emotions, 
emotional suppression and affective distress between pre-treatment and post-
treatment were predictors and changes in global impact from pre-treatment to follow-
up was the outcome variable. This was conducted to test whether earlier changes in 
predicted processes can predict later changes in global impact. By implementing a 
clear timeline (using earlier changes to predict later changes), it is possible to further 
evaluate the proposed direction of causality put forward in this thesis.  
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It was expected that changes in beliefs about emotions, emotional suppression 
and affective distress would predict later changes in global impact. However, none of 
the predictors were significant. It is likely that only having 21 participants who had 
scores at all three time points meant this test was under powered. Further investigation 
is needed in a study where fewer participants drop out of the study. It may be useful 
in future to control for baseline scores on the outcome measure (i.e. the FIQr) to 
account for individual differences in the severity of the condition.  
A substantial issue with the current study is the low sample size. This was in part 
due to issues during the recruitment and data collection at certain sites and also due to 
attrition of participants throughout the study. While some attrition was expected, the 
number of participants with data at all time points was not expected to be less than 
50% of the sample. In the current study, it was 27%. This does not appear to be due to 
characteristics of the participants (at least with regards to those measured in the current 
study). Many of the participants were invited to take questionnaires home and return 
them by post for the post-treatment and follow-up time points, which may have meant 
participants were likely to forget to complete the questionnaire and also forget to post 
it. This meant that many questionnaires were not returned to the researcher. There 
were no set guidelines given to therapists regarding reminding participants to 
complete their questionnaires either by post or online. While some therapists did send 
email reminders or contact participants by phone, others did not, which may explain 
why many participants did not complete questionnaires at the second and third time 
points4 . The number of completers therefore differs between therapists, meaning 
                                                 
4 The number of ‘completers’ varied between the therapists at the different sites: 5.6%, 40.9%, 25% 
and 80% of the participants completed all of the questionnaires in each therapist group. 
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therapist effects should be investigated in future research where the sample size is 
sufficient. 
A better method would have been to collect questionnaires in person at the 
therapy sessions, however this was not always feasible within the timeframe allocated 
to each therapy session. To address this issue, participants later in the study were 
offered the option to complete the questionnaire online as it was thought this would 
be less demanding of the participant and more convenient than posting a questionnaire. 
This method however was rarely used by participants and therefore did not adequately 
address the attrition rates. 
Linear mixed modelling meant that the differences between the different time-
points were still sufficiently powered as participants were not excluded on the basis 
of having missing data. However, correlation and regression analyses could not 
account for this issue and were therefore likely underpowered. The current study 
therefore has not supported the proposed model whereby changes in beliefs about 
emotions result in reduced global impact via a reduction in emotional suppression and 
consequent affective distress. Further research with much larger samples to account 
for attrition would need to be conducted. 
It may also be of interest for future research to account for or even explore the 
effects of different interventions. With a larger sample, it would have been possible to 
explore the four intervention groups as a second independent variable to see if perhaps 
one intervention elicits greater changes in beliefs about emotions and emotional 
suppression compared to others and to account for therapist effects. In future research 
exploring this model, it may be useful to also include the BASIE given that Chapter 
Six has shown this to be related to outcomes in FMS. The BASIE was however not 
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fully developed or validated at the time of data collection in the current study and was 
therefore not included. 
The current study did not find evidence that changes in beliefs about emotions 
and emotional suppression are related to changes in affective distress and global 
impact, meaning that the findings do not support the role of emotional suppression 
and beliefs about emotions as processes of change in psychological therapy for FMS. 
However, the lack of power in the correlational analyses might explain why the 
correlational findings of the current study were not significant yet beliefs about 
emotions did change during the intervention and maintain lower at follow-up. This 
indicates the value in continuing to explore these beliefs in relation to treatment.  
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8. Chapter Eight: An intervention addressing beliefs about emotions and 
emotional suppression: A single case series 
 
8.1. Introduction 
Throughout this thesis, a role of emotional suppression in IBS has been 
evidenced in previous as well as the current studies. Ali et al. (2000) found in a small 
sample that individuals with IBS (n=25) scored higher on a measure of self-silencing 
compared to a reference value (which aimed to represent the general population) and 
compared with individuals with IBD (n=25). In the current thesis (see Chapter Three 
and Four, pages 83 and 96), emotional suppression was not found to be different 
between those with IBS and healthy controls or those with IBD. 
Emotional expression has been used as a therapeutic technique in persistent 
physical symptoms such as FMS. As discussed in Chapter One (Section 1.4, page 44), 
asking participants with FMS to write emotively (compared to controls who wrote 
about neutral topics) has been shown to elicit improvements in symptoms and quality 
of life (Broderick et al., 2005; Gillis et al., 2006).  
This finding has been replicated in an uncontrolled pilot study in 103 
participants with IBS (Halpert et al., 2010). While the pilot study did not use a control 
group, individuals who completed the intervention (n=82) were compared to those 
who did not complete the intervention (n=21). These comparisons revealed a 
difference between the two groups with regards to changes from baseline to three-
month follow-up. However, these group differences were only found in measures of 
functional bowel disease cognitions and symptom severity – although the writing 
group showed improvements in quality of life at three-month follow-up, and the non-
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writers showed no improvements, the difference between groups was not statistically 
significant.  
Overall, these three studies on written emotional disclosure support the idea that 
interventions encouraging more emotional expression could be beneficial to 
participants with IBS, though more rigorous testing with a larger sample and a control 
group is warranted. Furthermore, these studies did not measure changes in beliefs 
surrounding emotional expression even though it has been suggested that changes in 
beliefs may play a role in the influence of emotional expression on outcomes (Gillis 
et al.,2006; see Chapter Three of this thesis, page 78). 
Previous research in this thesis (See Chapter Four, page 96) found that 
individuals with IBS report more belief that expressing emotions is unacceptable when 
compared with healthy controls (though not when compared to individuals with IBD) 
and that this difference is no longer statistically significant after accounting for 
affective distress. Though this suggests that affective distress might explain this group 
difference in beliefs about the unacceptability of emotion, the initial finding that these 
beliefs are more prevalent in IBS, along with evidence from this thesis that these 
beliefs are related to poorer outcomes, suggests a need to explore these beliefs as a 
target in interventions for IBS. 
Further to this, Chapter Four demonstrated evidence that the relationship 
between beliefs about emotions and quality of life in IBS is mediated serially by 
emotional suppression and affective distress in that particular order. This finding 
supports a proposed model in which believing the expression and experience of 
emotions to be unacceptable is related to an increase in actual emotional suppression. 
This in turn is associated with an increase in affective distress and subsequently a 
decrease in quality of life.  
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While this proposed model posits a causal direction, the previous evidence in 
this thesis has used correlational methods. To fully evaluate this proposed direction of 
causality, an experimental method with a timeline is necessary. Furthermore, given the 
need to understand the role of these beliefs about emotions and emotional suppression 
within the context of psychological interventions, it is paramount to investigate 
whether targeting these variables using cognitive behavioural techniques results in 
improvements in distress and quality of life for those with IBS. 
The current study aimed to test whether beliefs about emotions and emotional 
suppression could be adapted and whether efforts to adapt these would result in 
changes in distress and quality of life. A cognitive behavioural approach was chosen 
as there is a body of evidence on psychological interventions in IBS, with more 
evidence for CBT than other therapies: A systematic review of 15 randomised control 
trials testing psychological treatments for IBS found moderate to large improvements 
in quality of life (as well as symptom severity) across a range of treatments, with seven 
of the included studies looking at CBT, two studies examining cognitive therapy, two 
behavioural therapy, and four further studies looking at stress-management, 
psychodynamic therapy, mindfulness and psychoeducation (Altayar et al., 2015). 
When comparing findings of studies that evaluated CBT with studies that evaluated 
other psychological interventions, there was no significant difference in treatment 
effects. Thus, this suggests that the use of psychological intervention, with more 
studies reported for cognitive behavioural therapy (CBT), may be beneficial for those 
with IBS.  
In the previous chapter (Chapter Seven) it was found that beliefs about the 
unacceptability of emotions reduced following psychological treatment for FMS, 
suggesting these beliefs can be addressed therapeutically, even when the focus on the 
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intervention was not specifically on beliefs and behaviours around emotional 
expression. It was argued in the previous discussion that addressing emotionally 
suppressive tendencies (which did not change in the treatment for FMS) in addition to 
beliefs about expressing emotions might result in longer lasting reductions in distress 
on a person’s life.  
The current study therefore explores the effects of an intervention using 
cognitive behavioural techniques aimed at reducing emotional suppression through 
addressing beliefs about the unacceptability of expressing emotions and emotionally 
suppressive behaviours. This intervention focuses more specifically on these factors 
so as to test the model which to this point has been supported using cross-sectional 
correlational designs. Further to this, the current study will explore changes not just 
in outcome measures (namely quality of life) but will also investigate changes in the 
proposed mechanisms of beliefs about the unacceptability of emotions, emotional 
suppression and affective distress. 
 
8.1.1. Hypotheses 
The current study therefore evaluated a group-based cognitive behavioural 
intervention designed to address beliefs about the unacceptability of expressing and 
experiencing emotions and emotional suppression. Based on the above evidence four 
hypotheses can be proposed: 
1. There will be a significant reduction in beliefs that expressing and 
experiencing emotions is unacceptable following the intervention. 
2. There will be a significant reduction in emotional suppression following 
the intervention. 
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3. There will be a significant reduction in affective distress following the 
intervention. 
4. There will be a significant improvement (i.e. an increase in scores) in 
quality of life following the intervention. 
 
8.2. Methods 
8.2.1. Participants 
Eleven participants were recruited online through campus webpages, local 
online forums and IBS-focussed forums and social media. Five of those participants 
responded to the recruitment email providing further information about the study. One 
of those five withdrew from the study early in the pre-treatment phase. This resulted 
in a sample of four female participants (mean age=45.5, SD= 9.75) all of whom had 
been diagnosed with IBS by a clinician and met three or more of the Manning Criteria 
for Irritable Bowel. Only results from these four participants are discussed.  
The idea of selecting participants who scored highly on the BES and CECS was 
discussed however once recruitment had started, it was realised that the response rate 
was low. Thus, the four participants who responded and consented to take part were 
involved in the current study.  
Participants had symptoms of IBS for a mean of 19.75 years (SD=6.60) and had 
been diagnosed on average 18.25 years prior to the study (SD=6.50). Participants’ age 
ranged from 31 to 52. One participant was Indian (with regards to both ethnicity and 
nationality) while the other three were White British and English. Education level 
ranged from sixth form/college in one participant to post-graduate in another 
participant. The remaining two participants were educated to undergraduate level.  
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8.2.2. Materials 
Participants were initially given full copies of the BES, CECS, HADS and IBS-
QoL (see section 2.2, page 59 for more details on these measures). The questionnaires 
were adapted to be idiographic measures in that they are designed to be used for a 
particular respondent (Haynes, Mumma, & Pinson, 2009). These idiographic 
questionnaires were created in order to reduce the burden on the participant who 
would be completing the questionnaire bi-weekly throughout the intervention and for 
up to eight weeks’ follow-up. One of the methods for creating an ideographic measure 
is to select a subset of items from an existing standardised questionnaire. Given that 
an idiographic measure is designed to increase the relevance of an instrument to a 
particular individual (Haynes et al., 2009), after completing the full measures at the 
first time point, these questionnaires were reduced to include only the highest scoring 
items for that participant. As there is no set guideline for selecting items which will 
comprise an idiographic measure, it was decided (between the clinical health 
psychologist, a second clinical psychologist with experience in idiographic measures 
and myself) that higher scoring items on each measure reflect particular thoughts, 
feelings and behaviours that are problematic for that individual and as such, selecting 
these items would increase the relevance of the measure.  
All items for which a participant scored the maximum possible score were 
included in their idiographic shortened questionnaire. For example, all items of the 
BES to which the participant responded “Totally agree” were included in their 
ideographic version of the BES. This meant participants completed variations of the 
questionnaires that varied in their number of items. For participants who either did not 
score any item at the maximum, or only scored one item at the maximum, the next 
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highest score was used. For example, for a participant who did not say “Totally agree” 
to any item on the BES, all items to which they responded “Very much agree” were 
used in their version of the BES. 
 
8.2.3. Procedure 
A five- session course was designed with an accompanying booklet (see 
Appendix G for full booklet). The key components of the course were developed in 
conjunction with the clinical health psychologist supervising the project.  
 This course aimed to address beliefs about emotions and emotional suppression 
in five 60-90 minute group CBT sessions, using CBT skills including Socratic 
questioning, identifying maintaining cycles considering helpful and unhelpful aspects 
of identified thoughts and behaviours, and testing out making changes. Session one 
provided an introduction to the course with brief education on IBS and an introduction 
to the relationship between stress and IBS symptoms, introducing the idea of a 
‘vicious cycle’ between stress and symptoms. Session two focussed on the 
consequences of suppressing emotions as a long-term emotion regulation strategy, 
focussing on ironic processing effects, reduced social support and increased tension. 
Session three focussed on thought challenging and involved a discussion of the 
potential benefits to sharing emotions with others and asked participants to set goals. 
In this session, participants raised the issue of how one can cope with difficult 
emotions, if not avoid them and asked about relaxation techniques. As such, in this 
session relaxation techniques were briefly discussed. The goals set in session three 
were revisited in session four and the role of anxiety and avoidance in IBS was 
discussed. In this session participants were presented a ‘vicious cycle’ within the 
context of emotional suppression and beliefs about emotions (see Figure 8.1). This 
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session discussed acceptance of emotions and used exercises that are popular in ACT 
(i.e. Passengers on a Bus and The Unwelcome Party Guest) to encourage the 
acceptance of emotion. Session five provided a review of the course and covered 
managing setbacks and plans for the future (including setting more long term goals). 
 
 
Figure 8.1 ‘Vicious cycle’ presented to participants in the fourth session 
 
In addition to the weekly group sessions, each week participants were set home 
tasks that were designed to support their learning during the intervention.  
It should also be noted that, as it was a group session, with significant 
participation from all of the individuals, the focus of the group work was not rigidly 
on beliefs and behaviours around emotional expression when participants raised other, 
related issues. For example, when individuals discussed expression of emotion to 
friends, this led to a discussion about letting friends/family know about the foods they 
could eat. These discussions, which were deemed helpful, were not ended in order not 
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to interrupt the flow and peer support from the group, but were steered back to beliefs 
and behaviours about emotional expression as appropriate. 
Participants were reminded to complete the questionnaire twice per week across 
all three phases of the studies, though they did not always respond to this reminder. 
As such the number of data points and the length of time for each phase varied for 
each individual. The length of the baseline phase was also influenced by the date on 
which the individual started the study. Participants were paid for the completion of 
questionnaires. In order to encourage the completion of questionnaires, participants 
were paid £10 for every phase (of the three-phase experiment) for which they had 
completed all questionnaires. 
At the end of the study, three of the four participants met for a semi-structured 
group interview (see Appendix L for transcript). The aim of the interview was to 
uncover the feasibility of the intervention and to find out if participants felt that they 
had improved as a result. The interview was conducted by the PhD student. 
 
8.2.4. Design and Analysis 
This study used an AB single case series design, where phase A is the pre-
treatment phase and phase B is the treatment phase (Kratochwill et al., 2013). The pre-
treatment or baseline phase consisted of five data points for three participants and four 
data points for one participant. This phase ranged from a duration of one week and 
one day to two weeks and two days due to some participants missing questionnaires 
at the beginning of this phase. The treatment phase consisted of two parts. Phase B1 
was during the intervention and phase B2 was after treatment. Phase B1 comprised of 
between nine and thirteen data points across participants spread over nine weeks, 
while B2 comprised nine to twelve data points over a period ranging from seven weeks 
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and four days to eight weeks and four days depending on the participant completing 
their questionnaires on schedule.  
The data were analysed using Tau-U non-overlap analysis to determine 
differences in levels and trends between phases by considering the proportion of data 
that is non-overlapping between phases. This analysis is specifically designed for 
single case research and uses all data points as opposed to averages (Willson et al., 
2016). Comparisons were made for each participant individually (A vs B1 and B1 vs 
B2) for each of the four variables. Corrections for baseline trends were applied when 
a significant baseline trend was present. Weighted averages were then calculated for 
each of the four variables (weighted by the inverse of the variance of the Tau statistic) 
which reflects the overall non-overlapping data across all four cases. Significance was 
determined through examination of confidence intervals of the effect, where 
confidence intervals that do not contain zero indicate a significant proportion of non-
overlap between phases. 
Thematic analysis was conducted on interview data identifying themes after 
reading and coding the qualitative data. A research assistant also read, coded and 
identified themes in the data. The research assistant was kept blind to the aims of the 
research so as to avoid any potential bias. The research assistant and I then discussed 
and agreed upon themes found in the data.   
8.3. Results 
8.3.1. Attendance 
All of the participants missed at least one session, which may be due to 
timetabling during working hours. If a session was missed, the participant(s) was 
caught up in person or by phone. The handbooks given to each participant covered the 
content of the sessions and therefore also supported those who missed a session. In 
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this sense, none of the participants missed any of the information given during the 
intervention. 
8.3.2. Beliefs about emotions 
Looking at the weighted average across participants, there was a significant 
reduction in BES scores during the intervention period (i.e. when comparing phase A 
with phase B1) and during follow-up (comparing phase B1 with B2). Confidence 
intervals and Tau statistics are presented in Table 8.1. Only one of the participants 
(case B) showed a decrease in BES scores when comparing phase A and phase B1 and 
this was maintained during follow-up (phase B2). However, cases A and C did show 
a reduction in BES scores during the follow-up period (phase B1 compared to phase 
B2). Case D showed no improvements from phase A to phase B1 and unexpectedly 
showed an increase in BES scores in the follow-up period (phase B1 compared to B2). 
See Figure 8.2 for participant scores over time. 
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Table 8.1 Tau statistics and confidence intervals for BES scores 
 Tau SD Tau p value 85% CI 
Case A     
  A vs B1 -0.4063 0.3680 0.2696 -0.936 <> 0.124 
  B1 vs B2 -0.9219 0.2976 0.0019 -1.350 <>-0.493* 
Case B     
  A vs B1 -0.5111 0.3333 0.1252  -0.991 <>-0.031* 
  B1 vs B2 -0.3457 0.2796 0.2164  -0.748 <> 0.057 
Case C     
  A vs B1 -0.3500 0.3162 0.2684  -0.805 <> 0.105 
  B1 vs b2 -0.6429 0.2817 0.0225  -1.049 <>-0.237* 
Case D     
  A vs B1 -0.4600 0.3266 0.1590  -0.930 <> 0.010 
  B1 vs B2  0.5545 0.2582 0.0317   0.183 <> 0.926* 
Weighted Average     
  A vs B1 -.4315 
 
 0.0104 -0.674 <>-0.189* 
  B1 vs B2 -0.3112  0.0260 -0.513 <>-0.110* 
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Figure 8.2 Beliefs about emotions over time for each case. 
Note. Scores were converted to be on a scale from 0 to 100 so as to compare across 
cases. 
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8.3.3. Emotional suppression 
Across the four cases there was a significant reduction in emotional suppression 
(as measured using the CECS) during the intervention (phase A compared with B1) 
and during the follow-up period (phase B1 compared with B2) (see Table 8.2 for Tau 
statistics and confidence intervals). As with beliefs about emotions, only one 
participant (case C) showed a reduction in CECS scores during the intervention (phase 
A compared with phase B). This continued to decrease during the follow-up phase 
(phase B1 compared with B2). For cases A and B, changes were not observed until the 
follow-up period where there was a significant reduction in CECS scores. Case D did 
not change on this measure of emotional suppression during the intervention or during 
follow-up. See Figure 8.3 for CECS scores over time for each case. 
 
Table 8.2 Tau statistics and confidence intervals for CECS scores 
Case Tau SD Tau  p value 85% CI 
A     
  A vs B1 -0.3438 0.3680 0.3502 -0.874 <>  0.186 
  B1 vs B2 -1.0000 0.2976 0.0008 -1.428 <> -0.572* 
B     
  A vs B1† -0.3556 0.3333 0.2861 -0.836 <>  0.124 
  B1 vs B2 -0.5309 0.2796 0.0576 -0.934 <> -0.128* 
C     
  A vs B1 -0.5833 0.3162 0.0651 -1.039 <> -0.128* 
  B1 vs b2 -0.7262 0.2817 0.0099 -1.132 <> -0.321* 
D     
  A vs B1 0.1600 0.3266 0.6242 -0.310 <> 0.630 
  B1 vs B2 -0.1818 0.2582 0.4813 -0.554 <> 0.190 
Weighted Average     
  A vs B1 -0.3498  0.0950 -0.523 <> -0.039* 
  B1 vs B2 -0.5507  0.0000 -0.796 <> -0.394* 
Note. †Indicates a correction for baseline trends  
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Figure 8.3 Emotional suppression over time for each case. 
Note. Scores were converted to be on a scale from 0 to 100 so as to compare across 
cases.  
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8.3.4. Affective distress 
The weighted average across the four cases shows that there was no change in 
affective distress (as measured by HADS scores) during the intervention phase 
compared to baseline (phase B1 compared to phase A). However, there was a 
significant reduction in HADS scores during the follow-up phase (phase B2 compared 
to phase B1) (see Table 8.3 for Tau statistics and confidence intervals). Looking at the 
individual cases, only one participant (case B) showed a reduction in HADS scores 
when comparing phase B1 (intervention) to phase A (baseline). This continued to 
decrease during the follow-up period. Cases A and B showed a reduction in HADS 
scores during the follow-up phase only, while case C showed no changes in HADS 
scores throughout. Scores for each participant over time are presented in Figure 8.4. 
Table 8.3 Tau statistics and confidence intervals for HADS scores 
Case Tau SD Tau p value 85% CI 
A     
  A vs B1 .1563 .368 .6711 -0.374 <>  0.686 
  B1 vs B2 -1.0000 .2976 .0008 -1.428 <> -0.572* 
B     
  A vs B1† -.5778 .3333 .0830 -1.058 <> -0.098* 
  B1 vs B2 -.7778 .2976 .0054 -1.180 <> -0.375* 
C     
  A vs B1 -.2500 .3162 .4292 -0.705 <>  0.205 
  B1 vs b2 -.3571 .2817 .2049 -0.763 <>  0.049 
D     
  A vs B1 .1800 .3266 .5815 -0.290 <>  0.650 
  B1 vs B2 -.7091 .2582 .0060 -1.081 <>  -0.337* 
Weighted Average     
  A vs B1 -.2219  .1872 -0.464 <>  0.020 
  B1 vs B2 -.7073  .0000 -0.909 <> -0.506* 
Note. †Indicates a correction for baseline trends. 
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Figure 8.4 Affective distress over time for each case. 
Note. Scores were converted to be on a scale from 0 to 100 so as to compare across 
cases. 
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8.3.5. Quality of life 
Using the weighted average across all cases, there was no immediate 
improvement in quality of life (measured using the IBS-QOL) during the treatment 
phase compared to baseline (phase B1 compared with phase A). Tau statistics and 
confidence intervals are presented in Table 8.4. However, there was a significant 
increase in IBS-QOL scores indicating improvement during the follow-up phase 
compared to baseline (phase B2 compared to phase A). As with the other measures, 
only one participant (case B) showed improvements during the treatment phase. This 
improvement continued into follow-up. For the remaining three participants (cases A, 
C and D) there were improvements in IBS-QOL scores during the follow-up period 
only. Scores across this measure for each participant are presented in Figure 8.5. 
Table 8.4 Tau statistics and confidence intervals for IBS-QoL scores. 
Case Tau SD Tau  p value 85% CI 
A     
  A vs B1 0.0000 .3680 1.0000 -0.530 <> 0.530 
  B1 vs B2 1.0000 .2976 .0008  0.572 <>  1.428* 
B     
  A vs B1 .7556 .3333 .0234  0.276 <>  1.236* 
  B1 vs B2 .5926 .2796 .0341  0.190 <>  0.995* 
C     
  A vs B1 -.3167 .3162 .3166 -0.077 <> 0.139 
  B1 vs b2 .7967 .2817 .0046  0.395 <>  1.203* 
D     
  A vs B1† -.4600 .3266 .1590 -0.930 <> 0.010 
 B1 vs B2 .6273 .2582 .0151  0.255 <> 0.999* 
Weighted Average     
  A vs B1 .1624  .3347 -0.080 <> 0.405 
  B1 vs B2 .7480  .0000  0.547 <> 0.949* 
†Indicates a correction for baseline trends. 
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Figure 8.5  Quality of life over time for each case 
Note. Scores were converted to be on a scale from 0 to 100 so as to compare across 
cases. 
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8.3.6. Qualitative analysis 
Two researchers analysed the qualitative data independently and then combined 
themes (see Appendix L for a full transcript of the interview). The qualitative analysis 
supported the quantitative findings in that there were themes surrounding sharing 
feelings with others and improvements in their thoughts and behaviours.  
 
Sharing 
The theme ‘Sharing’ was identified which indicated that in particular identifying 
and sharing thoughts and feelings with others was beneficial. Within this theme, it was 
found that participants felt uncomfortable talking to others.  
 
Case C: Because it isn’t one of those things that you’re happy to talk about like 
you might talk about a broken ankle or something to somebody you’re not going to 
sort of raise it in normal day to day conversation. 
 
They felt that keeping their IBS and their feelings about their IBS a secret was 
a burden and that it was a relief to discuss these issues with others.  
 
Case B: And for me talking about it to my partner and a close friend is like, it 
was like a pressure released that you didn’t even realise was there because you live 
with it. 
 
Reassurance in identifying with others 
In particular, it was noted that meeting with other individuals who have IBS was 
beneficial. A theme named ‘Reassurance in identifying with others’ was identified 
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where participants reported feeling less lonely and feeling understood. There was a 
sense that participants’ thoughts and feelings were normalised through identifying 
with others who also have IBS. 
 
Case B: My solution to this problem would be doing this which is quite normal 
in my world but you would never dream of telling anyone else, and then you find out 
that “yeah that’s my solution to that problem as well”. It’s reassuring and 
enlightening really.  
 
Changes/improvements in cognition, emotion and behaviour 
Within the theme of ‘Changes/improvements in cognition, emotion and 
behaviour’, participants noted a shift in their perception of talking with others, in 
particular, with one individual (Case D) reporting feeling ‘less awful’ about talking 
about her IBS.  
 
Case D: I’d already shared things with family and work and things so I didn’t 
need to change that. But it did make me feel less awful about it. Less like I was some 
kind of problem. 
 
Similarly, in this theme, there appeared to be a shift in behaviour with regards 
to making an effort to see friends and to talk about IBS. The reporting of these changes 
are particularly interesting given that the participants reported feeling as though the 
questionnaires had not changed despite reporting changes in cognitions and 
behaviours. 
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Case B: We were given challenges. It made you rethink your whole situation but 
we weren’t given challenges to deal with other people or change our our normal 
routine of just saying no we don’t want to go to dinner, we don’t want to do this, or 
I’m not going to tell anyone about it. It actually challenged me and the others too to 
do something new. 
 
Avoidance 
There was also evidence of avoidance prior to attending the intervention noted 
by participants. Participants reported that previously they had been avoiding activity 
(e.g. avoiding going out to dinner) and avoiding thinking about their IBS.  
 
Case C: I refused to sort of…either not dealing with it not trying to think about 
it ignore it 
 
Changes/improvements in the perception and understanding of IBS 
Analysis revealed that there was a shift in participants’ perception of their IBS 
in that they now understood the relation between stress and symptoms and had also 
learned to ‘draw a line’ separating the two.  
 
Case D: when it happens when you have a bad bout it’s so easy to get more and 
more and more stressed about what’s happening once it once it kicks off once you feel 
the first like.., mm.., and then to just worry about it and it gets worse and worse and 
then it gets worse and worse and worse and it’s a bit sort of self—perpetuating to 
think— to try and sort of relax about it if you can which isn’t that easy but to sort of 
draw a line where the pain starts I suppose 
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How other people view IBS 
Participants also explained their understanding of other people’s perceptions of 
IBS. In particular, they spoke of the lack of support from their GP, the marginalisation 
of the disorder and expressed appreciation for the fact that this research was being 
conducted on IBS. 
 
Case D: I know I also thought when I saw it on the college intranet I sort of 
thought ‘thank God somebody’s doing something that looks at this’ because nobody– 
it’s like we said in the sessions, like nobody really seems to sort of — it’s quite 
marginalised. I thought “somebody’s actually looking at it!” You know it’s like you 
say the GPs don’t just tell you you’ve got it and don’t really..,  that’s it.  
 
Acceptance 
There were additional themes identified which were not directly related to the 
current aims. Acceptance was identified as a theme where participants note the value 
of accepting their IBS, and acknowledge that symptoms are only temporary.  
 
Case D: It’s definitely made me accept that it happens to other people therefore 
it’s nothing to be you know. It’s just one of those things. Not a very nice thing, but one 
of those. 
 
Within this theme, it was also noted that relaxation was seen as a useful coping 
tool in dealing with IBS.  
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Case B: We did learn some techniques to relax which I do find useful especially 
when it is bad or it does — I said it’s frustrating it’s annoying it gets you down. 
 
For some acceptance of the symptoms resembled a mindful approach. 
 
Case C: Quite often you sort of get this feeling it is never going to end. And what 
are you going to do, how are you going to manage. And then you have to keep 
reminding myself it will pass and I’ll be ok again but just not at the moment. 
 
Practical comments 
Participants made practical comments about the intervention. They felt that five 
meetings was a good amount to benefit from the intervention, but also felt that 
continuing to meet with each other as a means of support would be useful.  
 
Case C: [Five sessions is] Probably enough but it would be nice to sort of carry 
on. 
 
The questionnaires, while generally well received, were at times difficult to 
answer. In particular, one individual noted that the questions were not always well 
suited to reflect day-to-day changes.  
 
Case C: Some of the questions asked about your emotions in the last few days 
and I was thinking.., sort of feeling angry was one of them. And I found it hard to 
answer because if I didn’t recall feeling angry in the last week 
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One participant highlighted that the analogies used in the intervention (in 
relation to the idea of acceptance) were not useful for her.  
 
Case C: I found that the sort of analogies like the playing tennis and the bus one. 
I didn’t find they worked of me. 
 
Overall, the qualitative data suggests that participants generally liked the 
intervention and felt as though there were a range of positive changes as a result. 
 
8.4. Discussion 
The current study tested a group-based intervention using a single case series 
with four participants. The intervention was specifically designed to target beliefs that 
expressing emotions is unacceptable and target actual emotional suppression, using 
cognitive behavioural techniques.  
Looking at weighted averages across participants, there were significant 
improvements in beliefs about emotions and emotional suppression during the 
intervention phase of the experiment. These improvements were maintained during 
the follow-up period. Overall, affective distress and quality of life also improved, 
however these changes were not apparent until later during the follow-up phase of the 
experiment. It therefore appears that beliefs about emotions and suppressive behaviour 
changed initially and improvements in distress and quality of life occurred after these 
initial changes. The timing of these changes is consistent with a model in which beliefs 
about emotions and emotional suppression are potential process variables with a 
possible causal effect of changes in these beliefs and behaviours on the outcomes of 
affective distress and quality of life. 
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The particular order in which these mechanisms work (i.e. the relationship 
between beliefs about emotions and quality of life that is mediated serially by first 
emotional suppression and then affective distress) warrants further investigation in a 
larger sample using mediation analyses in an experimental design with a clear timeline. 
However, the current findings are in line with a model whereby improving beliefs 
about emotions may consequently reduce emotional suppression. This may then 
improve quality of life through a reduction in affective distress, which would not only 
improve coping but might directly influence symptoms in IBS (Blomhoff et al., 2000; 
Dancey et al., 1998). However, mediation models in CBT, psychoeducation and 
waitlist controls with IBS (n=147) has found that there is a direct effect of CBT on 
symptom improvement in IBS that is independent of distress (Lackner et al., 2009). 
This has not been explored in the current study, thus future research could better 
disentangle the separate influences of distress reduction and other treatment 
components on treatment outcomes. 
Through finding that the designed intervention resulted in significant changes 
in beliefs about emotions and emotional suppression, the current study demonstrated 
that beliefs about emotions and emotional suppression can be influenced using 
cognitive behavioural techniques particularly targeted to these beliefs and behaviours 
which may be of value in treating individuals who may have difficulty expressing 
emotions. 
Further to this, the current study showed that an intervention which aimed to 
specifically change beliefs about the unacceptability of emotions and emotional 
suppression may elicit changes in affective distress and quality of life. This is in line 
with the mediation model previously tested in this thesis (see Figure 4.1, page 106) in 
which the relationship between beliefs about emotions and quality of life is mediated 
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by emotional suppression and distress. While the current evidence supports this causal 
direction, further research with a control condition would be essential in ruling out the 
role of other factors eliciting influence on the outcomes measures. 
The current study used mixed methodology. The qualitative data from the group 
interview supported the statistical findings of this study. Themes around the idea of 
sharing emotions were identified indicating that the intervention did successfully 
address beliefs about emotions and emotional suppression. The overall view of the 
intervention was positive and the treatment was well-received by the participants.  
However, it should be acknowledged that for the purpose of this PhD thesis, the 
interviews were conducted by the PhD student which may have caused participants to 
answer in a socially desirable manner. While the bias of the PhD student was 
accounted for in analysis (by having a second researcher, blind to the aims, code the 
qualitative data) it is possible that there was experimenter bias in the data collection 
process. 
The qualitative analysis revealed that participants perceived benefits of the 
intervention that were not part of the current aims, such as a reduction in avoidance of 
activities, acceptance of the disorder, viewing symptoms as temporary and coping by 
using relaxation techniques. While the intervention discussed acceptance of emotions, 
it is possible that these discussions also encouraged acceptance more broadly which 
then resulted in participants being more accepting of having IBS. Similarly, when 
talking about problems with avoiding talking about one’s feelings, participants may 
have also reflected on avoidance more generally, leading to less avoidance of activity. 
Relaxation techniques were reported as being useful by some of the participants. 
Though relaxation was not a key component planned in the intervention, there was 
discussion around relaxation techniques as participants specifically asked about 
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relaxation. As such, it seems that this discussion was useful as participants reported 
using relaxation techniques to deal with the stress that comes with IBS. Interestingly, 
there was no explicit discussion regarding viewing symptoms as temporary as a 
coping technique, however participants reported finding this useful. This shift in the 
perception of symptoms is surprising and indicates that although particular coping 
strategies are not taught, individuals may generalise learned skills and adopt new 
coping strategies as a result of intervention. This demonstrates the value of using a 
mixed methods design with an inductive approach in that there may be processes that 
are beneficial to participants that may not be detected when measuring only 
hypothesised variables. 
 While the overall changes across participants support the hypotheses, the 
changes were not consistent across all four cases. For example, with BES scores, 
whilst all participants made improvements, changes across the intervention stage were 
only significant in one participant, with the rest of the participants showing significant 
changes during the follow-up period. However, the weighted average across 
participants seems to suggest that while the changes were not so great as to achieve 
statistical significance in a single participant, once weighted with other cases, there 
were significant improvements. 
 Conversely, Case D unexpectedly showed an increase in their beliefs about the 
unacceptability of emotions. This might be explained by a marked decrease in scores 
for the last two data points during the intervention phase (see Figure 8.2) as opposed 
to an overall worsening since the intervention started. This is further supported with 
evidence that there was no significant difference between the baseline and the follow-
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up phase5. This seems to indicate there was no change in beliefs about emotions as 
opposed to a worsening of these beliefs. This lack of change fits with the participant’s 
reporting that she considered herself to be quite open with others emotionally during 
the interview, stating “I’d already shared things with family and work and things, so I 
didn’t need to change that”. However, she went on to say “But [the intervention] did 
make me feel less awful about it, less like I was some kind of problem,” which seems 
to suggest that while her emotional suppression may not have changed, her beliefs 
about expressing emotions might have. The particular belief that one is a ‘problem’ or 
burden for sharing emotions is not directly addressed in the beliefs about emotions 
scale, which may explain why this change was not detected in the statistical analysis. 
There was a similar pattern with emotional suppression as in beliefs about 
emotions regarding individual changes in that only one participant showed significant 
improvements in emotional suppression during the intervention phase. However as 
before, the overall improvements as seen in the weighted averages may reflect small 
changes within each case. Case D did not change in emotional suppression during the 
intervention or follow-up phases of the experiment. However as previously stated, this 
participant reported already being able to express feelings with family and work 
colleagues which may be why there was no change.  
For affective distress, case B showed improvements early on compared to the 
rest of the group who did not show improvements until the follow-up phase. These 
early changes for case B in affective distress and beliefs about emotions could be 
reflective of her making significant changes in her behaviour during the intervention: 
“And for me talking about it to my partner and a close friend is like – it was like a 
                                                 
5 For case D, phase A and phase B2 were not significantly different (Tau=-0.0545, SD 
Tau=0.3210, 85% CI [-0.517, 0.408]). 
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pressured released that you didn’t even realise was there because you live with it.” It 
could be that this participant in particular benefited the most from a targeted 
intervention as she particularly struggled with talking about her feelings and her IBS 
to even her partner and close friend until she attended the intervention.  
Case C surprisingly showed no improvements in affective distress however this 
participant had much lower levels of distress at the start of the intervention, resulting 
in only two items on her idiographic measure which perhaps limited variance to the 
extent that changes would not be detected if they had occurred. These floor effects 
may therefore explain the lack of change in affective distress for Case C. 
The findings for quality of life were more consistent, with all four participants 
improving during the follow-up period. Case B again also improved during the 
intervention phase though this was not reflected in the averages across participants. 
Perhaps the changes for this participant are again reflective of her particularly closed 
nature and her earlier improvements in affective distress. 
It is perhaps unexpected that case D showed improvements in quality of life and 
affective distress given that there were no changes in emotional expression or beliefs 
about emotions. This may be indicative of other mechanisms at play in the intervention 
that may have benefitted the participant. For example, during the interview this 
participant reported the value in understanding the relation between stress and 
symptoms, relaxation techniques and viewing the symptoms as temporary as a means 
to manage living with IBS. She also highlighted that discussing IBS with a group of 
people who understood the condition was very helpful. It may be these factors which 
resulted in improvements in affective distress and quality of life as opposed to beliefs 
about the unacceptability of emotions and emotional suppression. Had the current 
study selected participants only with high BES and CECS scores during recruitment, 
241 
 
it may not have been possible to learn that an individual who reports being emotionally 
expressive can still benefit from this intervention through other mechanisms. 
By using a single case experimental design, it is possible to explore the effects 
of the intervention on each individual participant as opposed to looking across 
participants at the average scores. This method, along with using qualitative data, has 
allowed exploration of the intervention on an individual level, for example finding 
that there may be other processes at play for Case D compared with Cases A, B and 
C. This raises questions for future research which may find differential responses to 
treatment. In larger samples, analyses of subgroups (or clusters) may be beneficial. 
Using idiographic measures lightened the work-load for participants by asking 
them to complete fewer items, which is beneficial when asking participants to 
complete two questionnaires per week for several months. However these measures 
have only previously been validated as constructs with all items and have not been 
validated as shortened constructs. They therefore may measure slightly different latent 
variables for each individual. For example, when measuring emotional suppression, 
one participant may only be answering items related to anger suppression which 
means that the suppression of other emotions is not being measured. Furthermore, 
these items may have been selected in the first instance simply because the individual 
was feeling (for example) angry at the time of completing the first questionnaire. It 
may be that different emotions arose during the intervention (e.g. sadness) and that 
the suppression of these emotions was not being measured by the idiographic 
questionnaire. Future research investigating this intervention in a larger sample would 
allow for questionnaires to be completed less frequently which would mean the full 
validated versions of questionnaires could be used.  
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The current study took a flexible approach in that topics deemed helpful by 
participants which arose in discussions were not ended. In addition when participants 
requested information about relaxation techniques as a means of dealing with distress 
in an alternate way this was not discouraged. While this flexible and individualised 
approach to treatment is beneficial, introducing relaxation as a means of coping with 
emotional difficulties may have confounded the current study.  
A systematic review and meta-analysis of eight studies looking at the effects of 
relaxation therapy in IBS found that relaxation treatments elicit improvements in 
quality of life, symptom severity and anxiety (Park, Han, & Kang, 2014). Given the 
qualitative evidence that relaxation was useful, it is possible that relaxation played 
some part in improving quality of life and affective distress in the current study. 
However, the findings regarding statistically significant changes in beliefs about the 
unacceptability of emotions and in emotional suppression, along with qualitative 
evidence that sharing feelings with others was a beneficial change following the 
intervention, seem to suggest that beliefs about emotions and emotional suppression 
are still key mechanisms of the intervention, even if changes in relaxation did explain 
some of the improvements in affective distress and quality of life. 
Despite participants’ reporting satisfaction with the intervention, attendance to 
the meetings could have been improved. All four participants missed at least one group 
meeting. However, participants were met with individually to cover the session that 
they missed, meaning they did not miss any of the content of the intervention. Given 
that participants were generally happy with the intervention, it may be that extraneous 
factors (such as scheduling the meetings during work hours) influenced attendance. 
Data on reasons for missing sessions was not collected, but would have provided 
further insight into the feasibility of the intervention.  
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The current study has found early support for an intervention targeting beliefs 
about emotions and emotional suppression in IBS. However, this was only tested with 
four participants and no control group. It might be that other participants with IBS 
who do not hold unhelpful beliefs about the expression of emotions may not benefit 
from such intervention. Case D reported that she was emotionally expressive before 
the intervention and thereby did not change with respect to beliefs about emotions and 
emotional suppression. However, quality of life and distress did improve for this 
participant regardless. Similarly, for the participant who reported low levels of distress 
prior to intervention (Case C), though distress did not change, quality of life did. It 
may therefore be that different mechanisms of treatment are useful for different 
individuals and thus larger samples with subgroup analyses would be beneficial. 
Doing so would enable an individualised approach to interventions where treatment 
is based on individualised formulations (Hallam, 2013).  
Further to this, a fully randomised control trial would be useful in accounting 
for any effects of other unmeasured mechanisms such as peer support, and time to talk 
about living with IBS. Additionally, using regularly used forms of CBT as a control 
condition compared with the same CBT with the addition of the current content on 
beliefs about emotions and emotional expression would be useful in determining the 
additive value of addressing beliefs about emotions and emotional expression in this 
sample.  
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9. Chapter Nine: General Discussion 
The current thesis aimed to explore the role of psychosocial factors in persistent 
physical symptoms. By exploring cognitive and behavioural factors, the current thesis 
attempted to improve our understanding of beliefs and behaviours that are relevant to 
a potential maintaining cycle in people with persistent physical symptoms. The thesis 
focused on beliefs about emotions, emotional suppression, support-seeking, beliefs 
about sharing illness experiences and outcomes in people with FMS and IBS.  
These aims were addressed using a range of research methods. Chapters Three, 
Four and Five used correlational and cross-sectional designs to explore differences 
between clinical groups and to investigate mediation models involving beliefs about 
emotions and emotional suppression. Chapter Six used similar online methods that 
incorporated mediation and group comparisons to validate a newly developed measure 
of beliefs about sharing illness experiences. Chapter Seven tested the role of beliefs 
about emotions and emotional suppression in existing psychological therapies for 
FMS, while Chapter Eight involved designing and testing an intervention that used 
cognitive behavioural techniques focusing on beliefs about emotions and emotional 
suppression with individuals with IBS, including following participants after the 
intervention to assess long-term changes. 
The current chapter summarises the findings across all studies in this thesis 
before discussing possible conclusions in relation to beliefs about emotions and beliefs 
about sharing illness experiences in persistent physical symptoms. Implications and 
limitations of the current findings are then discussed.  
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9.1. Summary of findings 
Chapters Three and Four both showed that individuals with IBS score higher on 
a measure of beliefs about the unacceptability of emotions compared to healthy 
controls (this finding was only approaching significance in Chapter Four), but do not 
differ on a measure of emotional suppression. Chapter Four examined whether the 
stronger belief that expressing emotions is unacceptable was specific to IBS or 
whether there is something more broadly about having persistent bowel symptoms 
that might be related to believing it is unacceptable to express one’s emotions.  A 
comparison between individuals with IBS, individuals with IBD and healthy controls 
was therefore conducted. In doing so, it appeared that those with IBS did not differ 
from those with IBD on measures of beliefs about emotions and emotional 
suppression. Interestingly, after controlling for affective distress (which is found to be 
higher in those with IBS compared to control groups (Deary et al., 2007; Muscatello 
et al., 2014)) the difference between those with IBS and healthy controls was no longer 
significant. In both Chapter Three and Four there were no differences in emotional 
suppression between the groups. 
However in Chapter Five, looking at individuals with FMS, a different pattern 
emerged. When comparing individuals with FMS to those with psoriatic arthritis and 
to healthy controls, there were no differences in beliefs about the unacceptability of 
emotions. This may be explained by the healthy controls having stronger beliefs about 
emotions than previous healthy control groups in this thesis (see Section 5.4, page 
138). However, those with FMS were more emotionally suppressive than healthy 
controls, though were not different from those with psoriatic arthritis. After controlling 
for affective distress, the difference between FMS and healthy controls became non-
significant and the arthritis group scored significantly higher than those with FMS.  
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When testing mediation models, Chapters Three and Four found support for a 
model where the relationship between emotional suppression and quality of life is 
mediated by beliefs about emotions in IBS, suggesting that expressing one’s emotions 
may modulate beliefs about emotions, which may then influence quality of life.  This 
supports proposed mechanisms of change in written emotional disclosure 
interventions in FMS (Gillis et al., 2006), though further investigation with 
experimental methods is warranted. This model was not supported in FMS in Chapter 
Five however. Along with the mediation findings of Chapters Four and Five (where 
emotional suppression and affective distress mediated the relationship between beliefs 
about emotions and outcomes), this mediation effect of beliefs about emotions on the 
relationship between emotional suppression and quality of life in IBS may form part 
of a self-maintaining cycle where the relationship between beliefs and behaviours is 
reciprocal, fitting with Deary et al.’s (2007) description of autopeotic cycles in 
persistent physical symptoms. 
Chapter Three tested a mediation model where the relationship between beliefs 
about emotions and quality of life was mediated by emotional suppression, however 
this was not found to be significant. It was noted in the discussion that this study 
(Chapter Three) did not measure affective distress which was suspected to play an 
important role in the relationship between beliefs about emotions and quality of life. 
In line with ironic processing theory (Wenzlaff & Wegner, 2000) it was proposed that 
beliefs about emotions would relate to poorer quality of life through an increase in 
emotional suppression which would then be associated with an ‘ironic’ increase in the 
emotions that were being suppressed. This increase in unpleasant emotions (measured 
as affective distress) was then expected to relate to poorer disorder-specific outcomes.  
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This proposed model was therefore tested in Chapters Four and Five by 
measuring affective distress. It was found that the relationship between beliefs about 
emotions and either quality of life (in IBS) or global impact (in FMS) was mediated 
serially by emotional suppression and then affective distress in that particular order. It 
was also expected that believing it is unacceptable to express one’s emotions would 
relate to poorer outcomes through a reduction in seeking support. Support-seeking 
however was not a significant mediator of the relationship between beliefs about 
emotions and outcomes in IBS and FMS. 
To investigate further the beliefs related to support-seeking, a new questionnaire 
measuring beliefs about sharing illness experiences was validated in a sample of 
individuals with FMS. This questionnaire was found to be reliable and valid and there 
was evidence that the scale consisted of two distinct factors: ‘beliefs about sharing 
struggles’ and ‘benefits of sharing illness experiences’. Using this questionnaire as the 
predictor variable and global impact as the outcome, a mediation model was tested. 
This mediation model found that all-or-nothing behaviour and support-seeking for 
personal/emotional problems were significant mediators, while limiting behaviour 
and support-seeking for symptoms of FMS were not. 
In Chapter Seven, beliefs about emotions, emotional suppression, affective 
distress and global impact were measured before and after NHS treatment for 
individuals with FMS. This chapter found that changes in beliefs about emotions over 
the course of treatment were positively correlated with changes in emotional 
suppression. However, the relationship between changes in beliefs and changes in 
affective distress was only marginally significant and was non-significant for global 
impact. Changes in emotional suppression from pre-treatment to post-treatment were 
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related to changes in affective distress and changes in affective distress were 
correlated with changes in global impact.  
These individual relationships appear to provide support for beliefs about 
emotions and emotional suppression relating to global impact via the path laid out in 
the serial mediation model tested in Chapters Four and Five of this thesis. However, 
beliefs about emotions and emotional suppression were not directly related to global 
impact, which would be expected in a test of bivariate correlations given that shared 
variance is not accounted for. However, these correlations were conducted only on 
those who had complete both pre-treatment and post-treatment measures (n=39) 
which may have been too small a sample to detect these relationships. Furthermore, 
evidence from Chapter Five suggests that while the direct relationship between beliefs 
about emotions and global impact is not significant, there is still an indirect effect 
through which they relate. Thus, it is possible that there is an indirect effect, despite 
the lack of significant relationship between beliefs about emotions and emotional 
suppression. 
Beliefs about emotions did significantly reduce over the period of treatment and 
remained lower at 12-week follow-up. Emotional suppression however did not change. 
This suggests that while beliefs about emotions may be a key process in the given 
interventions (though the correlational evidence cannot support this), emotional 
suppression does not appear to be influenced by the treatments in this study. It may be 
that changes in beliefs about emotions are sufficient for lasting improvements in 
global impact (which were evident in this chapter), though it is also possible that a 
reduction in emotional suppression may provide greater benefit to patients.   
Based on the mediation models supported in Chapters Three, Four and Five, the 
final study of this thesis, presented in Chapter Eight, designed and tested a brief group 
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intervention specifically aimed at addressing beliefs about emotions and emotional 
suppression in IBS to test the notion that there is a causal relation between beliefs 
about emotions and quality of life in IBS. It was hypothesised that the intervention, 
which used cognitive behavioural techniques, would support individuals in making 
helpful changes in beliefs and behaviours around emotional expression and would 
result in improvements in quality of life.  
In four individuals with IBS it was found that quality of life improved after the 
intervention. There was also a significant reduction in affective distress during the 
follow-up period for three of the four participants. Three of the participants showed 
significant reductions in unhelpful beliefs about emotions and in emotional 
suppression and weighted averages show the changes in these two variables to be 
significant during treatment with no significant overall change at follow-up. 
Qualitative evidence from this experiment highlighted expressing emotions as a 
potential mechanism of treatment along with other possible mechanisms, such as 
acceptance. From the interviews, it was evident that participants liked the 
interventions and felt that it had benefitted them. 
Across these studies, support has been provided for the proposal that beliefs 
about emotions and emotional suppression may play a role in a maintaining cycle of 
symptoms in IBS and in FMS. There is also evidence that support-seeking for 
personal/emotional problems, all-or-nothing behaviour and beliefs about sharing 
illness experiences may too play a role in maintaining symptoms in FMS, though 
further evidence with a clear timeline is needed. 
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9.2. Beliefs about emotions and their role in persistent physical 
symptoms 
The findings in this thesis support previous research suggesting that beliefs 
about emotions may be relevant to the cognitive behavioural model of persistent 
physical symptoms. This research has demonstrated this association in both IBS and 
FMS. In IBS beliefs about the unacceptability of emotions were related to poorer 
outcomes, such that greater beliefs were associated with poorer quality of life. The 
causality of this model is in part supported by the non-significant alternate model in 
Chapter Four and by the changes evidenced following a cognitive behavioural 
intervention focusing on beliefs about emotions and emotional suppression in Chapter 
Eight. Further experimental testing comparing changes in beliefs and behaviours with 
a control group who receive cognitive behavioural therapy that does not focus on 
beliefs and behaviours around emotions would help support this hypothesised 
causality.  
In FMS however, beliefs about the unacceptability of emotions were not directly 
related to global impact, despite there being a significant indirect effect. The non-
significant direct relationship in Chapter Five was argued to be potentially caused by 
either an unmeasured moderator or mediator having an influence on the relationship 
between beliefs about emotions and global impact. There is early evidence, using 
cluster analysis, that emotion processing varies across subgroups of individuals with 
FMS, in particular, in participants who were categorised as ‘interpersonally distressed’ 
emotional suppression was related to more negative affect and less positive affect. 
This was not found for individuals classified as ‘dysfunctional’ or ‘adaptive copers’ 
though the ‘dysfunctional’ patients showed the highest levels of emotional 
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suppression (López-Cicheri et al., 2013). This could mean that there are differential 
relationships between beliefs about emotions and outcomes across different subgroups 
of individuals with FMS, which should be explored in future research as they may 
explain finding an indirect effect with no direct relation between the predictor and 
outcome.  
In Chapter Seven when this model was tested, the indirect effect was not 
significant while the direct relationship between beliefs about emotions and global 
impact was. It is possible that those who are referred for psychological treatment are 
more likely to be from a particular subgroup identified by López-Cicheri et al. (though 
it is unclear from the cluster analysis which of these particular subgroups most likely 
fit the findings of Chapter Seven). Conversely, using an online sample in Chapter Five 
might have meant participants reflected more than one of these subgroups which 
might explain why the direct relationship was not significant in Chapter Five. It 
therefore appears that while beliefs about the unacceptability of emotions are of 
interest in FMS, its relation to outcomes is more varied across participants than in IBS. 
 
9.3. Distress and its role in persistent physical symptoms 
In Chapters Four and Five, support was found for emotional suppression and 
affective distress as key variables explaining the relationship between beliefs about 
emotions and outcomes. Distress in particular was a key mechanism explored in this 
thesis as the mediation model in Chapter Three was non-significant when emotional 
suppression alone was tested as a mediator. Based on these studies it therefore appears 
that greater beliefs about the unacceptability of emotions is related to lower emotional 
suppression which in turn results in an increase in affective distress. The findings 
suggest that the increase in affective distress results in poorer outcomes as opposed to 
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emotional suppression being directly related to outcomes. This is in line with ironic 
processing explanations which suggest that emotional suppression results in an ‘ironic’ 
increase in the emotion being suppressed (Wenzlaff & Wegner, 2000) and with 
evidence linking distress with physical symptoms (Blomhoff et al., 2000; Dancey et 
al., 1998; Lee et al., 2013; Montgomery et al., 2010; van Koulil et al., 2007). 
Some might argue based on this evidence that existing interventions targeting 
affective distress are sufficient in that they address this specific aspect of the model 
which relates to disorder-specific outcomes. Effective therapy for reducing distress 
focuses on identifying and adapting cognitions and behaviours which are related to 
the experience of depression/anxiety (which may encompass emotion regulation 
strategies such as emotional expression), while interventions addressing these 
affective symptoms alone (i.e. through the use of antidepressant medication) are less 
effective and less cost-effective (Dobson, Hollon, Schmaling, Kohlenberg, & Gallop, 
2008; Koeser, Donisi, Goldberg, & McCrone, 2015). Evidence in treatments for 
individuals with chronic pain and depression have shown that stepped care (i.e. anti-
depressant treatment followed by a self-management pain program) results in 
clinically significant improvements in only 26% of patients (Kroenke et al., 2007). 
Additionally, beliefs and cognitions of participants predicted response to treatment 
(Ang et al., 2010), suggesting a need to focus on maladaptive cognitions that might 
relate to distress.  
Given that beliefs can affect the response to treatment, it is imperative to 
investigate cognitions and behaviours that relate to the experience of distress, as 
opposed to focussing solely on the symptoms of distress, in order to improve response 
to treatment. This is especially prudent as in Chapter Seven there were significant 
changes in beliefs about the unacceptability of emotions during psychological 
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treatment for FMS after controlling for affective distress, suggesting these beliefs are 
addressed independently of reductions in distress. 
  
9.4. Support-seeking and its role in persistent physical symptoms 
Support-seeking was not found to be a significant mediator of the relationship 
between beliefs about emotions and outcomes in IBS and FMS. This was surprising 
given that cognitive behavioural models of persistent physical symptoms proposed the 
that beliefs about unacceptability of emotions lead people to not ask for help, which 
in turn leads to a reduction in social support and poorer outcomes in terms of distress 
and physical symptoms such as fatigue and bowel disturbance (Ali et al., 2000; Rimes 
& Chalder, 2010; Surawy et al., 1995). This finding was, however, in line with one 
previous study which found that the relationship between beliefs about emotions and 
fatigue was not mediated by support-seeking in healthy individuals (Sydenham et al., 
2016).  
The current study measured support-seeking as opposed to support received. 
While support-seeking was related to beliefs about emotions it was not related to 
outcome measures in Chapters Four and Five. It may be that believing that emotions 
are unacceptable does lead to less support-seeking, but this does not necessarily lead 
to a helpful form of support being received, in that the support received may be 
inadequate. This could be particularly an issue when considering evidence that those 
with IBS and FMS tend to also score highly on measures of alexithymia (Huber, 
Suman, Biasi, & Carli, 2009; Phillips et al., 2013; Porcelli, De Carne, & Leandro, 
2014; van Middendorp et al., 2008). Consequently, it may be that despite expressing 
emotions and then seeking support, individuals may be inaccurately or ineffectively 
expressing emotions due to an inability to understand and describe one’s emotions. 
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This would mean that although one might express emotions and seek support for this, 
they may not receive the support that would be beneficial.  
Based on previous evidence on stigma and secrecy in these conditions and the 
relationship between stigma, social support and outcomes (Frohlich, 2014; McInnis et 
al., 2015) (see sections 1.1.2, 4.1 and 5.1 on pages 22, 96 and 121), it was argued that 
concerns about stigma and social judgements of others regarding the condition would 
be more relevant than beliefs about sharing emotions (see section 4.4 and 5.4 on pages 
115 and 138). A measure of beliefs about sharing illness experiences was therefore 
developed. Support-seeking was found to mediate the relationship between beliefs 
about sharing illness experiences and global impact. It could be therefore that beliefs 
about sharing illness experiences leads to receiving more helpful and appropriate 
support, perhaps because illness experiences may be more easily understood and 
described than emotional experiences for those who are alexithymic. This then means 
that support-seeking mediates the relationship between beliefs about sharing illness 
experiences and global impact.  
 
9.5. Beliefs about sharing illness experiences and their role in persistent 
physical symptoms 
An academic supervisor of this PhD project had previously developed a measure 
of beliefs about sharing illness experiences. This measure was then evaluated in 
Chapter Six of this thesis in participants with FMS and found to be a reliable and valid 
measure with two underlying factors (beliefs about sharing struggles and benefits of 
sharing illness experiences). This research found that unhelpful beliefs about sharing 
illness experiences were related to poorer outcomes (i.e. greater impact of the disorder 
and greater affective distress).  
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Further mediation analyses revealed that seeking support for personal/emotional 
problems was a significant mediator of the relationship between beliefs about sharing 
illness experiences and global impact while support-seeking for problems relating to 
symptoms was not. It therefore seems that greater negative judgements and perceived 
negative judgements of others in relation to sharing illness experiences, the less likely 
they are to seek emotional support, which then results in a greater impact of the 
disorder on their lives.  
Practical support-seeking however was not a significant mediator of this 
relationship. It may be that this kind of support-seeking is more influenced by the 
distinction between social support for autonomy which is beneficial and social support 
for dependence which can be detrimental (Matos et al., 2015) (discussed in more detail 
in section 9.9): Being dependent on practical or physical support may be more 
detrimental than being dependent in terms of emotional support. When others are 
completing physical tasks on a person’s behalf, that person is thereby avoiding activity 
and perhaps there is a degree of physical deconditioning (Vlaeyen & Linton, 2000), 
which may then influence outcomes. Furthermore, the question of the practical 
support-seeking measure was modified from the original GHSQ whereas the 
personal/emotional measure was not. It may be that this modification resulted in a 
reduction in validity/reliability resulting in an ability to capture support-seeking 
intentions in relation to FMS. 
All-or-nothing behaviour was also found to mediate the relationship between 
beliefs about sharing illness experiences and global impact in parallel with the 
mediation effect of personal/emotional support-seeking. This indicates that if one has 
greater negative judgements around sharing experiences about one’s illness, they may 
overexert themselves in an effort to appear as though they are not struggling (McInnis 
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et al., 2015). It is possible this overexertion may then force them into periods of 
prolonged rest before re-engaging in overexertion to compensate for the prolonged 
rest period (Spence, Moss-Morris, & Chalder, 2005). This cycle of all-or-nothing 
behaviour then results in a greater impact of the disorder on the individual’s life.  
The current thesis has therefore found evidence for two potential mechanisms 
through which beliefs about sharing illness experiences might relate to outcomes in 
FMS. This evidence along with the validation of the questionnaire enables future 
research to further explore the role of beliefs about sharing illness experiences in other 
conditions.  
 
9.6. Differences between those with FMS and IBS 
Researchers have often used the term ‘medically unexplained symptoms’ by 
which they refer to conditions such as IBS and FMS (among others) that have no clear 
medical explanation for the physical symptoms that patients experience. Some 
researchers have aimed to develop biopsychosocial or cognitive behavioural models 
which aim to describe psychosocial features of persistent physical symptoms with 
uncertain aetiology, spanning the specific diagnoses (Deary et al., 2007; Salkovskis et 
al., 2016). Salkovskis notes similarities as well as differences within this broad 
category of so called ‘medically unexplained symptoms’.  
In the current thesis, there are subtle, but noteworthy differences between the 
findings of those with IBS and those with FMS. For example, in IBS, it was found 
across two studies that those with IBS hold stronger beliefs about the unacceptability 
of emotions compared with healthy controls, but that they do not differ with regards 
to the suppression of emotion. Interestingly in FMS, there were no differences in 
beliefs about emotions, but there were differences in emotional suppression. It is 
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possible therefore that these two variables play similar, but still different roles in these 
two conditions. It is worth noting however that the healthy controls in Chapter Five 
scored significantly higher than those in Chapter Four on the measure of beliefs about 
emotions, which might explain the lack of a significant difference when measuring 
beliefs about emotions in Chapter Five, suggesting that with regards to beliefs about 
emotions, those with FMS may still differ from healthy controls as did those with IBS.  
It could be worth further investigating the role of embarrassment and stigma in 
IBS and FMS to understand these differences. For example, beliefs about the 
unacceptability of emotions (which focuses on social judgements in particular) may 
be higher in those with IBS due to the inherently embarrassing nature of bowel 
symptoms which is arguably less potent for symptoms of chronic pain and fatigue 
(Frohlich, 2014). However, in Chapter Six, it was found that those with FMS had 
greater negative judgements (of self and perceived judgements of others) around 
sharing illness experiences compared with healthy controls, suggesting that 
judgements about sharing more broadly might be higher than healthy controls in FMS 
as well as in IBS, despite the use of slightly different measures. Based on these 
findings in Chapter Six, a replication of Chapter Five with a different sample of 
healthy controls would be useful in determining whether the findings in beliefs about 
emotions were in fact a type II error. 
Another noteworthy difference between the findings of Chapters Four and Five 
involves the direct relationship between beliefs about emotions and the disorder-
specific outcome measure. In IBS (Chapter Four), beliefs about emotions were 
directly related to quality of life, while in FMS (Chapter Five), this relationship was 
not significant (despite finding a significant indirect effect). However, as described 
above, these findings were not supported in a clinical sample in Chapter Seven. 
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In line with previous research finding distinct subgroups of individuals with 
FMS that differ in their emotion processing (López-Cicheri et al., 2013), it could be 
that for those with FMS who are within the previously identified ‘interpersonally 
distressed’ subgroup (where emotional suppression was related to more negative and 
less positive affect), beliefs about emotions may result in poorer outcomes through 
emotional suppression and increased negative affect. Alternatively, for those who are 
‘dysfunctional’ or coping adaptively, there may be other mediators of this relationship 
which may in fact result in a positive indirect effect. However, the findings of López-
Chicheri et al. do not provide any clear evidence for this suggesting more research 
into subgroups of individuals with FMS is needed. 
This early evidence of subgroups within a FMS sample with regards to emotion 
processing demonstrates a lack of homogeneity in FMS samples with regards to 
emotion regulation and its relation to distress. The differences between those with 
FMS and IBS may therefore be explained by individuals with IBS making up a more 
homogenous group in terms of their emotional suppression and beliefs about emotions, 
while samples of individuals with FMS are made up of distinct subgroups where 
beliefs about emotions relate differently to distress and outcomes for different 
subgroups. Investigations into the heterogeneity of samples of IBS with regards to 
emotion processing variables would be needed to further test this supposition.   
Despite the subtle differences in emotional suppression and beliefs about 
emotions between samples with FMS and IBS, there is still consistent evidence in the 
online samples supporting the indirect relationship between beliefs about the 
unacceptability of emotions and outcomes via emotional suppression and affective 
distress.  
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9.7. Implications for clinical practice 
Chapters Three, Four and Five provided the basis for developing an intervention 
that targeted beliefs about the unacceptability of emotions and emotional suppression 
in IBS. As beliefs about emotions were related to quality of life via emotional 
suppression and affective distress, it was hypothesised that if an individual could be 
supported, using cognitive behavioural techniques, in adapting their unhelpful beliefs 
about emotions to become more accepting of emotions, this would result in a reduction 
in emotional suppression (which may also be directly addressed through cognitive 
behavioural methods) which would then result in less affective distress and improved 
quality of life. The aim was therefore to attempt to disrupt a potential unhelpful 
maintaining cycle of beliefs, emotions and behaviours that may work to maintain poor 
quality of life in IBS by changing beliefs and behaviours.  
Chapter Eight showed that an intervention addressing unhelpful beliefs about 
the unacceptability of emotions and emotional suppression may result in 
improvements in distress and quality of life in IBS. Firstly, this supports the notion 
that individuals with IBS can benefit from cognitive behavioural approaches, 
demonstrating the value of investigations into the particular features of this treatment 
approach. Secondly, the evidence from Chapter Eight suggests that targeting these 
particular beliefs about emotions may be useful in treating individuals with IBS. In 
order to investigate whether this evidence could be applied to clinical practice, further 
research should compare Chapter Eight’s intervention with other CBT protocols for 
IBS (in addition to wait-list controls) in order to understand whether adding content 
on beliefs about emotions and emotional suppression contributes to greater 
improvements when compared to similar treatment methods that do not address these 
factors.  
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Given the evidence that psychological, and in particular cognitive behavioural 
intervention is useful for those with IBS, it is important to explore the potential 
mechanisms through which these treatments are effective. This may then allow for 
better targeted intervention and increased effectiveness. It has been argued that the 
research on CBT for IBS has too often focussed on whether CBT works and instead 
should investigate particular components of effective psychological treatment in order 
to understand better the aetiology and prognosis of the disorder and to refine and 
streamline CBT for IBS (Lackner et al., 2009). Therefore, by targeting change in 
specific theory driven beliefs and behaviours (in this case beliefs about emotions and 
emotional suppression) using cognitive behavioural techniques, and measuring their 
change during and after intervention, it is possible to begin exploring mechanisms of 
treatment in IBS. 
In FMS, it has also been suggested that the mechanisms of psychological 
treatment are unclear and should be investigated further (Eccleston et al., 2009). It is 
possible that in NHS interventions for FMS which include an integrative CBT, ACT 
and mindfulness approach to pain management in a group setting, beliefs about 
emotions and emotional suppression are adapted due to discussions around emotion 
processing in these treatments.  
It was found that beliefs about the unacceptability of emotions (though not 
emotional suppression) reduced during these NHS psychological treatments for FMS, 
which suggests that these psychological interventions do indeed modify beliefs about 
emotions. However, interestingly, in Chapter Seven, emotional suppression was not 
affected by these interventions, while in the intervention designed in Chapter Eight, 
emotional suppression did change over the intervention phase of the study. It could be 
that current interventions for FMS could benefit from directly addressing emotional 
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suppression since the qualitative findings in Chapter Eight seemed to indicate this was 
useful for individuals with IBS. Analyses of these interventions with a specific focus 
on beliefs about the unacceptability of emotions and emotional expression, compared 
to a control group that does not contain this aspect, would be vital. 
It is important to note that different therapeutic models may consider emotional 
expression using different approaches. For example, second wave CBT may directly 
consider the role of behaviours and beliefs, and the consequences, including 
unintended consequences, of such beliefs and behaviours. Third wave therapy (e.g. 
ACT) may consider more directly the concept of ‘acceptance’ , defined as “permitting 
the presence of experiences that are unwanted, such as feelings, physical sensations, 
memories and urges” (McCracken, 2011). Acceptance of emotions and symptoms was 
part of the NHS psychological interventions, as well as the use of second wave 
cognitive behavioural techniques (identifying and evaluating cognitions around 
emotions).  
Acceptance of emotions (not of symptoms) was a focus of the intervention 
described in Chapter Eight. However, a theme that was highlighted during the 
qualitative analysis of Chapter Eight included acceptance of symptoms. It is likely, 
then, that each of the interventions in Chapters Seven and Eight encouraged 
acceptance in participants of both emotions and of their symptoms. It could be that 
individuals generalise the increased acceptance of the expression and experience of 
emotions to acceptance in other areas (such as acceptance of physical symptoms). As 
such, changes in beliefs about unacceptability of emotions may therefore have resulted 
in increasing levels of acceptance of emotions, and individuals generalised these skills 
in considering the experience of symptoms. However, the acceptance of emotion was 
not measured in this research and therefore this would require confirmation from 
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future research. This idea is however consistent with research that suggests that 
acceptance of symptoms increases through second wave CBT interventions; and 
beliefs about pain are adapted in third wave ACT interventions (Wetherell et al., 2011). 
It seems therefore that the mechanism of change around beliefs about emotions and 
acceptance could be somewhat overlapping. The particular mechanisms of change in 
terms of beliefs and behaviours around acceptance of emotions and acceptance of 
symptoms, should be investigated further as acceptance was not measured in the 
current studies. 
It is however worth noting that the mediation effect sizes in the current study 
were generally small which indicates that this maintaining cycle surrounding beliefs 
about emotions and beliefs about sharing illness experiences plays a small part in a 
much bigger cycle of cognitions and behaviours. These beliefs and related mediating 
behaviours should be targeted in treatments alongside other cognitions and behaviours 
which have been evidenced in IBS and FMS. 
The current thesis produced a valid and reliable measure of beliefs about sharing 
illness experiences and found these to be related to the impact of FMS on a person’s 
life via support-seeking and all-or-nothing behaviour (see Chapter Six, page 146). 
Though this measure requires further validation in additional samples, it may prove 
useful in clinical settings. Such a measure may help clinicians identify barriers to 
sharing illness experiences with others. These unhelpful beliefs may then be addressed 
using CBT (though further evidence that these beliefs can be modified using CBT and 
that the BASIE is sensitive to change is needed). If CBT addressing these beliefs is 
successful, it may in turn reduce all-or-nothing behaviour and increase support-
seeking for personal/emotional problems which may then result in FMS having less 
impact on the person’s life. While further research is needed on the BASIE, this thesis 
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has provided valuable early evidence that beliefs about sharing illness experiences 
could be a useful construct to consider when working with clients with FMS. 
Furthermore, by creating a scale to measure these beliefs, clinicians can measure this 
construct in practice. 
 
9.8. Relating these findings to other long term conditions 
Chapters Four and Five compared individuals with IBS and FMS to individuals 
with IBD and arthritis. There were no differences between those with IBS and those 
with IBD with regards to emotional suppression or beliefs about emotions. Similarly, 
there were no differences between those with FMS and those with arthritis until after 
controlling for affective distress, in which case those with arthritis were marginally 
more emotionally suppressive. It is likely then that role of emotional suppression and 
beliefs about emotions in these particular conditions, with uncertainty surrounding the 
aetiology, could be extended to the consideration of conditions where the aetiology is 
known. It is possible that there is something about persistent physical symptoms more 
broadly which is related to beliefs about the unacceptability of emotions and 
emotional suppression.  
Salkovskis et al. (2016) argue that furthering our understanding of so-called 
persistent physical symptoms will likely generalise to other long-term conditions as 
both involve the experience of psychological distress that is associated with living 
with a chronic condition. As an example, Salkovskis et al. describe the role of health 
anxiety and how it negatively impacts the perception of disability and quality of life 
in long-term conditions, regardless of whether there is a medical explanation. 
Similarly, since persistent physical symptoms (regardless of their aetiological 
explanations) are associated with distress about the condition (Moss-Morris, 2013; 
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Salkovskis et al., 2016), one may question the effect of the individual’s response to 
that distress. For example, if both IBS and IBD are associated with distress about the 
symptoms, it is indeed possible that both conditions would be affected by emotional 
suppression and beliefs about the unacceptability of that distress. In fact there is 
evidence that emotional suppression and beliefs about emotions play a role in other 
psychological and physical conditions such as anxiety and mood disorders (Campbell-
Sills et al., 2006), anorexia nervosa and CFS (Hambrook et al., 2011), depression 
(Liverant et al., 2008), breast cancer (Schlatter & Cameron, 2010), social anxiety 
(Spokas et al., 2009) and psoriasis (Kossakowska et al., 2010). 
It was found in both Chapters Four and Five that after controlling for affective 
distress, previously found differences between those with FMS or IBS compared with 
healthy controls were no longer significant. This suggests that distress explains some 
of the variance in beliefs about emotions (for those with IBS) and emotional 
suppression (for individuals with FMS). However, in both studies, after controlling 
for affective distress, the clinical control groups (i.e. IBD and arthritis) were more 
emotionally suppressive than the groups with IBS and FMS. This suggests that while 
distress explains some of the variance in emotional suppression in IBS and FMS, this 
is not the case for IBD and psoriatic arthritis, which highlights a potential difference 
between persistent physical symptoms with and without a clear medical explanation 
with regards to the relation between distress and emotional suppression.  
The current thesis did not test the mediation models of Chapters Four and Five 
in conditions where there is a clearer understanding of the aetiology (i.e. in arthritis 
and IBD), though this would be useful in generalising the findings of the current thesis 
to persistent physical symptoms beyond those which lack a clear medical explanation. 
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Future research using trans-diagnostic outcome measures would better be able to 
compare the mediation models in conditions with and without a clear aetiology. 
It therefore appears that while some aspects of the current findings may be 
generalizable to other persistent physical symptoms with a clear aetiology, there are 
still potential differences between conditions with and without a medical explanation 
that need further investigation. 
 
9.9. Limitations and directions for future research 
The current studies relied on participants to self-report a diagnosis of either FMS 
or IBS, with the sample in Chapter Three including individuals who reported self-
diagnosed IBS. From Chapter Four onwards, individuals who were self-diagnosed (as 
opposed to being diagnosed by a clinician) were excluded from the analysis. This may 
mean that the sample in Chapter Three reflects a broader group of individuals who 
may not have IBS as defined by clinicians, meaning the application of findings to IBS 
samples may be limited. However, the findings of Chapter Three were replicated in 
Chapter Four where the sample included only those who had received a diagnosis of 
IBS from a clinician, indicating that perhaps the inclusion of self-diagnosed 
individuals did not greatly influence the findings of the study in Chapter Three.  
Research on IBS in the current thesis used the Manning Criteria for Irritable 
Bowel to support the self-reported diagnosis of IBS (Manning et al., 1978). While 
there is evidence that these criteria are comparable to more recent criteria (Saito et al., 
2000), most recent research relies on the Rome criteria which are regularly evaluated 
and updated (Drossman, 2006; Drossman & Corazzi, 2000; Lacy et al., 2016). There 
may therefore be discrepancies between the categorisation of individuals in the current 
study and other studies using the Rome criteria.  
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The NICE guidelines for diagnosing IBS in UK clinical practice however differ 
from both the Rome and the Manning criteria. Given that participants report receiving 
a diagnosis from a clinician, it can be assumed that they meet the criteria set out by 
the NICE guidelines which state that diagnosing IBS should be considered if the 
person has abdominal pain or discomfort that is either relieved by defecation or is 
associated with a change in bowel frequency or stool form, and is accompanied by at 
least two of these symptoms: altered stool passage (straining, urgency, incomplete 
evacuation); abdominal bloating, distension, tension or hardness; symptoms made 
worse by eating; and passage of mucus.(NICE, 2016). While there is some overlap 
between the NICE guidelines and the Manning criteria (i.e. pain/discomfort relieved 
by defecation or associated with looser stools, abdominal distension, incomplete 
evacuation and passage of mucus), there are differences in the criteria set by NICE 
compared with Manning’s criteria (e.g. symptoms being made worse by eating). This 
may result in less valid categorisations of individuals with IBS in the current thesis. 
Similarly, the current study used the LFESSQ to support the self-reported 
diagnosis of FMS by a clinician, though many recent studies adopt the American 
College of Rheumatology classification. This may mean that there is some 
discordance between the samples of the current study and other research on FMS due 
to differing classifications. However, as stated in Chapter Two (see section 2.1.2, page 
57) the LFESSQ has shown better sensitivity and specificity compared with the 
American College of Rheumatology criteria and the Fibromyalgia Rapid Screening 
Tool (Perrot et al., 2010; White et al., 1999; Wolfe et al., 1990), which is why it was 
used in Chapter Five of this thesis. Chapter Seven was not affected by the screening 
tool as participants were included based on their self-report of a clinician diagnosing 
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them with FMS and by their referral to group therapy by a rheumatologist or general 
practitioner for their FMS. 
Chapters Three, Four, Five and Six recruited participants online. This was 
beneficial as it allows for large sample sizes to be collected more cost-effectively. In 
addition, individuals living with persistent physical symptoms may be particularly 
difficult to recruit in research due to their difficulty in leaving the house and avoidance 
of activities (Golden, 2007; Nijs et al., 2013). Therefore, these methods were 
beneficial in recruiting large enough sample sizes to achieve sufficient statistical 
power to test mediation models in these samples.  
However there is some evidence that using online samples can result in bias with 
regards to financial motive, personality traits, self-esteem and the amount of missing 
data (Cantrell & Lupinacci, 2007; Goodman et al., 2012). There have been criticisms 
of this research that finds differences between pencil-and-paper and online 
participants in that many studies which make this comparison often have other 
differences between the two conditions which means differences cannot be solely 
attribute to online data collection (Weigold et al., 2013). Furthermore, when 
participants have been compared in a more controlled manner (i.e. where the only key 
difference between groups is that one sample is online and the other is pencil-and-
paper), personality traits and social desirability (which have previously differed 
between conditions) were comparable (Weigold et al., 2013).  
Despite the conflicting evidence on issues with online samples, online data 
collection and recruitment may be problematic for studies which aim to measure 
variables relating to emotional disclosure and sharing illness experiences. Many of the 
participants with clinical conditions were recruited from websites, forums and social 
media pages dedicated to that specific condition. As such, these individuals may be 
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more expressive than participants recruited through other means, that is, individuals 
who discuss their condition online may tend to be more open and expressive. This 
may mean that participants in these samples are biased with regards to their emotional 
expression, beliefs about emotions and beliefs about sharing illness experiences.  
Healthy controls were also recruited online however this was done through 
participant recruitment webpages (e.g. Reddit’s Sample Size page) and through 
snowball sampling via contacts of the experimenters. There is perhaps still an 
argument to be made that individuals who regularly take part in online research are 
likely to be more expressive than those who do not take part. Consequently, the 
samples in Chapters Three to Six may have underestimated the differences between 
groups and the relationships between variables. Alternatively, it is possible that the 
wording of the recruitment posts online might have influenced who chose to take part 
in the research, creating a bias in the healthy control groups. The recruitment posts 
stated that the study was interested in how the expression of emotions related to 
symptoms of IBS/FMS. It is possible that healthy controls reading this might assume 
that expression of emotion causes symptoms and therefore healthy individuals who 
are more suppressive may be more inclined to take part as they feel they would support 
the aims of the study. As such this might have resulted in the high BES scores of 
healthy controls, particularly in Chapter Five.  
Similarly, participants in Chapter Seven were individuals who attended group 
psychological interventions. Consequently, this sample may have been biased to 
include more emotionally expressive individuals as only those who attended the 
intervention were included in the study. Individuals with FMS who are seen within 
secondary care may not be referred for or agree to attend these interventions if they 
are unwilling to express their emotions to others. It is possible then that emotional 
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suppression may have changed if tested in a sample which may not have been biased 
in this manner. 
 In Chapters Four, Five and Six, support-seeking intentions were measured using 
the GHSQ. This measure was chosen as it can be modified to address support-seeking 
with regards to specific struggles related to a particular disorder. However, this 
advantage of being adaptable for different struggles also means that the particular 
items used in the current studies have not been validated. The reliability of the two 
scales was evaluated using Cronbach’s measure of internal consistency in IBS (see 
Chapter Four, section 4.2.2.1, page 103) and in FMS (see Chapter Five, section 5.2.2.1, 
page 127). While there was good internal consistency in the sample with FMS, in IBS 
the internal consistency of the two scales was poor and questionable. This may explain 
the non-significant indirect effect of support-seeking in the mediation model in IBS, 
however this does not explain why support-seeking was not a significant mediator in 
FMS. 
It has been argued (based on evidence from 250 older participants with pain) 
that there are two forms of social support, support that promotes functional autonomy 
(which is beneficial to an individual) and support that promotes functional dependence 
(which is not beneficial). Based on mixed evidence on the relationship between social 
support and pain-related outcomes in older participants, Matos et al. (2015) argued 
that social support can encourage either activity avoidance (through support which 
promotes dependence on others) or activity engagement (if the social support 
promotes autonomy). A measure of social support was developed and Matos et al. 
found support for a two-factor structure that included social support promoting 
autonomy and social support promoting dependence as two distinct factors. In their 
validation study, there was a positive relationship between social support promoting 
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autonomy and physical functioning, and a negative relationship between physical 
functioning and social support promoting dependence.  
This might explain the non-significant mediation effect of support-seeking in 
Chapter Five where the distinction between support promoting autonomy and 
dependence was not accounted for. It may be that those who score lower on the 
measure of beliefs about the unacceptability of emotions do engage more in support-
seeking, and those who score highly seek support less frequently (which is supported 
by the significant negative relationship found between these two variables – see 
Chapter Four, Table 4.4, page 111 and Chapter Five, Table 5.4, page 135). However, 
those who seek support less frequently may have poorer outcomes due to a lack of 
social support which promotes autonomy, while those who score high on measures of 
support-seeking intentions may also have poorer outcomes due to greater social 
support which promotes dependence. Thus, while the relationship between beliefs 
about the unacceptability of emotions and support-seeking is linear, the relationship 
between support-seeking and global impact may not be. This may therefore explain 
the non-significant mediation effect of support-seeking in Chapters Four and Five.  
A different pattern emerged however in Chapter Six when beliefs about sharing 
illness experiences were measured: Personal/emotional (and not symptom-related) 
support-seeking did in fact mediate the relationship between beliefs about sharing 
illness experiences and global impact. This inconsistency between the two types of 
support-seeking may be explained by a differential role of social support for 
dependence in relation to practical and personal/emotional support-seeking.  
Other measures included in this thesis included the BES and the CECS. No items 
on the BES are reverse scored and therefore all items are worded so that expressing 
and experiencing emotions is considered unacceptable. It is possible that the 
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negatively worded items could prime participants to view the expression of emotion 
as unacceptable which may impact later responses on the measure.  From Chapter 
Four onwards, the questionnaires were randomly ordered to avoid such order effects. 
A possible limitation of the way that this measure is used in this research to test 
the relationship with emotional suppression is that that measure does not distinguish 
between beliefs about the unacceptability of experiencing versus expressing emotions. 
Arguably, one might be accepting of experiencing emotions yet not be accepting of 
expressing emotions such that only beliefs about the expression of emotions is 
associated with emotional expression. It is possible that the lack of distinction in the 
current thesis explains inconsistencies in group comparisons across the BES and 
CECS as the CECS only measures internal suppression (i.e. not experiencing 
emotions) in a single item. For example, differences were found in the BES between 
those with IBS and healthy controls, and not the CECS, which might be explained by 
those with IBS being less accepting of the experience emotions, but not less accepting 
of the expression of emotions. Future research should measure both internal and 
external suppression and perhaps explore any differences between the two with 
regards to comparing clinical groups and with regards to its relationship with distress. 
Further to this, the non-significant mediation of the relationship between the 
BES and outcome measures by support-seeking might be explained by the BES 
measuring these two beliefs. Support-seeking may mediate the relationship between 
beliefs about expressing emotions and outcomes (external suppression), but may not 
mediate the relationship between beliefs about experiencing emotions and outcomes 
(internal suppression). Future research should aim to distinguish between individuals 
who hold beliefs about the unacceptability of experiencing emotions and those who 
hold beliefs about unacceptability of expressing emotions. It is worth noting however 
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that a factor analysis of the BES reliably extracted only one factor (in both those with 
CFS and healthy controls together, CFS patients alone and healthy controls alone) 
which explained more than 50% of the variance indicating that this questionnaire is 
measuring one overall construct. Despite a potential theoretical difference between 
the beliefs, it is likely that beliefs about internally experiencing and externally 
expressing emotions are strongly related. 
The BES is a useful and novel measure however due to its novelty, more 
evidence is needed to demonstrate its reliability and stability in participants over time 
and warrants further testing in different samples. 
The CECS has been used in research in clinical groups, however many studies 
use alternate measures of emotional suppression. This thesis selected the CECS as it 
does not contain measures of motivations or beliefs regarding suppression, instead 
focusing explicitly on whether particular emotions are expressed or not. It was 
considered advantageous that this measure highlighted specific emotions as opposed 
to speaking about emotions more generally as this would encourage participants to 
reflect on unpleasant emotions in particular. However, this questionnaire may be 
limited in that it may be influenced by the frequency with which one experiences a 
particular emotion listed: While talking broadly and not naming specific emotions 
may have limitations, this method does mean that if an individual has not recently or 
does not regularly experience an emotion, their emotion suppression score will not be 
impacted. 
 It is also possible that the wording may not have encompassed all unpleasant 
emotions felt by participants. For example, the word ‘afraid’ (used in the CECS) might 
indicate something different from ‘anxiety’ or ‘worry’ to different participants which 
might affect the validity of the measure. An individual may perceive the word ‘afraid’ 
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to be more extreme than ‘worry’ which may mean they indicate they would be more 
likely to express this emotion, but they may actually tend to suppress less intense 
feelings such as worry. It would be useful for future research to develop a 
questionnaire that measures emotional suppression separately from beliefs that 
focusses on unpleasant emotions but encompasses a range of terms corresponding to 
different emotions and emotional intensities. 
The current study has explored the relationships between beliefs, behaviours and 
outcomes in FMS and IBS across a range of methodologies. Chapters Four and Five 
supported emotional suppression and affective distress as mediators of the relationship 
between beliefs about the unacceptability of emotions and disorder-specific outcomes. 
It was proposed that this supports ironic processing effects and a causal chain was put 
forward where beliefs influence suppression which in turn results in increased 
affective distress which then results in poorer outcomes. This causal chain was 
supported by the non-significant alternate model where the order of the two mediators 
was inverted. Similarly, in Chapter Six a causal model was posited based on finding 
all-or-nothing behaviour and personal/emotional support-seeking to mediate the 
relationship between beliefs about sharing illness experiences and global impact in 
FMS. However, all of these studies proposed causal models based on correlational 
findings.  
Based on this evidence it is supposed that there is a causal path where believing 
it is unacceptable to express or experience one’s emotions causes more distress and 
then poorer outcomes. However a reverse direction of causality cannot be ruled out 
based on the current evidence: It is possible that those who have poorer quality of life 
will thereby feel more distressed by their symptoms and their quality of life. This 
increased distress may result in a greater desire to suppress one’s emotions. 
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Furthermore, the more distress a person experiences, the more likely they might be to 
have made previous attempts at sharing emotions. If these previous attempts have been 
met with criticism or were otherwise ill-received, this would then likely result in 
believing it is unacceptable to express or experience emotions. 
To address issues with causality in these studies, Chapters Seven and Eight used 
experimental methods. Chapter Seven used a quasi-experimental design and measured 
variables from the models in Chapters Four and Five (i.e. beliefs about emotions, 
emotional suppression, affective distress and global impact) across three time points. 
By adopting a clear timeline, it was hoped that a direction of causality could be 
inferred. Regressions exploring changes from pre-treatment to post-treatment in 
beliefs about emotions, emotional suppression and affective distress as predictors of 
changes in global impact from pre-treatment to follow-up were not significant. 
However, the high attrition rate in Chapter Seven meant that there were only 21 
participants with data at all three time points which is likely to leave the study under-
powered meaning this study was unable to support the proposed causal relationships.  
The final study of this thesis, presented in Chapter Eight, used a single case 
series experimental design. The intervention tested in Chapter Eight was specifically 
designed so as to target beliefs about the unacceptability of emotions and emotional 
suppression. These two variables did indeed change during the course of the 
intervention. Following these changes during the intervention, there were significant 
changes in quality of life and affective distress during the follow-up phase of the study. 
The timing of these changes supports a causal model where the intervention helped 
reduce unhelpful beliefs about emotions and reduce emotional suppression and then 
these reductions in beliefs and behaviours resulted in later changes in outcomes.  
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Due to the nature of single case designs, it was not possible to test the 
relationships between changes in earlier phases of the intervention and changes in 
outcomes during the follow-up period. This would have helped to support a causal 
relationship between these variables. Furthermore, without a control condition, it is 
possible that there were effects of the interventions that were not simply those of focus 
in the study. For example, participants attended a group setting, with people who share 
similar experiences, and received peer support. Such aspects could account for the 
changes, particularly when considering Case D, whose beliefs about emotions and 
emotional suppression did not change, but quality of life did. It would be important in 
future research to include a control group with a similar group setting, using cognitive 
behavioural techniques that do not focus on beliefs and behaviours around emotional 
expression. Furthermore, the different findings for Case D compared with other cases 
highlights the need for individualised formulations in order to offer the most 
appropriate and targeted therapeutic support (Hallam, 2013). 
 
9.10. The cognitive behavioural model of persistent physical symptoms 
Existing models of persistent physical symptoms have described self-
perpetuating cycles of beliefs, behaviours and the consequences of these that work to 
maintain symptoms. It is believed that there is often a physiological or psychosocial 
trigger which activates this cycle, such as life events, abuse and illness (Deary et al., 
2007). Once initial symptoms have been triggered, the individual’s response to these 
symptoms is crucial in determining whether they are maintained and how much the 
individual’s life will be impacted by the symptoms (see section 1.1.1, page 18).  
The findings of the current thesis support research that places beliefs about the 
unacceptability of emotions and beliefs about sharing illness experiences within this 
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cycle. The current findings highlight the role of distress in this maintaining cycle. 
Once the symptoms have been initiated, individuals are likely to experience distress 
about their symptoms (Moss-Morris, 2013). The current thesis suggests that beliefs 
about sharing illness experiences and beliefs about the unacceptability of emotions 
may determine to what extent this distress about symptoms is likely to influence the 
person’s life. For example, if an individual is distressed about their symptoms but they 
believe it is acceptable to experience and express their emotions and do not hold 
negative judgements surrounding sharing illness experiences, then this expected to be 
related to better outcomes.  
The current thesis also found evidence to support potential mechanisms through 
which these beliefs relate to outcomes. Mediation models found support for stronger 
beliefs about emotions being related to poorer outcomes via an increase in emotional 
suppression followed by an increase in affective distress. This may be explained by 
ironic processing theory where the suppression of unpleasant emotions, when 
experiencing high levels of negative affect, can result in an ‘ironic’ increase in the 
unpleasant emotions being suppressed (Dalgleish et al., 2009; Wenzlaff & Wegner, 
2000). However it may not just be the mechanisms described by Wenzlaff and Wegner 
through which beliefs about emotions and emotional suppression relate to an increase 
in distress. For example, as discussed in Chapter One of this thesis, the suppression of 
emotion may prevent more effective processing of an emotion-eliciting event (e.g. 
through cognitive reappraisal) (John & Gross, 2004). Furthermore, if one is avoiding 
the experience and the expression of a difficult emotion they may be less motivated to 
resolve the issue from which the emotion stems (Inzlight & Legault, 2012; Oatley & 
Johnson-laird, 1987) and they may be impaired in social interactions, resulting in 
isolation and therefore more distress (John & Gross, 2004). 
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In line with the cyclical nature described in models of persistent physical 
symptoms, it is then possible that this increased distress will then continue to be 
suppressed due to the individual’s beliefs about the unacceptability of emotions, 
resulting in self-perpetuating cycle (see Figure 9.1). Furthermore, Chapters Three and 
Four found that the relationship between emotional suppression and quality of life in 
IBS was mediated by beliefs about emotions, suggesting that emotional suppression 
may in fact modulate or update beliefs about the unacceptability of emotions, further 
maintaining these unhelpful beliefs. 
Similarly, the current thesis found evidence that the relationship between beliefs 
about sharing illness experiences and the impact of FMS on a person’s life was 
mediated by seeking support and all-or-nothing behaviour. It was suggested that if an 
individual holds beliefs about negative judgements about sharing their illness 
experiences, they would therefore be less inclined to seek support from those around 
them and this lack of support would mean the disorder would have a greater impact 
on that person’s life.  
The all-or-nothing cycle of behaviour has previously been described in IBS 
(Spence & Moss-Morris, 2007; Spence et al., 2005). The current thesis found support 
for this behavioural cycle explaining the relationship between beliefs about sharing 
illness experiences and global impact in FMS. Similarly, it was argued that having 
unhelpful beliefs about sharing illness experiences means that an individual is also 
likely to persist in the face of symptoms in order to keep up appearances. This over-
exertion would then result in forced periods of rest to which the individual will 
respond with more activity following the period of rest. The belief that there will be 
negative social evaluations regarding one’s illness experiences may then work to 
perpetuate or maintain this all-or-nothing behaviour pattern.  
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Therefore, the variables measured across the current thesis appear to form part 
of a self-maintaining cycle, which may fit within broader existing cognitive 
behavioural models of persistent physical symptoms (e.g. Deary et al., 2007; 
Salkovskis et al., 2016; Spence & Moss-Morris, 2007). 
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Figure 9.1 A self-maintaining cycle based on evidence from the current thesis. 
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9.11. Conclusions 
This thesis aimed to investigate potential psychosocial features of persistent 
physical symptoms in line with cognitive behavioural theory, and an ironic processing 
model. Specifically, beliefs around the unacceptability of emotions and around sharing 
illness experiences were explored along with potential behavioural factors such as 
emotional suppression, support-seeking and all-or-nothing behaviour. By starting with 
correlational cross-sectional designs to explore the relationships between these 
variables, it was possible to later test the role of these factors in treatments for 
individuals with persistent physical symptoms.  
A model has been proposed such that relevant beliefs and behaviours are added 
to existing cognitive models of persistent physical symptoms. In particular, beliefs 
about the unacceptability of experiencing and expressing emotions and beliefs about 
sharing illness experiences relate to poorer quality of life through emotional 
suppression and affective distress, all-or-nothing behaviour and support-seeking for 
personal and emotional problems. This model fits with previous cognitive behavioural 
models of persistent physical symptoms (Deary et al., 2007;  Spence & Moss-Morris, 
2007) and with evidence on ironic processing effects (Wenzlaff & Wegner, 2000). 
Complete understanding of causal and maintaining factors in persistent physical 
symptoms in the absence of a clear medical explanation is complex task; one which 
the current thesis has not achieved, nor aimed to achieve. However, by investigating 
particular psychosocial factors related to outcomes in these samples, the current thesis 
has provided evidence that beliefs about the unacceptability of experiencing emotions, 
alongside emotional suppression, beliefs about sharing illness experiences, support-
seeking, all-or-nothing behaviour, and distress, are important features of persistent 
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physical symptoms. These features fit within a much broader framework of 
understanding persistent physical symptoms.  
Though the current thesis has not solved the complex issue of understanding the 
cause or maintenance of persistent physical symptoms, it has identified a small piece 
of the puzzle which fits into a much larger picture yet to be fully uncovered.  
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10. Appendices 
10.1. Appendix A: Beliefs about Emotions Scale 
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10.2. Appendix B: Courtauld Emotional Control Scale 
Please read the following statements and tick the box to indicate how much each 
statement is true for you. Think about how you to tend to act most of the time. 
 
When I feel angry I keep quiet 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel angry I refuse to argue or say anything 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel angry I bottle it up 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel angry I say what I feel 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel angry I smother my feelings 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel angry I avoid making a scene 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel angry I hide my annoyance 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
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When I feel unhappy I refuse to say anything about it 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel unhappy I hide my unhappiness 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel unhappy I put on a bold face 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel unhappy I keep quiet 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel unhappy I let others see how I feel 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel unhappy I smother my feelings 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel unhappy I bottle it up 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel afraid I let others see how I feel 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel afraid I keep quiet 
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Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel afraid I refuse to say anything about it 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel afraid I tell others about it 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel afraid I say what I feel 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel afraid I bottle it up 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
When I feel afraid I smother my feelings 
Almost never 
☐ 
Sometimes 
☐ 
Often 
☐ 
Almost Always 
☐ 
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10.3. Appendix C: Hospital Anxiety and Depression Scale 
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10.4. Appendix D: Irritable Bowel Syndrome Quality of Life questionnaire 
 
Q1. I feel helpless because of my bowel problems. 
Q2. I am embarrassed by the smell caused by my bowel problems. 
Q3. I am bothered by how much time I spend on the toile t. 
Q4. I feel vulnerable to other illnesses because of my bowel problems. 
Q5. I feel fat because of my bowel problems. 
Q6. I feel like I’m losing control of my life because of my bowel problems. 
Q7. I feel my life is less enjoyable because of my bowel problems. 
Q8. I feel uncomfortable when I talk about my bowel problems. 
Q9. I feel depressed about my bowel problems. 
Q10. I feel isolated from others because of my bowel problems. 
Q11. I have to watch the amount of food I eat because of my bowel problems. 
Q12. Because of my bowel problems, sexual activity is difficult for me. 
Q13. I feel angry that I have bowel problems. 
Q14. I feel like I irritate others because of my bowel problems. 
Q15. I worry that my bowel problems will get worse. 
Q16. I feel irritable because of my bowel problems. 
Q17. I worry that people think I exaggerate my bowel problems. 
Q18. I feel I get less done because of my bowel problems. 
Q19. I have to avoid stressful situations because of my bowel problems. 
Q20. My bowel problems reduce my sexual desire.  
Q21. My bowel problems limit what I can wear. 
Q22. I have to avoid strenuous activity because of my bowel problems. 
Q23. I have to watch the kind of food I eat because of my bowel problems. 
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Q24. Because of my bowel problems, I have difficulty being around people I do not 
know 
Q25. I feel sluggish because of my bowel problems.  
Q26. I feel unclean because of my bowel problems. 
Q27. Long trips are difficult for me because of my bowel problems. 
Q28. I feel frustrated that I cannot eat when I want because of my bowel problems. 
Q29. It is important to be near a toile t because of my bowel problems. 
Q30. My life revolve s around my bowel problems.  
Q31. I worry about losing control of my bowels. 
Q32. I fear that I won’t be able to have a bowel movement. 
Q33. My bowel problems are affecting my closest relationships. 
Q34. I feel that no one understands my bowel problems. 
 
Items 1, 2, 4, 8-10, 12, 13, 16, 25-29, and 34 use the following response scale: 
1 = not at all, 2 = slightly, 3 = moderately, 4 = quite a bit, 5 = extremely. 
Items 3, 5-7, 11, 14, 15, 17-24, and 30-33 use the following response scale: 
1 = not at all, 2 = slightly, 3 = moderately, 4 = quite a bit, 5 = a great deal.  
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10.5. Appendix E: Revised Fibromyalgia Impact Questionnaire 
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10.6. Appendix F: Example recruitment posts 
Chapter Three 
Participants with IBS 
I'm a PhD student at the University of London and I'm conducting research 
into psychological factors which influence IBS symptoms and coping. It's well 
known that being upset and worried can give you an upset tummy, so I'm 
looking at how the expression of these negative emotions relate to the effects 
of IBS on a person's life. 
My study is a series of questionnaires that takes around 15 minutes to 
complete. They measure your emotions, how you express them and how 
much your IBS affects your quality of life. I'm hoping to get as many people 
with IBS to take part as possible to make sure I get a truly representative 
sample of people who have IBS. If you wouldn't mind taking part, and 
perhaps sharing this information with any friends who also have IBS, I'd be 
really grateful. 
If you take part you don't have to give your name and you only have to give 
your email address if you want to be entered into a prize draw to win an 
Amazon or Topshop/Topman voucher. 
The link to the questionnaire 
is http://edu.surveygizmo.com/s3/1441380/rhul-ibs 
Thanks! 
 
Healthy controls 
I'm looking for participants without Irritable Bowel Syndrome to take part in 
my study. I'm looking at beliefs about emotions and emotional expression in 
relation to how IBS influences a person's life. We all know that being upset or 
anxious can affect our bowels, so I'm looking at how these emotions and 
emotional expression might affect people with Irritable Bowel Syndrome. 
Only requirement is that you are over 18 years old. 
To do this I need to compare the results of people with IBS to the results of 
people without IBS. My study is a short series of questionnaires that takes 
around 15 minutes to complete. You'll be asked questions about irritable 
bowel symptoms, your beliefs about your emotions, how you express your 
emotions and then how digestive problems have influenced your life in the 
past. I'd be really grateful if you could take part and if you do you can enter 
into a prize draw to win an Amazon or Topshop/Topman voucher. 
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The survey can be found at: http://edu.surveygizmo.com/s3/1441380/rhul-
ibs 
Thanks! 
 
Chapter Five 
Participants with fibromyalgia 
Hello, 
I'm currently doing a PhD in clinical psychology. I'm conducting a piece of 
research looking at emotional processing, asking for support and the effects 
of fibromyalgia on a person's life to see how these variables are related. 
Fibromyalgia (as I'm sure you know) can be very difficult to live with, but 
there is still a lot we don't know about it.This is why more research is 
needed in this area. I've chosen to look at psychological aspects: As some of 
you may already be aware, psychological factors can play an important part 
in determining how much fibromyalgia can affect a person's life. 
If you have fibromyalgia and are from the UK, I would be really grateful if 
you could take part. To find out more and to sign up, click the link below. 
I'm also looking to compare these findings to people without fibromyalgia, 
so please also have a look if you don't have fibromyalgia. 
http://www.surveygizmo.com/s3/1787370/The-relationship-between-
emotional-processing-asking-for-help-and-fibromyalgia 
Many thanks! 
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10.7. Appendix G: BASIE questionnaire as it appears online 
Please contact the author for permission to use the BASIE 
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10.8. Appendix H: Inter-item correlations including items with coefficients 
greater than .8 (Chapter Six) 
 
Table 10.1 Inter-item correlations for BASIE 
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10.9. Appendix I: Group comparisons between those with FMS and healthy 
controls for BASIE scores after controlling for affective distress using the entire 
sample (Chapter Six). 
 
Table 10.2 Estimated marginal means, standard errors and F statistics for BASIE scores 
after controlling for affective distress 
 FMS Healthy controls F statistic 
 EMM SE EMM SE  
BASIE totals 1080.98 34.06 669.65 64.42 F(1, 157)=29.71, p<.001 
BASIE Factor One 623.40 23.67 382.82 44.77 F(1,57)=21.04, p<.001 
BASIE Factor Two 457.58 14.53 286.83 27.47 F(1,157)=28.15, p<.001 
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10.10. Appendix J: Participant booklet to accompany the intervention 
designed in Chapter Eight 
Please contact the author for permission to use this booklet 
Living with IBS:  
Managing difficult emotions 
and stress that can 
accompany living with IBS. 
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• Session 1 – Introduction to the Course  
 
• Why are we here? 
Everyone attending this course is here because they share the common experience 
of living with irritable bowel syndrome (IBS). Every individual might differ in terms 
of what difficulties they have, what can trigger symptoms and how they might deal 
with these, but all of you have some level of symptoms which can impact on your 
daily life. 
Taking part in this course involves answering questionnaires before, during and 
after the course. This will allow the researchers to look at trends and how they 
might change over the course. More information about the research itself can be 
found in your ‘Information Sheet’. 
• About these sessions 
This course will last a total of 5 sessions. In each session we will be learning new 
information that should help with skills around living with IBS. These sessions will 
include group discussions which means, if you like, you can all share information 
with each other about your shared experiences and how you cope with some of 
your experiences of living with IBS.  
We have made some basic assumptions about you while designing this course. This 
is so it can be designed so you can get the most information from it. These 
assumptions are: 
• Your symptoms and your discomfort are very real. We may not be able to see 
it or measure it, but we know that you experience discomfort and symptoms on a 
regular basis.  
• Your IBS has a negative impact on your life in some way 
• You are ready to learn about IBS and how you think and feel about your 
symptoms in the hope that you can make some positive changes. This will involve 
some effort on your part to implement some of the changes we will talk about. 
 
• More information about the group 
The group will be run by Dr. Abigail Wroe (Clinical Psychologist) and Hannah 
Bowers (PhD student), whose contact information is provided below 
The groups will be held on the following dates at [time]. We will meet at [location, 
address].  
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Abigail Wroe 
Tel: 01784 276532 
Email: Abigail.Wroe@rhul.ac.uk 
Hannah Bowers 
Tel: 01784 44 3703 
Email: 
Hannah.Bowers.2010@live.rhul.a
c.uk  
 During this course, we will be talking about symptoms, how we deal with them and 
how they make us feel. We will also be thinking about how we deal with those 
emotions. The aims of the course are to teach you new skills to help you cope with any 
stress and anxiety that can come with IBS. Some people find it difficult to think about, 
and talk about emotions, and in some case this can affect your symptoms. This might 
mean you might feel slightly worse before you start to feel better. Remembering this 
might help relieve any anxiety you might feel at the beginning of the course. 
1. What is IBS? 
Irritable Bowel Syndrome (or IBS) is a collection of bowel symptoms that might vary 
from person to person, but can affect a person’s daily life and most often includes 
abdominal (tummy) pain. It has been found to occur in around 10-20% of people in 
Western countries. These symptoms are not due to a physical disease, but are related 
to a problem with how your digestive system functions.  
 
 
These symptoms can really affect a person’s life (personal relationships, work, leisure 
activities) so they should be taken seriously. However, IBS is not a disease. This means 
there is not any identifiable damage or infection in your body to diagnose the disorder. 
Instead it is called a syndrome, which means it is diagnosed due to a collection of 
ongoing symptoms in a particular person. Because there is no noticeable damage or 
infection, this means IBS is not life threatening, although it should still be taken 
seriously. 
The symptoms of IBS can include: 
• Abdominal pain and spasms, often relieved by going to the toilet. 
• Diarrhoea, constipation or an erratic bowel habit 
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• Bloating or swelling of the abdomen. 
• Rumbling noises and excessive passage of wind. 
• Urgency (An urgent need to visit the toilet). 
• Incontinence (If a toilet is not nearby). 
• Sharp pain felt low down inside the rectum. 
• Sensation of incomplete bowel movement. 
 
What causes IBS symptoms? 
The main reason you experience the symptoms of IBS is that there is an abnormality in 
the movement of the bowel, along with increased sensitivity to the bowel and an 
altered production of mucus. This means that for whatever reason, your bowel is 
moving in an irregular pattern which can cause some symptoms. Usually your muscles 
in your bowel will move in a coordinated and consistent way, but in IBS they may not. 
This will then affect the consistency of the stool and the number of times you go. It 
might also result in muscle cramps. Along with this inconsistent bowel muscle 
movement, over time you will become especially aware of the movement of your 
bowels which makes you more sensitive to discomfort and pain. You may also find that 
in response to this, your bowel produces more or less mucus than it normally would. 
How do the symptoms start? 
For some people the symptoms of IBS begin gradually over a long period of time and 
only become noticeable when they become more severe. For others the onset might 
be a bit faster. IBS can be triggered by a particular event. This might be a viral or 
bacterial infection (like gastroenteritis, also known as stomach flu) or by a stressful 
event in a person’s life. 
Stomach Flu and IBS 
Research has shown that around 10% of people who have a particular type of bacterial 
stomach flu go on to receive a diagnosis of IBS 6 months later. It is believed that this is 
due to some of the toxins present during the infection affecting the nerves that 
influence the bowel’s muscle movements as well as hormone production. It might also 
be that when someone has stomach flu, their sensitivity to their bowel habits increase 
which makes them feel pain and discomfort more than people without IBS. 
2. Stress and IBS 
You may find that during periods of stress, your symptoms get worse. This is quite 
common in people with IBS. This is because there is a very close relationship between 
the brain and the gut.  
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Fight or Flight 
The ‘fight or flight’ response refers to the response in our bodies when we experience 
stress. Humans are naturally primed to defend themselves when faced with a stressful 
situation. This means your nervous system becomes more active and there is an 
increase in stress hormones, such as adrenaline.  
Adrenaline has a number of effects on our bodies to help supply us with energy to fight 
or flea from the situation. It can… 
• Increase the heart rate  
• Increase breathing rate 
• Release more sugar from the liver 
• Bowel muscle movements slow down or stop 
This system used to be really useful when most stressful 
events (like attack of a wild animal) could be resolved by 
fight or flight, but nowadays stress tends to be caused by 
emotional, social or physical factors. 
All of these bodily changes in response to stress can 
affect the bowel. This might mean that your bowel 
moves faster or it might move more slowly. So you might 
find that stress can either result in diarrhoea or 
constipation, or a bit of both. Some people find stress 
can also make them feel nauseous. So this might mean 
that if you’re feeling nervous about an exam or a job interview, for example, you might 
experience these bowel symptoms.  
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Responding to stress 
How we respond to stress is really important. Some 
people like to tackle problems head on, while others 
like to power through as if the stress weren’t there. 
Many people can find themselves stuck in a vicious 
cycle of symptoms, pain and stress due to how they 
respond to both their symptoms and their stress.  
Here’s an example of someone who is stuck in a 
vicious cycle:  
 
 
 
 
Lara started to notice she was going to the toilet more often 
and that she had stomach cramps and diarrhoea. Lara was very 
worried by these symptoms, and had been told she had IBS. Lara 
became increasingly worried about finding herself out somewhere and 
not being able to find a bathroom quickly enough. In response to this 
worry, Lara started going out a bit less. This made her upset and 
anxious. Because of her worries and her upset, the symptoms got 
worse. Lara didn’t feel like she should tell anyone about how she’s 
feeling because she didn’t want to seem stupid or weak, so she tried to 
distract herself from these emotions but found certain thoughts would 
keep popping up anyway, which just made her worry more.  
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3. Stress, setbacks and control… 
During times of stress or change, your symptoms may flare up.   
Making some lifestyle changes can allow you to get your symptoms under control 
rather than allowing your symptoms to control you. There is no magic cure and this 
change happens gradually. If you manage to persevere in making some helpful 
changes, your confidence will grow and minor setbacks will become less traumatic. 
You will learn how powerful your thoughts are in influencing how you feel and what 
you can do. 
Trigger 
(Stressful event, infection, both) 
 
Changes in bowel 
function
Symptoms of IBS
Feeling worried 
and/or sad about 
symptoms
Try to ignore 
these feelings 
Feeling more 
worry and 
sadness
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Home task 
After each session you will be given a task to complete at home. It is really important 
that you try to do all home tasks as these will heavily support your learning throughout 
the course. 
For this home task, you are asked to jot down any time you notice a particular 
symptom that is bothersome to you. Along with this, you should write the thoughts 
you have in relation to this symptom, how this made you feel emotionally and then 
what you did with that emotion – did you tell someone about it or did you try to ignore 
it or distract yourself from it? 
There’s an example by Lara in the table below to help you fill out the table yourself. 
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Session 2 - Identifying and managing thoughts about emotions 
 
Review of Home Task 1 
• Were there any patterns you noticed?  
• Did you learn anything new about yourself or your way of thinking?  
• Do you think you could have responded differently? 
1. How we respond to our emotions 
Everyone experiences periods of worry or sadness in their lives, such as worrying about 
the results of a test. In a lot of these situations, people try to distract themselves or 
ignore the worry so they can go about their day. This can be effective for short-term 
problems like awaiting a test result. However if we use this strategy with long-term 
problems, it can have a negative impact on us mentally and physically.  
Some of the worries and struggles that come with IBS can be long-term, such as the 
daily worry of whether you will experience symptoms while you’re out and about. 
While short-term worries have an end-point, long-term worries don’t. This means that 
for long-term worries, we would need to suppress our negative feelings continually, 
which would be exhausting.  
If we try to control or suppress our thoughts and feelings, they tend to just get bigger 
and bigger. In this case, avoidance is not the answer. This means that a small to 
moderate sized worry can become much greater than it really is, just by us trying to 
avoid it. This can then make us feel even more stressed and anxious because now 
we’re also worried about having a particular thought or feeling. 
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White Bear Challenge 
 
So we know that trying to squash emotions it makes them stronger… 
 
 
2. What happens in our bodies when 
we try to control and suppress? 
 
If we’re trying really hard to control our thoughts and 
suppress our emotions, our bodies are going to 
become very tense, which can make us tired and can 
cause pain and cramps. If the muscles in our bodies 
are very tense and rigid, our abdomen will also be 
tense. If we want to have regular bowel movements, 
we need our abdomens to be relaxed and free of 
tension.  
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3. How else does trying to control and suppress our feelings 
affect us? 
 
If we keep our thoughts and feelings to ourselves and put on a brave face, the people 
around won’t know when we’re struggling. If we’re having a tough time, having the 
support of the people around can really help. If they don’t know we need some comfort 
or support because we’re keeping it all in, they can’t help us. If we keep things to 
ourselves, we can end up feeling alone and isolated from the people around us. 
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So in summary…. 
 
What happens when we try to push away, hide or ignore our feelings? 
1. It can make them stronger   
 
 
2. It causes muscles to tense 
e.g. shoulder pain, and muscles 
in tummy to cramp which can 
feel painful and lead to bloating 
and diarrhoea 
 
 
 
 
3. We may feel isolated and 
alone, and miss out of getting 
helpful practical and emotional 
support from others 
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4. What drives us to suppress our emotions? 
 
We all have negative/unhelpful thoughts sometimes. But we may not always be aware 
of these thoughts because they are automatic. We tend to be able to notice how we 
feel emotionally, but we don’t always notice the thoughts that might underlie these 
feelings. For example, if you’re out with your friends and you need to use the 
bathroom. You may notice that you feel tense and anxious. However you might not 
notice the thoughts going on like “I can’t let anyone know that I’m worried. I need to 
keep my cool.”  
In order to better deal with difficulties, we need to identify the negative thoughts that 
underlie them. Once you are able to identify these thoughts, you can start to examine 
and evaluate them. This means you can start to look for helpful, alternative ways of 
thinking. These alternative won’t necessarily be positive, but they will be more realistic 
ways of looking at a situation. 
There is no right or wrong way of thinking, but some thoughts are not as helpful as 
others. Learning to recognise these patterns of thinking is an important step towards 
managing your symptoms. 
Common unhelpful thoughts: 
Here are some common unhelpful thoughts that people with IBS have identified:  
1. People will think I’m stupid if I tell them what I’m worried about. 
2. I should be able to deal with these worries on my own. 
3. I should keep worries and upset to myself otherwise people won’t accept me. 
4. I shouldn’t give in to these feelings. I have to keep fighting. 
5. If I think bad thoughts, it means I am weak. 
6. People won’t like me if I show any signs of weakness. 
7. I should control my negative feelings. 
Do any of these sound familiar?  In the following sections we look at some of the 
common problems that underlie thoughts such as these.  
See if you recognize some of these unhelpful thoughts in your own ways of thinking.  
      
 
341 
 
Shoulds 
 
Many thoughts include the word ‘should’. The word ‘should’ suggests that there is a 
standard or rule that must be followed.  It can apply to us or to others.  We may feel 
that others ‘should’ act in a certain way.  We also may spend quite a lot of time telling 
ourselves how we ‘should’ be acting or what we ‘should’ be feeling.   
This can be unhelpful as it fills us with expectations of others and ourselves that are 
probably not possible and leave us feeling disappointed or upset.  The problem with 
‘should’ thoughts is that they are often not achievable in reality and so they leave us 
upset when we can’t achieve them. 
 
 
Black and white thinking: 
 
The tendency to think in black and white or in absolutes is another common unhelpful 
thought. Sometimes these thoughts sound like “if…then…” statements. They tend not 
to consider other possible outcomes.  
 
Examples 
“I should be able to deal with these worries on my own.” 
“I should keep worries and upset to myself otherwise people won’t accept 
me.” 
 
 
Examples 
“If I think bad thoughts, it means I am weak.” 
“People will think I’m stupid if I tell them what I’m worried about.” 
Example 
“I should be able to deal with these worries on my own.” 
Do you think this is always possible?  
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How might these thoughts affect us? 
 
Lara believes some of these unhelpful thoughts. Believing these thoughts means she 
feels a need to suppress her thoughts and feelings. Because of this suppression, Lara is 
feeling very tense which is giving her a tummy ache. She also feels quite worried and 
lonely. As we’ve already learned, keeping our thoughts and feelings to ourselves can 
have negative effects on us emotionally and physically, so this isn’t the best way to 
handle our emotions 
In addition to this, because Lara believes other people will reject her, or feel she is 
stupid if she shares her thoughts and feelings, she won’t tell people how she feels or 
that she needs support. If we are struggling emotionally or with physical symptoms, 
having support from the people around us can be really useful. If they don’t know you 
need help, they can’t help you. So because of this, Lara doesn’t have the support she 
needs from her friends and family, which makes things harder. 
Lara is so worried about showing other people how she’s feeling that she’s been 
avoiding seeing her friends and family. Because of this Lara has begun to feel lonely 
and isolated. 
Home Task 
 
1. This home task is very similar to Home Task 1. Once again you’ll be identifying 
thoughts and feelings that are bothersome to you and noticing how you respond to 
that thought/feeling. In addition, this time, you’re invited to write down alternative 
ways of responding. 
The aim is to notice when you experience emotions and what we do with them. If you 
can, try out new ways of responding to your emotions. 
2. Look over next week’s workbook (Session 3) and write down some goals in 
section “4 – Goals.” E.g. to notice when I experience an emotion. To notice what I do in 
Example 
 “People will think I’m stupid if I tell them what I’m worried about.” 
• What might be the impact of thinking like this?  
• If you believe this, how would you feel if you ask for help? 
• What are some of the other possible outcomes of this situation? 
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response to emotions, to think about people who I could be more open about my 
emotions, to practice expressing emotions e.g. to self, to others. 
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Session 3 - Thinking about change 
Review of Home Task 2 
• Did you notice any of the same patterns as before?  
• In what ways could you have responded differently? 
• How might this different response have changed the situation? 
 
Responding to our Feelings 
We know from previous sessions that stress and tension can affect us emotionally and 
physically. This can then affect our symptoms of IBS. As much as we may like to, we 
cannot stop ourselves having feelings. 
What we can change is how we respond to and deal with any feelings that might be 
unpleasant.  
In the box below, write down as many different possible ways of responding to this 
feeling: 
 
Talking to Others 
Sharing your worries and upset with others can be really helpful for many reasons. 
Firstly, you avoid the tension and added stress that comes with trying to control or 
suppress your thoughts and feelings, which means your body (and bowel) is more 
relaxed. Secondly it means others can offer you support and help which can alleviate 
some of your worries. They might be able to offer a new perspective that can help you 
feel better, they might have a solution to a pragmatic problem or they might just be 
able to offer you some comfort and emotional support. 
“I’m upset because my bowel is really bothering me today” 
Lara: 
I should cancel my plans with my friends and stay at home alone. I can tell them 
something important came up. 
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In the box below, list the people you think you could talk to about either emotional or 
physical struggles you might be experiencing. It might be a friend, family, partner or 
colleague. Alternatively it might be a more formal form of emotional support like a 
counsellor, support group or online forum. 
 
 
1. Problem solving 
Are there different ways we could express emotions? E.g. to others (identify certain 
people), to the group, to ourselves, in a journal? 
2. Thought challenging 
Once you have identified your patterns of negative thinking, the next step is to 
evaluate your thoughts and to look for more helpful alternatives.  
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Thoughts are not Facts 
Sometimes if we have a set way of 
thinking about things, we assume it’s 
always true. Actually, our thoughts are 
just thoughts, they are not facts. 
Sometimes it can be difficult to tease 
apart our thoughts from facts.  
Let’s think about ‘is the thought 
helpful?’ If not, then we can think of a 
few tools to manage the thought: 
One way to help with this is to try to 
notice your thoughts and rephrase 
them so that they begin with “I am 
having the thought that…” 
For example, if you were running late meeting a friend because you were felt unwell 
because you were worried about leaving the house, you might start thinking “they’re 
going to think I’m stupid for being worried about leaving the house”. Instead rephrase 
that as “I am having the thought that they’re going to think I’m stupid for being worried 
about leaving the house.” 
Does this change how this particular thought might make you feel now you’ve rephrased 
it? Often rephrasing it as a thought, and not a fact can make it much less daunting and 
seem more manageable. Once you can realise it is not a fact, you can start to challenge 
these unhelpful thoughts. 
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Weighing things up 
It may be helpful to consider how balanced the thought is. Imagine you are in court 
trying to weigh up how accurate the thought is.  
What is the evidence for this thought? 
What is the evidence against it?  
Is there a more helpful, more balanced thought? What would I tell someone else in this 
situation? 
You may also wish to ask yourself:  
• Am I seeing the situation in black and white? 
• I am expecting the worst or catastrophising? 
• Am I trying to read other people’s minds?   
• Am I jumping to conclusions? 
The goal of this for you to consider how helpful the thought is, and if it is not helpful, 
then to think about what you can do about it. Sometimes you can develop a more 
helpful, and more balanced thought.  
Lara’s example 
Thought: People will think I’m weak if I tell them I am upset about my IBS 
symptoms 
Evidence for Evidence against 
Some people think being ill is a sign of 
weakness 
When I did tell a friend, she 
helped me 
 Lots of people have symptoms 
of IBS 
      
 
349 
 
 Its ok to struggle if I am in pain 
  
  
  
New, more balanced thought: It’s ok to feel upset about my symptoms. Although 
I don’t want to tell everyone, there are a few friends I can trust and they will take 
me for who I am. They may be able to support me.  
(what would I tell someone else in this situation) 
 
3. Pros and Cons of Sharing with Others 
There are many reasons why we might choose to talk to others or to keep things to 
ourselves. 
Lara thinks about telling her close friend that she is struggling with symptoms and this 
upsets her and has filled out some pros and cons of telling her friend. Use the space 
below to list any positives and negatives you can think of about trying to share with 
others more. 
 
Pro Con 
She will understand why I 
sometimes say no to going out 
She may feel burdened by my 
problems 
She will stop wondering what is 
going on for me 
She may not understand 
She may be able to support me 
 
She may treat me differently 
She can help encourage my 
friends to go to places that are 
easy for me e.g. not go for a curry 
 
 
It will make me feel better that 
someone knows  
 
 
She will feel good that I have 
shared my feelings with her 
 
 
We will be become closer friends 
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Sharing with Each Other 
One of the added benefits of these sessions is that you are with other people who 
understand your experience with IBS. This means they can offer insight, understanding 
and compassion towards any struggles you might be experiencing. If you feel 
comfortable, you may want to share some of the 
thoughts or feelings that particularly bother you. 
For example, one of the situations written on your 
Home Task sheet from sessions one and two. 
Did you notice any unhelpful thoughts or worries 
about sharing with each other in that task? 
4. Goals 
Let’s set some clear goals. 
• Goals can help to give us focus and work towards 
particular things that are important to us.   
• Goal setting can also be a helpful process in 
helping to face our fears, BUT if we want them to be effective; we need to make them SMART! 
 
Short term goals (to focus on in the next 2 weeks) 
 
 
 
 
 
 
 
 
 
 
 
Lara’s short term goals: 
• To notice when I experience an emotion 
• To notice what I do in response to emotions 
• To think about people who I could be more open with about my emotions 
• To practice expressing emotions e.g. to self and in this group 
Your short term goals: 
•     
 
•     
  
•  
 
•     
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Medium term goals (by the end of the course) 
 
Long term goals (for the future) 
  
Lara’s medium term goals: 
• To be skilled at noticing my emotions 
• To talk to friends about my emotions 
• To go out for dinner with friends and tell them when I need the toilet 
• To tell friends why I might say no to going out 
Your medium term goals: 
•     
 
•     
  
•  
 
•     
 
•     
Lara’s short term goals: 
• To be able to express my emotions when helpful 
• To notice unhelpful thoughts about emotions and look for alternate ways of 
thinking 
 
Your long term goals: 
•     
 
•     
  
•     
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Home Task 
This week you’re going to be 
starting to write down your 
feelings. This involved jotting down 
how you’re feeling and what you’re 
thinking regularly. You should aim 
to do this at least once a day. We 
will contact you via phone, text or 
email to remind you and link you to 
your online writing portal. What 
you write down is only for you and 
the people running the group to 
read. What you write will not be 
shared with other participants of 
the group unless you choose to 
bring it up in person.  
In addition to your journals, you should try to identify any unhelpful thoughts about how 
you’re feeling and weigh up the evidence for and against. Use Lara’s example above to help 
you. Try to do this as often as you notice any of these thoughts.  
Thought: 
  
Evidence for Evidence against 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
New, more balanced thought:  
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Thought: 
  
Evidence for Evidence against 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
New, more balanced thought:  
 
 
 
 
Thought: 
  
Evidence for Evidence against 
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New, more balanced thought:  
 
 
 
 
 
Thought: 
  
Evidence for Evidence against 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
New, more balanced thought:  
 
 
 
 
Thought: 
  
Evidence for Evidence against 
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New, more balanced thought:  
 
 
 
 
 
Thought: 
  
Evidence for Evidence against 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
New, more balanced thought:  
 
 
 
 
Thought: 
  
Evidence for Evidence against 
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New, more balanced thought:  
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Session 4: Anxiety and Stress 
Review of Home Task 3 
How did you find it? Were there any challenges? Any unhelpful thoughts about 
completing the task? 
 
1. What is anxiety?  
Anxiety is a completely normal and natural response to situations that we perceive as 
threatening. Everyone experiences anxiety, although the level of anxiety and the 
situations in which it presents itself can differ from person to person. For example, 
some people are terrified of speaking in front of a large audience, whereas other 
people are able to do this and remain calm.  
 
Fight or Flight 
We already talked a little bit about Fight or Flight in session one, but let’s take a closer 
look at how being anxious can influence us. 
Anxiety serves a very important function – to protect 
us from danger. When we are faced with a threat our 
bodies produce a surge of adrenaline that equips us 
to deal with that threat. This is commonly referred to 
as ‘fight or flight’. 
 
Imagine this scene: A caveman is out hunting for his 
dinner, when he is faced by a hungry tiger.  
 
What does he need to do in order to survive? 
 
He needs to either fight the tiger off or run away! 
 
In order to fight or flee, the body must prepare itself in a number of ways: 
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• The brain sends messages to the body to pump adrenalin into the bloodstream 
and large skeletal muscles of the arms and legs 
• As a result the heart pumps faster and needs more oxygen 
• The body needs to cool down so it sweats,  causing clamminess or capillaries to 
come to the surface of the skin resulting in blushing  
• To be as light as possible there may be a need for the bowels to empty or 
frequent urination to occur  
 
In modern life it is very unlikely that we will be faced with hungry tigers – but we are 
still exposed to real or imagined threats or stressors in daily life and our bodies 
respond to these with the same response. If the situation is not physically threatening 
(e.g. giving a presentation) then this response is not helpful for coping with the 
situation and can actually be quite frightening.   
Anxiety:  What do you experience? 
 
 Palpitations/ rapid heart 
 Faintness/ dizziness 
 Numbness 
 Shortness of breath 
 Choking feeling 
 Butterflies 
 Appetite 
 Flushes/chills 
 Feel sick 
 Visual changes 
 Pins and needles 
 Dry mouth 
 
 Clammy hands 
 Tiredness 
 Sweating 
  Headaches 
  Chest pain/tightness 
  Stomach pains 
  Muscle ache/pain 
  Problems swallowing 
  Shaky / trembling 
  Pains in head 
  Voice tremor 
  Jelly legs 
  Bladder/bowels 
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What happens in our body when we’re anxious? 
 
      
 
360 
 
 
 
Breathing & Anxiety 
 
• Worries lead to changes in breathing 
patterns – short & shallow 
• Changes levels of oxygen & carbon 
dioxide – push out more CO2 
• Leads to other physical symptoms 
 
Vicious Cycle 
 
Anxiety symptoms can impact on your health.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Use the space below to jot down some worries, physical symptoms and negative 
thoughts that you think might be in your vicious cycle. 
stress/anxiety
Physical 
symptoms
Negative 
thoughts
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Stress/anxiety/worry: 
E.g. I might need to go to the toilet. 
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………
……………………………………..……………………………………………………………………………………………………………
……… 
Physical symptoms: 
E.g. Butterflies in tummy. 
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………………
……………………………………. 
Negative thoughts: 
E.g. I’m going to have a toilet accident and it will be humiliating. People will notice. I 
cant tell people I am worried as they will judge me 
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………………………
……………………………………………………………………………………………………………………………………..……………
………………………………………………………………………………………………………..…………………………………………
……………………………………… 
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2. What Keeps Anxiety Going? 
 
Avoidance 
 
Lara has found that when she is feeling unwell with her IBS that going out places with 
friends is quite stressful. To avoid this stress, Lara will often make an excuse to cancel 
plans with friends and instead stay at home alone when she is feeling unwell. 
Common sense says that if doing something makes you more tense, you should avoid 
it.  
COMMON SENSE IS WRONG. 
Avoiding may help in the short term, but in the long run, you just build up more 
trouble for yourself. You have to face up to the problems in your life. Facing up to 
stress will be hard in the short term but, in the long run, will greatly help you control 
your stress.  
Examples of avoidance include: 
• Not telling people what is going on for me 
• Reduced activity – seeing friends, interests 
• Ignoring things 
• Withdrawing 
• Not making decisions or taking responsibility 
• Taking the easy option 
 
Write some of your examples of avoidance here: 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
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Avoidance Cycle 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
What do you notice about this avoidance cycle? 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
SYMPTOMS OR 
WORRIES
AVOID SITUATIONS, 
PEOPLE OR PLACES 
THAT MAKE THINGS 
WORSE
DONT TELL PEOPLE 
HOW I AM FEELING
REDUCED ACTIVITY
FEELING WORSE –
LOW MOOD, LOSS OF 
PLEASURE
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Complete your own avoidance cycle below: 
 
 
 
What do you notice about your own avoidance cycle? 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
……………………………………………………………………………………………………………………………………………………
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Effects of Avoidance 
 
• Feeling like we can’t cope 
• Loss of pleasure/interest from life 
• Restricted lifestyle 
• Reduced confidence and self-esteem 
• We don’t find out that people may 
support us if we spoke to them 
 
 
Write some of the effects avoidance has for you here: 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
Start by noticing your avoidance strategies! 
 
 
 
 
 
 
NOTICE 
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Facing our fears 
 
What fears do you need to face? 
…………………………………………………………………………………………………………………………………………………… 
…………………………………………………………….…………………………………………………………………………………… 
………………………………………………………….……………………………………………………………………………………… 
…………………………………………………………………………………………………………………………………………………… 
……………….………………………………………………………………………………………………………………………………… 
…………….…………………………………………………………………………………………………………………………………… 
………….……………………………………………………………………………………………………………………………………… 
 
Acceptance 
In the space below write down the first thing that comes to mind when you think of 
the word ‘acceptance’. Think of this in terms of ‘accepting your emotions’ or ‘accepting 
your symptoms’. 
_____________________________________________________________________________ 
_____________________________________________________________________________ 
_____________________________________________________________________________ 
_____________________________________________________________________________ 
You can define acceptance as a way of addressing a situation or experience that cannot 
be changed. Acceptance isn’t the same as defeat, helplessness, quitting or giving in to 
a life of unhappiness. When we talk about acceptance of emotions, we are talking 
about allowing yourself to experience and express the emotions you’re feeling as 
opposed to trying to ignore them in the hopes that they go away.  
We already learnt in Session 2 that if we ignore, distract from or suppress our thoughts 
and feelings, it can often end up making us feel worse. This could be through the 
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‘white bear effect’, increased body tension or people who care about us being less able 
to show help and support. It’s one thing to express our thoughts and feelings to those 
around us, but it is a separate skill to be able to accept our emotions ourselves. 
Acceptance is an ongoing process. You might consider it a journey. On this journey you 
can learn to live your life more fully without trying to change, alter or control some of 
the thoughts and feelings you experience. 
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The Unwelcome Party Guest 
Below is an example of how acceptance can be beneficial, while ignoring or fighting a 
problem can be futile and often leave you feeling tired and more stressed. 
Watch the video here: https://www.youtube.com/watch?v=VYht-guymF4 
 
Willingness 
The aim of wiliness is to open yourself up to the vitality of the moment and to move 
more effectively towards the things you value. The goal is to feel all of the feelings that 
arise more completely, even the bad feelings. 
“Accept” comes from the Latin root "capere" meaning “take.” Acceptance 
is the act of receiving or “taking what is offered.” Sometimes, in English, 
“accept” means “to tolerate or resign yourself” (as in, “I guess I have to accept 
that”), and that is precisely not what is meant here. By “accept,” we mean 
something more like “taking completely, in the moment, without defense.” 
Rob Grellman, in Stephen Hayes “Get out of your Mind and into your Life” 
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Willingness is… 
• Holding your unpleasant emotions as you would hold a delicate flower in your 
hand 
• Embracing your emotions as you would embrace a crying child 
• Sitting with your emotions the way you would sit with a person who has a 
serious illness 
• Looking at your emotions the way you would look at an incredible painting 
• Walking with your emotions the way you would walk while carrying a sobbing 
infant 
• Honouring your emotions the way you would honour a friend by listening 
• Inhaling your emotions the way you would take a deep breath 
• Abandoning the war with your emotions like a soldier who puts down his 
weapons to walk home 
• Getting with your emotions like drinking a glass of pure water 
• Carrying your emotions the way you would carry a picture in your wallet 
 
Willingness is not… 
• Resisting your emotions 
• Ignoring your emotions 
• Forgetting your emotions 
• Burying your emotions 
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Home Task 
For this home task, you are asked to keep writing in your online journals. We will 
continue to send helpful reminders via text, phone or email. 
You should try to reflect on how you think it went, anything you noticed in your body 
and any thoughts (helpful or unhelpful) that came up for you. 
In line with keeping up with some of what we’ve been talking about, this week, you 
should start trying to share your feelings with others. The key to this task is to try to 
express a little more than you were before and see how it feels. You can decide how 
much you want to share and who you want to share it with. In the space provided, 
write down how you think this went.  
Starting thinking about your short and medium term goals from session three. Think 
about whether you are on track to reaching those goals and what you can do to keep 
working towards these. 
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Testing out Sharing Emotions at Home 
 
 
What you shared Who you shared 
with 
How it went 
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Session 5 -Maintaining Change 
Review of Home Task 4 
How did you find sharing your emotions with others? Were there any unhelpful 
thoughts you noticed? 
 
1. Coping with Setbacks 
Experiencing setbacks can be a normal and routine part of living with IBS. Experiencing 
difficult days is part of everyday life, and it happens for everyone regardless of their 
difficulties. If you have a setback, it can often feel like you are sliding backwards, and 
returning to old unhelpful patterns; such as avoiding seeing friends or talking to loved 
ones about what you’re going through. 
 
It is important to remember that setbacks are a part of managing any difficulties, and 
whilst they may not always be avoidable, it may be possible to manage them. It may be 
helpful to learn how to recognise a setback if it occurs, so that you can take some 
positive steps to help manage it. 
 
Common Triggers of setbacks 
Setbacks can sometimes occur for no clear reason, but there are also times where 
setbacks are more likely to happen. Setbacks may occur as a result of situations that 
increase the levels of fatigue you experience, and reduce your opportunities to 
maintain your regular activity. 
 
These types of situations may include: 
• An illness or infection 
• Major life events (e.g. moving house, bereavement, ending a relationship, a new 
job, etc) 
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• Stressful conditions (e.g. difficulties at work, family illness, children being off 
school) 
• Depressed mood 
• No longer using your helpful coping strategies 
 
 
Planning ahead for stressful events 
Sometimes you may not be able to predict or anticipate stressful life events; but often 
you can. For example, you might know when your car MOT is due for renewal, or when 
a family wedding is due to take place, and we definitely know when Christmas is each 
year. It can be tempting to pretend these things aren’t happening until the last minute 
and put off doing anything about it, but this isn’t usually a helpful strategy, because a 
normally stressful event can become even more stressful if you have not prepared for 
it. Planning ahead for such events or life-changes can greatly reduce any short term 
stress. 
 
Identifying when symptoms are returning 
If you experience a setback, sometimes symptoms do worsen or return and you may 
start finding things difficult again. Don’t panic if you notice these symptoms - it does 
not necessarily mean that you are getting worse!  
The first step is to be aware of your own warning signs. Often, when you experience a 
setback, you can be the last person to notice. Be aware of the signs and symptoms that 
you experience, such as avoiding things, aching more and lacking motivation. It can 
What are the events or situations that make me more vulnerable to my 
difficulties and a setback? 
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also help to get someone you trust to watch out for these symptoms too, so that if 
they happen, they can talk to you about it. 
  
My warning signs are…. 
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2. How to manage setbacks…a few tips! 
 
 
The importance of practice  
If you have tried some of the techniques in this booklet, you may have found that 
some are more helpful for you than others. We would recommend practicing the 
techniques that are most helpful for you. 
 
Nip it in the bud! 
Try to tackle your difficulties as soon as you notice you aren’t managing as well as you 
have been, or that your symptoms are returning, as it will take you less time to get 
back on track again. 
 
Prioritise 
If you aren’t able to do all of your planned activities, or don’t have the time, don’t give 
up on them, but modify your plan so that you can get back on track again. 
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Balance 
Try to make sure your days have a balance (and variety) of activities and relaxation. 
Manage your expectations 
When things are difficult, you may not be able to do as much as you have previously 
been doing. It is important to lower your expectations of what you can manage, and 
remind yourself of what you have achieved – and give yourself praise for this! 
 
3. Planning for the Future 
We hope that this workbook has supported you to think of different strategies you can 
use to manage your symptoms, and given you more confidence to be able to do this. In 
order to continue your progress, and maintain the improvements you have already 
made, it can be helpful to reflect on what you have learnt from this course: 
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What techniques seem to help me? 
What factors may contribute to my difficulties continuing? 
(thoughts, behaviours, physical sensations and emotions that keep my 
problems going) 
 
 
 
What are my warning signs to a setback? 
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4. Continuing your progress 
Setting Goals 
You may wish to add to your long terms goals- what will you continue to do when the 
group has finished? 
Lara’s goals: 
Goal 1: I will let my friends know how I am feeling 
Week Target 
1 I will mention to someone if I’m feeling stressed/overwhelmed 
2 I will explain what’s been giving me stress/making me worried to 
someone I’m close to 
3 I will be open with that person about when I’m struggling 
emotionally 
4 I will be open with that person about when I’m struggling 
emotionally, or with my symptoms 
(In this example, the goal is to practice speaking to others about emotions until they 
become a habit. This means once you have mastered how to open up to others, you 
can do so easily and only use it when needed) 
Goal 1: ____________________________________________________________________  
Week Target 
1  
2  
3  
4  
 
Goal 2: ____________________________________________________________________ 
What should I do if I notice these warning signs? 
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Week Target 
1  
2  
3  
4  
 
Goal 3: ____________________________________________________________________ 
Week Target 
1  
2  
3  
4  
 
Goal 4: ____________________________________________________________________ 
Week Target 
1  
2  
3  
4  
 
Goal 5: ____________________________________________________________________ 
Week Target 
1  
2  
3  
4  
 
 
Goodbyes… 
Over the past 5 sessions we have covered a whole range of different factors that relate 
to living with IBS. We have talked about how stress and anxiety can affect our bodies, 
how our response to our emotions can be unhelpful, how certain thoughts about our 
emotions can be unhelpful and how to think differently and try to reduce anxiety and 
stress. 
As we discussed in the previous session, acceptance is a journey, an ongoing process. 
This means that even though the course is over, you should still try to learn and grow 
from everything you’ve learnt in these sessions.  
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Resource List 
Books 
Author Title Topics 
   
Leonora 
Brosan& 
Gillian 
Todd 
 
Stephen 
Hayes 
Overcoming Stress  
 
 
The Happiness 
Trap 
Managing stress 
 
 
Managing emotions 
   
Rosemary 
Nicol  
The Irritable Bowel 
Stress Book 
(Overcoming 
common problems) 
IBS 
   
 
Websites 
IBS Network: http://www.theibsnetwork.org/ 
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10.11. Appendix K: Ideographic measures for each Case 
 
Case A 
IBS-QoL 
I feel fat because of my bowel problems 
I have to avoid stressful situations because of my bowel problems 
I have to watch what kind of food I eat because of my bowel problems 
HADS 
I get a sort of frightened feeling as if something awful is about to happen 
Worrying thoughts go through my mind 
I feel as if I am slowed down 
I feel restless as if I had to be on the move 
CECS 
When I feel angry I keep quiet 
When I feel unhappy I put on a bold face 
When I feel afraid I let others see how I feel 
When I feel afraid I keep quiet 
When I feel afraid I tell others about it 
When I feel afraid I say what I feel 
BES 
I should be able to control my emotions 
I should be able to cope with difficulties on my own without turning to others for 
support 
It would be a sign of weakness to show my emotions in public 
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Case B 
IBS-QoL 
I feel fat because of my bowel problems 
 
I feel like I’m losing control of my life because of my bowel problems 
I feel uncomfortable when I talk about my bowel problems 
I worry that my bowel problems will get worse 
I have to watch what kind of food I eat because of my bowel problems 
I feel sluggish because of my bowel problems 
I fear that I won’t be able to have a bowel movement 
 
HADS 
I can sit at ease and feel relaxed 
I feel restless as if I had to be on the move 
 
CECS 
When I feel angry I say what I feel 
When I feel unhappy I put on a bold face 
When I feel unhappy I let others see how I feel 
When I feel unhappy I smother my feelings 
When I feel afraid I let others see how I feel 
When I feel afraid I tell others all about it 
When I feel afraid I say what I feel 
 
BES 
If I have difficulties I should not admit them to others 
I should be able to control my emotions 
If I am having difficulties it is important to put on a brave face 
I should not let myself give in to negative feelings 
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I should be able to cope with difficulties on my own without turning to others for 
support 
Others expect me to always be in control of my emotions 
 
Case C 
IBS-QoL 
I feel like my life is less enjoyable because of my bowel problems 
I have to watch the amount of food I eat because of my bowel problems 
I have to watch what kind of food I eat because of my bowel problems 
HADS 
I get a sort of frightened feeling as if something awful is about to happenCECS 
When I feel angry I say what I feel 
When I feel angry I avoid making a scene 
When I feel angry I hide my annoyance 
When I feel unhappy I refuse to say anything about it 
When I feel unhappy I keep quiet 
When I feel unhappy I bottle it up 
When I feel afraid I keep quiet 
When I feel afraid I tell others all about it 
When I feel afraid I say what I feel 
When I feel afraid I bottle it up 
BES 
It is a sign of weakness if I have miserable thoughts 
I should be able to control my emotions 
If I am having difficulties it is important to put on a brave face 
I should not let myself give in to negative feelings 
It would be a sign of weakness to show my emotions in public 
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Case D 
IBS-QoL 
I feel embarrassed by the smell caused by my bowel problems 
I feel isolated from others because of my bowel problems 
Long trips are difficult for me because of my bowel problems 
It is important to be near a toilet because of my bowel problems 
HADS 
I feel tense or wound up 
I get a sort of frightened feeling as if something awful is about to happen 
I feel restless as if I had to be on the move 
CECS 
When I feel angry I keep quiet 
When I feel angry I say what I feel 
When I feel angry I avoid making a scene 
When I feel afraid I let others see how I feel 
When I feel afraid I tell others about it 
When I feel afraid I say what I feel 
BES 
If I lost control of my emotions in front of others, they will think less of me 
I should be able to control my emotions 
I should not let myself give in to negative feelings 
It would be a sign of weakness to show my emotions in public 
 
 
 
 10.12. Appendix L: Transcript from participant interview following 1 
intervention in Chapter Eight 2 
 [Start of interview] 3 
Interviewer: So the first thing I wanted to ask was what aspects of the 4 
group sessions and the meetings did you like or find helpful? 5 
D: I think knowing, feeling.., knowing that .., not so isolated knowing 6 
other people you know have similar you know problems. It was just 7 
really nice to be among people who were experiencing similar things. 8 
Definitely. 9 
C: Yeah I’d agree with that as well that’s definitely the best thing. 10 
Because it isn’t one of those things that you’re happy to talk about like 11 
you might talk about a broken ankle or something to somebody you’re 12 
not going to sort of raise it in normal day to day conversation. 13 
B: And it was nice to hear their reactions and the way they deal with it 14 
the same as you, so you don’t feel that you’re a complete lunatic 15 
sometimes. Is this… My solution to this problem would be doing this 16 
which is quite normal in my world but you would never dream of 17 
telling anyone else, and then you find out that “yeah that’s my solution 18 
to that problem as well”. It’s reassuring and enlightening really. 19 
D: Yeah 20 
Interviewer: So you mentioned it was nice to be able to talk about 21 
these things because you wouldn’t normally talk about them outside 22 
of, kind of, that context. In what way did you find that, you said that 23 
it’s reassuring to hear other people say it and enlightening to hear 24 
other people do it… In terms of just talking with other people were 25 
there any other benefits to that? 26 
B: We were given challenges. It made you rethink your whole situation 27 
but we weren’t given challenges to deal with other people or change 28 
our our normal routine of just saying no we don’t want to go to dinner, 29 
we don’t want to do this, or I’m not going to tell anyone about it. It 30 
actually challenged me and the others too to do something new. And 31 
for me talking about it to my partner and a close friend is like, it was 32 
like a pressure released that you didn’t even realise was there because 33 
you live with it. You didn’t realise what a relief it was to discuss it and 34 
get it out in the open.  35 
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D: Kind of liberating 36 
B: Yeah 37 
Interviewer: So is that something you two have also found, or did you 38 
find something a bit different? 39 
D: I guess a bit different because I have.., well I have talked about to 40 
other people but obviously nobody really understood. So it was nice to 41 
be in a room full of people who understand um.., And again just kind of 42 
feeling.., although I… because I’d already shared things with family and 43 
work and things so I didn’t need to change that. But it did make me 44 
feel less awful about it. Less like I was some kind of problem or... Does 45 
that make any sense? Definitely yeah although I didn’t actually do 46 
anything differently, the fact that I knew other people were going 47 
through the same things changed how I thought about it. For sure. 48 
Interviewer: That’s really interesting thank you. Is that something you 49 
also found? 50 
C: I think it was something. I refused to sort of…either not dealing with 51 
it not trying to think about it ignore it until it sort of sort of physical 52 
nature of it sort of totally impinged um so that I think this was helpful 53 
in getting me to sort of think about it instead of ignoring it and think 54 
about how I can live my life and make choices, better choices than 55 
perhaps I have been doing.  56 
D: I think the bits about um it kind of taught me it’s kind of a self—57 
perpetuating thing as well. You had the stress and the symptoms I 58 
suppose and the symptoms create even more and more stress so 59 
learning that.., you know that you can make it worse helped to kind of 60 
divide those extra feelings of  — and try and relax a bit more about it 61 
when it happens I suppose. And it’s definitely made me accept that it 62 
happens to other people therefore it’s nothing to be you know. It’s just 63 
one of those things. Not a very nice thing, but one of those. 64 
Interviewer: So that’s different from how you’ve thought about it 65 
before? 66 
D: Well yeah because when it happens when you have a bad bought 67 
it’s so easy to get more and more and more stressed about what’s 68 
happening once it once it kicks off once you feel the first like.., mm.., 69 
and then to just worry about it and it gets worse and worse and then it 70 
gets worse and worse and worse and it’s a bit sort of self—71 
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perpetuating to think— to try and sort of relax about it if you can 72 
which isn’t that easy but to sort of draw a line where the pain starts I 73 
suppose and then…, yeah and accept that it’s just happening and it just 74 
is you know a thing that happens. 75 
C: And it will pass. 76 
D: Yeah it will go. 77 
C: Quite often you sort of get this feeling it is never going to end. And 78 
what are you going to do, how are you going to manage. 79 
D: yeah.., yeah… 80 
C: And then you have to keep reminding myself it will pass and I’ll be 81 
ok again but just not at the moment. 82 
D: And you can forget that you have been alright and you feel like it’s 83 
gone on forever and you have to keep reminding yourself that no this 84 
has happened before and it has gone and it will go again and this is not 85 
you know… yeah…yeah 86 
Interviewer: That all sounds really good. Is there anything else anyone 87 
wants to add to that in terms of what they’ve found helpful. 88 
B: We did learn some techniques to relax which I do find useful 89 
especially when it is bad or it does — I said it’s frustrating it’s annoying 90 
it gets you down. When you start to think actually like you said it will 91 
be temporary I can deal with this I can use these techniques and they 92 
do help to relax which we learnt which I had no idea these techniques 93 
even existed but they were really useful to just sit down on your own 94 
and go you know what just breathe think about something else, think 95 
of it and try and see the positive side of this it was really useful. 96 
Interviewer: That’s really good. So when you said see the positive side, 97 
of the kind of the relaxation bit? 98 
B: Yeah and it has a knock on effect of making you just feel better 99 
whether it’s because you feel you’re better able to cope whether you 100 
feel.., um, there’s light at the end of the tunnel, that it’s temporary or 101 
you just know there’s other people going through the same thing it 102 
makes you feel a lot more positive, which has a knock on effect for the 103 
symptoms as well I think 104 
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D: You feel more relaxed about it when it happens which has got to 105 
help.., I think.., sort of 106 
B: It’s not like here we go again… 107 
D: Yeah stress stress stress. 108 
B: Oh god stress stress stress. 109 
Interviewer: So you think some of these things have had a knock on 110 
effect on you physically? 111 
B: Yeah. 112 
D: Yeah I think so. 113 
Interviewer: So the second thing I wanted to ask was was there 114 
anything in here you would like to see improved. Was there anything 115 
you found that we did that wasn’t helpful? Or anything that we didn’t 116 
do that you might have found helpful and you would have liked to have 117 
seen? 118 
(Laughter) 119 
B: I don’t know. It’s hard. I’ve never done anything like this before. 120 
D: Me neither. 121 
B: I’ve never had any counselling any… 122 
D: Oh I’ve had counselling. 123 
B: Just apart from seeing a GP that’s it so…, I don’t know what I’m 124 
missing almost. 125 
C: Yeah I don’t think probably may not have been appropriate for this 126 
group, but when I first came I was hoping that I’d get some sort of help 127 
I didn’t actually get from the GP I might some useful advice on how to 128 
actually treat it with diet or or or whatever.., but you know as time 129 
went on I sort of like I sort of got to understand what the purpose of 130 
the group was and saw the benefit of it but yeah initially I was still sort 131 
of annoyed about the lack of support from the GP and was hoping 132 
there would be some kind of you know practical advice I could take 133 
away from it or what to do. 134 
Interviewer: So is there anything else like that maybe expectations you 135 
had that you would kind of get and we didn’t do? 136 
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D: I don’t know I kind of knew that it was going to be about.., not —137 
well I kind of had a vague idea that it was going to be about.., not 138 
about finding solutions which you always hope somebody’s going to 139 
hand you the miracle cure or diet or whatever that’s going to solve the 140 
whole problem I kind of knew it wasn’t going to be yeah… I mean it 141 
would have been great [laughter] I don’t know what I expected really I 142 
didn’t know what to expect.., I think.., I think I was hoping for some 143 
kind of psychological cure, which obviously couldn’t happen anyway 144 
but I guess that’s where my unreal expectations were really that I’m 145 
going to sit and talk through this and.., you know.., I’ll be cured, I’ll be 146 
fine, so yeah… Yeah. It’s kind of interesting because I think we’ve all 147 
come into it from different – although we’ve all got this thing, we’ve all 148 
come into it with different kind of from different angles different 149 
expectations and different.., different lives and different you know 150 
reasons for it all sorts of different — so it’s kind of yeah I don’t know I 151 
don’t know. It’s not very helpful, is it?  152 
[To 2] Interviewer:  So is there anything you kind of went in expecting 153 
that we would do that we didn’t 154 
B: I had no expectations at all. I thought about doing it. And thought 155 
“mmmm”.., you know I didn’t expect it to help in anyway at all but you 156 
just think I’ve had this problem for years, it said have I been diagnosed 157 
with this, yes I have, had it for years, lived with it, what harm could it 158 
do just to tell people so I had no expectations that I would benefit. I 159 
just thought I was giving out my experiences that’s what I thought I’d 160 
be doing. This is how it affects my life. I did not expect it to help me at 161 
all, and it did, so… 162 
Interviewer: That’s really interesting 163 
D: I know I also thought when I saw it on the college intranet I sort of 164 
thought ‘thank god somebody’s doing something that looks at this’ 165 
because nobody– it’s like we said in the sessions, like nobody really 166 
seems to sort of — it’s quite marginalised. I thought “somebody’s 167 
actually looking at it!” You know it’s like you say the GPs don’t just tell 168 
you you’ve got it and don’t really..,  that’s it. I think yeah. Thank 169 
goodness somebody’s actually taken this and is yeah looking into it I 170 
suppose is what I thought. 171 
C: I’m just remembering before I came to the first one I can remember 172 
thinking about what it was going to be like and for a start I thought 173 
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there was going to be a lot of people because I knew it’s a it is a 174 
common problem even though it’s not addressed but so I did think it 175 
was going to be a room full of people but also I remember thinking it 176 
would be a bit like sort of what I imagine what going to an AA meeting 177 
is like [laughter] 178 
D: Yes! Yeah yeah yeah… 179 
(Inaudible) 180 
C: Feeling a bit ashamed, a bit ashamed…  181 
(Laughter) 182 
C: It just shows you what my mind-set was, that it was something 183 
shameful. 184 
D: Yeah yeah yeah. I did think there was going to be a circle full of 185 
people and like we’re going to have to share the most intimate details 186 
of everything and I was yeah yeah I didn’t know quite what to expect 187 
on that score.., At least it wasn’t that! 188 
(Laughter) 189 
Interviewer: So was there anything maybe that we did that not 190 
necessarily something you would improve or maybe wasn’t particularly 191 
relevant for you? Anything we sort of discussed or talked about that 192 
you thought this is interesting but this isn’t something for me? 193 
D: I definitely found it interesting that… because I’ve sort talked about 194 
it, but I’ve got a history of kind of having therapy and all sorts of stuff 195 
— but how other people -although there’s certain aspects I keep quiet 196 
about it- but how other people kept it so close into themselves without 197 
letting anybody know I thought that was really you know.., kind of how 198 
successfully people hide it from other people because.., it’s quite a big 199 
thing, and the rigmarole that you go through. You know, and don’t hide 200 
it from family and close friends they don’t really get it. Um. Yeah.  201 
Interviewer: So is there anything that we talked about for you two that 202 
you thought maybe wasn’t as relevant for you that we covered? 203 
B: Well at the time I might not have thought it was relevant certain 204 
things like some of the relaxation techniques and other stuff you think 205 
‘This isn’t really me’. But then I found out you know, give it a go what 206 
harm can it do and it did help but at the time when she first started 207 
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telling us “why do I need to relax? That’s not going to help me” that’s 208 
how I saw it. But yeah ok I’ll try that and then well let’s give it a go and 209 
it did actually work, so.., I just didn’t think it would help. It was relevant 210 
to me – “relaxing? Why do I need to relax?”, but it helped. 211 
C: I found that the sort of analogies like the playing tennis and the bus 212 
one. I didn’t find they worked of me. 213 
D: Oh I did find them— that people on the bus one, although I was 214 
thinking oh I kind of know this, but I really found that stayed in my 215 
head. The bus people shouting everywhere 216 
C: Interesting. It didn’t really do anything for me, but it’s still 217 
interesting to see about it and see other people taking it.  218 
 Interviewer: So was it any of the particular analogies or just the 219 
analogies as a whole? 220 
C: Just as a whole really. Yeah. 221 
Interviewer: Okay that’s interesting. Um, so if you were going to kind of 222 
give us any advice if we were going to do this again. What kind of 223 
advice would you give to tweak anything or change anything? 224 
C: I suppose in the initial advert maybe just say a little bit more about it 225 
because.., yeah I mean the IBS thing obviously leapt out at us, but I 226 
don’t recall there being much else that might attract people.  227 
Interviewer: I think part of the reason we didn’t do that is because we 228 
wanted to collect questionnaires from people before they’d had any 229 
influence of kind of what we were trying to do so we thought if we 230 
don’t give too much information away there then we know that when 231 
they do the questionnaires that they’re not thinking ‘oh this is going to 232 
be relevant’ too much. So that’s why we didn’t do it. But that’s really 233 
good to know, hearing all of your different expectations or that you 234 
didn’t have any expectations is really useful. If we were to do it again 235 
it’s definitely something to take on board that could be clearer. Any 236 
other points on that? 237 
D: I think I just generally have a problem with questionnaires and 238 
getting the questions wrong. Because I know from talking to Abigail, 239 
one of the things we had that I kind of felt like ‘oh I’d never taken that 240 
question like that’ so but that might just be me and my strange brain I 241 
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don’t know. But it’s kind of you know I thought ‘I hadn’t read it as that I 242 
hadn’t’ so yeah… 243 
Interviewer: That’s really good to know because I think these 244 
questionnaire often are somewhat subjective  245 
D: Yeah very subjective yeah. 246 
Interviewer: So I think that’s ok to take a different meaning as long as 247 
you’re the one taking that meaning fairly consistently then.  248 
(Inaudible) 249 
Interviewer: And that’s how you interpreted it. That’s really interesting 250 
thank you. So is there anything else about the groups in particular 251 
before we start talking about the questionnaires?...So was 5 sessions 252 
enough? Too much? 253 
B: It wasn’t too much. 254 
D: No, it wasn’t too much. In fact I really missed them actually. 255 
B: Yeah. 256 
Interviewer: Do you feel like 5 meetings was enough.., I mean to get 257 
what you got out of it?  258 
C: Probably enough but it would be nice to sort of carry on. 259 
D: Yeah. 260 
Interviewer:  So it would be nice to keep going, but 5 probably was 261 
enough?  262 
C: Yeah 263 
Interviewer: I mean there’s nothing stopping you guys, you know, 264 
going and meeting in ______ or whatever for a catch up  265 
B: Well we did say at the last meeting that we would like to keep in 266 
touch especially as we’re all around college it would be good to that 267 
Interviewer: That might be a really nice way to sort of carry it on.., 268 
Okay so back to the questionnaires, I know you said you had some 269 
trouble or at least different ways of interpreting the questions. Did 270 
anyone else have any issues with the questions themselves and 271 
anything like that? 272 
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C: Well just.., some of the questions asked about your emotions in the 273 
last few days and I was thinking.., sort of feeling angry was one of 274 
them. And I found it hard to answer because if I didn’t recall feeling 275 
angry in the last week then it’s — you feel like you’re sort of making it 276 
up in a way.  277 
D: Yeah if you had an uneventful, I mean – I don’t think I was very good 278 
at the questionnaires really but I kind of — it was hard not to see 279 
certain parts of your life as constant so therefore my answers weren’t 280 
very varied because I was seeing certain things as constant, so I found 281 
it really hard to just think of the past few days 282 
C: Yeah 283 
D: And I was looking back overall at you know, I don’t know, you know 284 
my life I suppose and the sort of person I see myself as and I found it 285 
really hard to separate my picture of me, how I am with what had 286 
happened weekly, if you see what I mean. 287 
Interviewer: [to 2] How did you find it in terms of reflecting on the last 288 
few days? 289 
B: Like I said mine was pretty constant because like you said this is me 290 
this is my life oh oh oh  but it’s only the last — I think I tried to answer 291 
sort of quickly because you go by your— rather than brew over it. Just 292 
actually how has it been over the last few days but I think for some of 293 
the more recent ones my answers changed a bit because specifically 294 
how you’re feeling do you, you know, is this going to be something you 295 
can deal with you know that’s just slightly a problem yeah slightly a 296 
problem, you know it’s –  297 
D: Yeah I did a little bit in the end. 298 
B: Rather than very much very much very much so it did ease that 299 
much and I thought hold on. Normally it’s just yeah yeah totally agree 300 
and then it did alter as we went along so they did change slightly but 301 
generally it was staying the same because as you said, that’s the 302 
person I am. That’s how I’ve been dealing with stuff. 303 
Interviewer: That’s interesting. Is there anything else about the 304 
questionnaires I mean how did you find it in general having to do 305 
them? 306 
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D: They were ok. They were all quite short. Weren’t they? Quite quick 307 
to do. 308 
C: It was useful to have the reminders though. 309 
D: Yeah definitely. 310 
(Laughter) 311 
C: Yeah it’s the sort of thing you can easily forget if you don’t get the 312 
reminder. 313 
D: I found myself thinking ‘I hope nobody walks behind me’ while I’m 314 
doing this on my computer in the office like yeah. 315 
Interviewer: Um, do you think that the questions that we asked kind of 316 
captured what we talked about in the sessions? Or did they capture 317 
things that you felt might be changing over that period of time? 318 
(Silence) 319 
 Interviewer: I know you said there was a bit of a shift in some of those 320 
things. 321 
B: There was for me yeah the earlier set about how you actually felt. 322 
And how you were coping and can you sit at ease and things like that. 323 
They did change. So yeah for me it was all -obviously the questions 324 
were adjusted- but you know they were relevant about the emotions 325 
and how you deal with and do you tell other people and that yeah 326 
Interviewer: How about you two? Do you feel that they kind of 327 
captured the stuff that we’d talked about that things that were helpful 328 
and things that might have changed?  329 
C: Yeah I think so I found it — I just found it difficult if I hadn’t 330 
experienced some of the things I was being asked to say how I felt 331 
about them. Um… 332 
D: I don’t know, but I think because I’d talked — I’d not kept things — 333 
They did highlight something weird to me actually. Because I had sort 334 
of talked about it to people, I thought I was being quite open um. Yet 335 
still going through hoops trying to live with it in a warped weird way. I 336 
think the questions in the more emotional part… and I kept I.., I kept 337 
thinking well I’m almost sort of in the middle or slightly agree or… 338 
because I my ideas of myself were different probably to what maybe I 339 
really am if that makes any sense.  340 
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Interviewer: So you kind of found it hard to decide? 341 
D: Well I kind of knew what I like I say my answers didn’t change that 342 
much especially in that emotional bit about bits about feeling anger 343 
and stuff.., and I’d always thought I was a fairly open sort of person. 344 
But — and I did answer all the questions truthfully that I slightly — but 345 
I it did make me wonder about how really how open I was about it all 346 
and… do you see what I mean? and yeah. 347 
Interviewer: So I guess there’s different ways to be open about it? 348 
D: Yeah so although I probably did mostly the same thing over and over 349 
again it did make me think actually 350 
Interviewer: So even though the answers may not have changed, the 351 
way you kind of thought about those questions did change? 352 
D: Yeah 353 
Interviewer: Um, did you find answering the questionnaires alongside 354 
doing kind of going to the meetings and stuff, did you find the 355 
questionnaires helped at all? Or did you find them just sort of 356 
something you did alongside? 357 
C: Yeah just found them something outside 358 
D: Yeah 359 
C: Didn’t really sort of connect the two to be honest 360 
Interviewer: [To 4 and 2] Okay. Is that something you two kind of 361 
found?  362 
D: Yeah I think I felt like… yeah I didn’t connect between the… 363 
Interviewer: [To 2] What about you was it the same or a bit different? 364 
B: Like I said they didn’t really connect with what we’d actually 365 
discussed in the meetings but they did separately make me think as I 366 
was answering them going “good grief I’m just giving the same answers 367 
here. Is this me?” 368 
D: I know! I kept thinking oh no how disappointing 369 
B: You know they’re going to get the same form the same unknown 370 
D: I really thought it was just me 371 
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B: Am I really? I don’t do this and I don’t do that. Keep it to myself and 372 
you just think. And it made me think about me because of the answers 373 
I kept giving.  374 
Interviewer: So there was some reflection there even if it wasn’t 375 
connected to the actual 376 
B: Oh yeah! —to the actual discussion 377 
Interviewer: Um, so if you had to kind of summarise what you’ve got 378 
out of this group how you sort of summarise the key things you’ve 379 
taken away from this? 380 
B: Relief! 381 
(Laughter) 382 
D: Yeah definitely that you’re not on your own you know that, 383 
yeah…and to actually talk about it with people properly, like people 384 
who know what it is like it’s such a new thing it’s kind of.., support I 385 
suppose 386 
Interviewer: [to 3] Did you have anything you wanted to add to that? 387 
C: No. I’d agree with that as well. 388 
[End of interview]  389 
  390 
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